<SEC-DOCUMENT>0001193125-18-128728.txt : 20180424
<SEC-HEADER>0001193125-18-128728.hdr.sgml : 20180424
<ACCEPTANCE-DATETIME>20180424155734
ACCESSION NUMBER:		0001193125-18-128728
CONFORMED SUBMISSION TYPE:	DEFR14A
PUBLIC DOCUMENT COUNT:		8
FILED AS OF DATE:		20180424
DATE AS OF CHANGE:		20180424
EFFECTIVENESS DATE:		20180424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFR14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		18771425

	BUSINESS ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFR14A
<SEQUENCE>1
<FILENAME>d573774ddefr14a.htm
<DESCRIPTION>DEFR14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFR14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>SANGAMO THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which the transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which the transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of the transaction computed pursuant to Exchange Act Rule
<FONT STYLE="white-space:nowrap">0-11</FONT> (set forth the amount on which the filing fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of the transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sangamo Therapeutics, Inc. (the &#147;Company&#148;) is filing this revised definitive proxy statement solely to correct inadvertent clerical errors contained
in footnote (2)&nbsp;to the table titled &#147;Security Ownership of Certain Beneficial Owners and Management&#148; beginning on page 47 of the original definitive proxy statement filed with the Securities and Exchange Commission earlier on
April&nbsp;24, 2018. No other changes have been made to the original proxy statement. The Company will distribute and make available to its stockholders this revised definitive proxy statement in lieu of the original definitive proxy statement.
</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANGAMO THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held June&nbsp;11, 2018 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>To the
Stockholders of Sangamo Therapeutics, Inc.: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">NOTICE IS HEREBY GIVEN that the 2018 Annual Meeting of Stockholders of
Sangamo Therapeutics, Inc., a Delaware corporation (the &#147;Company,&#148; &#147;Sangamo&#148; or &#147;we&#148;), will be held on Monday, June&nbsp;11, 2018, at 9:00 a.m. Pacific Time at 501 Canal Boulevard, Richmond, California 94804, for the
following purposes, as more fully described in the proxy statement accompanying this Notice: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to elect eight nominees for director named in the accompanying proxy statement to serve on the Board of
Directors until the next annual meeting of stockholders to be held in 2019 or until their successors are duly elected and qualified; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to approve, on an advisory basis, the compensation of our named executive officers, as described in the
accompanying proxy statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to approve the Sangamo Therapeutics, Inc. 2018 Equity Incentive Plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to approve an amendment to the Sangamo Therapeutics Inc. 2010 Employee Stock Purchase Plan (the &#147;Purchase
Plan&#148;) to increase the number of shares of our common stock reserved for issuance under the Purchase Plan by 2,500,000 shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to ratify the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm
for the year ending December&nbsp;31, 2018; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to transact such other business as may properly come before the meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In accordance with rules established by the Securities and Exchange Commission, we are providing you access to our proxy
materials over the Internet. Accordingly, we plan to mail a Notice of Internet Availability of Proxy Materials (the &#147;Notice&#148;), to our stockholders on or about May&nbsp;1, 2018. The Notice will describe how to access and review our proxy
materials, including our proxy statement and annual report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> The Notice as well as the printed copy of proxy cards will also describe how you may submit your proxy on the Internet or by telephone.
If you received a Notice by mail and would like to receive a printed copy of our proxy materials, you should follow the instructions for requesting such materials included in the Notice. As a courtesy, we will also mail our registered stockholders a
printed copy of all proxy materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Only stockholders of record at the close of business on April&nbsp;17, 2018, are
entitled to notice of and to vote at the annual meeting. Our stock transfer books will remain open between the record date and the date of the annual meeting. A list of stockholders entitled to vote at the annual meeting will be available for
inspection at our executive offices. All stockholders are cordially invited to attend the annual meeting in person. To attend the annual meeting you will need a form of photo identification. If your shares are held in street name, you will also need
to bring proof of your ownership of our common stock, such as your most recent brokerage statement. Whether or not you plan to attend the annual meeting, please vote as soon as possible. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sincerely,</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g573774g82k09.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>Alexander D. Macrae</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>President and Chief Executive Officer</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Richmond, California </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April
24, 2018 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the Stockholder Meeting to be Held on June&nbsp;11, 2018 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>at 9:00 a.m. Pacific Time at 501 Canal Boulevard, Richmond, California 94804 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Proxy Statement, Proxy Card and Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for 2017 are available at: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>www.envisionreports.com/SGMO </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>YOUR VOTE IS VERY IMPORTANT </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:2pt; padding-top:2pt; margin-left:2%; margin-right:2%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>You are cordially invited to attend the meeting in person. Whether or not you expect to
attend the meeting, please vote over the telephone or the Internet, or, if you receive a paper proxy card by mail, by completing, dating, signing and returning the proxy mailed to you, as promptly as possible in order to ensure your representation
at the meeting. Even if you have voted by proxy, you may still vote in person if you attend the meeting. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must
obtain a proxy issued in your name from that record holder. </B></P></div> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANGAMO THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>501 Canal Boulevard </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Richmond, California 94804 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE
ANNUAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held On June&nbsp;11, 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why did I receive</B><B><I> </I></B><B>a notice regarding the availability of proxy materials on the Internet? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to rules adopted by the Securities and Exchange Commission (the &#147;SEC&#148;), we have elected to provide access
to our proxy materials over the Internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the &#147;Notice&#148;) because the Board of Directors (the &#147;Board of Directors&#148; or the &#147;Board&#148;) of
Sangamo Therapeutics, Inc. (sometimes referred to as the &#147;Company,&#148; &#147;Sangamo&#148; or in the first person) is soliciting your proxy to vote at the 2018 Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;), including at any
adjournments or postponements of such meeting. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access
the proxy materials over the Internet or to request a printed copy may be found in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We intend to mail the
Notice on or about April 26, 2018 to all stockholders of record entitled to vote at the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Will I receive any other proxy
materials by mail? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may send you a proxy card, along with a second Notice, on or after May&nbsp;6, 2018. We also
intend to mail a full set of proxy materials to our stockholders of record on or about April 26, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>How do I attend the Annual
Meeting? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The meeting will be held on Monday, June&nbsp;11 at 9:00 a.m. Pacific Time at 501 Canal Boulevard, Richmond,
California 94804. Directions to the Annual Meeting may be found at <I>www.sangamo.com/about/contact</I>. Information on how to vote in person at the Annual Meeting is discussed below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Who can vote at the Annual Meeting? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Only stockholders of record at the close of business on April&nbsp;17, 2018 will be entitled to vote at the Annual Meeting. On
this record date, there were 87,145,700 shares of common stock outstanding and entitled to vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Stockholder of Record: Shares
Registered in Your Name </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If on April&nbsp;17, 2018 your shares were registered directly in your name with our transfer
agent, then you are a stockholder of record. As a stockholder of record, you may vote in person at the meeting or vote by proxy. Whether or not you plan to attend the meeting, we urge you to vote your shares electronically over the Internet or by
telephone, or by completing and returning a printed proxy card that you may request or that we may elect to deliver at a later time, to ensure your vote is counted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Beneficial Owner: Shares Registered in the Name of a Broker or Bank </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If on April&nbsp;17, 2018<B> </B>your shares were held, not in your name, but rather in an account at a brokerage firm, bank
or other similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and the Notice is<B> </B>being forwarded to you by that organization. The organization holding your account is considered to be the
stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual
Meeting. However, because you are not the stockholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker, bank or other agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What am I voting on? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are five matters scheduled
for a vote: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">election of eight directors (Proposal No.&nbsp;1); </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advisory approval of the compensation of our named executive officers, as disclosed in this proxy statement
(the &#147;Proxy Statement&#148;) in accordance with SEC rules (Proposal No.&nbsp;2); </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval of our 2018 Equity Incentive Plan (the &#147;2018 Plan&#148;) (Proposal No.&nbsp;3); and
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approve an amendment to our 2010 Employee Stock Purchase Plan (the &#147;Purchase Plan&#148;) to increase the
number of shares of our common stock reserved for issuance under the Purchase Plan by 2,500,000 shares (Proposal No.&nbsp;4); and </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ratification of the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting
firm for our fiscal year ending December&nbsp;31, 2018 (Proposal No.&nbsp;5). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if another matter is properly brought before the
meeting? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any
other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I vote? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For each
of the other matters to be voted on at the Annual Meeting, including each nominee for director, you may vote &#147;For&#148; or &#147;Against&#148; or abstain from voting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The procedures for voting are fairly simple: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record: Shares Registered in Your Name </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a stockholder of record, you may vote in person at the Annual Meeting, vote by proxy over the telephone, vote by
proxy through the Internet or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. You may
still attend the meeting and vote in person even if you have already voted by proxy. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To vote using the proxy card, simply complete, sign and date the proxy card that may be delivered<B> </B>and
return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To vote over the telephone, dial toll-free <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-800-652-VOTE</FONT></FONT></FONT> (8683)&nbsp;using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and control number from the Notice. Your telephone vote must be
received by 1:00 a.m. Eastern Time on June&nbsp;11, 2018 to be counted. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To vote through the Internet, go to http://www.envisionreports.com/SGMO<B> </B>to complete an electronic proxy
card. You will be asked to provide the company number and control number from the Notice. Your Internet vote must be received by 1:00 a.m. Eastern Time on June&nbsp;11, 2018 to be counted. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner: Shares Registered in the Name of Broker or Bank </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a
Notice containing voting instructions from that organization rather than from us. Simply follow the voting instructions in the Notice to ensure that your vote is counted. Alternatively, you may vote by telephone or over the Internet as instructed by
your broker or bank. To vote in person at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact that
organization to request a proxy form. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:0%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Internet proxy voting may be provided to allow you to vote your shares online, with procedures designed to
ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your Internet access, such as usage charges from Internet access providers and telephone companies.
</B></P></div> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes do I have? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On each matter to be voted upon, you have one vote for each share of common stock you owned as of April&nbsp;17, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>If I am a stockholder of record and I do not vote, or if I return a proxy card or otherwise vote without giving specific voting
instructions, what happens? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a stockholder of record and do not vote through the Internet, by telephone, by
completing a proxy card that may be delivered to you<B> </B>or in person at the Annual Meeting, your shares will not be voted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted,
&#147;For&#148; each of the proposals, including for each nominee for director. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best
judgment.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>If I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting
instructions, what happens? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a beneficial owner of shares held in street name and you do not instruct your
broker, bank or other agent how to vote your shares, your broker, bank or other agent may still be able to vote your shares in its discretion. In this regard, under the rules of the New York Stock Exchange (&#147;NYSE&#148;), brokers, banks and
other securities intermediaries that are subject to NYSE rules may use their discretion to vote your &#147;uninstructed&#148; shares with respect to matters considered to be &#147;routine&#148; under NYSE rules, but not with respect to <FONT
STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters. In this regard, we believe that Proposals Nos. 1, 2, 3 and 4 are considered to be <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> under NYSE rules meaning that your
broker may not vote your shares on those proposals in the absence of your voting instructions. However, Proposal No.&nbsp;5 is considered a &#147;routine&#148; matter under NYSE rules, meaning that if you do not return voting instructions to your
broker by its deadline, your shares may be voted by your broker in its discretion on Proposal No.&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B></B><B><I>If
you are </I></B><B></B><B><I>a beneficial owner of shares held in street name</I></B><B></B><B><I>, to ensure your shares are voted in the way you would prefer, you </I></B><B></B><B><I><U>must</U></I></B><B></B><B><I> provide voting instructions to
your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent</I></B><B>. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Who is paying for this proxy solicitation? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may
also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost
of forwarding proxy materials to beneficial owners.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>What does it mean if I receive more than one Notice? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please
follow the voting instructions on the Notices to ensure that all of your shares are voted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Can I change my vote after submitting my
proxy? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Stockholder of Record: Shares Registered in Your Name </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Yes. You can revoke your proxy at any time before the final vote at the meeting. If you are the record holder of your shares,
you may revoke your proxy in any one of the following ways: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You may grant a subsequent proxy by telephone or through the Internet. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You may submit another properly completed proxy card with a later date. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You may send a timely written notice that you are revoking your proxy to our Secretary at 501 Canal Boulevard,
Richmond, California 94804. Such notice will be considered timely if it is received at the indicated address by the close of business on Friday, June&nbsp;8, 2018. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You may attend the Annual Meeting and vote in person. Simply attending the meeting will not, by itself, revoke
your proxy. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Your most current proxy card or telephone or Internet proxy is the one that is counted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner: Shares Registered in the Name of Broker or Bank </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If your shares are held by your broker, bank or other agent, you should follow the instructions provided by your broker, bank
or other agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How are votes counted? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Votes will be counted by the inspector of election appointed for the meeting, who will separately count votes &#147;For&#148;
and &#147;Against,&#148; abstentions and, if applicable, broker <FONT STYLE="white-space:nowrap">non-votes.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are &#147;broker <FONT
STYLE="white-space:nowrap">non-votes?&#148;</FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As discussed above, when a beneficial owner of shares held in
street name does not give voting instructions to his or her broker, bank or other securities intermediary holding his or her shares as to how to vote on matters deemed to be <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> under NYSE
rules, the broker, bank or other such agent cannot vote the shares. These un-voted shares are counted as &#147;broker <FONT STYLE="white-space:nowrap">non-votes.&#148;</FONT> Proposals Nos. 1, 2, 3 and 4 are considered to be <FONT
STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> under NYSE rules and we therefore expect broker <FONT STYLE="white-space:nowrap">non-votes</FONT> to exist in connection with those proposals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B></B><B><I>As a reminder, if you are </I></B><B></B><B><I>a beneficial owner of shares held in street
name</I></B><B></B><B><I>, to ensure your shares are voted in the way you would prefer, you </I></B><B></B><B><I><U>must</U></I></B><B></B><B><I> provide voting instructions to your broker, bank or other agent by the deadline provided in the
materials you receive from your broker, bank or other agent</I></B><B>. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes are needed to approve each proposal? How are abstentions and broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> treated? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table summarizes the minimum vote needed to
approve each proposal and the effect of abstentions and broker <FONT STYLE="white-space:nowrap">non-votes.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Proposal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Proposal Description</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Vote&nbsp;Required&nbsp;for&nbsp;Approval</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Effect of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Abstentions</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Effect of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Broker&nbsp;Non-</FONT></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Votes</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Election of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; votes from the majority of the votes cast with respect to each respective nominee. Pursuant to our Second
Amended and Restated Bylaws, as amended (our &#147;Bylaws&#148;), any incumbent director who does not receive the required majority votes at the Annual Meeting will promptly tender his or her resignation to the Board, and the Board, after
considering the recommendation of the Nomination and Corporate Governance Committee regarding such resignation, shall determine whether to accept or reject the resignation. For a more detailed description of the majority voting process, see
&#147;Proposal No.&nbsp;1: Election of Directors&#151;General&#148; below.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Advisory approval of the compensation of our named executive officers</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; votes from holders of a majority of the stock having voting power present in person or represented by proxy
at the Annual Meeting.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Against</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Approval of the 2018 Plan</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; votes from holders of a majority of the stock having voting power present in person or represented by proxy
at the Annual Meeting.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Against</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Approval of an amendment to the Purchase Plan to increase the number of shares of our common stock reserved for issuance
under the Purchase Plan by 2,500,000 shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; votes from holders of a majority of the stock having voting power present in person or represented by proxy
at the Annual Meeting.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Against</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ratification of the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the
year ending December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;For&#148; votes from holders of a majority of the stock having voting power present in person or represented by proxy
at the Annual Meeting.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Against</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Brokers have discretion to vote <SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">This proposal is considered a &#147;routine&#148; matter under NYSE rules. Accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank or other agent that holds your
shares, your broker, bank or other agent has discretionary authority under NYSE rules to vote your shares on this proposal. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is the quorum requirement? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders<B> </B>holding<B>
</B>at least a majority of the outstanding shares entitled to vote are present at the meeting in person or represented by proxy. On the record date, there were 87,145,700&nbsp;shares<B> </B>outstanding and entitled to vote. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your
broker, bank or other nominee) or if you vote in person at the meeting. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted towards the quorum requirement. If there is no quorum, the Chair of the Board may
adjourn the meeting to another date without a stockholder vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I find out the results of the voting at the Annual Meeting? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a
current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a
<FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> within four business days after the meeting, we intend to file a <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> to publish preliminary results and, within four business days after the
final results are known to us, file an additional <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> to publish the final results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When are
stockholder proposals and director nominations due for next year&#146;s Annual Meeting? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To be considered for
inclusion in next year&#146;s proxy materials, your proposal must be submitted in writing by December 27, 2018, to our Secretary at 501 Canal Boulevard, Richmond, California 94804, and you must comply with all applicable requirements of Rule <FONT
STYLE="white-space:nowrap">14a-8</FONT> promulgated under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to our Bylaws, if you wish to bring a proposal before the stockholders or nominate a director at the 2019 Annual
Meeting of stockholders, but you are not requesting that your proposal or nomination be included in next year&#146;s proxy materials, you must notify our Secretary, in writing, not later than the close of business on March&nbsp;13, 2019 nor earlier
than the close of business on February&nbsp;11, 2019. However, if our 2019 Annual Meeting of stockholders is not held between May&nbsp;12, 2019 and July&nbsp;11, 2019, to be timely, notice by the stockholder must be received not later than the 10th
day following the day on which the first public announcement of the date of the 2019 Annual Meeting is made or the notice of the meeting is mailed, whichever first occurs. You are also advised to review our Bylaws, which contain additional
requirements about advance notice of stockholder proposals and director nominations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The chair of the Annual Meeting may
determine, if the facts warrant, that a matter has not been properly brought before the meeting and, therefore, may not be considered at the meeting. In addition, the proxy solicited by the Board for the 2019 Annual Meeting of Stockholders will
confer discretionary voting authority with respect to any proposal (i)&nbsp;presented by a stockholder at that meeting for which we have not been provided with timely notice and (ii)&nbsp;made in accordance with our Bylaws, if (x)&nbsp;the 2019
proxy statement briefly describes the matter and how management&#146;s proxy holders intend to vote on it, and (y)&nbsp;the stockholder does not comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14a-4(c)(2)</FONT> promulgated
under the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL NO. 1: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION OF DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Board consists of eight directors and one vacancy due to the resignation of William R. Ringo effective as of
January&nbsp;1, 2018. There are eight nominees for director this year. Each director to be elected and qualified will hold serve until the next annual meeting of stockholders or until a successor for such director is duly elected and qualified, or
until the death, resignation or removal of such director. The nominees for election have agreed to serve if elected, and management has no reason to believe that such nominees will be unavailable to serve. In the event the nominees are unable or
decline to serve as directors at the time of the annual meeting, the proxies will be voted for any nominee who may be designated by the present Board of Directors to fill the vacancy. Proxies may not be voted for a greater number of persons than the
number of nominees named. Unless otherwise instructed, the proxy holders will vote the proxies received by them FOR the nominees named below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the eight nominees other than Roger Jeffs, Ph.D., and Joseph Zakrzewski, has been previously elected by the
stockholders. Dr.&nbsp;Jeffs&#146; and Mr.&nbsp;Zakrzewski&#146;s candidacies were recommended to the Nominating and Corporate Governance Committee by the Chief Executive Officer and another member of the Nominating and Corporate Governance
Committee. While the Nominating and Corporate Governance Committee and the Board chose to nominate Alexander D. Macrae, our Chief Executive Officer, for election to the Board for the reasons set forth in his biography below, Dr.&nbsp;Macrae&#146;s
employment agreement also provides that the Board shall nominate Dr.&nbsp;Macrae for election as a member of the Board at each annual meeting of stockholders occurring while Dr.&nbsp;Macrae&#146;s employment agreement is in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the eight nominees set forth in this Proxy Statement will be elected by the majority of the votes cast with respect to
such nominee. If an incumbent director does not receive the required majority vote, the director shall promptly tender his or her resignation to the Board. Within 90 days after the annual meeting, the Nominating and Corporate Governance Committee of
the Board will make a recommendation to the Board of Directors as to whether to accept or reject the resignation. The Board will act by taking into account such committee&#146;s recommendation. If the Board does not accept the resignation, the Board
is required to publicly disclose its decision and the rationale behind the decision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following includes a brief
biography of each nominee for director, including their respective ages as of April&nbsp;24, 2018. Each biography includes information regarding the specific experience, qualifications, attributes or skills that led the Nominating and Corporate
Governance Committee and the Board to determine that the applicable nominee should serve as a member of the Board as of the date of this proxy statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nominees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Alexander D.
Macrae, M.B., Ch.B., Ph.D.</I>, age 55 has served as our President and Chief Executive Officer and as a member of our Board of Directors since June 2016. He has twenty years of experience in the pharmaceutical industry most recently serving as the
Global Medical Officer of Takeda Pharmaceuticals, from 2012 to March 2016, where he established and led the Global Medical Office, which encompasses medical affairs, regulatory affairs, pharmacovigilance, outcomes research and epidemiology,
quantitative sciences and knowledge and informatics. From 2001 to 2012, Dr.&nbsp;Macrae held roles of increasing responsibility at GlaxoSmithKline, including Senior Vice President, Emerging Markets Research and Development (&#147;R&amp;D&#148;),
from 2009 to 2012. In that position, he provided expertise and resources to create a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-of-its-kind</FONT></FONT></FONT> group to expand GSK&#146;s
global reach by providing R&amp;D strategies, clinical development and regulatory resources to enter emerging markets and Asia-Pacific. From 2007 to 2008, he was Vice President, Business Development. In that position, he was responsible for
scientific assessment and business development project leadership for the neurology, psychiatry, cardiovascular and metabolic therapeutic areas. Earlier in his career, he worked for SmithKline Beecham, where he was responsible for clinical
development in the therapeutic areas of neurology </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
and gastroenterology. Dr.&nbsp;Macrae received his B.Sc. in pharmacology and his M.B., Ch.B. with honors from Glasgow University. He is a member of the Royal College of Physicians.
Dr.&nbsp;Macrae also earned his Ph.D. in molecular genomics at King&#146;s College, Cambridge. The Nominating and Corporate Governance Committee and the Board believe that Dr.&nbsp;Macrae&#146;s <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day</FONT></FONT> leadership and intimate knowledge of our business and operations, as well as our relationships with partners, collaborators and investors, provide the Board with an
<FONT STYLE="white-space:nowrap">in-depth</FONT> understanding of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Robert F. Carey</I>, age 59, has served
as a member of our Board of Directors since June 2016. Mr.&nbsp;Carey has been executive vice president, chief business officer for Horizon Pharma plc, a biopharmaceutical company, since March 2014. Prior to that, he served as managing director and
head of the healthcare investment banking group at JMP Securities LLC, a full-service investment bank from March 2003 to March 2014. Prior to JMP, Mr.&nbsp;Carey was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and
Vector Securities International, Inc. He has also held roles at Shearson Lehman Hutton and Ernst&nbsp;&amp; Whinney. Mr.&nbsp;Carey has served on the board of directors of Argos Therapeutics, Inc., a life science company, since September 2015.
Mr.&nbsp;Carey received his B.S. in accounting from the University of Notre Dame. The Nominating and Corporate Governance Committee and the Board believe that Mr.&nbsp;Carey&#146;s extensive experience and knowledge in the healthcare investment
banking industry, particularly with financings, global expansion and other strategic transactions by life-science companies, as well as his role in business development for a public biopharmaceutical company, will provide the Board with valuable
insight and contribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Stephen G. Dilly, M.B.B.S., Ph.D.</I>, age 58, has served as a member of our Board of
Directors since March 2010. Since May 2014, Dr.&nbsp;Dilly has served as Chief Executive Officer and a member of the board of directors of Aimmune Therapeutics, Inc. (formerly Allergen Research Corporation), a biotechnology company developing
treatments for food allergies. From January 2012 to December 2012, he was Chief Executive Officer of PhotoThera, Inc., a medical device company. From 2006 to December 2011, he served as President and Chief Executive Officer and a member of the board
of directors of APT Pharmaceuticals, Inc., a drug development company. From 2007 to 2009, he served as a member of the board of directors of Avigen, Inc., a biopharmaceutical company that merged with MediciNova, Inc. in December 2009. From 2003 to
2006, he served as Chief Medical Officer and Senior Vice President of Development of Chiron BioPharma, a biotechnology company that was later acquired by Novartis International AG. From 1998 to 2003, he held various management positions at
Genentech, Inc., including Vice President of Development Sciences from 2002 to 2003 and Vice President of Medical Affairs from 1998 to 2001. From 1988 to 1998, Dr.&nbsp;Dilly held various management positions in drug development with SmithKline
Beecham in the U.K. During his career, Dr.&nbsp;Dilly has been closely associated with the development and launch of marketed drugs for many therapeutic areas, including Kytril, Paxil, Kredex, Requip, TNKase, Xolair, Avastin, Raptiva, Tarceva,
Lucentis and Cubicin. In 1982 Dr.&nbsp;Dilly received an M.B.B.S., the equivalent of an M.D. in the United States, from the University of London in the U.K. and a Ph.D. in cardiac physiology from University of London in 1988. Dr.&nbsp;Dilly brings
medical expertise and significant drug development experience to our Board. The Nominating and Corporate Governance Committee and the Board believe that Dr.&nbsp;Dilly&#146;s extensive experience in all stages of drug development, from project
prioritization through clinical trial design and data analysis to product launch, provides the Board with valuable insight into this process as the Company continues to advance and develop our pipeline of novel genomic and cell therapy assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Roger Jeffs, Ph.D., </I>age 56, has served as a member of our Board of Directors since June 2017. Prior to his retirement
in 2016, Dr.&nbsp;Jeffs served as President and <FONT STYLE="white-space:nowrap">co-Chief</FONT> Executive Officer of United Therapeutics Corp., where he worked for 18 years, joining the company in its
<FONT STYLE="white-space:nowrap">start-up</FONT> phase in 1998 as Director, Research, Development and Medical and serving as President and Chief Operating Officer from 2001 to 2014. He has over 25 years of experience in the biopharmaceutical
industry in R&amp;D, clinical development, regulatory and medical affairs. While at United Therapeutics, Dr.&nbsp;Jeffs led the clinical development, regulatory approval and commercialization of six rare disease products and managed the commercial
effort that led to a greater than 20% compound annual growth rate (CAGR) and $1.5&nbsp;billion annual revenue run rate.&nbsp;Prior to joining United Therapeutics, he held positions in clinical development at Amgen, Inc. and Burroughs Wellcome Co.
Dr.&nbsp;Jeffs currently also serves as a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
member of the board of directors of Albireo Pharma, Inc., Axsome Therapeutics, Inc., Axovant Sciences Ltd. and Dova Pharmaceuticals, Inc. He received a B.A. in Chemistry from Duke University and
his Ph.D. in Pharmacology from the University of North Carolina School of Medicine. The Nominating and Corporate Governance Committee and the Board believe that Dr.&nbsp;Jeffs&#146; extensive experience at a publicly traded biotechnology company
commercializing rare diseases provides the Board with important qualifications and skills as the Company moves towards the possible commercialization of its novel genomic and cell therapy assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Steven J. Mento, Ph.D.</I>, age 66, has served as a member of our Board of Directors since May 2005. Since July 2005,
Dr.&nbsp;Mento has served as President and Chief Executive Officer of Conatus Pharmaceuticals Inc., a biotechnology company engaged in the development of human therapy for liver disease. From 1997 to 2005, he was President and Chief Executive
Officer of Idun Pharmaceuticals. From 1992 to 1997, Dr.&nbsp;Mento was an executive officer at Viagene, Inc. In January of 1992 he joined Viagene, Inc. as Vice President of Research and Development, where he was responsible for directing the
company&#146;s transition from basic research through initiation of the first company sponsored Phase I and Phase II clinical trials in the emerging field of gene therapy. In October of 1995, Chiron Corporation acquired Viagene, Inc., and renamed
the company Chiron Viagene, Inc. Prior to that, from 1982 to 1992, Dr.&nbsp;Mento held various positions at American Cyanamid Company, the last one being the Director of Viral Vaccine Research and Development at Lederle-Praxis Biologicals, a
business unit of American Cyanamid Company. Dr.&nbsp;Mento currently serves on the boards of BIOCOM, the BIOCOM Institute and the Biotechnology Industry Organization (BIO), as well as a member of the BIO ECS Governing Body, the BIO Health Section
Governing Body, the Donald P. Shiley BioScience Center at SDSU Scientific Advisory Board and Cal State San Marcos Advisory Council. Dr.&nbsp;Mento received a B.A., M.S., and a Ph.D. in microbiology from Rutgers University. He completed his
post-doctoral fellowship in somatic cell genetics at the University of Toronto. The Nominating and Corporate Governance Committee and the Board believe that Dr.&nbsp;Mento&#146;s scientific technical background and extensive operational experience
in the early stages of the development of biologic drugs provide the Board with expertise in the management and development of our novel genomic and cell therapy assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>H. Stewart Parker</I>, age 62, has been a member of our Board of Directors since June 2014. Ms.&nbsp;Parker has over 30
years of experience in the biotechnology industry. Prior to focusing on boards and consulting, she served as the Chief Executive Officer of The Infectious Disease Research Institute (IDRI), a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">not-for-profit</FONT></FONT> global health Research institute from March 2011 to December 2013. In 1992 Ms.&nbsp;Parker founded Targeted Genetics Corporation, a publicly traded Seattle-based biopharmaceutical company
formed to develop gene-based treatments for acquired and inherited diseases that became a world leader in AAV gene therapy. She held the position of President and Chief Executive Officer and was a member of its board of directors from the
company&#146;s inception until November 2008. Prior to founding Targeted Genetics, Ms.&nbsp;Parker served in various capacities at Immunex from August 1981 through December 1991, most recently as Vice President, Corporate Development. From February
1991 to January 1993, Ms.&nbsp;Parker served as President and a Director of Receptech Corporation, a company formed by Immunex in 1989 to accelerate the development of soluble cytokine receptor products. She has served on the board of directors and
the executive committee of BIO, the primary trade organization for the biotechnology industry. She currently serves as a member of the board of directors for several <FONT STYLE="white-space:nowrap">for-profit</FONT> companies including C3J
Therapeutics (formerly C3 Jian Inc), Achieve Life Sciences, Inc., StrideBio Inc. and Nexgenia and on the advisory boards of the University of Washington Foundation and College of Arts&nbsp;&amp; Sciences. Ms.&nbsp;Parker received her B.A. and M.B.A.
from the University of Washington. The Nominating and Corporate Governance Committee and the Board believe that Ms.&nbsp;Parker&#146;s senior executive experience in AAV gene therapy and biotechnology drug development provides valuable operational,
commercial assessment and management skills to the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Saira Ramasastry</I>, age 42, has served as a member of our
Board of Directors since June 2012. Since April 2009, she has served as Managing Partner of Life Sciences Advisory, LLC, a company that she founded to provide strategic advice, business development solutions and innovative financing strategies for
the life science industry. From August 1999 to March 2009, Ms.&nbsp;Ramasastry was an investment banker with Merrill Lynch&nbsp;&amp; Co., Inc. where she helped establish the biotechnology practice and was responsible for origination of mergers
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
and acquisitions (&#147;M&amp;A&#148;), strategic and capital markets transactions. Prior to joining Merrill Lynch she served as a financial analyst in the M&amp;A group at Wasserstein
Perella&nbsp;&amp; Co., an investment banking firm, from July 1997 to September 1998. Ms.&nbsp;Ramasastry currently serves on the Industry Advisory Board of the Michael J. Fox Foundation for Parkinson&#146;s Research, the board of directors of Pain
Therapeutics, Inc., and lead business advisor for the European Prevention of Alzheimer&#146;s Dementia consortium. Ms.&nbsp;Ramasastry received her B.A. in economics with honors and distinction and an M.S. in management science and engineering from
Stanford University, as well as an M. Phil. in management studies from the University of Cambridge where she is a guest lecturer for the Bioscience Enterprise Programme and serves on the Cambridge Judge Business School Advisory Council.
Ms.&nbsp;Ramasastry is also a Health Innovator Fellow of the Aspen Institute and a member of the Aspen Global Leadership Network. The Nominating and Corporate Governance Committee and the Board believe that Ms.&nbsp;Ramasastry&#146;s extensive
experience in global healthcare investment banking and strategic advisory consulting provides valuable financial, commercial assessment and business development skills to the Board and her thorough understanding of our technology and programs
provides the Board with valuable insight in the development of our novel genomic and cell therapy assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Joseph S.
Zakrzewski</I>, age 55, has served as a member of our Board of Directors since June 2017. Mr.&nbsp;Zakrzewski has over 25 years of experience in the biopharmaceutical industry with senior leadership experience in R&amp;D, supply chain and
manufacturing operations, business development and commercialization. Prior to focusing on serving on boards and investments, from 2010 through 2013, he was Chairman and Chief Executive Officer of Amarin Corporation PLC (formerly Amarin
Pharmaceuticals, Inc.), where he led the development and commercialization of the company&#146;s first product, Vascepa. Mr.&nbsp;Zakrzewski previously served as a Venture Partner with Orbimed Advisors LLC, a venture capital firm, and as Chairman,
President and CEO of Xcellerex, Inc., a privately held company focused on the commercialization of its proprietary manufacturing technology for biotherapeutics and vaccines. Earlier, he served as COO of Reliant Pharmaceuticals, Inc. before its
acquisition by GlaxoSmithKline in 2007 and held various executive positions at Eli Lilly&nbsp;&amp; Company in the areas of R&amp;D, manufacturing, finance and business development. Mr.&nbsp;Zakrzewski currently serves as a member of the board of
directors of various public and private companies, including Acceleron Pharma, Inc., Amarin, Insulet Corporation and Onxeo SA where he serves as Chairman. Mr.&nbsp;Zakrzewski received a B.S. in Chemical Engineering and an M.S. in Biochemical
Engineering from Drexel University, and an M.B.A. in Finance from Indiana University. The Nominating and Corporate Governance Committee and the Board believe that Mr.&nbsp;Zakrzewski&#146;s significant experience as a Chief Executive Officer and
leading a variety of functional areas including supply and manufacturing operations provides the Board with an important set of skills to assist in the oversight of the development of our novel genomic and cell therapy assets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Independence </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Board of Directors has determined that William R. Ringo was, and each of its current and nominated directors is, independent under applicable listing standard of Nasdaq Stock Market LLC (&#147;Nasdaq&#148;), except for Dr.&nbsp;Macrae, who is our
Chief Executive Officer. There are no family relationships between any of our directors and any of our executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees and
Meetings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board of Directors held 10 meetings during 2017. The Board of Directors has an Audit Committee, a
Compensation Committee, and a Nominating and Corporate Governance Committee. Each director attended or participated in 75% or more of the aggregate of (i)&nbsp;the total number of meetings of the Board of Directors and (ii)&nbsp;the total number of
meetings held by all committees of the Board on which such director served during 2017, in each case held during the period for which each respective director was serving as a director. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audit Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit Committee consists of three directors: Mr.&nbsp;Carey, Ms.&nbsp;Ramasastry, and Mr.&nbsp;Zakrzewski.
Mr.&nbsp;Zakrzewski was appointed to serve on the Audit Committee in September 2017. Mr.&nbsp;Carey serves as the Chairman of this committee. Mr.&nbsp;Ringo served on the Audit Committee for all of 2017. His resignation from the Board, including all
of its committees, was effective January&nbsp;1, 2018. Our Board of Directors has determined that Mr.&nbsp;Ringo was, and each member of the Audit Committee is, independent under the applicable listing standard of Nasdaq and SEC rules. The Board of
Directors has determined that Mr.&nbsp;Carey is an &#147;audit committee financial expert&#148; as defined under SEC rules and has the requisite financial sophistication in accordance with the applicable Nasdaq listing standards. The Audit Committee
held five meetings during 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit Committee assists the Board of Directors in its oversight of the integrity of
our financial statements, the risk management and our internal controls and our compliance with legal and regulatory requirements. The Audit Committee interacts directly with, and evaluates the performance of, the independent registered public
accounting firm, including determining whether to engage or dismiss the independent registered public accounting firm and to monitor the independent registered public accounting firm&#146;s qualifications and independence. The Audit Committee also <FONT
STYLE="white-space:nowrap">pre-approves</FONT> all audit services and permissible <FONT STYLE="white-space:nowrap">non-audit</FONT> services provided by the independent registered public accounting firm. The Audit Committee Report is included herein
on page 82. The Audit Committee has a written charter, which is available on our website at www.sangamo.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee consists of three directors: Dr.&nbsp;Mento, Ms.&nbsp;Parker and Dr.&nbsp;Jeffs, each of whom is
independent under applicable Nasdaq and SEC rules. Mr.&nbsp;Ringo served on the Compensation Committee for all of 2017 and was independent under applicable Nasdaq and SEC rules. His resignation from the Board, including all of its committees, was
effective January&nbsp;1, 2018. Dr.&nbsp;Mento serves as the Chairman of this committee. In September 2017, Dr.&nbsp;Jeffs was appointed to serve on the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee&#146;s responsibilities include (i)&nbsp;adopting, administering and reviewing compensation plans
and programs for our executive officers, including incentive and equity plans and programs; (ii)&nbsp;approving compensation arrangements for our executive officers; (iii)&nbsp;evaluating the performance of our executive officers;
(iv)&nbsp;adjusting compensation arrangements as appropriate based upon performance; (v)&nbsp;reviewing, considering and approving compensation programs applicable to <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Board of
Directors; (vi)&nbsp;reviewing and monitoring management development and succession plans and activities and (vii)&nbsp;administering, concurrently with the Board of Directors, the Sangamo Therapeutics Inc. 401(k) Profit Sharing Plan and Trust,
originally effective on January&nbsp;1, 1998, and as most recently amended and restated as of June&nbsp;24, 2015 (the &#147;401(k) Plan&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee may delegate any responsibility or authority of the Compensation Committee under its charter to one
or more members of the Compensation Committee, as appropriate and as consistent with applicable laws and rules. Further, the Compensation Committee may delegate to one or more employees or one or more other members of the Board, the authority to
grant awards of equity securities pursuant to our equity incentive plans, in each case to any persons who are not executive officers or key employees in accordance with such guidelines as may be established by the Compensation Committee. The
Compensation Committee may also form and delegate authority to a committee composed solely of our employees to serve as an administrative and/or investment committee, with fiduciary responsibilities under the Employee Retirement Income Security Act
of 1974 (&#147;ERISA&#148;), with respect to one or more of our plans that are subject to ERISA. The Compensation Committee may also form and delegate authority to a subcommittee composed solely of at least two members of the Compensation Committee
who are <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> directors&#148; under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> to grant awards of equity securities and to take such other actions as may be necessary or appropriate to
qualify transactions in our equity securities under the Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> exemptions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee is authorized to engage, oversee and terminate
independent compensation consultants and other professionals to assist in the design, formulation, analysis and implementation of compensation programs for our executive officers and other key employees. The Compensation Committee retained the
services of Radford, an Aon Hewitt Company (&#147;Radford&#148;), in order to (i)&nbsp;assess compensation levels and mix of elements for our executive officers and vice presidents for 2017, (ii) review the peer group criteria and to recommend
specific companies, (iii)&nbsp;assess the compensation of the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and (iv)&nbsp;advise the committee on executive compensation and governance trends based on peer group trends and market
practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee held five meetings during 2017. The Compensation Committee has a written charter,
which is available on our website at www.sangamo.com. For information regarding our processes and procedures for the consideration and determination of executive and director compensation, please see &#147;Executive Compensation&#151;Compensation
Discussion and Analysis&#148; and &#147;&#151;Director Compensation,&#148; respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During 2017, Dr.&nbsp;Mento, Ms.&nbsp;Parker, Dr.&nbsp;Jeffs, and William R. Ringo, who resigned from the Board and
all committees thereof effective January&nbsp;1, 2018, served on the Compensation Committee. None of our Compensation Committee members has been an officer or employee of Sangamo at any time. None of our executive officers serves on the board of
directors or compensation committee of any entity that has one or more executive officers serving as a member of our Board or our Compensation Committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nominating and Corporate Governance Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nominating and Corporate Governance Committee consists of three directors: Dr.&nbsp;Dilly, Ms.&nbsp;Parker and
Dr.&nbsp;Jeffs, each of whom is independent under applicable Nasdaq listing standards. Mr.&nbsp;Ringo served on the Nominating and Corporate Governance for all of 2017. His resignation from the Board, including all of its committees, was effective
January&nbsp;1, 2018. As of March 2018, Dr.&nbsp;Jeffs chairs the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee considers and periodically reports on matters relating to the size, identification,
selection and qualification of the Board of Directors and candidates nominated for the Board of Directors and its committees, and develops and recommends governance principles and policies applicable to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nominating and Corporate Governance Committee held one meeting and acted once by unanimous written consent in lieu of a
meeting during 2017. The Nominating and Corporate Governance Committee has a written charter, which is available on our website at www.sangamo.com. The Nominating and Corporate Governance Committee considers properly submitted stockholder
recommendations for candidates for membership on the Board of Directors as described below under &#147;&#151;Identification and Evaluation of Nominees for Directors.&#148; In evaluating such recommendations, the Nominating and Corporate Governance
Committee seeks to achieve a balance of knowledge, experience and capability on the Board of Directors and to address the membership criteria set forth below under &#147;&#151;Director Qualifications.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Director Qualifications </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nominating and Corporate Governance Committee will use a variety of criteria to evaluate the qualifications and skills
necessary for members of our Board of Directors. The Nominating and Corporate Governance Committee may assess character, judgment, business acumen and scientific expertise, and familiarity with issues affecting the biotechnology and pharmaceutical
industries. Other qualifications will be determined on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis, depending on whether the Nominating and Corporate Governance Committee desires to fill a
vacant seat or increase the size of the Board to add new directors. In addition, the Nominating and Corporate Governance Committee may also evaluate whether a potential director nominee&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
skills are complementary to existing Board members&#146; skills or meet the Board&#146;s need for operations, management, commercial, financial or other expertise. While the Nominating and
Corporate Governance Committee does not prescribe specific diversity standards, as a matter of practice, the committee considers diversity in the context of the Board as a whole and takes into account the personal characteristics and experiences of
current and prospective directors that reflect a broad range of perspectives in the Board&#146;s decision-making process. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Identification and
Evaluation of Nominees for Directors </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nominating and Corporate Governance Committee utilizes a variety of methods
for identifying and evaluating nominees for director. The Nominating and Corporate Governance Committee assesses the appropriate size of the Board of Directors, and whether any vacancies on the Board of Directors are expected due to retirement or
otherwise. In the event that vacancies are anticipated, or otherwise arise, the Nominating and Corporate Governance Committee considers various potential candidates for director. Candidates may come to the attention of the Nominating and Corporate
Governance Committee through current members of the Board of Directors or senior management, executive recruiting firms, stockholders or other persons. With respect to the appointment of Dr.&nbsp;Jeffs and Mr.&nbsp;Zakrzewski, the Nominating and
Corporate Governance Committee paid a fee to a third-party executive recruiting firm to assist with the identification and vetting potential candidates for the Board. These candidates are evaluated at regular or special meetings of the Nominating
and Corporate Governance Committee, and may be considered at any point during the year. The Nominating and Corporate Governance Committee considers properly submitted stockholder recommendations for candidates for the Board of Directors. Stockholder
nominees will receive the same consideration that nominees of the Board receive. Any stockholder recommendations proposed for consideration by the Nominating and Corporate Governance Committee must provide all information requested by the Nominating
and Corporate Governance Committee relating to such recommendation, including the candidate&#146;s name and qualifications for membership on the Board of Directors and should be addressed to Investor Relations at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Investor Relations Department </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Sangamo Therapeutics, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">501
Canal Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Richmond, CA 94804 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In evaluating such recommendations, the Nominating and Corporate Governance Committee applies the qualifications standards discussed above and
seeks to achieve a balance of knowledge, experience and capability on the Board of Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Leadership Structure of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under our Bylaws, the Board is not required to appoint our Chief Executive Officer as the Chair of the Board, and the Board
does not have a policy on whether or not the roles of Chief Executive Officer and Chair of the Board should be separate. Currently two individuals serve these two positions. Ms.&nbsp;Parker currently serves as the Chair of the Board. Ms.&nbsp;Parker
has extensive knowledge and experience in the life science industry and an <FONT STYLE="white-space:nowrap">in-depth</FONT> understanding of our business strategies and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations, which makes her well suited to set the agenda and lead the discussions at Board meetings as the Chair. The Chair is responsible for chairing Board
meetings and meetings of stockholders, setting the agenda for Board meetings and providing information to the Board members in advance of meetings and between meetings. In addition, our Chief Executive Officer, Dr.&nbsp;Macrae, also serves as a
director on our Board. The Board believes that Dr.&nbsp;Macrae&#146;s membership as a director provides the Board with an <FONT STYLE="white-space:nowrap">in-depth</FONT> understanding of our business operations because of his extensive experiences
and knowledge of the <FONT STYLE="white-space:nowrap">day-today</FONT> management of all aspects of our operations. This will also facilitate communications between the Board and management by ensuring a regular flow of information, thereby
enhancing the Board&#146;s ability to make informed decisions on critical issues facing our company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Of the eight directors on the Board following the annual meeting, seven
directors are independent under applicable Nasdaq corporate governance rules. The Board believes that this establishes a strong independent board that provides effective oversight of the Company. Moreover, in addition to feedback provided during the
course of Board meetings, the independent directors conduct regular executive sessions without the presence of Dr.&nbsp;Macrae or any other members of management. We believe that our leadership structure of the Board is appropriate given the nature
and size our businesses, because it provides both effective independent oversight and expertise in the complexity and management of our operations as a life sciences company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Oversight of Risk Management by the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Board of Directors is generally responsible for the oversight of corporate risk in its review and deliberations relating to
our activities and has determined that our principal source of risk falls into two categories: (1)&nbsp;financial and (2)&nbsp;product development and testing. The Audit Committee oversees management of risks associated with our financial and
accounting systems, public financial reporting, investment strategies and policy, and certain other matters delegated to the Audit Committee, including risks associated with our information technology systems (including cybersecurity risks). Our
Board of Directors regularly reviews information regarding our cash position, liquidity and operations, as well as the risks associated with each. The Board regularly reviews plans, results and potential risks related to our lead therapeutic
development programs and other preclinical programs as well as financial and strategic risk related to our operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
addition, the Nominating and Corporate Governance Committee monitors the effectiveness of our corporate policies and manages risks associated with the independence of the Board of Directors and potential conflicts of interest. Our Compensation
Committee oversees risk management as it relates to our compensation plans, policies and practices for all employees, including executives, particularly whether our compensation programs may create incentives for our employees to take excessive or
inappropriate risks that could have a material adverse effect on the Company. While each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire Board of Directors is regularly informed through
committee reports about such risks. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual Meeting Attendance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although we do not have a formal policy regarding attendance by members of the Board of Directors at our annual meetings of
stockholders, directors are encouraged to attend annual meetings of our stockholders. Six directors attended the 2017 annual meeting of stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Communications with the Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although we do not have a formal policy regarding communications with the Board of Directors, stockholders may communicate with
the Board of Directors, including the <FONT STYLE="white-space:nowrap">non-management</FONT> directors, by sending a letter to the Sangamo Board of Directors, c/o Investor Relations, 501 Canal Boulevard, Richmond, California 94804. Stockholders who
would like their submission directed to a particular member of the Board of Directors may so specify. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct and Ethics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board of Directors has adopted a Code of Business Conduct and Ethics, which is applicable to all employees and directors of
the Company. A copy of our Code of Business Conduct and Ethics is available on our website at www.sangamo.com in the Investors&nbsp;&amp; Media Section under Corporate Governance. In the event that we make any amendments to or grant any waivers of,
a provision of the Code of Business Conduct and Ethics that applies to the principal executive officer, principal financial officer, or principal accounting officer that requires disclosure under applicable SEC rules, we intend to disclose such
amendment or waiver and the reasons therefore, on our website at www.sangamo.com, in the Investors&nbsp;&amp; Media section. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth certain information regarding the compensation of each
<FONT STYLE="white-space:nowrap">non-employee</FONT> director for service as a member of the Board of Directors during 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:28.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Fees&nbsp;Earned&nbsp;or&nbsp;&nbsp;&nbsp;&nbsp;</B><br><B>Paid in Cash</B><br><B>($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Option&nbsp;Awards&nbsp;&nbsp;&nbsp;&nbsp;</B><br><B>($)&nbsp;(2)&nbsp;(3)&nbsp;(4)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B><br><B>($)</B></TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert F. Carey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">60,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">45,718</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">105,718</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen G. Dilly</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">50,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">45,718</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">95,718</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roger Jeffs (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">21,875</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">165,729</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">187,604</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward O. Lanphier II (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">40,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">40,000</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven J. Mento</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">57,500</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">45,718</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">103,218</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Stewart Parker</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">82,500</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">45,718</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">128,218</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Saira Ramasastry</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">50,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">45,718</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">95,718</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William R. Ringo (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">65,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">45,718</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">110,718</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph S. Zakrzewski (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">22,500</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">165,729</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">188,229</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of the annual retainer fee for service as a member of the Board of Directors or any Board committee.
For further information concerning such fees, see the section below entitled &#147;&#151;Director Annual Retainer and Meeting Fees.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pursuant to the Automatic Grant Program in effect under our Amended and Restated 2013 Stock Incentive Plan
(the &#147;2013 Plan&#148;), Ms.&nbsp;Parker, Mr.&nbsp;Carey, Dr.&nbsp;Dilly, Dr.&nbsp;Mento, Ms.&nbsp;Ramasastry, and Mr.&nbsp;Ringo each received an option to purchase 10,000 shares of common stock with an exercise price per share of $7.20 on the
date of the 2017 annual meeting of stockholders, and each such option had an aggregate grant date fair value of $45,718, calculated in accordance with Financial Accounting Standards Board (&#147;FASB&#148;) Accounting Standards Codification Topic
718 (&#147;ASC 718&#148;), <I>Compensation - Stock Compensation,</I> using the Black-Scholes option valuation model and without taking into account any estimated forfeitures. On June&nbsp;27, 2017, Mr.&nbsp;Jeffs and Mr.&nbsp;Zakrzewski each
received an option to purchase 30,000 shares of common stock with an exercise price per share of $8.70 in connection with their appointments to the Board of Directors on June&nbsp;26, 2017 and each such option had an aggregate grant date fair value
of $165,729, calculated in accordance with ASC 718 using the Black-Scholes option valuation model and without taking into account any estimated forfeitures. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The assumptions used in the calculation of such grant date fair values are described in Note 4 to our
consolidated financial statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2017. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As of December&nbsp;31, 2017, the following <FONT STYLE="white-space:nowrap">non-employee</FONT> directors
held options to purchase the following number of shares of our common stock: Ms.&nbsp;Parker, 80,000 shares; Mr.&nbsp;Carey, 40,000 shares; Dr.&nbsp;Dilly, 120,000 shares; Mr.&nbsp;Jeffs, 30,000 shares; Dr.&nbsp;Mento, 80,000 shares;
Ms.&nbsp;Ramasastry, 59,450 shares; Mr.&nbsp;Ringo (former director), 50,000 shares; and Mr.&nbsp;Zakrzewski 30,000 shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Jeffs and Mr.&nbsp;Zakrzewski were appointed as <FONT STYLE="white-space:nowrap">non-employee</FONT>
members of the Board of Directors on June&nbsp;26, 2017; accordingly, their retainer fees were <FONT STYLE="white-space:nowrap">pro-rated</FONT> over their period of service. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Lanphier did not stand for <FONT STYLE="white-space:nowrap">re-election</FONT> to the Board of
Directors at the 2017 annual meeting of stockholders (the &#147;2017 Annual Meeting&#148;); accordingly, his retainer fees were <FONT STYLE="white-space:nowrap">pro-rated</FONT> over his period of service. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Ringo resigned as a <FONT STYLE="white-space:nowrap">non-employee</FONT> member of the Board of
Directors effective January&nbsp;1, 2018. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Processes and Procedures for Determining Director Compensation. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The charter of the Compensation Committee provides the Compensation Committee with the responsibility for reviewing,
considering and approving compensation programs applicable to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. It is the practice of the Compensation Committee to seek input from outside compensation consultants, including Radford,
our Compensation Committee&#146;s compensation consultant, as it deems appropriate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Director Annual Retainer and Meeting Fees </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each <FONT STYLE="white-space:nowrap">non-employee</FONT> member of the Board of Directors receives an annual cash retainer of
$40,000. To the extent the Board of Directors meets more than 10 times in any year, each <FONT STYLE="white-space:nowrap">non-employee</FONT> member of the Board of Directors will receive, for each meeting in excess of 10, a per meeting fee of
$1,000 if attended in person and $500 if attended by video or telephone conference. The Chairman of the Board of Directors receives an additional annual cash retainer of $35,000. In addition, the <FONT STYLE="white-space:nowrap">non-employee</FONT>
members of the Board of Directors serving as the Chairman of the Audit Committee, the Chairman of the Compensation Committee and the Chairman of the Nominating and Corporate Governance Committee receive an additional annual cash retainer of $20,000,
$15,000 and $10,000, respectively. Each <FONT STYLE="white-space:nowrap">non-employee</FONT> member of the Board of Directors serving as a member of the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance
Committee, other than the Chairman, receives an additional annual cash retainer of $10,000, $7,500 and $5,000, respectively. All retainer fees are subject to <FONT STYLE="white-space:nowrap">pro-ration</FONT> for directors who join or leave the
Board of Directors or the respective committee or begin or cease to serve Chairman of the Board or the respective committee, during the year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Automatic Grant Program under the 2013 Plan specifically provides the Compensation Committee with the ability to implement
a program whereby directors are given the option to elect to convert their cash board retainer fees into restricted stock unit (&#147;RSU&#148;) grants. The Compensation Committee has not implemented such a deferral program. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity Incentives Granted Under 2013 Stock Incentive Plan </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the Automatic Grant Program in effect under the 2013 Plan, on the date of each annual stockholders meeting, each
continuing <FONT STYLE="white-space:nowrap">non-employee</FONT> member of the Board of Directors who served as a director for the previous six months automatically receives an option to purchase 10,000 shares of our common stock. Each option granted
under the Automatic Grant Program will have an exercise price per share equal to the fair market value per share of our common stock on the option grant date and will have a maximum term of 10 years, subject to earlier termination following the
optionee&#146;s cessation of Board service. Each option is immediately exercisable for all the option shares, but any shares purchased under the option will be subject to repurchase by the Company, at the exercise price paid per share, upon the
optionee&#146;s cessation of Board service prior to vesting in those shares. The shares subject to each automatic option grant will vest in successive equal monthly installments upon completion of each month of Board service over a <FONT
STYLE="white-space:nowrap">one-year</FONT> period. However, the shares subject to each automatic option grant will immediately vest upon (i)&nbsp;the optionee&#146;s death or permanent disability while serving as a member of the Board of Directors,
(ii)&nbsp;an acquisition of the Company by merger or asset sale, (iii)&nbsp;the successful completion of a tender offer for more than 50% of our outstanding voting stock or (iv)&nbsp;a change in the majority of the Board of Directors effected
through one or more proxy contests for Board of Directors membership. The Automatic Grant Program under the 2018 Plan that is the subject of Proposal No.&nbsp;3 provides for a similar program for continuing
<FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Board of Directors who served as a director for the previous six months, although the amount, type and vesting terms of the awards to be automatically granted are modified.
Accordingly, if Proposal No.&nbsp;3 is approved by the stockholders, our <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Board of Directors will continue to receive automatic equity award grants on the date of each annual
stockholders meeting. Additionally, if Proposal No.&nbsp;3 is approved by the stockholders, newly appointed or elected <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Board will receive equity grants automatically upon their
initial appointment or election. See &#147;&#151;Proposed New Automatic Grant Program Under 2018 Equity Incentive Plan&#148; below for more information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee awarded Dr.&nbsp;Jeffs and Mr.&nbsp;Zakrzewski an
initial option to purchase 30,000 shares of our common stock on June&nbsp;27, 2017, with an exercise price per share equal to the closing price per share of our common stock on that date. The option will vest in 36&nbsp;successive equal monthly
installments over the 36-month period measured from the grant date, subject to Dr.&nbsp;Jeffs&#146; and Mr.&nbsp;Zakrzewski&#146;s continued service as a member of the Board on each monthly vesting date. The remaining terms of their options are
similar to the terms of the annual grants under the Automatic Grant Program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Automatic Grant Program in effect under
the 2013 Plan provides the Compensation Committee with discretion to grant, in lieu of the option grant that would otherwise be awarded under such program, a number of shares of restricted stock or RSUs to the
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors with a fair market value substantially equal to the grant date fair value of the option that would otherwise be awarded. The Automatic Grant Program under the 2018 Plan that is the
subject of Proposal No.&nbsp;3 does not retain this feature and instead provides for automatic grants of a specified number of options and RSUs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the Automatic Grant Program in effect under the 2013 Plan, on the date of the 2017 annual meeting of stockholders,
Mr.&nbsp;Carey, Dr.&nbsp;Dilly, Dr.&nbsp;Mento, Ms.&nbsp;Parker, Ms.&nbsp;Ramasastry and Mr.&nbsp;Ringo each received an option to purchase 10,000 shares of common stock with an exercise price per share of $7.20. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposed New Automatic Grant Program Under 2018 Equity Incentive Plan </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Proposal No.&nbsp;3 is approved at the Annual Meeting as of such date the Automatic Grant Program under the 2013 Plan will be replaced by a
new Automatic Grant Program under the 2018 Plan. Under the automatic grant program of the 2018 Plan, on the date of each annual stockholders meeting commencing with the Annual Meeting, each individual serving as a
<FONT STYLE="white-space:nowrap">non-employee</FONT> Board member at that time, who has served on our Board for at least six months, and who will continue serving as a <FONT STYLE="white-space:nowrap">non-employee</FONT> Board member immediately
after such stockholders meeting will automatically be granted a nonqualified stock option (&#147;NSO&#148;) to purchase 15,000 shares of common stock and a RSU in respect of 2,500 shares of common stock under the 2018 Plan. The shares subject to
each annual 15,000 share automatic NSO grant made to a continuing Board member will vest in 12 successive equal monthly installments upon such director&#146;s completion of each month of Board service over the12-month period measured from the grant
date.&nbsp;The shares subject to each 2,500 share automatic RSU grant will fully vest on the earlier of (x)&nbsp;the first anniversary of the date of grant or (y)&nbsp;the day prior to the next annual stockholders meeting, subject to the
director&#146;s continued service on the Board through the applicable vesting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the automatic grant program of the 2018 Plan,
each <FONT STYLE="white-space:nowrap">non-employee</FONT> Board member who is initially appointed or elected to the Board on or after the Annual Meeting will automatically be granted a NSO to purchase 30,000 shares of common stock and a RSU award in
respect of 5,000 shares of common stock under the 2018 Plan. The shares subject to each initial 30,000 share automatic NSO grant made to a newly appointed Board member will vest in 36 successive equal monthly installments upon such director&#146;s
completion of each month of Board service over the <FONT STYLE="white-space:nowrap">36-month</FONT> period measured from the grant date.&nbsp;The shares subject to each 5,000 share automatic RSU grant will vest with respect to 1/3<SUP
STYLE="font-size:85%; vertical-align:top">rd</SUP> of the shares in three equal annual installments over the three-year period measured from the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each automatic NSO grant will have an exercise price per share equal to the fair market value per share of our common stock on
the grant date and will have a term of 10 years, subject to earlier termination following the optionee&#146;s cessation of Board service.&nbsp;Each NSO option grant will be immediately exercisable for all of the option shares; however, we may
repurchase, at the lower of the exercise price paid per share or the fair market value per share, any shares purchased under the NSO that are not vested at the time of the optionee&#146;s cessation of Board service.&nbsp;The shares subject to each
automatic NSO grant and each automatic RSU grant will immediately vest in full upon the director&#146;s death or disability or upon the occurrence of a change of control or hostile takeover (as such terms are defined in Proposal No.&nbsp;3 below) in
each subject to the director&#146;s continued Board service through such date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If Proposal No.&nbsp;3 is approved at the Annual Meeting the options to
purchase 105,000 shares of our common stock and RSU awards in respect of 17,500 shares of our common stock will be automatically granted to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors as a group on such date under the 2018
Plan. If Proposal No.&nbsp;3 is not approved at the Annual Meeting, the 2013 Plan will remain in effect so that options to purchase 70,000 shares of our common stock will be automatically granted to our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors as a group on such date under the 2013 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board of Directors
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Board of Directors recommends that the stockholders vote FOR the election of the nominees listed above. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL NO. 2: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under
Section&nbsp;14A(a)(1) of the Exchange Act, our stockholders are entitled to vote to approve, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation of our named executive officers as disclosed in this Proxy
Statement in accordance with SEC rules (commonly referred to as a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> vote). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named
executive officers and the philosophy, policies and practices described in this Proxy Statement. Based on the voting results from the 2017 annual meeting of stockholders, our stockholders voted for, and we have adopted an annual advisory vote on the
compensation of the named executive officers in our proxy materials, which will remain in effect until the next required vote on the frequency of stockholder votes on the compensation of named executive officers. Although the vote is <FONT
STYLE="white-space:nowrap">non-binding,</FONT> the Board of Directors and the Compensation Committee of the Board value the opinions of our stockholders and will consider the outcome of the vote when making future compensation decisions affecting
our executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We encourage stockholders to read closely the &#147;Executive Compensation&#148; section of this
Proxy Statement, beginning with the Compensation Discussion and Analysis (&#147;CD&amp;A&#148;) on page 50, which describes in detail our executive compensation programs, policies and practices with respect to the compensation of our named executive
officers in the year ended December&nbsp;31, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our overarching compensation goal is to create a positive relationship
between our compensation program and our corporate performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We design our executive compensation program to implement
our core objectives of attracting and retaining highly qualified executives with extensive industry or scientific experience, rewarding executives for success in meeting our annual clinical development and other research and operational goals,
aligning the interests of our executives with those of our stockholders and recognizing executives&#146; individual performance and, for executives other than our Chief Executive Officer, achievement of their individual goals and those of the
functional organizations that they manage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee established the 2017 compensation program and the
associated Company goals in accordance with the foregoing goals and philosophy. During 2017, we continued the important work of laying the foundation for the Company as a sustainable, fully integrated company that develops, manufacturers and
commercializes novel genomic therapies on our own and, where appropriate, in collaboration with industry partners. We now have six active clinical programs, with additional preclinical assets advancing toward an investigational new drug, or IND,
application. The highlights of our business successes in 2017 are summarized under the heading &#147;2017 and Early 2018 Performance Highlights&#148; in the CD&amp;A. The Board of Directors believes our executive compensation program uses
appropriate structures and sound pay practices that are effective in achieving our core objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Resolution </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board is asking our stockholders to indicate their support for the compensation of our named executive officers, as
described in this Proxy Statement, by casting a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory vote &#147;FOR&#148; the following resolution: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>&#147;Resolved that the Company&#146;s stockholders hereby approve, on an advisory basis, the compensation of the
Company&#146;s named executive officers as disclosed in this Proxy Statement pursuant to the</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
<B>compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the various compensation tables and the accompanying narrative discussion and any related material
included in this Proxy Statement.&#148;</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Advisory approval of this Proposal No.&nbsp;2 requires votes &#147;FOR&#148;
from holders of a majority of the stock having voting power present in person or represented by proxy at the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the
Board of Directors </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Board of Directors recommends an advisory vote FOR the resolution to approve, on an
advisory basis, the compensation of the named executive officers as disclosed in this Proxy Statement pursuant to the compensation disclosure rules of the SEC.</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL NO. 3: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2018 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Compensation Committee approved the Sangamo Therapeutics, Inc. 2018 Equity Incentive Plan, or the 2018 Plan, on April 23,
2018, subject to approval by our stockholders. The 2018 Plan is intended to be the successor to the Amended and Restated 2013 Stock Incentive Plan, or the 2013 Plan. Currently, we maintain the 2013 Plan to grant equity awards to provide long-term
incentives to our employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants. In light of changes in 2017 to federal tax laws and other changes that have occurred since the 2013 Plan was originally adopted, our
Compensation Committee decided to adopt and seek approval for the 2018 Plan to update our equity plan provisions to align with current tax and regulatory rules and market practices. In addition, the 2018 Plan will include a new reserve of 8,800,000
shares of common stock (in addition to the shares of common stock that are, or would become, available under our 2013 Plan) to ensure that we can continue to grant equity awards to attract and retain high quality employees, <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors and consultants. Additionally, the 2018 Plan includes an automatic grant program for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If this Proposal No.&nbsp;3 is approved by our stockholders, the 2018 Plan will become effective as of the date of the Annual
Meeting and no additional equity awards will be granted under the 2013 Plan. However, all outstanding equity awards granted under the 2013 Plan will continue to be subject to the terms and conditions as set forth in the agreements evidencing such
awards and the terms of the 2013 Plan. Stockholder approval of this Proposal No.&nbsp;3 will also constitute <FONT STYLE="white-space:nowrap">pre-approval</FONT> of each award granted under the 2018 Plan pursuant to the provisions of the automatic
grant program for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors as described below in this Proposal No.&nbsp;3. In the event that our stockholders do not approve this Proposal No.&nbsp;3, the 2018 Plan will not become effective
and the 2013 Plan will continue to be effective in accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why You Should Vote to Approve the 2018 Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Awards Are an Important Part of Our Compensation Philosophy </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Board believes that the issuance of equity awards is a key element underlying our ability to attract, retain and motivate
key personnel, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants because of the strong competition for highly trained and experienced individuals among biotechnology and pharmaceutical companies, especially in the
greater San Francisco Bay area. Therefore, the Board believes that the 2018 Plan is in the best interests of our business and our stockholders and recommends a vote in favor of this Proposal No.&nbsp;3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Approval of the 2018 Plan by our stockholders will allow us to continue to grant equity awards at levels we determine to be
appropriate. The 2018 Plan will also allow us to utilize equity awards as long-term incentives to secure and retain the services of our employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants, consistent with our
compensation philosophy and common compensation practice for our industry in the greater San Francisco Bay Area. To date, equity incentives have been a key aspect of our program to attract and retain key employees,
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants. We believe the use of equity awards strongly aligns the interests of our employees with those of our stockholders by placing a considerable proportion of our
employees&#146; total compensation &#147;at risk&#148; because it is contingent on the appreciation in value of our common stock. In addition, we believe equity awards encourages employee ownership of our common stock and promotes retention through
the reward of long-term Company performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We Carefully Manage the Use of Equity Awards and the Size of our Share Reserve is Reasonable
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our compensation philosophy reflects broad-based eligibility for equity incentive awards, and we generally grant
equity awards to all of our employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. However, we recognize that equity awards dilute existing stockholders, and, therefore, we are mindful to responsibly manage the growth of our
equity compensation program. We are committed to effectively monitoring our equity compensation share reserve, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
including our &#147;burn rate,&#148; to ensure that we maximize stockholders&#146; value by granting the appropriate number of equity awards necessary to attract, reward, and retain employees, <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors and consultants. The tables below show certain historical overhang and burn rate percentages. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Determination of Number of Shares to Request for the 2018 Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In its determination to approve the 2018 Plan, our Compensation Committee reviewed an analysis prepared by Radford, its compensation
consultant, which included an analysis of our historic and estimated prospective share usage needs and the potential costs of the 2018 Plan. Specifically, our Compensation Committee considered: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>Market Competitiveness</B>.<B> </B>The 2018 Plan plays an important role in our effort to align the interests of participants and stockholders. Moreover, in our industry, equity compensation awards are an important
tool in recruiting, retaining and motivating highly skilled and critical employee talent, upon whose efforts our success is dependent. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>Estimated Equity Usage and Share Pool Duration</B>. Our Compensation Committee considered our historic burn rate levels in determining how long the 2018 Plan share authorization could potentially last. We expect the
share authorization under the 2018 Plan to provide us with enough shares for awards for approximately two years, with actual timing dependent on a variety of factors, including the price of our shares and hiring activity during the next few years,
rates of forfeiture of outstanding awards, and noting that future circumstances may require us to change our current equity grant practices. We cannot predict our future equity grant practices, the future price of our shares or future hiring
activity with any degree of certainty at this time, and the share reserve under the 2018 Plan could last for a shorter or longer period of time. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>External Factors</B>. Radford&#146;s analysis, which is based on generally accepted evaluation methodologies, concluded that the number of shares under the 2018 Plan is well within generally accepted standards as
measured by an analysis of its cost relative to industry standards. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Historic Use of Equity and Outstanding Awards </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Overhang </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides
certain additional information regarding use of equity. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;As&nbsp;of&nbsp;April&nbsp;17,&nbsp;2018&nbsp;&nbsp;<BR>Record Date</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to outstanding stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">8,455,564</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average exercise price of outstanding stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$10.57</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average remaining term in years of outstanding stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">7.60</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to outstanding full value awards granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">280,579</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock available for grant under the 2013 Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1,618,588</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock available for grant under other equity incentive
plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">835,674*</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">87,145,700</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Per-share</FONT> closing price of common stock as reported on
Nasdaq Global Select Market</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$19.52</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:15%">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">* Reflects
the number of shares available under the Purchase Plan as of the record date. No other shares are available for grant under any other equity incentive plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Burn Rate </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides detailed information regarding the activity related to our 2013 Plan for fiscal year 2017. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For&nbsp;the&nbsp;Year&nbsp;Ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>December&nbsp;31, 2017</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to stock options granted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3,091,125</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to full value awards granted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">12,600</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average number of shares of common stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">78,084,108</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Burn Rate</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3.97%</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Requested Shares </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to adjustment for certain changes in our capitalization, if this Proposal No.&nbsp;3 is approved by our stockholders,
the aggregate number of shares of our common stock that may be issued under the 2018 Plan will not exceed the sum of (i)&nbsp;the number of unallocated shares remaining available for the grant of new awards under the 2013 Plan as of the effective
date of the 2018 Plan (which is equal to 1,618,588 shares as of April&nbsp;17, 2018), (ii) 8,800,000 new shares, and (iii)&nbsp;certain shares subject to outstanding awards granted under the 2013 Plan and 2004 Stock Incentive Plan, which together
are the Prior Plans, that may become available for grant under the 2018 Plan as such shares become available from time to time (as further described below under &#147;&#151;Description of the 2018 Plan&#151;Shares Available for Stock Awards&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the 2018 Plan and the new share reserve of 8,800,000 shares is approved by our stockholders, we expect to have
approximately 10,418,588 shares available for grant after our Annual Meeting (based on shares available as of April&nbsp;17, 2018). We believe the adoption of the 2018 Plan and new share reserve of 8,800,000 shares is necessary for us to remain
competitive in the greater San Francisco Bay Area marketplace and support our equity grant practices to align the interests of our employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors with our stockholders. We anticipate the
available pool of shares in the 2018 Plan will be sufficient for our equity awards for approximately the next two years after considering our present average share usage rate, and that such pool of shares is necessary to provide a predictable amount
of available equity awards for attracting, retaining, and motivating employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We do not as a matter of course make public forecasts as to our utilization of equity awards due to the unpredictability of
the underlying assumptions and estimates. The inclusion of the information set forth above should not be regarded as an indication or prediction of actual future outcomes, and the statements should not be relied upon as such. Neither we nor any
other person makes any representation to any of our stockholders regarding actual outcomes compared to the information contained in the forward-looking statements set forth above. Although presented with some numerical specificity, these statements
are not fact and reflect numerous assumptions and estimates as to future events made by our management that our management believed were reasonable at the time this filing was prepared and other factors such as industry performance and general
business, economic, regulatory, market and financial conditions, as well as factors specific to our business, all of which are difficult to predict and many of which are beyond the control of our management. The forecasts are forward-looking
statements within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21A of the Exchange Act. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those in the
forward-looking statements, including our ability to attract and retain talent, achievement of performance metrics, if any, with respect to certain equity awards, the extent of option exercise activity, forfeiture rates, and other factors described
in this Proxy Statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Features of the 2018 Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The 2018 Plan includes many of the same provisions from the 2013 Plan that are designed to protect our stockholders&#146;
interests and to reflect corporate governance best practices. The following are features added to the 2018 Plan that will further moderate the number of shares available for new grants of equity awards and reflect best practices: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Additional prohibition on liberal share counting or recycling of appreciation awards</I>. The 2013 Plan
provides that shares tendered to or withheld by us as consideration for of the exercise price of stock options or stock appreciation rights, to cover tax withholding obligations upon exercise of stock options or stock appreciation rights, or to
cover tax withholding obligations related to any other stock awards will not be returned to the share reserve. The 2018 Plan retains such provisions and also provides that any shares repurchased by us on the open market with the proceeds of the
exercise or purchase price of a stock award granted under the 2018 Plan or a Prior Plan is not eligible to be issued under the 2018 Plan. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Additional Restrictions on dividends</I>. The 2013 Plan provides that no dividends or dividend equivalents
may be paid with respect to any shares of our common stock subject to a performance stock award before the date such shares have vested and any dividends or dividend equivalents that are credited with respect to any such shares will be subject to
all of the terms and conditions applicable to such shares under the terms of the applicable performance stock award agreement (including any vesting conditions). The 2018 Plan retains such provisions and also provides that such restrictions are also
applicable to stock awards that are not performance stock awards. The 2018 Plan additionally provides that any dividends or dividend equivalents that are credited with respect to any shares or share equivalents will be forfeited to us on the date
such shares or share equivalents are forfeited to or repurchased by us due to a failure to vest. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following are such
provisions in the 2018 Plan that are continuing unchanged from the 2013 Plan: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Fungible share counting. </I>The 2018 Plan contains a &#147;fungible share counting&#148; structure,
whereby the number of shares of our common stock available for issuance under the 2018 Plan will be reduced by (i)&nbsp;one share for each share issued pursuant to a stock option or stock appreciation right with an exercise price that is at least
100% of the fair market value of our common stock on the date of grant, referred to as an Appreciation Award, granted under the 2018 Plan and (ii) 1.33 shares for each share issued pursuant to a stock award that is not an Appreciation Award,
referred to as a Full Value Award, granted under the 2018 Plan. As part of such fungible share counting structure, the number of shares of our common stock available for issuance under the 2018 Plan will be increased by (i)&nbsp;one share for each
share that becomes available again for issuance under the terms of the 2018 Plan subject to an Appreciation Award and (ii) 1.33 shares for each share that becomes available again for issuance under the terms of the 2018 Plan subject to a Full Value
Award. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Minimum vesting. </I>The 2018 Plan contains a minimum vesting requirement for stock awards, such that no
stock award may vest until at least 12 months following the date of grant of such award, except that up to 5% of the share reserve of the 2018 Plan may be subject to awards that do not meet such vesting requirements. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>No liberal change in control definition</I>. The change in control definition in the 2018 Plan is not a
&#147;liberal&#148; definition. A change in control transaction must actually occur in order for the change in control provisions in the 2018 Plan to be triggered. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Repricing is not allowed</I>. The 2018 Plan prohibits the repricing of outstanding stock options and stock
appreciation rights and the cancellation of any outstanding stock options or stock appreciation rights that have an exercise or strike price greater than the then-current fair market value of our common stock in exchange for cash or other stock
awards under the 2018 Plan without prior stockholder approval. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stockholder approval is required for additional shares</I>. The 2018 Plan does not contain an annual
&#147;evergreen&#148; provision. The 2018 Plan authorizes a fixed number of shares, so that stockholder approval is required to issue any additional shares, allowing our stockholders to have direct input on our equity compensation program.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Awards subject to forfeiture/clawback</I>. Awards granted under the 2018 Plan will be subject to recoupment
in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street
Reform and Consumer Protection Act or other applicable law. In addition, we may impose other clawback, recovery or recoupment provisions in a stock award agreement or employment agreement, including a reacquisition right in respect of previously
acquired shares or other cash or property upon the occurrence of cause. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>No discounted stock options or stock appreciation rights</I>. All stock options and stock appreciation
rights granted under the 2018 Plan must have an exercise or strike price equal to or greater than the fair market value of our common stock on the date the stock option or stock appreciation right is granted. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Material amendments require stockholder approval</I>. Consistent with Nasdaq rules, the 2018 Plan requires
stockholder approval of any material revisions to the 2018 Plan. In addition, certain other amendments to the 2018 Plan require stockholder approval. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of the 2018 Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The material features of the 2018 Plan are described below. The following description of the 2018 Plan is a summary only and
is qualified in its entirety by reference to the complete text of the 2018 Plan. Stockholders are urged to read the actual text of the 2018 Plan in its entirety, which is attached to this proxy statement as Appendix A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Purpose </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The 2018
Plan is designed to secure and retain the services of our employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants, provide incentives for our employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors
and consultants to exert maximum efforts for the success of our company and our affiliates, and provide a means by which our employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants may be given an opportunity to
benefit from increases in the value of our common stock. The 2018 Plan also designed to align employees&#146; interests with stockholder interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Successor to 2013 Plan </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The 2018 Plan is intended to be the successor to the 2013 Plan. If the 2018 Plan is approved by our stockholders, no
additional stock awards will be granted under the 2013 Plan. If the 2018 Plan is not approved by our stockholders, the 2018 Plan will not become effective and the 2013 Plan will continue to be effective in accordance with its terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Types of Stock Awards </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The terms of the 2018 Plan provide for the grant of incentive stock options, nonstatutory stock options, stock appreciation
rights, restricted stock awards, restricted stock unit awards, other stock awards, and performance stock awards that may be settled in cash, stock, or other property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Shares Available for Stock Awards </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to adjustment for certain changes in our capitalization, the aggregate number of shares of our common stock that may
be issued under the 2018 Plan, will not exceed the sum of (i)&nbsp;the number of unallocated shares remaining available for the grant of new stock awards under the 2013 Plan as of the effective date of the 2018 Plan (which is equal to 1,618,588
shares as of April&nbsp;17, 2018), (ii) 8,800,000 new shares, and (iii)&nbsp;any Returning Shares (as defined below) from the 2018 Plan or the Prior Plans, as such shares become available from time to time. The number of shares of our common stock
available for issuance under the 2018 Plan will be reduced by one share for each share of common stock issued pursuant to an Appreciation Award and 1.33 shares for each share of common stock issued pursuant to a Full Value Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;Returning Shares&#148; are shares subject to outstanding stock awards granted under the Prior Plans or granted under the
2018 Plan and that in each case from and after the effective date of the 2018 Plan: (i)&nbsp;are not issued because the stock award expires or otherwise terminates without all of the shares covered by the stock award having been issued or is settled
in cash, or (ii)&nbsp;are forfeited back to or repurchased by us because of the failure to meet a contingency or condition required for the vesting of such shares. For each Returning Share subject to a Full Value Award granted under the 2018 Plan,
or Returning Share subject to Full Value Award granted under the Prior Plans, the number of shares of common stock available for issuance under the 2018 Plan will increase by 1.33 shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any shares of common stock reacquired or withheld (or not issued) by us to satisfy the exercise or purchase price of a stock
award granted under the Plan or a Prior Plan will no longer be available for issuance under the 2018 Plan, including any shares subject to such stock award that are not delivered to a participant because the stock award is exercised through a
reduction of shares subject to the stock award. In addition, any shares reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection with a stock award granted under the 2018 Plan or a Prior Plan and any shares
repurchased by us on the open market with the proceeds of the exercise or purchase price of a stock award granted under the 2018 Plan or a Prior Plan will not be available for issuance under the 2018 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Eligibility </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All
of our approximately 192 employees, seven <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and approximately 10 consultants as of April&nbsp;17, 2018 are eligible to participate in the 2018 Plan and may receive all types of awards
other than incentive stock options. Incentive stock options may be granted under the 2018 Plan only to our employees, including our executive officers. However, participation in the automatic grant program is limited to the seven <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors (see &#147;&#151;Automatic Grant Program for <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors&#148; below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Administration </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Compensation Committee administers the 2018 Plan (except the <FONT STYLE="white-space:nowrap">non-discretionary</FONT>
grant program, which is automatic) and may delegate authority to administer the 2018 Plan to a subcommittee of <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. Our Compensation Committee may, at any time, revest in itself some or all
of the power delegated to such a committee. The Compensation Committee and any other committee of <FONT STYLE="white-space:nowrap">non-employee</FONT> directors to whom the Compensation Committee may delegate authority to administer the 2018 Plan
are each considered to be a Plan Administrator for purposes of this Proposal No.&nbsp;3. Subject to the terms of the 2018 Plan, the Plan Administrator may determine the recipients, the types of stock awards to be granted, the number of shares of our
common stock subject to or the cash value of stock awards, and the terms and conditions of stock awards granted </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
under the 2018 Plan, including the period of their exercisability and vesting, subject to the minimum vesting requirements. The Plan Administrator also has the authority to provide for
accelerated exercisability and vesting of stock awards. Subject to the limitations set forth below, the Plan Administrator also determines the fair market value applicable to a stock award and the exercise or strike price of stock options and stock
appreciation rights granted under the 2018 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan Administrator may also delegate to one or more executive
officers the authority to designate employees who are not executive officers to be recipients of certain stock awards and the number of shares of our common stock subject to such stock awards. Under any such delegation, the Plan Administrator will
specify the total number of shares of our common stock that may be subject to the stock awards granted by such executive officer. The executive officer may not grant a stock award to himself or herself. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Repricing; Cancellation and <FONT STYLE="white-space:nowrap">Re-Grant</FONT> of Stock Options or Stock Appreciation Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the 2018 Plan, the Plan Administrator does not have the authority to reprice any outstanding stock option or stock
appreciation right by reducing the exercise or strike price of the stock option or stock appreciation right or to cancel any outstanding stock option or stock appreciation right that has an exercise or strike price greater than the then-current fair
market value of our common stock in exchange for cash or other stock awards without obtaining the approval of our stockholders. Such approval must be obtained within 12 months prior to such an event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Options </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock options may be granted under the 2018 Plan pursuant to stock option agreements. The 2018 Plan permits the grant of stock
options that are intended to qualify as incentive stock options, or ISOs, and nonstatutory stock options, or NSOs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
exercise price of a stock option granted under the 2018 Plan may not be less than 100% of the fair market value of the common stock subject to the stock option on the date of grant and, in some cases (see &#147;&#151;Limitations on Incentive Stock
Options&#148; below), may not be less than 110% of such fair market value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The term of stock options granted under the
2018 Plan may not exceed ten years and, in some cases (see &#147;&#151;Limitations on Incentive Stock Options&#148; below), may not exceed five years. Except as otherwise provided in a participant&#146;s stock option agreement or other written
agreement with us, if a participant&#146;s service relationship with us (referred to in this Proposal No.&nbsp;3 as &#147;continuous service&#148;) terminates (other than for cause or the participant&#146;s death or disability), the participant may
exercise any vested stock options for up to three&nbsp;months following the participant&#146;s termination of continuous service. Except as otherwise provided in a participant&#146;s stock option agreement or other written agreement with us, if a
participant&#146;s continuous service terminates due to the participant&#146;s disability, the participant may exercise any vested stock options for up to 12 months following the participant&#146;s termination due to the participant&#146;s
disability. Except as otherwise provided in a participant&#146;s stock option agreement or other written agreement with us, if a participant&#146;s continuous service terminates due to the participant&#146;s death (or the participant dies within a
specified period, if any, following termination of continuous service), the participant&#146;s beneficiary may exercise any vested stock options for up to 18 months following the participant&#146;s termination due to the participant&#146;s death.
Except as explicitly provided otherwise in a participant&#146;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#146;s continuous service is terminated for cause (as defined in the 2018 Plan), all
stock options held by the participant will terminate upon the participant&#146;s termination of continuous service and the participant will be prohibited from exercising any stock option from and after such termination date. Except as otherwise
provided in a participant&#146;s stock option agreement or other written agreement with us or one of our affiliates, the term of a stock option may be extended if the exercise of the stock option following the participant&#146;s termination of
continuous service (other than for cause or the participant&#146;s death or disability) would be prohibited by applicable securities laws or if the sale of any common stock received upon exercise of the stock option following the participant&#146;s
termination of continuous service (other than for cause) would violate our insider trading policy. In no event, however, may a stock option be exercised after its original expiration date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Acceptable forms of consideration for the purchase of our common stock
pursuant to the exercise of a stock option under the 2018 Plan will be determined by the Plan Administrator and may include payment: (i)&nbsp;by cash, check, bank draft or money order payable to us; (ii)&nbsp;pursuant to a program developed under
Regulation T as promulgated by the Federal Reserve Board; (iii)&nbsp;by delivery to us of shares of our common stock (either by actual delivery or attestation); (iv) by a net exercise arrangement (for NSOs only); or (v)&nbsp;in other legal
consideration approved by the Plan Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock options granted under the 2018 Plan may become exercisable in
cumulative increments, or &#147;vest,&#148; as determined by the Plan Administrator at the rate specified in the stock option agreement. Shares covered by different stock options granted under the 2018 Plan may be subject to different vesting
schedules as the Plan Administrator may determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan Administrator may impose limitations on the transferability
of stock options granted under the 2018 Plan in its discretion. Generally, a participant may not transfer a stock option granted under the 2018 Plan other than by will or the laws of descent and distribution or, subject to approval by the Plan
Administrator, pursuant to a domestic relations order or an official marital settlement agreement. However, the Plan Administrator may permit transfer of a stock option in a manner that is not prohibited by applicable tax and securities laws. In
addition, subject to approval by the Plan Administrator, a participant may designate a beneficiary who may exercise the stock option following the participant&#146;s death. Options may not be transferred to a third party financial institution for
value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Limitations on Incentive Stock Options </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In accordance with current federal tax laws, the aggregate fair market value, determined at the time of grant, of shares of
our common stock with respect to ISOs that are exercisable for the first time by a participant during any calendar year under all of our stock plans may not exceed $100,000. The stock options or portions of stock options that exceed this limit or
otherwise fail to qualify as ISOs are treated as NSOs. No ISO may be granted to any person who, at the time of grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power unless the following conditions are
satisfied: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the exercise price of the ISO must be at least 110% of the fair market value of the common stock subject to the ISO on the date of grant; and </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the term of the ISO must not exceed five years from the date of grant. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to adjustment for certain changes in our capitalization, the aggregate maximum number of shares of our common stock
that may be issued pursuant to the exercise of ISOs under the 2018 Plan is 17,600,000 shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Appreciation Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock appreciation rights may be granted under the 2018 Plan pursuant to stock appreciation right agreements. Each stock
appreciation right is denominated in common stock share equivalents. The strike price of each stock appreciation right will be determined by the Plan Administrator, but will in no event be less than 100% of the fair market value of the common stock
subject to the stock appreciation right on the date of grant. The Plan Administrator may also impose restrictions or conditions upon the vesting of stock appreciation rights that it deems appropriate. The appreciation distribution payable upon
exercise of a stock appreciation right may be paid in shares of our common stock, in cash, in a combination of cash and stock, or in any other form of consideration determined by the Plan Administrator and set forth in the stock appreciation right
agreement. Stock appreciation rights will be subject to the same conditions upon termination of continuous service and restrictions on transfer as stock options under the 2018 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Awards </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Restricted stock awards may be granted under the 2018 Plan pursuant to restricted stock award agreements. A restricted stock
award may be granted in consideration for cash, check, bank draft or money order payable to us, the participant&#146;s services performed for us, or any other form of legal consideration acceptable to the Plan Administrator. Shares of our common
stock acquired under a restricted stock award may be subject to forfeiture to or repurchase by us in accordance with a vesting schedule to be determined by the Plan Administrator. Rights to acquire shares of our common stock under a restricted stock
award may be transferred only upon such terms and conditions as are set forth in the restricted stock award agreement. A restricted stock award agreement may provide that any dividends paid on restricted stock will be subject to the same vesting
conditions as apply to the shares subject to the restricted stock award. Upon a participant&#146;s termination of continuous service for any reason, any shares subject to restricted stock awards held by the participant that have not vested as of
such termination date may be forfeited to or repurchased by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Unit Awards </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Restricted stock unit awards may be granted under the 2018 Plan pursuant to restricted stock unit award agreements. Payment of
any purchase price may be made in any form of legal consideration acceptable to the Plan Administrator. A restricted stock unit award may be settled by the delivery of shares of our common stock, in cash, in a combination of cash and stock, or in
any other form of consideration determined by the Plan Administrator and set forth in the restricted stock unit award agreement. Restricted stock unit awards may be subject to vesting in accordance with a vesting schedule to be determined by the
Plan Administrator. Dividend equivalents may be credited in respect of shares of our common stock covered by a restricted stock unit award, provided that any additional shares credited by reason of such dividend equivalents will be subject to all of
the same terms and conditions of the underlying restricted stock unit award. Except as otherwise provided in a participant&#146;s restricted stock unit award agreement or other written agreement with us, restricted stock units that have not vested
will be forfeited upon the participant&#146;s termination of continuous service for any reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance Awards </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The 2018 Plan allows us to grant performance stock awards. A performance stock award is a stock award that is payable
(including that may be granted, may vest, or may be exercised) contingent upon the attainment of <FONT STYLE="white-space:nowrap">pre-determined</FONT> performance goals during a performance period. A performance stock award may require the
completion of a specified period of continuous service. The length of any performance period, the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained
will be determined by the Plan Administrator in its discretion. In addition, to the extent permitted by applicable law and the applicable stock award agreement, the Plan Administrator may determine that cash may be used in payment of performance
stock awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Performance goals under the 2018 Plan will be based on any one or more of the following performance
criteria: (i)&nbsp;earnings (including earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii)&nbsp;earnings before interest, taxes, depreciation and amortization; (iv)&nbsp;earnings before interest, taxes,
depreciation, amortization and legal settlements; (v)&nbsp;earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (vi) earnings before interest, taxes, depreciation, amortization, legal
settlements, other income (expense) and stock-based compensation; (vii)&nbsp;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue;
(viii)&nbsp;total stockholder return; (ix)&nbsp;return on equity or average stockholder&#146;s equity; (x)&nbsp;return on assets, investment, or capital employed; (xi)&nbsp;stock price; (xii)&nbsp;profit (including gross profit) and/or margin
(including gross margin); (xiii) income (before or after taxes); (xiv) operating income; (xv)&nbsp;operating income after taxes; <FONT STYLE="white-space:nowrap">(xvi)&nbsp;pre-tax</FONT> profit; (xvii)&nbsp;operating cash flow; (xviii)&nbsp;sales
or revenue targets; (xix)&nbsp;increases in revenue or product revenue; (xx)&nbsp;expenses and cost reduction goals; (xxi)&nbsp;improvement in or attainment of working capital levels; (xxii)&nbsp;economic value added (or an equivalent metric);
(xxiii) market share; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(xxiv)&nbsp;cash flow; (xxv)&nbsp;cash flow per share; (xxvi)&nbsp;share price performance; (xxvii)&nbsp;debt reduction; (xxviii)&nbsp;implementation or completion of projects or processes;
(xxix)&nbsp;employee retention; (xxx)&nbsp;stockholders&#146; equity; (xxxi)&nbsp;capital expenditures; (xxxii)&nbsp;debt levels; (xxxiii)&nbsp;operating profit or net operating profit; (xxxiv)&nbsp;workforce diversity; (xxxv)&nbsp;growth of net
income or operating income; (xxxvi)&nbsp;billings; (xxxvii) bookings; and (xxxviii)&nbsp;other measures of performance selected by the Plan Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Performance goals may be based on a company-wide basis, with respect to one or more business units, divisions, affiliates or
business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. The Plan Administrator may, in its sole discretion, provide that one or more
objectively determinable adjustments shall be made to one or more of the performance goals. Such adjustments may include one or more of the following: (i)&nbsp;items related to a change in accounting principle; (ii)&nbsp;items relating to financing
activities; (iii)&nbsp;expenses for restructuring or productivity initiatives; (iv)&nbsp;other <FONT STYLE="white-space:nowrap">non-operating</FONT> items; (v)&nbsp;items related to acquisitions; (vi)&nbsp;items attributable to the business
operations of any entity acquired by us during the performance period; (vii)&nbsp;items related to the disposal of a business or segment of a business; (viii)&nbsp;items related to discontinued operations that do not qualify as a segment of a
business under applicable accounting standards; (ix)&nbsp;items attributable to any stock dividend, stock split, combination or exchange of stock occurring during the Performance Period; (x)&nbsp;any other items of significant income or expense
which are determined to be appropriate adjustments; (xi)&nbsp;items relating to unusual or extraordinary corporate transactions, events or developments, (xii)&nbsp;items related to amortization of acquired intangible assets; (xiii)&nbsp;items that
are outside the scope of our core, <FONT STYLE="white-space:nowrap">on-going</FONT> business activities; (xiv)&nbsp;items related to acquired <FONT STYLE="white-space:nowrap">in-process</FONT> research and development; (xv)&nbsp;items relating to
changes in tax laws; (xvi)&nbsp;items relating to major licensing or partnership arrangements; (xvii)&nbsp;items relating to asset impairment charges; (xviii)&nbsp;items relating to gains or losses for litigation, arbitration and contractual
settlements; (xix)&nbsp;items relating to any other unusual or nonrecurring events or changes in applicable laws, accounting principles or business conditions; or (xx)&nbsp;any other items selected by the Plan Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the Plan Administrator retains the discretion to reduce or eliminate the compensation or economic benefit due
upon the attainment of any performance goals and to define the manner of calculating the performance criteria it selects to use for a performance period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Automatic Grant Program for <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the automatic grant program, on the date of each annual stockholders meeting, each individual serving as a <FONT
STYLE="white-space:nowrap">non-employee</FONT> Board member at that time, who has served on our Board for at least six months, and who will continue serving as a <FONT STYLE="white-space:nowrap">non-employee</FONT> Board member immediately after
such stockholders meeting will automatically be granted a NSO purchase 15,000 shares of common stock and restricted stock unit award in respect of 2,500 shares of common stock. The shares subject to each annual 15,000 share automatic NSO grant made
to a continuing Board member will vest in 12 successive equal monthly installments upon such director&#146;s completion of each month of Board service over the <FONT STYLE="white-space:nowrap">12-month</FONT> period measured from the grant
date.&nbsp;The shares subject to each 2,500 share automatic restricted stock unit grant will fully vest on the earlier of (x)&nbsp;the first anniversary of the date of grant or (y)&nbsp;the day prior to the next annual stockholders meeting, subject
to the director&#146;s continued service on the Board through the applicable vesting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the automatic grant
program, each <FONT STYLE="white-space:nowrap">non-employee</FONT> Board member who is initially appointed or elected to the Board on or after the 2018 annual stockholders meeting will automatically be granted a NSO to purchase 30,000 shares of
common stock and restricted stock unit award in respect of 5,000 shares of common stock. The shares subject to each initial 30,000 share automatic NSO grant made to a newly appointed Board member will vest in 36 successive equal monthly installments
upon such director&#146;s completion of each month of Board service over the <FONT STYLE="white-space:nowrap">36-month</FONT> period measured from the grant date.&nbsp;The shares subject to each 5,000 share automatic restricted stock unit grant will
vest with respect to 1/3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> of the shares in three equal annual installments over the three year period measured from the date of grant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each automatic NSO grant will have an exercise price per share equal to the
fair market value per share of our common stock on the grant date and will have a term of 10 years, subject to earlier termination following the optionee&#146;s cessation of Board service.&nbsp;Each NSO option grant will be immediately exercisable
for all of the option shares; however, we may repurchase, at the lower of the exercise price paid per share or the fair market value per share, any shares purchased under the NSO that are not vested at the time of the optionee&#146;s cessation of
Board service.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The shares subject to each automatic NSO grant and each automatic restricted stock unit grant will
immediately vest in full upon the director&#146;s death or disability or upon the occurrence of a change of control or hostile takeover (as defined below) in each subject to the director&#146;s continued Board service through such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Stock Awards </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Other forms of stock awards valued in whole or in part by reference to, or otherwise based on, our common stock may be granted
either alone or in addition to other stock awards under the 2018 Plan. Subject to the terms of the 2018 Plan, the Plan Administrator will have sole and complete authority to determine the persons to whom and the time or times at which such other
stock awards will be granted, the number of shares of our common stock to be granted and all other terms and conditions of such other stock awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clawback Policy </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards granted under the 2018 Plan will be subject to recoupment in accordance with any clawback provisions in a
participant&#146;s employment agreement or other agreement with us or any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is
otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the Plan Administrator may impose other clawback, recovery or recoupment provisions in a stock award agreement as the Plan
Administrator determines necessary or appropriate, including a reacquisition right in respect of previously acquired shares of our common stock or other cash or property upon the occurrence of cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Changes to Capital Structure </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event of certain capitalization adjustments, the Plan Administrator will appropriately adjust: (i)&nbsp;the class(es)
and maximum number of securities subject to the 2018 Plan; (ii)&nbsp;the class(es) and maximum number of securities that may be issued pursuant to the exercise of ISOs; (iii)&nbsp;the class(es) and number of securities to be granted under the
automatic grant program, and (iv) the class(es) and number of securities and price per share of stock subject to outstanding stock awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change
in Control or Hostile Takeover </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event of a change in control (as defined in the 2018 Plan and described
below) outstanding stock awards shall be assumed, continued or substituted for similar stock awards by the surviving or acquiring corporation. If any surviving or acquiring corporation fails to assume, continue or substitute such stock awards, the
vesting of stock awards held by participants who are our employee or <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and whose continuous service has not terminated will be accelerated in full to a date prior to the change in control
as determined by our Board. All stock awards not assumed, continued or substituted for similar stock awards by the surviving or acquiring corporation will terminate upon the change in control. In addition, our Board may also provide, in its sole
discretion, that the holder of a stock award that will terminate upon the occurrence of a change in control will receive a payment, if any, equal to the excess of (1)&nbsp;the value of the property the participant would have received upon exercise
of the stock award over (2)&nbsp;the exercise price otherwise payable in connection with the stock award. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the 2018 Plan, a change in control generally will be deemed
to occur if (1)&nbsp;we are acquired pursuant to a merger, consolidation or other reorganization approved by our stockholders, (2)&nbsp;a stockholder approved sale of all or substantially all our assets, or (3)&nbsp;there occurs any transaction or
series of related transactions pursuant to which any person or group of related persons becomes directly or indirectly the beneficial owner of securities possessing (or convertible into or exercisable for securities possessing) more than fifty
percent of the total combined voting power of our securities outstanding immediately after the consummation of such transaction or series of related transactions, whether such transaction involves a direct issuance from us or the acquisition of
outstanding securities held by one or more of our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the 2018 Plan, a stock award may be subject to
additional acceleration of vesting and exercisability upon or after a change in control or hostile takeover (as defined in the 2018 Plan and described below, as may be provided in the participant&#146;s stock award agreement, in any other written
agreement with us, but in the absence of such provision, no such acceleration will occur. The awards granted to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors under our Automatic Grant Program will automatically immediately fully
accelerate vesting upon a change in control or hostile takeover subject to the director&#146;s continued services on the Board through such date. The acceleration of vesting of a stock award in the event of a change in control or hostile takeover
event under the 2018 Plan may be viewed as an anti-takeover provision, which may have the effect of discouraging a proposal to acquire or otherwise obtain control of us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the 2018 Plan, a hostile takeover will be deemed to occur if (1)&nbsp;there is a change in the majority of our
Board as a result of one or more contested elections for Board membership, or (2)&nbsp;securities possessing more than 50% of the total combined voting power of our outstanding securities are acquired pursuant to a hostile tender offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Plan Amendments and Termination </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan Administrator will have the authority to amend or terminate the 2018 Plan at any time. However, except as otherwise
provided in the 2018 Plan or a stock award agreement, no amendment or termination of the 2018 Plan may materially impair a participant&#146;s rights under his or her outstanding stock awards without the participant&#146;s consent. We will obtain
stockholder approval of any amendment to the 2018 Plan as required by applicable law and listing requirements. No incentive stock options may be granted under the 2018 Plan after the tenth anniversary of the date the 2018 Plan became effective,
which is the date of the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Income Tax Consequences </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a summary of the principal United States federal income tax consequences to participants and us with respect
to participation in the 2018 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current federal
income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#146;s tax adviser regarding
the federal, state, local and other tax consequences of the grant or exercise of a stock award or the disposition of stock acquired the 2018 Plan. The 2018 Plan is not qualified under the provisions of Section&nbsp;401(a) of the Internal Revenue
Code of 1986, as amended, (the &#147;Code&#148;) and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974. Our ability to realize the benefit of any tax deductions described below depends on our generation
of taxable income as well as the requirement of reasonableness and the satisfaction of our tax reporting obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nonstatutory Stock Options
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price
equal to the fair market value of the underlying stock on the grant date. Upon exercise, a participant will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
recognize ordinary income equal to the excess, if any, of the fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is
employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#146;s tax basis in those shares will be equal to his or her fair market value on the date of exercise of the stock option, and the
participant&#146;s capital gain holding period for those shares will begin on that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the requirement of
reasonableness, the provisions of Section&nbsp;162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Incentive Stock Options </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The 2018 Plan provides for the grant of stock options that are intended to qualify as &#147;incentive stock options,&#148; as
defined in Section&nbsp;422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of an ISO. If the participant holds a share received upon exercise of an ISO for more than two years
from the date the stock option was granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable
disposition of that share and the participant&#146;s tax basis in that share will be long-term capital gain or loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If,
however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of
the disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price. However, if the sales proceeds are less than the fair market value of the share on
the date of exercise of the stock option, the amount of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the
share on the date of exercise of the stock option, that excess will be short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon
exercise of an ISO exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#146;s alternative minimum taxable income for the year in which the stock option is exercised. If, however, there is a
disqualifying disposition of the share in the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative minimum taxable income, the tax basis of
a share acquired upon exercise of an ISO is increased by the amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option is exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are not allowed a tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon
exercise of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant, subject to the
requirement of reasonableness, the provisions of Section&nbsp;162(m) of the Code, and provided that either the employee includes that amount in income or we timely satisfy our reporting requirements with respect to that amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Awards </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to
the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is not vested when it is received (for example, if the employee is required to work for a
period of time in order to have the right to sell the stock), the recipient </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
generally will not recognize income until the stock becomes vested, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the stock
on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30&nbsp;days following his or her receipt of the restricted stock
award, to recognize ordinary income, as of the date the recipient receives the restricted stock award, equal to the excess, if any, of the fair market value of the stock on the date the restricted stock award is granted over any amount paid by the
recipient for the stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The recipient&#146;s basis for the determination of gain or loss upon the subsequent disposition
of shares acquired from a restricted stock award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock becomes vested. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the Code, and the satisfaction of a tax
reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Unit Awards </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, the recipient of a restricted stock unit award structured to comply with the requirements of Section&nbsp;409A of
the Code or an exception to Section&nbsp;409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange
for the stock. To comply with the requirements of Section&nbsp;409A of the Code, the stock subject to a restricted stock unit award may generally only be delivered upon one of the following events: a fixed calendar date (or dates), separation from
service, death, disability or a change in control. If delivery occurs on another date, unless the restricted stock unit award otherwise complies with or qualifies for an exception to the requirements of Section&nbsp;409A of the Code (including
delivery upon achievement of a performance goal), in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any taxes owed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The recipient&#146;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a
restricted stock unit award will be the amount paid for such shares plus any ordinary income recognized when the stock is delivered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the Code, and the satisfaction of a tax
reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock unit award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Appreciation Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, if a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying
stock on the grant date, the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon such exercise. Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the Code,
and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation right.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Plan Benefits </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information regarding future benefits under the 2018 Plan. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7.5pt; font-family:Times New Roman"><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Dollar<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number&nbsp;of<BR>Shares</B></TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President and Chief Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Ward Wolff</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Former Executive Vice President and Chief Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(2)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President and Chief Medical Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts, III</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President and Chief Business Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers as a group (5 persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current directors who are not executive officers as a group (7 persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(3)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current employees, including current officers who are not executive officers, as a group (192
persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(1)</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) As described above in this Proposal No. 3 future benefits under the 2018 Plan are generally discretionary for our employees, including executive officers,
and consultants, and therefore are not currently determinable. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Mr. Wolff retired from his position as Executive Vice President and Chief Financial
Officer effective as of February 28, 2017 and is not eligible to receive future benefits under the 2018 Plan. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) As described above in this Proposal No.
3 under &#147;&#151;Automatic Grant Program for Non-Employee Directors&#148; on the date of each annual stockholders meeting, commencing with the Annual Meeting, each individual serving as a non-employee Board member at that time, who has served on
our Board for at least six months and will continue to serve on our Board immediately following such annual stockholders meeting will automatically be granted a NSO to purchase 15,000 shares of common stock and restricted stock units in respect of
2,500 shares of our common stock. Additionally, each non-employee Board member who is initially appointed or elected to the Board on or after the Annual Meeting will automatically be granted a NSO to purchase 30,000 shares of common stock and
restricted stock unit award in respect of 5,000 shares of common stock. If this Proposal No. 3 is approved at the Annual Meeting options to purchase 105,000 shares of our common stock and restricted stock units with respect to 17,500 shares of our
common stock will be automatically granted to our non-employee directors as a group on the date of the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Approval of this Proposal No.&nbsp;3 requires votes &#147;FOR&#148; from holders of a majority of the stock having voting
power present in person or represented by proxy at the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Board of Directors recommends that the stockholders vote FOR the adoption of the Sangamo Therapeutics, Inc. 2018 Equity
Incentive Plan. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL NO. 4: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2010 EMPLOYEE STOCK PURCHASE PLAN AMENDMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Compensation Committee approved an amendment to our 2010 Employee Stock Purchase Plan, or the Purchase Plan, on April 23,
2018, subject to approval by our stockholders, to increase the number of shares of our common stock reserved for issuance under the Purchase Plan by 2,500,000 shares. In the event that our stockholders do not approve this Proposal No.&nbsp;4, the
amendment will not be effected so that the share increase will not be implemented and the Purchase Plan will continue to be effective in accordance with its existing terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why You Should Vote to Approve the Amendment of the Purchase Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Purchase Plan is an Important Part of Our Employee Compensation Program </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board believes that equity compensation is a key element underlying our ability to attract, retain and motivate our employees because of
the strong competition for highly trained and experienced employees among biotechnology and pharmaceutical companies, especially in the greater San Francisco Bay area. Additionally, the Board believes the Purchase Plan encourages our employees to
acquire an ownership interest in our Company and thereby encourages them to remain in our employ and more closely aligns their interests with those of the stockholders. Approval of amendment to the Purchase Plan will allow us to continue to offer
the Purchase Plan to our employees at levels we determine to be appropriate. Therefore, the Board believes that the amendment to the Purchase Plan is in the best interests of us and our stockholders and recommends a vote in favor of this Proposal
No.&nbsp;4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Size of the Purchase Plan Share Reserve is Reasonable </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of April&nbsp;17, 2018 only 835,674 shares of common stock remained available under the Purchase Plan. In its determination
to approve the increase to the share reserve of the Purchase Plan our Compensation Committee reviewed the remaining available share reserve and an analysis of our historic and estimated prospective share usage needs. Our Compensation Committee also
considered that the Purchase Plan is an important element in our market competitiveness. Based on our historic participation rates, we anticipate that if this Proposal No.&nbsp;4 is approved the share reserve of the Purchase Plan will last for
approximately two years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of the Purchase Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The material features of the Purchase Plan as would be effective if the requested share increase set forth in this Proposal
No.&nbsp;4 is approved are described below. The following description of the Purchase Plan is a summary only and is qualified in its entirety by reference to the complete text of the Purchase Plan. Stockholders are urged to read the actual text of
the Purchase Plan in its entirety, which is attached to this proxy statement as Appendix&nbsp;B. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Administration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Plan is administered by our Compensation Committee, referred to as the ESPP Administrator in this Proposal No.&nbsp;4. As ESPP
Administrator, the Compensation Committee has full authority to adopt administrative rules and procedures and to interpret the provisions of the Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Shares Subject to the Purchase Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of April&nbsp;17, 2018, an aggregate of 1,264, 326 shares of our common stock had been purchased under the Purchase Plan and 835,674 shares
of common stock remained available for future purchase under the Purchase Plan. Upon approval of this Proposal No.&nbsp;4 an additional 2,500,000 shares will become available for future purchases under the Purchase Plan beginning with the next
offering period that commences on or after the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Annual Meeting. If purchase rights granted under the Purchase Plan expire, lapse or otherwise terminate without being exercised, the shares of our common stock not purchased under such
unexercised and expired rights again become available for issuance under the Purchase Plan. The shares issuable under the Purchase Plan may be made available from authorized but unissued shares of our common stock or from shares of common stock
repurchased by us, including shares repurchased on the open market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should any change be made to our outstanding common stock by reason
of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares, <FONT STYLE="white-space:nowrap">spin-off</FONT> transaction or other change affecting the outstanding common stock as a class without our receipt of
consideration or should the value of the outstanding shares of our common stock be substantially reduced as a result of a <FONT STYLE="white-space:nowrap">spin-off</FONT> transaction or an extraordinary dividend or distribution, then equitable
adjustments will be made by the ESPP Administrator to (i)&nbsp;the maximum number and/or class of securities issuable under the Purchase Plan, (ii)&nbsp;the maximum number and/or class of securities purchasable per participant during any offering
period and on any one purchase date during that offering period, (iii)&nbsp;the maximum number and/or class of securities purchasable in total by all participants on any one purchase date and (iv)&nbsp;the number and/or class of securities and the
price per share in effect under each outstanding purchase right. The adjustments will be made in such manner as the ESPP Administrator deems appropriate and such adjustments shall be final, binding and conclusive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Offering Periods and Purchase Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Plan allows our eligible employees and those of our participating subsidiaries (whether now existing or subsequently acquired or
established) to purchase shares of common stock at a discounted price at designated intervals through their accumulated payroll deductions or other permitted contributions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of our common stock will be offered for purchase under the Amended Purchase Plan through a series of offering periods. Unless otherwise
specified by the ESPP Administrator prior to the start of the applicable offering period: (i)&nbsp;each offering period has a duration of 24&nbsp;months, and (ii)&nbsp;offering periods commence on the first business day of May and the first business
day of November each year, so that offerings run concurrently. Unless otherwise determined by the ESPP Administrator, the next offering period under the Purchase Plan is scheduled to commence on November&nbsp;1, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms and conditions of each offering period may vary, and two or more offering periods may run concurrently under the Purchase Plan, each
with its own terms and conditions. In addition, special offering periods may be established with respect to entities that are acquired by us or under such other circumstances as the ESPP Administrator deems appropriate. However, the participants in
each separate offering period will have equal rights and privileges under that offering in accordance with the requirements of the federal tax laws and regulations applicable to employee stock purchase plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified by the ESPP Administrator prior to the start of the applicable offering period, each offering period will be
comprised of four successive purchase intervals. Purchase intervals will run from the first business day in May to the last business day in October each year and from the first business day in November each year to the last business day in April in
the following year, unless the ESPP Administrator specifies different purchase intervals prior to the start of the applicable offering period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should the fair market value per share of our common stock on any purchase date within an offering period be less than the fair market value
per share of our common stock on the start date of that offering period, then the individuals participating in that offering period will, immediately after the purchase of our common stock on their behalf on such purchase date, be transferred from
that offering period and automatically enrolled in the new offering period commencing on the next business day following such purchase date, provided the fair market value per share on the start date of that new offering period is lower than the
fair market value per share of our common stock on the start date of the offering period in which they were currently enrolled. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Eligibility and Participation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any individual who is employed on a basis under which he or she is regularly expected to work for more than twenty hours per week for more than
five months per calendar year in the employ of any participating parent or subsidiary corporation (whether any such corporation is now in existence or is subsequently established at any time during the term of the Purchase Plan) will be eligible to
participate in any offering period implemented under the Purchase Plan. However, for one or more distinct separate offering periods, the ESPP Administrator may waive either or both of the twenty hour or five month service requirements. To
participate in a particular offering period, an eligible employee must complete and file the requisite enrollment forms on or before the start date of that offering period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of April&nbsp;17, 2018, 192 employees, including five executive officers, were eligible to participate in the Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Payroll Deductions and Stock Purchases </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For each offering period, the ESPP Administrator may allow contributions to the Purchase Plan to be effected in the form of periodic payroll
deductions or one or more other permissible forms specified by the ESPP Administrator prior to the start date of the applicable offering period. However, all contributions, whether in the form of payroll deductions or other mode, must be based
solely on either the participant&#146;s cash earnings or base salary, as determined by the ESPP Administrator prior to the start of the offering period and may not exceed 15% of base salary or cash earnings, unless the ESPP Administrator authorizes
a different maximum percentage prior to the start date of the applicable offering period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accumulated contributions will
automatically be applied to the acquisition of common stock at <FONT STYLE="white-space:nowrap">six-month</FONT> intervals. Accordingly, on each such purchase date (the last business day in April and October each year, unless the ESPP Administrator
specifies other purchase date prior to the start of the applicable offering period), each participant&#146;s payroll deductions or other permitted form of contribution accumulated for the purchase interval ending on that purchase date will
automatically be applied to the purchase of whole shares of common stock at the purchase price in effect for the participant for that purchase date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Purchase Price </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purchase price
of the common stock acquired on each semi-annual purchase date will be fixed by the ESPP Administrator at the start of each offering period and will not be less than 85% of the<I>&nbsp;lower</I>&nbsp;of (i)&nbsp;the fair market value per share of
our common stock on the start date of the offering period or (ii)&nbsp;the fair market value on the purchase date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair market value
per share of our common stock on any particular date under the Purchase Plan will be deemed to be equal to the closing price per share on such date on the national stock exchange serving as the primary market for our common stock at that time. On
April&nbsp;17, 2018, the fair market value of our common stock determined on such basis was $19.52 per share, the closing price per share on that date on the Nasdaq Global Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Special Limitations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase
Plan imposes certain limitations upon a participant&#146;s rights to acquire common stock, including the following limitations: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Purchase rights granted to a participant may not permit such individual to purchase more than $25,000 worth of our common stock (valued at the time each purchase right is granted) for each calendar year those purchase
rights are outstanding at any time. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Purchase rights may not be granted to any individual if such individual would, immediately after the grant, own or hold outstanding options or other rights to purchase, stock possessing 5%&nbsp;or more of the total
combined voting power or value of all classes of our outstanding stock or the outstanding stock of any of our affiliates. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">No participant may purchase more than 2,000 shares of common stock on any one purchase date or more than 8,000 shares per offering period. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The maximum number of shares of common stock purchasable in total by all participants on any one purchase date will be limited to 200,000 shares. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP Administrator will have the discretionary authority to increase or decrease the per participant and total participant purchase
limitations as of the start date of any new offering period under the Purchase Plan, with the new limits to be in effect for that offering period and each subsequent offering period. As indicated above, the applicable limitations will be adjusted
for any stock split, stock dividend, stock reclassification or similar transaction affecting the number of shares of our outstanding common stock without our receipt of consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Termination of Purchase Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The participant may withdraw from the Purchase Plan at any time up to the next scheduled purchase date, and his or her accumulated payroll
deductions or other permitted contributions for the purchase interval in which that purchase date occurs will, at the participant&#146;s election, either be applied to the purchase of shares on the next scheduled purchase date or be refunded
immediately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The participant&#146;s purchase right will immediately terminate upon his or her cessation of employment or loss of eligible
employee status. Any payroll deductions or other permitted contributions which the participant may have made for the purchase interval in which such cessation of employment or loss of eligibility occurs will be refunded and will not be applied to
the purchase of common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No participant will have any stockholder rights with respect to the shares covered by his or her purchase rights until the shares are actually
purchased on the participant&#146;s behalf and the participant has become a holder of record of the purchased shares. No adjustment will be made for dividends, distributions or other rights for which the record date is prior to the date of such
purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Assignability </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No
purchase rights will be assignable or transferable by the participant, and the purchase rights will be exercisable only by the participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change
in Control </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should we be acquired by merger, or should there occur a sale of substantially all of our assets or of securities
possessing more than 50% of the total combined voting power of our outstanding securities, then all outstanding purchase rights will automatically be exercised immediately prior to the effective date of such transaction. The purchase price will not
be less than 85% of the<I>&nbsp;lower</I>&nbsp;of (i)&nbsp;the fair market value per share of common stock on the start date of the offering period in which such transaction occurs or (ii)&nbsp;the fair market value per share of common stock
immediately prior to such transaction. The actual percentage purchase price will be equal to the percentage purchase price previously set by the ESPP Administrator for the offering period in which the transaction occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation on the maximum number of shares purchasable by each participant (but not the limitation on all participants in the aggregate)
on any one purchase date will be applicable to any purchase date attributable to such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Share
<FONT STYLE="white-space:nowrap">Pro-Ration</FONT> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should the total number of shares of common stock to be purchased pursuant to
outstanding purchase rights on any particular date exceed the number of shares then available for issuance under the Purchase Plan, then the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ESPP Administrator will make a <FONT STYLE="white-space:nowrap">pro-rata</FONT> allocation of the available shares on a uniform and nondiscriminatory basis, and the payroll deductions or other
permitted contributions of each participant, to the extent in excess of the aggregate purchase price payable for the common stock <FONT STYLE="white-space:nowrap">pro-rated</FONT> to such individual, will be refunded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Duration, Amendment and Termination </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Plan was originally adopted by our Board of Directors on March&nbsp;31, 2010 and by our stockholders on June&nbsp;2, 2010. The
Purchase Plan will terminate upon the earliest to occur of (i)&nbsp;the last business day in April&nbsp;2020, (ii)&nbsp;the date on which all shares available for issuance thereunder are sold pursuant to exercised purchase rights or (iii)&nbsp;the
date on which all purchase rights are exercised in connection with a change in control or ownership. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP Administrator may alter or
amend the Purchase Plan at any time to become effective as of the start date of the next offering period thereafter. In addition, the ESPP Administrator may suspend or terminate the Purchase Plan at any time to become effective immediately following
the close of any purchase interval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In no event may our Board of Directors effect any of the following amendments or revisions to the
Purchase Plan without the approval of the stockholders: (i)&nbsp;increase the number of shares of our common stock issuable under the Purchase Plan, except for permissible adjustments in the event of certain changes in our capitalization or
(ii)&nbsp;modify the eligibility requirements for participation in the Purchase Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Purchase Plan Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth, as to the individuals and groups indicated, the number of shares of our common stock purchased under the
Purchase Plan from its original effective date through April&nbsp;17, 2018 and the weighted average purchase price paid per share. As described above, only our employees are eligible to purchase shares of our common stock under the Purchase Plan.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7.5pt; font-family:Times New Roman"><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number&nbsp;of<BR>Shares<BR>Purchased&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Weighted<BR>Average<BR>Purchase<BR>Price&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President and Chief Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Ward Wolff(1)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Former Executive Vice President and Chief Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;3.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President and Chief Medical Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;4.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts, III</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President and Chief Business Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">24,522</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;4.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers as a group (5&nbsp;persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;3.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All employees, including current officers who are not executive officers, as a group
(173&nbsp;persons)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,215,871</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;3.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Mr.&nbsp;Wolff retired from his position as Executive Vice President and Chief Financial Officer effective as of February&nbsp;28, 2017. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Reflects the number of our employees who have previously purchased shares under the Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participation in the
Purchase Plan is voluntary and each eligible employee will make his or her own decision regarding whether and to what extent to participate in the Purchase Plan. It is, therefore, not possible to determine the benefits or amounts that will be
received in the future by individual employees or groups of employees under the Purchase Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Federal Income Tax Consequences </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the principal United States federal income taxation consequences to participants and us with respect to
participation in the Purchase Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current federal
income tax rules and therefore is subject to change when those rules change. The Purchase Plan is not qualified under the provisions of Section&nbsp;401(a) of the Code and is not subject to any of the provisions of the Employee Retirement Income
Security Act of 1974, as amended. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Plan is intended to be an &#147;employee stock purchase plan&#148; within the meaning of
Section&nbsp;423 of the Code. Under a plan which so qualifies, no taxable income will be recognized by a participant, and no deductions will be allowable to us, upon either the grant or the exercise of the purchase rights. Taxable income will not be
recognized by the participant until there is a sale or other disposition of the shares acquired under the Purchase Plan or in the event the participant should die while still owning the purchased shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the participant sells or otherwise disposes of the purchased shares within two years after the start date of the offering period in which
such shares were acquired or within one year after the purchase date of those shares, then the participant will recognize ordinary income in the year of sale or disposition equal to the amount by which the fair market value of the shares on the
purchase date exceeded the purchase price paid for those shares, and we will be entitled to an income tax deduction, for the taxable year in which such sale or disposition occurs, equal in amount to such excess. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the participant sells or disposes of the purchased shares more than two years after the start date of the offering period in which the
shares were acquired and more than one year after the purchase date of those shares, then the participant will recognize ordinary income in the year of sale or disposition equal to the lesser of (i)&nbsp;the amount by which the fair market value of
the shares on the sale or disposition date exceeded the purchase price paid for those shares or (ii)&nbsp;15%&nbsp;of the fair market value of the shares on the start date of that offering period, and any additional gain upon the disposition will be
taxed as a long-term capital gain. We will not be entitled to an income tax deduction with respect to such sale or disposition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the
participant still owns the purchased shares at the time of death, then the participant will recognize ordinary income at such time equal to the lesser of (i)&nbsp;the amount by which the fair market value of the shares on the date of death exceeds
the purchase price or (ii)&nbsp;15%&nbsp;of the fair market value of the shares on the start date of the offering period in which those shares were acquired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of this Proposal No.&nbsp;4 requires votes &#147;FOR&#148; from holders of a majority of the stock having voting power present in
person or represented by proxy at the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Board of Directors recommends that the stockholders vote FOR the adoption of the amendment to the 2010 Employee Stock Purchase Plan to
increase the share reserve by 2,500,000 shares. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL NO. 5: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit Committee has appointed Ernst&nbsp;&amp; Young LLP, our independent registered public accounting firm during 2017,
to serve in the same capacity for the year ending December&nbsp;31, 2018, and is asking the stockholders to ratify this appointment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of Ernst&nbsp;&amp;
Young LLP as our independent registered public accounting firm. However, the Audit Committee is submitting the selection of Ernst&nbsp;&amp; Young LLP to the stockholders for ratification as a matter of good corporate practice. In the event the
stockholders fail to ratify the appointment, the Audit Committee will reconsider its selection. Even if the selection is ratified, the Audit Committee in its discretion may direct the appointment of a different independent registered public
accounting firm at any time during the year if the Audit Committee believes that such a change would be in the best interests of Sangamo and its stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A representative of Ernst&nbsp;&amp; Young LLP is expected to be present at the annual meeting and will have the opportunity
to make a statement if he or she desires to do so, and will be available to respond to appropriate questions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Principal Accounting Fees and Services
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table presents fees for professional audit services rendered by Ernst&nbsp;&amp; Young LLP for the audit
of our annual financial statements for 2017 and 2016, and fees billed for other services rendered by Ernst&nbsp;&amp; Young LLP during 2017 and 2016: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit fees and expenses (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,415,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,194,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit - related fees </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax fees (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All other fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,458,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,238,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Includes fees and expenses for the audit of our annual financial statements included in our annual reports on
Forms <FONT STYLE="white-space:nowrap">10-K</FONT> and the related audit of internal control over financial reporting, review of interim financial statements included in our quarterly reports on Forms <FONT STYLE="white-space:nowrap">10-Q,</FONT>
consultations regarding accounting and auditing matters, fees in connection with our future public offering of shares of our common stock under the &#147;at the market&#148; agreement, fees in connection with the filing of our registration
statements on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> and related amendments and services normally provided in connection with statutory and regulatory filings. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of fees billed for professional services for tax compliance, tax advice and tax planning.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Policy on Audit Committee <FONT STYLE="white-space:nowrap">Pre-Approval</FONT> of Audit and Permissible <FONT
STYLE="white-space:nowrap">Non-Audit</FONT> Services </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under its charter, the Audit Committee must <FONT
STYLE="white-space:nowrap">pre-approve</FONT> all engagements of the independent registered public accounting firm for the performance of all audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services that are not prohibited and the fees
for such services. The Audit Committee has delegated to its Chairman the authority to evaluate and approve </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
service engagements on behalf of the full committee in the event a need arises for specific <FONT STYLE="white-space:nowrap">pre-approval</FONT> between committee meetings. If the Chairman
approves any such engagements, he will report such approval to the full Audit Committee not later than the next committee meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit Committee has determined that the rendering of other professional services for tax compliance and tax advice by
Ernst&nbsp;&amp; Young LLP is compatible with maintaining their independence. The Audit Committee has established a policy governing our use of Ernst&nbsp;&amp; Young LLP for <FONT STYLE="white-space:nowrap">non-audit</FONT> services. Under the
policy, management may use Ernst&nbsp;&amp; Young LLP for <FONT STYLE="white-space:nowrap">non-audit</FONT> services that are permitted under SEC rules and regulations, provided that management obtains the Audit Committee&#146;s approval before such
services are rendered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The services provided by Ernst&nbsp;&amp; Young LLP in 2017 were
<FONT STYLE="white-space:nowrap">pre-approved</FONT> in accordance with this policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Approval of this Proposal No.&nbsp;5
requires votes &#147;FOR&#148; from holders of a majority of the stock having voting power present in person or represented by proxy at the Annual Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Recommendation of the Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Board of Directors recommends that the stockholders vote FOR the ratification of the appointment of Ernst&nbsp;&amp;
Young LLP to serve as our independent registered public accounting firm for the year ending December&nbsp;31, 2018. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board knows of no other matters that will be presented for consideration at the annual meeting. If any other matters
properly come before the annual meeting, it is the intention of the persons named in the accompanying proxy to vote the shares they represent in accordance with their best judgment. Discretionary authority with respect to such other matters is
granted by the execution of your proxy card. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth information regarding our executive officers as of April&nbsp;24, 2018: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:27.50pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">55</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">47</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Vice President and Chief Financial Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;(Principal Financial and Accounting Officer)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heather D. Turner</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">45</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, General Counsel and Secretary</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">45</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President and Chief Medical Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts, III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">37</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President and Chief Business Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Alexander D. Macrae.</I> Biographical information regarding Dr.&nbsp;Macrae is set forth
under &#147;Proposal No.&nbsp;1: Election of Directors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Kathy Y. Yi </I>has served as our Senior Vice President
and Chief Financial Officer since February 2017. Ms.&nbsp;Yi has over 17 years of experience in corporate finance, including financial analysis in support of M&amp;A transactions, licensing and other business development activities. Prior to joining
us, Ms.&nbsp;Yi served as Head of Finance for Global Inhalation Technical Research&nbsp;&amp; Development at Novartis Pharmaceutical Corporation since 2014. From 2007 to 2014, Ms.&nbsp;Yi held various financial management positions of increasing
seniority at Life Technologies Corporation, a Nasdaq-listed life science company that was acquired by Thermo Fisher Scientific in 2014, including Finance Leader, Corporate FP&amp;A from 2012 to 2014, Director of Finance, M&amp;A/Corporate
Development from 2010 to 2012, and Director of Finance, Global Manufacturing Operations from 2007 to 2010. From 2001 to 2007, Ms.&nbsp;Yi held increasing roles of responsibilities in Corporate Finance at Intel Corporation. Ms.&nbsp;Yi began her
career as a process engineer for Bechtel Corporation. Ms.&nbsp;Yi received a B.S. in Chemical Engineering at the University of California at Berkeley and an M.B.A. from Columbia University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Heather D. Turner, J.D.</I>, has served as our Senior Vice President and General Counsel since February 2018, and as our
Secretary since March 2018. Ms.&nbsp;Turner has over 18 years of experience advising public and private life science companies on various matters, including corporate governance, compliance, reporting, public reporting, public offering, mergers and
acquisitions, and commercial, manufacturing and development contracts. Prior to joining us, from 2015 to February 2018, Ms.&nbsp;Turner was at Atara Biotherapeutics, Inc. where she served as executive vice president, general counsel and secretary,
and also, most recently, as head of portfolio strategy. From 2007 to 2015, she served as General Counsel and Secretary at Orexigen Therapeutics, Inc., where she led various general and administrative functions including compliance, risk management,
legal, human resources and facilities. Earlier in her career, she worked as an associate in the corporate securities group at Cooley LLP. Ms.&nbsp;Turner holds a J.D. from the University of California Los Angeles School of Law and is a member of the
State Bar of California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Edward R. Conner, M.D. </I>has served as our Senior Vice President and Chief Medical Officer
since November 2016. He has over 10 years of industry experience in early and late stage clinical development in a broad range of disease areas including rare diseases, oncology and infectious diseases. Prior to joining us, Dr.&nbsp;Conner served as
Vice President, Clinical Sciences at Ultragenyx Pharmaceuticals, a biopharmaceutical company developing novel products for the treatment of rare and ultra-rare diseases since January 2015. Prior to joining Ultragenyx, from October 2013 to November
2014, he served as Senior Medical Director at BioMarin Pharmaceutical Inc., where he led protocol development and regulatory interaction for its global phase 3 program in Pompe disease. From 2008 to 2013, Dr.&nbsp;Conner served as Medical Director
at Genentech, Inc. and was the clinical science team leader of several product candidates, one of which is now a commercial drug product. Dr.&nbsp;Conner completed his Internal Medicine residency training at the University of Michigan and was a
fellow in Clinical Immunology&nbsp;&amp; Allergic Diseases at Johns Hopkins School of Medicine. He received a B.S. in Biology, cum laude, from Duke University and his M.D. from the University of California, San Francisco. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Curt A. Herberts, III </I>has served as our Senior Vice President and
Chief Business Officer since December 2016 and oversees our business functions and plans for commercialization of its therapeutics. Mr.&nbsp;Herberts has over 10 years of experience in commercial strategy and corporate development. He joined us in
October 2010 as Director, Corporate Development and Strategy and was promoted to Senior Director in January 2012, and Vice President and Head of Corporate Development in July 2015. During this time, we established a number of collaborative
agreements, including global collaborations with Shire plc, in 2012, Biogen, Inc., in 2014, Pfizer Inc., in 2017 and Kite, a Gilead company in 2018. Prior to joining us, Mr.&nbsp;Herberts held several positions of increasing responsibility at
Campbell Alliance Group, Inc., including leadership roles in the corporate development and commercial strategy practice areas, from June 2006 to October 2010. Mr.&nbsp;Herberts holds an A.B. in Human Biology from Stanford University and a M.B.S.
from Keck Graduate Institute of Applied Life Sciences. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth certain information known to Sangamo with respect to the beneficial ownership of our common
stock as of April&nbsp;17, 2018, except as noted, by (i)&nbsp;all persons who were beneficial owners of five percent (5%) or more of our common stock based on 87,145,700 shares outstanding as of April&nbsp;17, 2018, (ii) each current director and
each nominee for director, (iii)&nbsp;the executive officers named in the Summary Compensation Table of the Executive Compensation of this Proxy Statement, and (iv)&nbsp;all current directors and executive officers as a group. Unless otherwise
indicated, the principal address of each of the stockholders below is c/o Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA 94804. Except as otherwise indicated or to the extent authority may be shared by both spouses under applicable
law, and subject to applicable community property laws, we believe the persons named in the table have sole voting and investment power with respect to all shares of common stock held by them. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares</B><br><B>&nbsp;&nbsp;Beneficially&nbsp;&nbsp;</B><br><B>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B><br><B>of Shares</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;Beneficially&nbsp;&nbsp;&nbsp;&nbsp;</B><br><B>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc. (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;55 East 52<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Street</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;New York, NY 10055</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,871,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.9%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FMR LLC (2)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;245 Summer Street</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Boston, MA 02210</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,355,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.1%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vanguard Group Inc. (3)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;100 Vanguard Blvd.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Malvern, PA 19355</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,479,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.1%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">470,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert F. Carey (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D. (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen G. Dilly, M.B.B.S., Ph.D. (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts III (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roger Jeffs (9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven J. Mento, Ph.D. (10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Stewart Parker (11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Saira Ramasastry (12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heather D. Turner</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Ward Wolff (13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi (14)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph S. Zakrzewski (15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current directors and executive officers as a group (12 persons) (16)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,017,504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.2%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Less than one percent. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">This information is based solely on information contained in the Schedule 13G/A filed with the SEC on
January&nbsp;23, 2018 by BlackRock, Inc. (&#147;BlackRock&#148;). BlackRock, as a parent holding company or control person, may be deemed to beneficially own the indicated shares and has sole dispositive power over 6,871,509 shares and sole voting
power over 6,707,510 shares. BlackRock reported its beneficial ownership on behalf of itself and the following: BlackRock International Limited, BlackRock Advisors, LLC, BlackRock (Netherlands) B.V., BlackRock Institutional Trust Company, National
Association, BlackRock Asset Management Ireland Limited, BlackRock Financial Management, Inc., BlackRock Japan Co., Ltd., BlackRock Asset Management Schweiz AG, BlackRock Investment Management, LLC, BlackRock Investment Management (UK) Limited,
BlackRock Asset Management Canada Limited, BlackRock (Luxembourg) S.A., BlackRock Investment Management (Australia) Limited, BlackRock Fund Advisors. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
The Schedule 13G/A provides information only as of December&nbsp;31, 2017 and, consequently, the beneficial ownership of the above-mentioned entities may have changed between December&nbsp;31,
2017 and April&nbsp;17, 2018. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">This information is based solely on information contained in the Schedule 13G filed with the SEC on
February&nbsp;13, 2018 by FMR LLC and Abigail P. Johnson. FMR LLC, as a parent holding company or control person, may be deemed to beneficially own the indicated shares and has sole dispositive power over 5,355,450 shares and sole voting power over
29 shares. FMR LLC reported its beneficial ownership on behalf of itself and certain of its subsidiaries and affiliates, and other companies. Abigail P. Johnson, as a Director, the Chairman, and the Chief Executive Officer of FMR LLC, may be deemed
to beneficially own the indicated shares and has sole dispositive power over 5,355,450 shares. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of
FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders&#146; voting agreement under which all Series B voting common shares will be voted in accordance
with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders&#146; voting agreement, members of the Johnson family may be deemed, under the Investment
Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the
Investment Company Act (&#147;Fidelity Funds&#148;) advised by Fidelity Management&nbsp;&amp; Research Company, a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds&#146; Board of Trustees. Fidelity Management&nbsp;&amp;
Research Company carries out the voting of the shares under written guidelines established by the Fidelity Funds&#146; Boards of Trustees. The Schedule 13G provides information only as of December&nbsp;31, 2017 and, consequently, the beneficial
ownership of the above-mentioned entities may have changed between December&nbsp;31, 2017 and April&nbsp;17, 2018. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">This information is based solely on information contained in the Schedule 13G filed with the SEC on
February&nbsp;9, 2018 by The Vanguard Group, Inc. (&#147;Vanguard&#148;). Vanguard may be deemed to beneficially own the indicated shares and has sole dispositive power over 4,316,104 shares, shared dispositive power over 163,865 shares, sole voting
power over 164,575 shares and shared voting power over 7,045 shares. Vanguard reported its beneficial ownership on behalf of itself and the following: Vanguard Fiduciary Trust Company and Vanguard Investments Australia, Ltd., each a wholly owned
subsidiary of Vanguard. The Schedule 13G provides information only as of December&nbsp;31, 2017 and, consequently, the beneficial ownership of the above-mentioned entities may have changed between December&nbsp;31, 2017 and April&nbsp;17, 2018.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Includes 470,000 shares of common stock subject to options exercisable within 60 days after April&nbsp;17,
2018. Excludes RSUs covering an additional 31,500 shares of common stock that may vest and become issuable more than 60 days after April&nbsp;17, 2018. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of 40,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;17, 2018,
of which 30,000 shares fully vest within 60 days of April&nbsp;17, 2018. The remaining 10,000 shares are currently exercisable but do not vest within 60 days of April&nbsp;17, 2018 and would be subject to repurchase upon cessation of service to
Board if exercised prior to vesting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Includes 50,000 shares of common stock subject to options exercisable within 60 days after April&nbsp;17,
2018. Excludes RSUs covering an additional 6,125 shares of common stock that may vest and become issuable more than 60 days after April&nbsp;17, 2018. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of 120,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;17, 2018.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Includes 7,958 shares of common stock subject to options exercisable within 60 days after April&nbsp;17, 2018.
Excludes RSUs covering an additional 14,625 shares of common stock that may vest and become issuable more than 60 days after April&nbsp;17, 2018. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of 30,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;17, 2018,
of which 9,166 shares fully vest within 60 days of April&nbsp;17, 2018. The remaining 20,834 shares are currently exercisable but do not vest within 60 days of April&nbsp;17, 2018 and would be subject to repurchase upon cessation of service to Board
if exercised prior to vesting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of 40,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;17, 2018.
Also includes 32,214 shares held in family trust. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of 80,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;17, 2018.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of 50,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;17, 2018
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Includes 109,478 shares of common stock subject to options exercisable within 60 days after April&nbsp;17,
2018. Mr.&nbsp;Wolff retired from his position as Executive Vice President and Chief Financial Officer effective as of February&nbsp;28, 2017. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Includes 52,500 shares of common stock subject to options exercisable within 60 days after April&nbsp;17,
2018. Excludes RSUs covering an additional 7,250 shares of common stock that may vest and become issuable more than 60 days after April&nbsp;17, 2018. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of 30,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;17, 2018,
of which 9,166 shares fully vest within 60 days of April&nbsp;17, 2018. The remaining 20,834 shares are currently exercisable but do not vest within 60 days of April&nbsp;17, 2018 and would be subject to repurchase upon cessation of service to Board
if exercised prior to vesting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The percentages are calculated based on 87,145,700 shares outstanding as of April&nbsp;17, 2018. Shares of
common stock issuable upon the exercise of options currently exercisable or exercisable within 60 days after April&nbsp;17, 2018, are deemed outstanding for purposes of computing the percentage ownership of the person holding such options, but are
not deemed outstanding for computing the percentage ownership of any other person. Because Mr.&nbsp;Wolff retired effective February&nbsp;28, 2017 and his last day of employment was March&nbsp;8, 2017, the number of shares and percentage ownership
indicated in the table above with respect to the beneficial ownership of all directors and executive officers as a group do not include any shares beneficially owned by Mr.&nbsp;Wolff. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMPENSATION DISCUSSION AND ANALYSIS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">It is our intent in this CD&amp;A to inform our stockholders of the policies and objectives underlying the compensation
programs for our executive officers. Accordingly, we will address and analyze the key elements of the compensation provided to our chief executive officer, the two individuals who served as our chief financial officers during 2017 and the other
executive officers named in the Summary Compensation Table which follows this discussion. We refer to these officers as our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Summary </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our Business </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that
transform patients&#146; lives using our industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found
in humans. We have used our knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically
modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this
platform, we have accrued significant scientific, manufacturing and regulatory capabilities and <FONT STYLE="white-space:nowrap">know-how</FONT> that are generally applicable in the broader field of gene therapy and have capitalized this knowledge
into a conventional gene therapy platform based on adeno-associated viral vector, or AAV, cDNA gene transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our Business Strategy </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our strategy is to maximize the value and therapeutic use of our technology platforms. In certain therapeutic areas we intend
to capture the value of our proprietary genome editing and gene therapy products by forward integrating into manufacturing, development and commercial operations. In other therapeutic areas we intend to partner with biopharmaceutical companies to
develop products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are focused on the development of human therapeutics for diverse diseases with well-characterized
genetic causes. We have several proprietary clinical and preclinical product candidates in development and have strategically partnered certain programs with biopharmaceutical companies to obtain funding for our own programs and to expedite clinical
and commercial development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2017 and Early 2018 Performance Highlights </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">During 2017, we received special regulatory designations for the following clinical programs:
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9671;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the U.S. Food and Drug Administration, or FDA, granted orphan drug designation to <FONT
STYLE="white-space:nowrap">SB-318,</FONT> our genome editing product candidate for the treatment of Mucopolysaccharidosis Type I, or MPS I; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9671;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA granted rare pediatric disease designation for <FONT STYLE="white-space:nowrap">SB-318;</FONT>
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9671;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA granted orphan drug designation to <FONT STYLE="white-space:nowrap">SB-913,</FONT> our genome editing
product candidate for the treatment of Mucopolysaccharidosis Type II, or MPS II; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9671;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">from the European Medicines Agency, or EMA, we obtained EMA Recommendation of Orphan Medicinal Product
Designation for Investigational Genome Editing Treatments for MPS I and MPS II. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In January 2017, the FDA allowed our Investigational New Drug, or IND, application for <FONT
STYLE="white-space:nowrap">SB-525,</FONT> a cDNA gene therapy for the treatment of hemophilia A. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In May 2017, we entered into a global collaboration and license agreement with Pfizer Inc., or Pfizer, for the
research, development, and commercialization of <FONT STYLE="white-space:nowrap">SB-525</FONT> and closely related products. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In June 2017, we completed an underwritten public offering of our common stock, in which 11.5&nbsp;million
shares of our common stock were sold at a public offering price of $7.25 per share. Net proceeds after deducting underwriting discounts and commissions and other estimated offering expenses, were appropriately $78.1&nbsp;million.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In October 2017, the FDA accepted an IND application for <FONT STYLE="white-space:nowrap">ST-400,</FONT> a
gene-edited cell therapy candidate for people with transfusion-dependent beta-thalassemia. We are developing <FONT STYLE="white-space:nowrap">ST-400</FONT> as part of an exclusive worldwide collaboration with Bioverativ Inc. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In November 2017, we treated the first patient in the Phase 1/2 clinical trial evaluating <FONT
STYLE="white-space:nowrap">SB-913.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In December 2017, we entered into a new research collaboration and license agreement with Pfizer for the
development and commercialization of potential gene therapy products that use zinc finger proteins transcription factors, or ZFP TFs, to treat amyotrophic lateral sclerosis, or ALS, and frontotemporal lobar degeneration, or FTLD, linked to mutations
of the <I>C9ORF72</I> gene. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In February 2018, together with Case Western Reserve University, we announced an $11&nbsp;million grant from
the National Institutes of Health for a planned study of gene-edited T cells designed to eradicate persistent HIV infection in patients receiving anti-retroviral therapy. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In February 2018, we entered into a global collaboration and license agreement with Kite Pharma, Inc., a
wholly-owned subsidiary of Gilead Sciences, Inc., for the research, development and commercialization of potential engineered cell therapies for cancer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Alignment of Executive Compensation Program with Business Strategy </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pharmaceutical research, development and commercialization require sustained and focused effort over many years, and involves
a high degree of risk, particularly in the early stages of clinical development. As a consequence, the Compensation Committee believes our compensation program must balance long-term incentives that rewards for the realization of our long-term
strategic objectives with near-term compensation that rewards for the achievement of annual goals that further the attainment of our long-term objectives and align the interests of our executives with those of our stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee generally believes that a formulaic or purely quantitative approach to executive compensation is
not the best way to foster long-term success for us as a clinical stage biotechnology company that is not yet profitable. Instead, the Compensation Committee sets annual performance objectives on which it believes our executive officers should focus
during the year in order to achieve our business goals, including, for 2017, aggressive <FONT STYLE="white-space:nowrap">pre-established</FONT> clinical, research and development, business and corporate development objectives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee strives to create a positive relationship between
its compensation program and our corporate performance and considers competitive market dynamics, the business environment in which the results were achieved and any unplanned positive or negative events when making compensation decisions. A
significant portion of the total compensation opportunity for each of our named executive officers is directly related to our stock price and to other performance factors that measure our progress against our strategic objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In order to assure that the compensation programs for our named executive officers remain competitive with peer companies,
accomplish our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> objectives, and create rewards for the realization of our long-term strategic objectives, the Compensation Committee works with
Radford to obtain the advice and market data needed to ensure that the compensation programs achieve these goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Key Features of Our Executive
Compensation Program </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>&nbsp;What We Do</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>&nbsp;What We Don&#146;t Do</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#4fddff">&nbsp;&#10003;</FONT> Design executive compensation to align pay with performance</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#4fddff">&nbsp;&#10003;</FONT> Emphasize performance-based compensation,
with 100% of CEO&#146;s cash incentive compensation based on <FONT STYLE="white-space:nowrap">pre-established</FONT> corporate performance goals</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#4fddff">&nbsp;&#10003;</FONT> Cap the cash incentive plan payouts</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#4fddff">&nbsp;&#10003;</FONT> Subject our program to independent review by the Compensation Committee&#146;s independent compensation
consultant</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#4fddff">&nbsp;X</FONT> Provide tax <FONT STYLE="white-space:nowrap">gross-ups</FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#4fddff">&nbsp;X</FONT> Allow repricing stock options without stockholder
approval</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#4fddff">&nbsp;X</FONT> Offer significant perquisites or
personal benefits to our named executive officers</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#4fddff">&nbsp;X</FONT> Allow hedging or pledging of our securities by employees</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#4fddff">&nbsp;X</FONT> Offer a defined benefit pension plan, deferred
compensation plan or supplemental executive retirement plan</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How We Determine Executive Compensation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Role of the Compensation Committee and Executive Officers </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee assists the Board of Directors in fulfilling its fiduciary responsibilities with respect to the
oversight of our affairs in the areas of our compensation plans, policies and programs, especially those regarding executive compensation and employee benefits. Either the Compensation Committee or the independent members of our Board of Directors,
upon recommendation from the Compensation Committee, approve compensation of our Dr.&nbsp;Macrae, and references in this CD&amp;A to our Board of Directors approving Dr.&nbsp;Macrae&#146;s compensation refer to the independent members of our Board
of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee&#146;s responsibilities include (i)&nbsp;adopting, administering and reviewing
compensation plans and programs for our executive officers, including incentive and equity plans and programs; (ii)&nbsp;approving compensation arrangements for our executive officers; (iii)&nbsp;evaluating the performance of our executive officers;
(iv)&nbsp;adjusting compensation arrangements as appropriate based upon performance; (v)&nbsp;reviewing, considering and approving compensation programs applicable to <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Board of
Directors; (vi)&nbsp;reviewing and monitoring management development and succession plans and activities and (vii)&nbsp;administering, concurrently with the Board of Directors, the 401(k) Plan. The Compensation Committee does not delegate any of its
functions to others in determining executive compensation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In making executive compensation determinations, the Compensation Committee
considers recommendations from Dr.&nbsp;Macrae. In making his recommendations, Dr.&nbsp;Macrae receives input from our human resources department and from the individuals who manage the other executive officers. While Dr.&nbsp;Macrae discusses his
recommendations for the other executive officers with the Compensation Committee, he does not participate in the deliberations or determination of his own compensation. Members of our finance, human resources and legal departments also attend
Compensation Committee meetings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Objectives of Our Compensation Program </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are focused on translating groundbreaking science into genomic therapies that transform people&#146;s lives using our
platform technologies in genome editing, gene therapy, gene regulation and cell therapy. To achieve this strategic business objective, we emphasize recruiting executives with significant industry or scientific experience, including in the areas of
clinical development, medical affairs, product development, commercial planning and research innovation. This is a highly competitive industry and our success depends upon our ability to attract and retain qualified executives through competitive
compensation packages. The Compensation Committee administers the compensation programs for our executive officers with this competitive environment and need to attract and retain qualified executives in mind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To this end, the primary objectives of our compensation program are to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; text-indent:2%">


<IMG SRC="g573774g06r49.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Factors Used in Determining Executive Compensation </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee sets the compensation of our executive officers at levels that the Compensation Committee
determines to be competitive and appropriate for each named executive officer, using the Compensation Committee&#146;s professional experience and judgment. The Compensation Committee does not use a formulaic approach to setting executive pay, but
rather it considers multiple relevant factors, which may vary from year to year. The figure below reflects the factors the Compensation Committee generally considers in determining and approving the amount, form and mix of pay for our named
executive officers. In the case of Dr.&nbsp;Macrae, the Compensation Committee also evaluates his performance against our annual goals and longer-term objectives <FONT STYLE="white-space:nowrap">pre-established</FONT> by the Board of Directors,
together with market data regarding executive compensation at comparable companies and realized and realizable values under previous equity awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g573774g06d72.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Role of Independent Compensation Consultant </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee retained the services of Radford in order to (i)&nbsp;assess compensation levels and mix of
elements for our executive officers and vice presidents for 2017, (ii) review the peer group selection criteria and specific peer companies and (iii)&nbsp;advise the Compensation Committee on executive compensation and governance trends based on
peer group trends and market practices. In 2017, Radford also provided comparative data in connection with setting the compensation for Ms.&nbsp;Yi when she joined us and for Mr.&nbsp;Herberts at the time of his promotion. The Compensation Committee
determined that Radford was independent using criteria established by Nasdaq for evaluating the independence of advisors to the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Comparative Analysis </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of measuring the competitive positioning of our compensation packages, peer companies are generally selected by
the Compensation Committee primarily using the following criteria: (i)&nbsp;companies that fall within a specific market capitalization range of approximately <FONT STYLE="white-space:nowrap">one-third</FONT> to three times our market capitalization
at the time of the peer evaluation ($100M to $1B at the time we selected our 2017 peer group); (ii) biotechnology companies in the same sector with an emphasis towards <FONT STYLE="white-space:nowrap">pre-commercial</FONT> companies;
(iii)&nbsp;companies with 50 to 500 employees. In addition, we prefer companies that are headquartered in the San Francisco Bay Area where we both recruit and may lose executive talent. Because the biotechnology industry is a dynamic industry, the
comparator group used by the Compensation Committee to measure the competitive positioning of our compensation packages is periodically updated to ensure that companies continue to meet the established criteria. At the time the peer group was
established, our market capitalization was comparable to the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of the peers, validating the reasonableness of the peer group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The selected comparable companies for purposes of making compensation decisions for 2017, or the 2017 peer group, were as
follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Audentes Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Infinity Pharmaceuticals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">bluebird bio</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Intellia Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Celldex Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">MannKind</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">ChemoCentryx</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Osiris Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Cytokinetics</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Peregrine Pharmaceuticals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Dimension Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REGENXBIO</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Dynavax Technologies</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Rigel Pharmaceuticals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Editas Medicine</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Spark Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Geron</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ultragenyx Pharmaceutical</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">ImmunoGen</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Voyager Therapeutics</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Use of Comparative Data </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">When setting pay, the Compensation Committee examines the market data derived by Radford from the peer group that ranges from
the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to the 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentiles. We do not have a set formula or benchmark for pay, but rather the Compensation Committee references the
market data as one input before making position-specific compensation decisions. We generally seek to manage compensation between the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and
75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentiles of the peer group data, if warranted by performance and other factors the compensation committee considers relevant in making specific decisions. A specific executive officer may
be paid below or above the target range based on individual performance, experience, skills and the importance of the executive&#146;s position to us. The Compensation Committee considers this positioning appropriate given that we are based in the
San Francisco Bay Area where there is a high concentration of talent competitors creating competitive pressure that requires us to ensure that our overall compensation program is competitive to attract and retain strong leadership for our long-term
success based on performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2017 Advisory Vote on Executive Compensation </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At the 2017 Annual Meeting, we conducted our third advisory vote on executive compensation. At such meeting, approximately 81%
of the votes cast on the advisory vote proposal were supportive of our named executive officer compensation program as disclosed in our proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board of Directors and Compensation Committee reviewed the advisory vote results in the context of our overall
compensation philosophy and programs, and based on the level of support, determined that no significant changes to our compensation policies and programs were necessary. The Compensation Committee will continue to take into account future
stockholder advisory votes on executive compensation and other relevant market developments affecting executive officer compensation in order to determine whether any subsequent changes to our executive compensation programs and policies would be
warranted to reflect any stockholder concerns reflected in those advisory votes or to address market developments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Design of the Executive
Compensation Program and Key Components </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Target Total Compensation </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As discussed above, the development and commercialization of pharmaceutical products involves a high degree of risk,
particularly in the early stages of clinical development. The Compensation Committee regularly evaluates the relative importance of equity and cash components of total compensation when determining the level and structure of annual pay based on the
business priorities established by the Board. Target total compensation for 2017, as shown below for Dr.&nbsp;Macrae, reflects annual base salary, annual target cash incentive bonus and the grant date fair value of stock options granted during the
year (as such stock options are reported in the Summary Compensation Table). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g573774g91g84.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Key Elements of Our Executive Compensation Program </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="33%"></TD></TR>
<TR BGCOLOR="#143fdd" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Component</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Key
Features</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Purpose</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="32" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="32" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="32" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt"><B>Base Salary</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Fixed cash compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Enables us to
attract and retain skilled and experienced executives and to provide a level of economic security for executives from year to year</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;No amount is guaranteed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="29" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="29" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="29" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Amounts are reviewed and determined
annually</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Provides fixed level of compensation that is competitive within our industry and geographic
area</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Amounts
determined based on individual performance, experience, skills and the importance of the executive&#146;s position</P> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="34%"></TD></TR>

<TR BGCOLOR="#143fdd" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Component</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Key
Features</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Purpose</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="27" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="27" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="27" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt"><B>Cash Incentive Awards</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Cash compensation under the Sangamo
Therapeutics, Inc. Incentive Compensation Plan, or the Incentive Plan, which is dependent upon achievement of performance objectives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Provides each
executive officer with a direct financial incentive in the form of a cash incentive award tied to our achievement of aggressive <FONT STYLE="white-space:nowrap">pre-established</FONT> clinical, research and development, business and corporate
development goals for the year based on our annual operating plan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Target amounts are reviewed and
determined annually and expressed as a percentage of base salary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Helps ensure that our total cash compensation is competitive when compared to the peer
companies</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="27" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="27" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="27" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Actual
amounts paid are based on the extent corporate objectives are attained as determined by the Compensation Committee, and for executive officers other than Dr.&nbsp;Macrae, on the achievement of <FONT STYLE="white-space:nowrap">pre-established</FONT>
individual goals that align with our overall priorities</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Ensures that a portion of each executive&#146;s cash compensation is contingent on goal
achievement, thereby increasing the performance-based component of each executive&#146;s total compensation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="27" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="27" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="27" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Compensation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Generally in the form of stock options
and/or restricted stock units, or RSUs, which are <FONT STYLE="white-space:nowrap">&#147;at-risk&#148;</FONT> because the realized value is dependent upon our stock price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Provides long-term
incentives that align the interests of our work force with the achievement of our long-term vision to develop and commercialize pharmaceutical products</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="32" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="32" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;The exercise price for stock options is
equal to the closing price of our stock on the option grant date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Given the time periods involved in pharmaceutical development, we believe that these long-term
incentives are critical to our success to provide long-term focus, aid in retention and mitigate short-term risk taking</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Each
RSU entitles the recipient to one share of our common stock at a designated issue date following the vesting of that unit, without the payment of an exercise price or other cash consideration for the issued share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"> <P STYLE="font-size:50pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Stock options produce realizable value to the holder only if our stock price increases over the
period of time that the award remains outstanding</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="34%"></TD></TR>

<TR BGCOLOR="#143fdd" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Component</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Key
Features</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Purpose</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Executives are eligible for equity awards in connection with annual performance reviews, and at
time of hire</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;RSUs reduce the dilutive effect of the equity incentive awards and provide us with the ability to
compete for talent and provide retention incentives</P> <P STYLE="font-size:48pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2017 Compensation Decisions </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2017 Base Salary </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
general, the base salaries of our named executive officers for 2017 were between the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentiles of the market data derived from
the peer group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In accordance with our practice, in December 2016 we conducted annual performance reviews for 2016 for
the named executive officers. The Compensation Committee considered these reviews, our 2016 performance, advice from Radford and competitive data from the peer group. In early 2017, the Compensation Committee determined (i)&nbsp;not to increase
Mr.&nbsp;Wolff&#146;s base salary because Mr.&nbsp;Wolff had announced his intent to retire as Executive Vice President and Chief Financial Officer, (ii)&nbsp;not to increase Dr.&nbsp;Conner&#146;s base salary because it had recently been determined
at the time of his commencement of employment in November 2016 and (iii)&nbsp;to increase Mr.&nbsp;Herbert&#146;s base salary by 1% given his competitive position in the peer group range and in comparison to internal peers. In early 2017, the Board
of Directors approved a modest increase in annual base salary for Dr.&nbsp;Macrae in line with the average increase for other employees after reviewing his competitive position in the peer group range. The base salary for Ms.&nbsp;Yi was established
in connection with her commencement of employment in February 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Base&nbsp;Salary&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Base&nbsp;Salary&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B><br><B>&nbsp;&nbsp;Increase&nbsp;&nbsp;</B></TD></TR>


<TR BGCOLOR="#e2f4fc" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$612,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$600,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$350,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&#151;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">N/A</TD></TR>
<TR BGCOLOR="#e2f4fc" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Ward Wolff (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$422,500</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$422,500</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">0%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D. (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$400,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$400,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">0%</TD></TR>
<TR BGCOLOR="#e2f4fc" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts, III (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$343,400</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$340,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">1%</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Effective as of February&nbsp;28, 2017 upon commencement of Ms.&nbsp;Yi&#146;s employment as Senior Vice
President and Chief Financial Officer. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Wolff retired from his position as Executive Vice President and Chief Financial Officer effective as
of February&nbsp;28, 2017. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dr.&nbsp;Conner commenced employment as Senior Vice President and Chief Medical Officer in November 2016.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Herberts was promoted to Senior Vice President and Chief Business Officer in November 2016.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2017 Cash Incentive Compensation </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We adopted 2017 Executive Officer Bonus Program, or the 2017 Cash Incentive Program, under the Incentive Plan that provides
for annual bonus awards to reward executive officers based on our achievement of specific corporate goals and their achievement of individual performance goals. For 2017, the target cash incentive for Dr.&nbsp;Macrae was 60% of base salary and for
each of our other named executive officers it was 35% of base salary. Dr.&nbsp;Macrae&#146;s cash incentive opportunity was based solely on corporate performance and each of our other named executive officer&#146;s cash incentive opportunity was
allocated between Company and individual performance (80% and 20%, respectively). Mr.&nbsp;Wolff retired prior to the adoption of the 2017 Cash Incentive Program, and thus was not eligible to receive an award under the 2017 Cash Incentive Program.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The clinical, research and development, business and corporate development objectives and weightings under the 2017 Cash
Incentive Program adopted in March 2017 are described in the chart below. The 2017 Cash Incentive Program also included a business development transaction objective that provided the opportunity to earn an additional payout in the event of certain
business development transactions, as further described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2018, the Compensation Committee determined
that our 2017 corporate objectives were attained at 104%, as further described below. In addition, the Compensation Committee approved individual achievement percentages for our named executive officers (other than Dr.&nbsp;Macrae, whose cash
incentive opportunity was tied solely to the achievement of the corporate objectives as approved by the Board of Directors) based on Dr.&nbsp;Macrae&#146;s assessment of and recommendations regarding each executive&#146;s accomplishments against <FONT
STYLE="white-space:nowrap">pre-established</FONT> individual objectives, as further described below. In January 2018, the Board of Directors confirmed the overall corporate achievement percentage of 104% and the Compensation Committee (and the Board
of Directors with respect to Dr.&nbsp;Macrae) approved the bonus payout amounts described below for our named executive officers. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g573774g23x22.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee and Board of Directors assessed the degree to which the 2017 Cash
Incentive Program were met based on the factors described below and determined the achievement percentages described below in January 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#143fdd">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#143fdd" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#ffffff"><B>&nbsp;&nbsp;Performance&nbsp;Category</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center"><FONT COLOR="#ffffff"><B>Objective and Achievement</B></FONT></TD></TR>
<TR BGCOLOR="#9e0c77" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" COLSPAN="3" ALIGN="center"><FONT COLOR="#ffffff"><B>LEAD ASSETS</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Hemophilia B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to enroll and successfully dose cohort 3, we
achieved the following: (i)&nbsp;short period of time from final protocol to first site active and from first site active to first subject screened; (ii)&nbsp;four sites activated; (iii)&nbsp;three subjects screened; (iv)&nbsp;positive
Medicines&nbsp;&amp; Healthcare products Regulatory Agency Scientific Advice meeting and feedback received with recommendation to file Clinical Trial Application, or CTA, with pediatric cohort; (v)&nbsp;first CTA for in vivo gene editing in the EU
(UK) completed by year end; and (vi)&nbsp;FDA Fast Track designation granted. These achievements contributed 2% toward our overall corporate achievement percentage.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#fff7c6" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;MPS I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to enroll and successfully dose cohort 2 with
path identified to pivotal studies, we achieved the following: (i)&nbsp;short period of time from final protocol to first site active and from first site active to first subject screened; (ii)&nbsp;seven sites activated; (iii)&nbsp;six subjects
screened; (iv)&nbsp;FDA Orphan Drug designation granted; (v)&nbsp;FDA Fast Track designation granted; (vi)&nbsp;FDA Rare Pediatric Disease designation granted; (vii)&nbsp;EU Orphan Drug designation granted; and (viii)&nbsp;amendment accepted to
allow for transplant and international patients to be considered. These achievements contributed 2% toward our overall corporate achievement percentage.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;MPS II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to enroll and successfully dose cohort 2 with
path identified to pivotal studies, we achieved the following: (i)&nbsp;short period of time from final protocol to first site active and from first site active to first subject screened; (ii)&nbsp;seven sites activated; (iii) 11 subjects screened;
(iv)&nbsp;first patient dosed; (v)&nbsp;Scientific Advice meeting in preparation for CTA submission in the EU; (vi)&nbsp;FDA Orphan Drug designation granted; (vii)&nbsp;FDA Fast Track designation granted; (viii)&nbsp;FDA Rare Pediatric designation
granted; and (ix)&nbsp;EU Orphan Drug designation granted. These achievements contributed 6% toward our overall corporate achievement percentage.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#fff7c6" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Hemophilia A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to understand pharmacodynamics sufficiently well
to identify the right dose for competitive product in the U.S. and EU, we achieved the following: (i)&nbsp;short period of time from final protocol to first site active and from first site active to first subject screened; (ii)&nbsp;eight sites
activated; (iii)&nbsp;first dose cohort enrolled, and Safety Monitoring Committee meeting held; (iv) FDA Orphan Drug designation granted; (v)&nbsp;EMA Orphan Drug designation granted; (vi)&nbsp;FDA Fast Track designation granted; (vii)&nbsp;protocol
amendment to allow expedited dosing decision between cohorts by Safety Monitoring Committee filed, and FDA allowed; (viii)&nbsp;EU Scientific Advice meeting planned; and (ix)&nbsp;on track with partner goals. These achievements contributed 6% toward
our overall corporate achievement percentage.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#143fdd">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#143fdd" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#ffffff">&nbsp;&nbsp;</FONT><FONT COLOR="#ffffff"><B>Performance&nbsp;Category</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center"><FONT COLOR="#ffffff"><B>Objective and Achievement</B></FONT></TD></TR>
<TR BGCOLOR="#9e0c77" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" COLSPAN="3" ALIGN="center"><FONT COLOR="#ffffff"><B>LEAD ASSETS</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Beta Thalassemia</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to complete required <FONT
STYLE="white-space:nowrap">IND-enabling</FONT> studies, submit IND, and be prepared to initiate Phase 1 study, or achieve all partner deliverables, we achieved the following: (i)&nbsp;IND completed as targeted; (ii)&nbsp;FDA review completed in
standard <FONT STYLE="white-space:nowrap">30-day</FONT> timeframe; and (iii)&nbsp;on track with partner goals. These achievements contributed 5% toward our overall corporate achievement percentage.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#9e0c77" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" COLSPAN="3" ALIGN="center"><FONT COLOR="#ffffff"><B>WORK STREAMS</B></FONT></TD></TR>
<TR BGCOLOR="#fff7c6" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Clinical Excellence</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to establish appropriately resourced function
that supports domestic (IND) and EU (CTA) filings and that leads to clinical trials for new indications each year, we achieved the following: (i)&nbsp;appropriate new hires made; (ii)&nbsp;substantial EU experience on the team and CRO expertise;
(iii)&nbsp;CTA completed for EU filing; and (iv)&nbsp;FDA and EMA special designations secured. These achievements contributed 10% toward our overall corporate achievement percentage.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Research Leadership</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to feed commercialization pipeline with new core
technology/research capabilities and novel therapeutic concepts (potential pipeline programs) that achieve proof of mechanism, we achieved the following: (i)&nbsp;Tau appropriately progressed; and (ii)&nbsp;improved zinc finger nuclease technology.
These achievements contributed 8% toward our overall corporate achievement percentage.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#fff7c6" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Voice of the Market</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to bring strong market perspective to program
development discussions advancing past &#147;research interest&#148; phase, we achieved the following: (i)&nbsp;new product strategy commercial assessments completed for specified internal programs; and (ii)&nbsp;new product strategy commercial
assessments completed for specified business development opportunities. These achievements contributed 5% toward our overall corporate achievement percentage.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Corporate Hygiene</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to complete efforts to create a &#147;fit to
purpose&#148; organization with appropriate professionalism and infrastructure that anticipates emergent needs, we achieved the following: (i)&nbsp;completed build outs on or ahead of schedule to support 2017 headcount growth; (ii)&nbsp;negotiated
lease and secured Brisbane building in conjunction with long term facility strategy and option analysis; (iii)&nbsp;implemented extensive IT upgrades; (iv)&nbsp;launched compliance charter and policy framework, performed business continuity and
document retention audits and developed mitigation plans for each, and updated policies to be current with industry standard and comply with SEC guidelines; (v)&nbsp;implemented improved financial services solutions and transitioned commercial
banking relationship following a competitive process; (vi)&nbsp;successfully raised $83&nbsp;million in <FONT STYLE="white-space:nowrap">follow-on</FONT> offering; (vii)&nbsp;implemented enhanced performance reviews with substantive and actionable
feedback; (viii)&nbsp;developed and implemented more competitive, comprehensive, and cost-effective benefits plan; (ix)&nbsp;initiated leadership development program, career ladders developed and talent review</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="71%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#143fdd">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR BGCOLOR="#143fdd" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#ffffff">&nbsp;&nbsp;</FONT><FONT COLOR="#ffffff"><B>Performance&nbsp;Category</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center"><FONT COLOR="#ffffff"><B>Objective and Achievement</B></FONT></TD></TR>
<TR BGCOLOR="#9e0c77" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" COLSPAN="3" ALIGN="center"><FONT COLOR="#ffffff"><B>WORK STREAMS</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">implemented, series of skills-building and enhancement training events; and (x)&nbsp;hired and <FONT
STYLE="white-space:nowrap">on-boarded</FONT> new employees. These achievements contributed 5% toward our overall corporate achievement percentage.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#fff7c6" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Image Management</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to launch and implement a refreshed brand and way
of engaging with stakeholders that establishes us as a knowledgeable and trusted resource we achieved the following: (i)&nbsp;successful financing in June; (ii)&nbsp;increased roster of coverage analysts and improved analyst sentiment with increased
price targets and ratings; (iii)&nbsp;successful media relations activities; and (iv)&nbsp;relaunched brand internally and externally (web, design, language, name, logo, messaging, and space). These achievements contributed 5% toward our overall
corporate achievement percentage.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Tech Ops</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective to build a premier Technical Operations Group
capable of executing process and analytical method development, product characterization and quality activities necessary for Phase 1 to Phase III manufacture of clinical candidates, we achieved the following: (i)&nbsp;successfully filed beta
thalassemia IND; (ii)&nbsp;built process development group with appropriate capabilities; (iii)&nbsp;completed quality audits of suppliers and managed quality systems; (iv)&nbsp;produced vector materials for research supporting all programs;
(v)&nbsp;oversaw availability of clinical drug product and ancillary components for programs, ensuring <FONT STYLE="white-space:nowrap">on-time</FONT> delivery for trial initiation; (vi)&nbsp;completed and approved contract manufacturing
organization contract establishing production commitment; (vii)&nbsp;hired new head of technical operations with strategically aligned expertise and industry connections; and (viii)&nbsp;established basis of design for Brisbane facility. These
achievements contributed 10% toward our overall corporate achievement percentage.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#9e0c77" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" COLSPAN="3" ALIGN="center"><FONT COLOR="#ffffff"><B>BUSINESS DEVELOPMENT TRANSACTION</B></FONT></TD></TR>
<TR BGCOLOR="#fff7c6" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Business Development &nbsp;&nbsp;Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee determined that with respect to the objective of major genome editing or gene therapy
partnership or technology license deal, we achieved the following: (i)&nbsp;execution of strategic transactions with Pfizer; and (ii)&nbsp;such transactions created extraordinary strategic value. These achievements contributed 40% toward our overall
corporate achievement percentage.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described above, Dr.&nbsp;Macrae does not have individual goals separate from our corporate objectives. For
our other named executive officers, the total cash incentive payout for 2017 was based on a weighting of 80% corporate and 20% individual goals. Dr.&nbsp;Macrae recommends individual goals for each other named executive officer, which are aligned
with our business strategy and linked with corporate goals, and our Compensation Committee approves these goals. The 2017 individual goals for the named executive officers include those listed below. These specific goals were in addition to the
general responsibilities each officer had for managing his or her respective functional operational area. In early 2018, based on the recommendation of Dr.&nbsp;Macrae, as well as the observations by Compensation Committee members of these executive
officers and its own assessment of each individual&#146;s effectiveness, the Compensation Committee determined the level of achievement of each named executive officer&#146;s individual performance goals as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ms.&nbsp;Yi &#150; The Compensation Committee determined that with respect to the objectives of keeping
compliant and managing all internal and external financial requirements through effective controls and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
processes, being a useful business partner as a <FONT STYLE="white-space:nowrap">go-to</FONT> function and going beyond her function and leading a high performing team, she exceeded expectations
by executing her finance responsibilities, upgrading processes, invigorating and integrating her team as well as other internal departments and supporting and leading transformative transactions. The Compensation Committee determined that
Ms.&nbsp;Yi achieved 120% of her individual objectives. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dr.&nbsp;Conner &#150; The Compensation Committee determined that with respect to the objectives of supporting
the development organization, ensuring data quality and Good Clinical Practices, or GCP, compliant study conduct and data collection, establishing a bioethics review board, raising the visibility of clinical development within our company and
supporting the career development of members of his team, he achieved nearly all of his individual objectives by establishing a clinical group that is on track to meet its milestones and objectives, establishing CDPs, performing clinical assessments
for pipeline projects, leading clinical contributions to Investigational New Drug Applications, establishing a bioethics review board, progressing with compassionate review policy, raising the visibility and successes of his department and
supporting the development and management of his team. The Compensation Committee determined that Dr.&nbsp;Conner achieved 85% of his individual objectives. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Herberts &#150; The Compensation Committee determined that with respect to the objectives related to
our strategic objectives, corporate development, commercial infrastructure, leading and mentoring his team and other internal departments and engaging with the Board of Directors, he exceeded expectations by supporting transformative transactions,
increasing the number and quality of partnership discussions, developing a thoughtful corporate strategy, improving our commercial modeling and forecasts, leading his department and supporting the development and management of other departments. The
Compensation Committee determined that Mr.&nbsp;Herberts achieved 120% of his individual objectives. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The table below sets forth the target and actual bonus awards for our named executive officers: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target&nbsp;Award</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual&nbsp;Award</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;of&nbsp;Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#e2f4fc" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$367,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$381,888</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$112,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$120,377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107.2%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#e2f4fc" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Ward Wolff (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$140,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$140,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.2%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#e2f4fc" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts, III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$120,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$128,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107.2%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Ms.&nbsp;Yi&#146;s actual amount was prorated to reflect that she commenced employment with us during 2017. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Wolff retired from his position as Executive Vice President and Chief Financial Officer effective as of February&nbsp;28, 2017. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2017 Equity Compensation </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have historically made annual equity grants in December of each fiscal year. However, the Compensation Committee in 2016
determined that it would be a better business and governance practice to make equity grants at the beginning of the fiscal year after our operating plan has been approved by the Board of Directors and the performance in the prior fiscal year
completed. Accordingly, the Compensation Committee approved the grant of stock options to Dr.&nbsp;Macrae and Mr.&nbsp;Herberts in January 2017. The Compensation Committee determined not to grant Dr.&nbsp;Conner an equity award in January 2017
because Dr.&nbsp;Conner was granted a stock option in November 2016 in connection with the commencement of his employment with us. To emphasize <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance,</FONT></FONT> the
Compensation Committee determined that the entire annual equity grant would be made in the form of stock options, which provide a return to our executive officers only if the market price of our common stock appreciates over the stock option term,
and that RSUs would not be used for 2017 annual grants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee considered data related to percent of common
stock outstanding as well as grant date value to determine the overall range for setting the pool of shares available for grants to executive officers and other employees in 2017 and the size of each executive&#146;s grant. In 2017, the percent of
common stock outstanding carried more weight due to the depressed stock price in light of the objective of managing overall dilution for stockholders. In general, the equity compensation of our named executive officers for 2017 fell within the
competitive range of the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentiles based on the market data provided by Radford. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with her commencement of employment in February 2017, Ms.&nbsp;Yi was a granted a stock option to acquire
200,000 shares of common stock with an exercise price per share equal to the closing price per share on the grant date. The stock option is subject to a four-year vesting schedule with 25% of the shares subject to the option vesting upon
Ms.&nbsp;Yi&#146;s completion of one year of service measured from the date Ms.&nbsp;Yi commenced employment with us and the balance of the shares vesting monthly thereafter for the next three years. The award is subject to accelerated vesting in
whole or in part in the event Ms.&nbsp;Yi&#146;s employment terminates under certain circumstances in connection with a change in control of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Elements of Executive Compensation Program </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The remaining elements of our executive compensation program, like our broader employee compensation programs, are intended to
make our overall compensation program competitive with those of our peer companies and all of the remaining elements of our executive compensation program (401(k) Plan; Medical, Dental, and Vision Plans; Life and Disability Insurance; and the
Purchase Plan) are available to all of our employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Compensation Information </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Severance Arrangements </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March 2017, the Compensation Committee adopted an Executive Severance Plan, or the Severance Plan, to provide severance
benefits to certain of our executive officers and other key employees, including our named executive officers, whose employment terminates under certain prescribed circumstances. The Severance Plan provides financial protection against the potential
loss of employment in designated circumstances, which the Compensation Committee believes will allow the executives to focus attention on the best interests of the stockholders, without undue concern as to an executive&#146;s own financial
situation. The Compensation Committee has been advised by its independent compensation consultant that the benefits provided under these agreements are consistent with peer company and broader market practices, and are fair and reasonable. The terms
of the Severance Plan are described below under &#147;&#151;Employment Contracts and Change in Control Arrangements&#151;2017 Executive Severance Plan.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with his retirement, Mr. Wolff entered into an amendment to his employment agreement with us, pursuant to which
we agreed, in recognition of Mr. Wolff&#146;s contributions to us, to reimburse Mr. Wolff for 12 months of COBRA expenses and to extend the post-termination exercise periods of Mr. Wolff&#146;s outstanding stock options (to the extent vested on his
termination date), such that each such stock option shall remain exercisable for a period of two years following Mr. Wolff&#146;s termination of employment, or until the end of the term of the option, if earlier.&nbsp;A summary of Mr. Wolff&#146;s
severance payments and benefits may be found in the section of the Proxy Statement entitled &#147;&#151;Employment Contracts and Change in Control Arrangements&#151;Senior Vice President Employment Agreements&#151;Mr. Wolff.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Tax and Accounting Effects of Executive Compensation </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended, or the Code, disallows a deduction to any publicly held
corporation and its affiliates for certain compensation paid to &#147;covered employees&#148; in a taxable year to the extent that compensation to a covered employee exceeds $1&nbsp;million. Prior to the recent
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
enactment of the Tax Cuts and Jobs Act, compensation that qualified as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code was not subject to this deduction
limitation. Pursuant to the Tax Cuts and Jobs Act, this exception for &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code was repealed, with respect to taxable years beginning after December&nbsp;31, 2017, except that
certain transition relief is provided by the Tax Cuts and Jobs Act for remuneration provided pursuant to a written binding contract which was in effect on November&nbsp;2, 2017 and which was not modified in any material respect on or after such
date. As a result, compensation paid to any of our &#147;covered employees&#148; in excess of $1&nbsp;million per taxable year generally will not be deductible unless among other requirements, it is intended to qualify, and is eligible to qualify,
as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code pursuant to the transition relief provided by the Tax Cuts and Jobs Act. Because of certain ambiguities and uncertainties as to the application and interpretation of
Section&nbsp;162(m) of the Code and the regulations issued thereunder, including the uncertain scope of the transition relief provided by the Tax Cuts and Jobs Act, no assurance can be given that any compensation we pay will be eligible for such
transition relief and, therefore, eligible for the &#147;performance-based compensation&#148; exception under Section&nbsp;162(m) of the Code. The Compensation Committee will continue to monitor the applicability of Section&nbsp;162(m) of the Code
to its ongoing compensation arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee also considers the impact of Section&nbsp;409A of
the Code, and in general, our executive plans and programs are designed to comply with the requirements of that section so as to avoid possible adverse tax consequences that may result from <FONT STYLE="white-space:nowrap">non-compliance.</FONT>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The accounting impact of our compensation programs is one of many factors that the Compensation Committee considers in
determining the structure and size of our executive compensation programs. In general, the Company accounts for equity compensation paid to our employees under the Financial Accounting Standards Board Accounting Standards Codification Topic 718,
Compensation&#151;Stock Compensation, or ASC 718, which requires us to estimate and record an expense over the service period of the equity award, and our cash compensation is recorded as an expense at the time the obligation is accrued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity Grant Timing </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Equity awards are
generally granted to employees, including executives, when they are hired, and employees are eligible for additional equity awards in connection with annual performance reviews each year. As described above, annual equity grants were historically
made in December of each fiscal year; however, in 2016, the Compensation Committee determined that it would be a better business and governance practice to make grants at the beginning of the fiscal year after our operating plan has been approved by
the Board of Directors and the performance in the prior fiscal year has completed. New hire equity awards are generally <FONT STYLE="white-space:nowrap">pre-authorized</FONT> and become effective on the
25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of the month immediately following the month during which the individual commences employment, with the exercise price of any stock option grants set at the closing price of our stock on
that date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table provides certain summary information for the years ended December&nbsp;31, 2017, 2016 and 2015, when
applicable, concerning the compensation earned by (i)&nbsp;our President and Chief Executive Officer, (ii)&nbsp;our current Senior Vice President and Chief Financial Officer, (iii)&nbsp;our former Executive Vice President and Chief Financial
Officer, (iv)&nbsp;and our two other executive officers who were serving as executive officers at the end of 2017 and whose total compensation exceeded $100,000. We did not have any other executive officers in 2017. These individuals are referred to
throughout this Proxy Statement as our &#147;named executive officers.&#148; We have omitted certain rows from the table when there is no disclosure of any compensation for the named executive officer for that fiscal year. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:6.5pt" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name and</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Principal</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Year&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Salary&nbsp;&nbsp;&nbsp;&nbsp;</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Bonus&nbsp;&nbsp;&nbsp;&nbsp;<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;Awards&nbsp;&nbsp;&nbsp;&nbsp;</B><br><B>($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>&nbsp;&nbsp;&nbsp;&nbsp;Awards&nbsp;&nbsp;&nbsp;&nbsp;<BR>($) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-</B><br><B>Equity</B><br><B>Incentive</B><br><B>Plan</B><br><B>&nbsp;&nbsp;Compensation&nbsp;&nbsp;</B><br><B>($) (3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>&nbsp;&nbsp;&nbsp;&nbsp;Compensation&nbsp;&nbsp;&nbsp;&nbsp;<BR>($) (4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Total&nbsp;&nbsp;&nbsp;&nbsp;</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(e)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(f)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(g)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(i)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(j)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">Alexander D. Macrae,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">612,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">795,564</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">381,888</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,795,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">President and Chief Executive Officer&nbsp;(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">347,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,883,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,580,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:Times New Roman">Kathy Y. Yi,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6.5pt; font-family:Times New Roman">Senior Vice President and Chief
Financial Officer&nbsp;(7)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">294,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">574,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">994,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#d6fff9">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">H. Ward Wolff,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">836,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,541</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">974,321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">Former Executive Vice President and Chief Financial</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">422,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">Officer (8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">352,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">407,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,316,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">Edward R Conner, M,D.,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">541,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">Senior Vice President and Chief Medical Officer (11)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(12)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">377,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">512,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#d6fff9">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">Curt A. Herberts III,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">343,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">165,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">642,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">Senior Vice President and Chief Business Officer (13)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">289,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">362,261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The amounts in column (e)&nbsp;reflect the aggregate grant date fair value of the RSUs awarded to the named executive officer for the applicable year, calculated in accordance with ASC 718, without taking into account
any estimated forfeitures. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Except as provided in the footnote (9)&nbsp;below, the amounts in column (f)&nbsp;represent the aggregate grant date fair value of the stock option grants for each indicated year in accordance with ASC 718 using the
Black-Scholes option valuation model and without taking into account any estimated forfeitures. The assumptions used in the calculation of such grant date fair values are described in Note 4 to our consolidated financial statements included in our
Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2017. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">The amounts in column (g)&nbsp;reflect the cash bonus awards made to the named executive officer under the cash incentive program under the Incentive Plan for the indicated year. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The amounts in column (i)&nbsp;include matching payments made to the named executive officer under our 401(k)
Plan, a qualified deferred compensation plan under section 401(k) of the Code ($4,000 for each of Dr.&nbsp;Macrae, Ms.&nbsp;Yi and Mr.&nbsp;Herberts and $3,000 for Mr.&nbsp;Wolff), with the remainder for executives
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
other than Mr.&nbsp;Wolff reflecting group term life insurance premiums paid on behalf of our named executive officers. For Mr.&nbsp;Wolff, also includes COBRA expenses. See footnote
(10)&nbsp;below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dr.&nbsp;Macrae was appointed as our President and Chief Executive Officer on June&nbsp;1, 2016.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Includes a <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus of $200,000 that was subject to repayment in
the event Dr.&nbsp;Macrae&#146;s employment was terminated without cause or by him without good reason within one year of his appointment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ms.&nbsp;Yi was appointed as our Senior Vice President and Chief Financial Officer on February&nbsp;28, 2017.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Wolff retired effective February&nbsp;28, 2017, and his last day of employment was March&nbsp;8,
2017. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Represents the aggregate incremental fair value calculated in accordance with ASC 718 in connection with the
modification of Mr.&nbsp;Wolff&#146;s option awards pursuant to the terms of his amended employment agreement with the Company. For more information on the modification of stock options held by Mr.&nbsp;Wolff during 2017, see &#147;&#151;Grants of
Plan-Based Awards&#148; and &#147;&#151;Employment Contracts and Change in Control Arrangements&#151;Senior Vice President Employment Agreements&#151;Mr.&nbsp;Wolff&#148; below. There were no option awards granted to Mr.&nbsp;Wolff in 2017.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Includes reimbursement of COBRA expense totaling $25,365 in connection with the terms of Mr.&nbsp;Wolff&#146;s
amended employment agreement with us. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dr.&nbsp;Conner commenced employment on November&nbsp;30, 2016. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consists of a <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus that was subject to repayment in the event
Dr.&nbsp;Conner&#146;s employment was terminated without cause or by him without good reason within one year of his appointment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Herberts was promoted as Senior Vice President and Chief Business Officer effective November&nbsp;30,
2016. Mr.&nbsp;Herberts was not an executive officer at any time during 2015. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Grants of Plan-Based Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows for the fiscal year ended December&nbsp;31, 2017, certain information regarding grants of plan-based awards to our
named executive officers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Estimated&nbsp;Possible&nbsp;Payouts&nbsp;Under&nbsp;Non-Equity</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>All Other</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Option</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Awards:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Under-</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exercise&nbsp;or</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Base</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Price of</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Grant</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Fair&nbsp;Value</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incentive Plan Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>lying</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Option&nbsp;or</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>of Stock<BR>and</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Award Type</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant</B><br><B>Date or<BR>Modification&nbsp;Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Approval&nbsp;Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B><br><B>($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B><br><B>($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum</B><br><B>($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options</B><br><B>(#) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards</B><br><B>($/Sh)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards</B><br><B>($) (3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(a)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">(e)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">(j)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">(k)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">(l)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Alexander D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Annual Cash</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">257,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">367,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">734,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Annual Option</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">795,564</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Kathy Y. Yi</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Annual Cash</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">207,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">New&nbsp;Hire Option</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/28/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">574,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">H. Ward Wolff</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Modified Option(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">280,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Modified Option(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Modified Option(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">230,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Modified Option(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">171,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Modified Option(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Modified Option(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Modified Option(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Modified Option(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/24/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Edward R.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Annual&nbsp;Cash</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">259,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Curt A.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Herberts, III</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Annual Cash</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">222,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Annual Option</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">165,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.3pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.25pt solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The dollar amounts represent the threshold, target and maximum amounts of each named executive officer&#146;s potential annual cash bonus award for the year ended December&nbsp;31, 2017 pursuant to the 2017 Cash
Incentive Program under the Incentive Plan, and in Ms.&nbsp;Yi&#146;s case, also reflect <FONT STYLE="white-space:nowrap">pro-ration</FONT> as she commenced employment with us during 2017. The amount shown as target reflects the target payment level
if Sangamo and each individual had achieved 100% of the corporate and individual performance established pursuant to the 2017 Bonus Program. Each of Dr.&nbsp;Conner&#146;s, Mr.&nbsp;Herberts&#146; and Ms.&nbsp;Yi&#146;s target bonuses were allocated
between corporate and individual performance (80% to 20%, respectively), and Dr.&nbsp;Macrae&#146;s target bonus was allocated 100% to corporate performance. Sangamo must have attained a corporate performance percentage of 70% or more for any
bonuses to become payable. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The amount shown as maximum reflects the payment level pursuant to the 2017 Cash Incentive
Program if Sangamo had achieved a 200% corporate performance percentage and each individual (other than Dr.&nbsp;Macrae) had achieved a 125% individual performance percentage, which were the maximum percentages allowed for the corporate and
individual performance percentages, respectively. Actual payouts differed based on the actual performance objectives achieved. The actual cash bonus award earned for the year ended December&nbsp;31, 2017 pursuant to the 2017 Cash Incentive Program
under the Incentive Plan for each named executive officer is set forth in the Summary Compensation Table above. As such, the amounts set forth in these columns do not represent additional compensation earned by the named executive officers for the
year ended December&nbsp;31, 2017. For more information regarding the 2017 Cash Incentive Program under the Incentive Plan see &#147;&#151;Compensation Discussion and Analysis&#151;2017 Compensation Decisions&#151;2017 Cash Incentive
Compensation&#148; above. For more information regarding the Incentive Plan, see &#147;&#151;Employment Agreements and Compensation Arrangements&#151;Annual Cash Bonus Awards&#148; below. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Except as provided in footnote (4)&nbsp;below, the reported option was granted under the 2013 Plan and will vest and become exercisable in accordance with the following schedule: 25% of the option shares will vest and
become exercisable on the one year anniversary of the option grant date and the remaining option shares will vest and become exercisable in 36 equal monthly installments over the <FONT STYLE="white-space:nowrap">36-</FONT> month period measured from
the first anniversary of the option grant date, provided the optionee continues to provide services through each applicable vesting date. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Represents the grant date fair value of such stock option or the incremental fair value resulting from the modification of such stock option, as applicable, in each case as determined in accordance with ASC 718. The
assumptions used in the calculation of the grant date fair values of each option grant are included in Note 4 of the Notes to Consolidated Financial Statements in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year
ended December&nbsp;31, 2017, filed with the Securities and Exchange Commission on March&nbsp;1, 2018. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">In connection with Mr.&nbsp;Wolff&#146;s retirement effective as of February&nbsp;28, 2017, each stock option held by Mr.&nbsp;Wolff was modified, effective February&nbsp;27, 2017, such that the post-termination
exercise period of Mr.&nbsp;Wolff&#146;s then outstanding stock options was extended so that each stock option will remain exercisable for a period of two years following Mr.&nbsp;Wolff&#146;s retirement, or until the end of the term of the stock
option, if earlier. There were no other modifications to the terms of these stock options, including no modification of or change to the vesting or exercise prices of these stock options. The stock options reported in the table above and identified
as a &#147;Modified Option&#148; represent the same stock options that were originally granted in prior years at the exercise price on the original grant date, with the shares as shown representing the number shares subject to such options on the
modification date, and the amount reported in the &#147;Grant Date Fair Value of Stock and Option Awards&#148; column with respect to the modified stock options represents the incremental fair value on the modification date associated with those
modified stock options. For purposes of these modified options, the &#147;Grant Date&#148; represents the modification date of these options, which was February&nbsp;27, 2017. For more information on Mr.&nbsp;Wolff&#146;s option modifications,
please see &#147;&#151;Compensation Discussion and Analysis&#151;Additional Compensation Information&#151;Severance Arrangements&#148; above and &#147;&#151;Employment Contracts and Change in Control Arrangements&#151;Senior Vice President
Employment Agreements&#151;Mr.&nbsp;Wolff&#148; below. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employment Agreements and Compensation Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Employment Agreements </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of our named executive officers has entered into a written employment agreement with our company. For a description of these employment
agreements, please see the section of this Proxy Statement under the heading &#147;&#151;Employment Contracts and Change in Control Arrangements&#148; below. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Annual Cash Bonus Awards</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In 2012, the Compensation Committee of the Board adopted the Incentive Plan, which is a performance-based cash incentive
program for our executive officers. Under the Incentive Plan, which was in effect in 2017, the Compensation Committee has discretion to implement one or more performance periods under the Incentive Plan, each of a duration determined by the
Compensation Committee. Within the first 90 days of each performance period, the Compensation Committee establishes the specific performance and individual objectives that must be attained in order for Incentive Plan participants to receive a bonus
for that performance period. For each performance and individual objective, the Compensation Committee may set threshold, target and above-target levels of attainment. The Compensation Committee will then establish for each participant dollar levels
for the bonus to which he or she may become entitled for that performance period based on the level at which the performance and individual objectives are actually attained. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Performance objectives established under the Incentive Plan are based on one or more of the following criteria:
(i)&nbsp;revenue, organic revenue, net sales, or <FONT STYLE="white-space:nowrap">new-product</FONT> revenue or net sales, (ii)&nbsp;achievement of specified objectives in the discovery and development of the our technology or of one or more of our
products, (iii)&nbsp;achievement of specified objectives in the commercialization of one or more of our products, (iv)&nbsp;achievement of specified objectives in the manufacturing of one or more of our products, (v)&nbsp;expense targets,
(vi)&nbsp;share price, (vii)&nbsp;total shareholder return, (viii)&nbsp;earnings per share, (ix)&nbsp;operating margin, (x)&nbsp;gross margin, (xi)&nbsp;return measures (including, but not limited to, return on assets, capital, equity, or sales),
(xii) productivity ratios, (xiii)&nbsp;operating income, (xiv)&nbsp;net operating profit, (xv)&nbsp;net earnings or net income (before or after taxes), (xvi) cash flow (including, but not limited to, operating cash flow, free cash flow and cash flow
return on capital), (xvii) earnings before or after interest, taxes, depreciation, amortization and/or stock-based compensation expense, (xviii)&nbsp;economic value added, (xix)&nbsp;market share, (xx)&nbsp;working capital targets,
(xxi)&nbsp;achievement of specified objectives relating to corporate partnerships, collaborations, license transactions, distribution arrangements, mergers, acquisitions, dispositions or similar business transactions, and (xxii)&nbsp;employee
retention and recruiting and human resources management. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Individual performance objectives established under the Incentive
Plan are based on one or more of the following criteria: (i)&nbsp;the participant&#146;s contribution toward the achievement of a specific Company performance objective, (ii)&nbsp;the contribution of the business unit or division supervised by the
participant toward the achievement of a specific Company performance objective, and (iii)&nbsp;the participant&#146;s development of professional skills. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A participant will not become entitled to a bonus under the Incentive Plan for a particular performance period unless the
participant remains employed by us through the date bonuses are paid to each participant following completion of that performance period. Following the close of the applicable performance period, the Compensation Committee will determine the actual
bonus amount for each participant based on the actual levels at which the actual performance objectives are attained, and bonuses will be paid promptly following the end of the applicable performance period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the terms of the Incentive Plan, should a change in control transaction be consummated prior to the completion of a
performance period that has been implemented under the Incentive Plan, then the performance period will terminate upon the consummation of that change in control and each participant in the Incentive Plan will receive a bonus in the dollar amount
previously set by the Compensation Committee at target level attainment of each performance objective; however such bonus will be <FONT STYLE="white-space:nowrap">pro-rated</FONT> to reflect each participant&#146;s actual period of service from the
start date of the performance period through the effective date of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the change in control. Any <FONT STYLE="white-space:nowrap">pro-rated</FONT> bonus paid pursuant to the terms of the Incentive Plan will reduce the amount of any severance payable to the
participant based on the participant&#146;s target bonus pursuant to the terms of any employment agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event
any payment to which a participant becomes entitled under the Incentive Plan would otherwise constitute a parachute payment under Section&nbsp;280G of the Code, then that payment will be subject to reduction to the extent necessary to assure that
such payment will be limited to the greater of (i)&nbsp;the dollar amount that can be paid to the participant without triggering a parachute payment under Code Section&nbsp;280G or (ii)&nbsp;the dollar amount of that payment which provides the
participant with the greatest <FONT STYLE="white-space:nowrap">after-tax</FONT> amount after taking into account any excise tax the participant may incur under Code Section&nbsp;4999 with respect to such payment and any other benefits or payments to
which the participant may be entitled in connection with any change in control of the Company or the subsequent termination of the participant&#146;s employment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We adopted a 2017 Cash Incentive Program under the Incentive Plan that provides for annual bonus awards to reward executive officers based on
our achievement of specific corporate goals and their achievement of individual performance goals. For more information regarding the 2017 Cash Incentive Program under the Incentive Plan, please see the section of this Proxy Statement under the
heading &#147;&#151;Compensation Discussion and Analysis&#151;2017 Compensation Decisions&#151;2017 Cash Incentive Compensation&#148; and footnote (1)&nbsp;to the Grants of Plan-Based Awards table above. We amended the Incentive Plan in March 2018.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stock Awards </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Discretionary options that we granted in 2017 under the 2013 Plan vest according to the following schedule: 25% of the option shares will vest
and become exercisable on the one year anniversary of the option grant date and the remaining option shares will vest and become exercisable in 36 equal monthly installments over the <FONT STYLE="white-space:nowrap">36-month</FONT> period measured
from the first anniversary of the option grant date, provided the executive officer continues to provide services through each applicable vesting date. Each option will vest on an accelerated basis in connection with certain terminations and
changes, as described under the heading &#147;&#151;Employment Contracts and Change in Control Agreements&#148; below. Each option has an expiration date at the end of <FONT STYLE="white-space:nowrap">10-year</FONT> period measured from the grant
date, unless terminated earlier following the optionee&#146;s termination of service. Options granted under the 2013 Plan have an exercise price equal to the fair market value on the date of grant (generally the closing price of our common stock on
the grant date on the Nasdaq Global Select Market), and the 2013 Plan permits the exercise price of stock options to be paid by cash, check, other shares of our common stock (with some restrictions), broker
<FONT STYLE="white-space:nowrap">assisted&nbsp;same-day&nbsp;sales,</FONT> and cashless &#147;net exercise&#148; arrangements. Although we did not grant any discretionary RSUs in 2017 under the 2013 Plan, previous grants of discretionary RSUs to
executive officers under such plan (including grants in January 2018) vest in three successive equal annual installments over the <FONT STYLE="white-space:nowrap">3-year</FONT> period measured from the grant date, provided the executive officer
continues to provide services through each applicable vesting date. For a discussion of the effect on outstanding equity awards under the 2013 Plan in connection with certain terminations and changes in control of the Company, including accelerated
vesting, see the discussion under the heading &#147;&#151;Employment Contracts and Change in Control Arrangements&#148; below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other
Compensatory Arrangements </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>401(k) Plan.</I> Our executive officers are eligible to participate in the 401(k) Plan. The 401(k) Plan
is intended to qualify as a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> plan under section 401 of the Code. The 401(k) Plan provides that each participant may contribute a portion of his or her
<FONT STYLE="white-space:nowrap">pre-tax</FONT> compensation, up to a statutory annual limit. The 401(k) Plan also permits us to make discretionary contributions and matching contributions, subject to established limits. In 2017, we made a matching
contribution which was subject to an annual limit of $4,000 per employee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other Benefits.</I> Our executive officers are eligible to participate in all of our
benefit plans, such as our medical, dental, vision, short-term disability, long-term disability and group life insurance plans and the Purchase Plan, in each case generally on the same basis as other employees. We also have a section&nbsp;125
flexible benefits healthcare plan and a flexible benefits childcare plan under which employees can set aside <FONT STYLE="white-space:nowrap">pre-tax</FONT> funds to pay for qualified healthcare expenses and qualified childcare expenses not
reimbursed by insurance. We do not currently offer pension or other retirement benefits in the U.S., but do offer pension or other retirement benefits in certain other countries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain summary information concerning outstanding equity awards held by the named executive officers as of
December&nbsp;31, 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:44.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Grant&nbsp;Date&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities</B><br><B>Underlying</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;Unexercised&nbsp;&nbsp;&nbsp;&nbsp;</B><br><B>Options
(#)</B><br><B>Exercisable</B><br><B>(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities</B><br><B>Underlying</B><br><B>Unexercised</B><br><B>Options (#)</B><br><B>Unexercisable</B><br><B>(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>&nbsp;&nbsp;Exercise&nbsp;&nbsp;</B><br><B>Price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;Expiration&nbsp;&nbsp;&nbsp;&nbsp;</B><br><B>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of</B><br><B>Shares<BR>or</B><br><B>Units&nbsp;of</B><br><B>Stock<BR>that</B><br><B>Have<BR>Not</B><br><B>Vested</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market</B><br><B>Value&nbsp;of</B><br><B>Shares&nbsp;or</B><br><B>Units of</B><br><B>Stock<BR>That</B><br><B>Have Not</B><br><B>Vested</B><br><B>($)
(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:43.30pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(d)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(e)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(f) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(g)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Alexander&nbsp;D. Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/25/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> &nbsp;<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="top" ALIGN="right"> 06/03/2016<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="top"> &nbsp;<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">437,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/02/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Kathy Y. Yi</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/28/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/27/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">H. Ward</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Wolff (4)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">12/08/2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">03/07/2019</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/11/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/06/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/08/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/07/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">Edward R. Conner, M.D.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/30/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,834</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/29/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">Curt A. Herberts III</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/25/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/08/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/08/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/07/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/27/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/26/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/11/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/10/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/11/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/06/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/05/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/08/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/07/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/01/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">08/31/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/18/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/17/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Except as otherwise provided in the footnotes below, each option was subject to the following vesting schedule: 25% of the option shares will vest and become exercisable on the one year anniversary of the option grant
date and the remaining option shares will vest and become exercisable in 36 equal monthly installments over the <FONT STYLE="white-space:nowrap">36-</FONT> month period measured from the first anniversary of the option grant date, provided the
executive officer continues to provide services through each applicable vesting date. Each option will vest on an accelerated basis in connection with certain terminations and changes in control, as described under the heading &#147;&#151;Employment
Contracts and Change in Control Agreements.&#148; Each option has an expiration date at the end of <FONT STYLE="white-space:nowrap">10-year</FONT> period measured from the grant date, unless terminated earlier following the optionee&#146;s
termination of service. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents an RSU award subject to vesting in three successive equal annual installments over the <FONT STYLE="white-space:nowrap">3-year</FONT> period measured from the grant date, provided the executive officer
continues to provide services to the Company through each applicable vesting date. The award will vest on an accelerated basis in connection with certain terminations and changes in control of the Company, as described under the heading
&#147;&#151;Employment Contracts and Change in Control Arrangements.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Based on the $16.40 closing price of our common stock on December&nbsp;29, 2017, the last trading day of fiscal 2017. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">In connection with his retirement, the post-termination exercise periods of Mr.&nbsp;Wolff&#146;s outstanding options were extended, such that each such option shall remain exercisable for a period of two years
following Mr.&nbsp;Wolff&#146;s termination of employment, or until the end of the term of the stock option, if earlier. Mr.&nbsp;Wolff&#146;s options ceased to vest as of March&nbsp;8, 2017, his last day of employment. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option Exercises and Stock Vested </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table sets forth the number of shares of our common stock acquired and the value realized upon the vesting of RSU awards and on each exercise of stock options for each of the named executive officers during the year ended December&nbsp;31,
2017: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="28%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:36.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>Shares</B><br><B>Acquired</B><br><B>&nbsp;&nbsp;on&nbsp;Exercise&nbsp;(#)&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;Realized</B><br><B>&nbsp;&nbsp;on&nbsp;Exercise&nbsp;($)&nbsp;(1)&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>Shares</B><br><B>Acquired&nbsp;on</B><br><B>Vesting</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;Value&nbsp;Realized&nbsp;&nbsp;</B><br><B>on</B><br><B>Vesting ($) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:17.30pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(d)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(e)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Alexander D. Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Kathy Y. Yi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">H. Ward Wolff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">462,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,012,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Edward R. Conner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Curt A. Herberts III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,395</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">438,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">158,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Value realized is determined by multiplying (i)&nbsp;the amount by which the market price of the common stock on the date of exercise exceeded the exercise price by (ii)&nbsp;the number of shares for which the options
were exercised. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Value realized is determined by multiplying the number of shares of common stock vested on the date of vesting by the market price of the common stock on such date. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pension Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We do
not sponsor a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined benefit retirement plan or a supplemental executive retirement plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nonqualified Deferred Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We do not sponsor a nonqualified deferred compensation plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Assessment of Compensation Policies and Practices </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our compensation programs throughout the organization are designed to maintain an appropriate balance between long-term and
near-term incentives by utilizing a combination of compensation components, including base salary, annual cash incentive awards, and long-term equity awards. Although not all employees in the organization may have compensation comprising all three
of those components, the compensation programs are generally structured so that any near-term cash incentives are not likely to constitute the predominant element of an employee&#146;s total compensation. The Compensation Committee annually reviews
our compensation policies and practices to assess whether they encourage employees to take inappropriate risks. After reviewing each of our compensation plans, and the checks and balances built into, and oversight of, each plan, in April 2017, the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Compensation Committee determined that any risks arising from our compensation policies and practices for our employees are not reasonably likely to have a material adverse effect on us as a
whole. In addition, the Compensation Committee believes that the mix and design of the elements of executive compensation do not encourage management to assume excessive risks, and significant compensation decisions, as well as decisions concerning
the compensation of our executive officers, include subjective considerations by the compensation committee or the board of directors, which restrain the influence of formulae or objective factors on excessive risk taking. Finally, the mix of
short-term compensation (in the form of salary and annual bonus, if any) and long-term compensation (in the form of stock options and RSUs) also prevents undue focus on short-term results and helps align the interests of our executive officers with
the interests of our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employment Contracts and Change in Control Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Chief Executive Officer Employment Agreement </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dr.&nbsp;Macrae </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In May
2016 we entered into an employment agreement with Dr.&nbsp;Macrae that took effect June&nbsp;1, 2016, which sets forth the terms and conditions of his employment as President and Chief Executive Officer. Pursuant to his employment agreement,
Dr.&nbsp;Macrae will receive a base salary of $600,000 per year and an annual cash bonus based upon our company&#146;s achievement of specified objectives under our Incentive Plan with a target bonus of 60% of his base salary. Dr.&nbsp;Macrae&#146;s
base salary and target bonus percentage are subject to annual review by the Compensation Committee and adjustment from time to time by such Committee, and was subject to <FONT STYLE="white-space:nowrap">pro-ration</FONT> for partial service in 2016.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dr.&nbsp;Macrae&#146;s employment agreement also provided for a $200,000 <FONT STYLE="white-space:nowrap">sign-on</FONT>
bonus, which was subject to repayment in the event Dr.&nbsp;Macrae&#146;s employment was terminated without cause or by him without good reason within one year of his appointment, as well as an initial equity grant of stock options under the 2013
Plan to acquire 700,000 shares of our common stock, which is vesting on the same terms as other discretionary awards under the 2013 Plan. Dr.&nbsp;Macrae is also entitled to be nominated for election to our Board of Directors for so long as his
employment agreement is in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although Dr.&nbsp;Macrae&#146;s employment agreement includes certain benefits payable
to him in connection with separation from service, such terms were waived by Dr.&nbsp;Macrae in connection with the March 2017 adoption of our Executive Severance Plan (the &#147;Severance Plan&#148;) which now governs his severance benefits. The
terms of the Severance Plan are described below under &#147;&#151;2017 Executive Severance Plan.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Senior Vice President
Employment Agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Ms.&nbsp;Yi </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Effective February&nbsp;28, 2017, we entered into an employment agreement with Kathy Y. Yi, which sets forth the terms and
conditions of her employment as Chief Financial Officer. Pursuant to her employment agreement, Ms.&nbsp;Yi will receive a base salary of $350,000 per year and an annual cash bonus based upon our company&#146;s and her individual achievement of
specified objectives under our Incentive Plan with a target cash bonus of 35% of her base salary. Ms.&nbsp;Yi&#146;s base salary and target bonus percentage are subject to annual review by the Compensation Committee and adjustment from time to time
by such Committee, and were also subject to <FONT STYLE="white-space:nowrap">pro-ration</FONT> for partial service in 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Ms.&nbsp;Yi&#146;s employment agreement also provided for an initial equity grant of stock options under the 2013 Plan to
acquire 200,000 shares of our common stock, which is vesting on the same terms as other discretionary awards under the 2013 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although Ms.&nbsp;Yi&#146;s employment agreement includes certain severance
benefits payable to her in connection with separation from service, such terms were waived by Ms.&nbsp;Yi in connection with the March 2017 adoption of the Severance Plan, which now governs her severance benefits. The terms of the Severance Plan are
described below under &#147;&#151;2017 Executive Severance Plan.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Mr.&nbsp;Wolff </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November 2007, we entered into an employment agreement with H. Ward Wolff, our former Executive Vice President and Chief
Financial Officer, which was amended and restated in December 2008 and December 2011 in order to implement technical changes. Pursuant to the terms of the agreement as amended and restated, Mr.&nbsp;Wolff&#146;s annual base salary was set at a
minimum of $375,000, increasing to $390,000 effective January&nbsp;1, 2012, or such higher rate as the Board determined from time to time, and he was eligible to receive an annual performance bonus of up to 40% of his base salary each calendar year,
based on our company&#146;s and his individual achievement of specific performance criteria established by the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If
we had terminated Mr.&nbsp;Wolff&#146;s employment without cause, or Mr.&nbsp;Wolff terminated his employment for good reason, within 12 months following a change in control and Mr.&nbsp;Wolff executed a general release of all claims in our favor,
then Mr.&nbsp;Wolff would have received the following severance benefits: (i)&nbsp;a severance payment equal to his annual base salary in effect on his termination date plus his target bonus for the year in which such termination occurred,
(ii)&nbsp;reimbursement of his health care coverage costs under COBRA for up to twelve months, (iii)&nbsp;accelerated vesting of all of his outstanding equity awards and (iv)&nbsp;a <FONT STYLE="white-space:nowrap">one-year</FONT> period measured
from his termination date to exercise any outstanding options for all the option shares, but in no event would any such option have remained exercisable following the expiration of the maximum option term. If we had terminated Mr.&nbsp;Wolff&#146;s
employment without cause, or Mr.&nbsp;Wolff had terminated his employment for good reason, in the absence of a change in control or more than 12 months after a change in control and Mr.&nbsp;Wolff executed a general release of all claims in our
favor, then Mr.&nbsp;Wolff would have received (i)&nbsp;salary continuation payments for a 12 month period following his termination date at his rate of base salary in effect on his termination date and (ii)&nbsp;reimbursement of his health care
coverage costs under COBRA for up to 12 months. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Effective as of February&nbsp;28, 2017, Mr.&nbsp;Wolff retired from his
position as our Executive Vice President and Chief Financial Officer. In connection with his retirement, Mr.&nbsp;Wolff entered into an amendment to his employment agreement, pursuant to which Mr.&nbsp;Wolff agreed that he would not be entitled to
receive any cash severance in connection with his retirement; however, we agreed to reimburse Mr.&nbsp;Wolff for the 12 months of COBRA expenses, and his outstanding stock options (to the extent vested on his termination date), will remain
exercisable for a period of two years following Mr.&nbsp;Wolff&#146;s termination of employment, or until the end of the term of the stock option, if earlier. We estimate the value of the COBRA expense payments to be $30,608 (of which $25,365 was
paid during the year ending December&nbsp;31, 2017) and have calculated the value of his option modifications to be $836,136.65, which represents the aggregate incremental fair value associated with the modifications of Mr.&nbsp;Wolff&#146;s stock
options as calculated in accordance with ASC 718. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dr.&nbsp;Conner </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Effective November&nbsp;1, 2016, we entered into an employment agreement with Dr.&nbsp;Conner, which sets forth the terms and
conditions of his employment as Chief Medical Officer. Pursuant to his employment agreement, Dr.&nbsp;Conner will receive a base salary of $400,000 per year, and an annual cash bonus based upon our company&#146;s and his individual achievement of
specified objectives under our Incentive Plan with a target cash bonus of 35% of his base salary. Dr.&nbsp;Conner&#146;s base salary and target bonus percentage are subject to annual review by the Compensation Committee and adjustment from time to
time by such Committee, and his salary was subject to pro ration for partial service in 2016. Dr.&nbsp;Conner was not eligible for a target cash bonus in 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dr.&nbsp;Conner&#146;s employment agreement also provided for an initial equity grant of stock options under the 2013 Plan to
acquire 200,000 shares of our common stock, which is vesting on the same terms as other discretionary awards under the 2013 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although Dr.&nbsp;Conner&#146;s employment agreement includes certain
severance benefits payable to him in connection with separation from service, such terms were waived by Dr.&nbsp;Conner in connection with the March 2017 adoption of the Severance Plan, which now governs his severance benefits. The terms of the
Severance Plan are described below under &#147;&#151;2017 Executive Severance Plan.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Mr.&nbsp;Herberts </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In August 2010, we entered into an employment agreement with Mr.&nbsp;Herberts setting forth the terms and conditions of his
employment as a Director, Corporate Development. In November 2016, Mr.&nbsp;Herberts was promoted to Chief Business Officer. As a Chief Business Officer, Mr.&nbsp;Herberts&#146; base salary was set a $340,000 per year and Mr.&nbsp;Herberts was
eligible for an annual cash bonus based upon our company&#146;s and his individual achievement of specified objectives under our Incentive Plan with a target cash bonus of 35% of his base salary. Mr.&nbsp;Herberts&#146; base salary and target bonus
percentage are subject to annual review by the Compensation Committee and adjustment from time to time by such Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Herberts&#146; employment agreement does not provide for any severance benefits. As an executive, Mr.&nbsp;Herberts
is an eligible employee under the Severance Plan and may receive benefits under such plan, which is described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2017 Executive Severance Plan
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March 2017, the Compensation Committee of the Board adopted the Severance Plan to provide severance benefits
to certain of our executive officers and other key employees whose employment terminates under certain prescribed circumstances. These eligible employees include our named executive officers Drs. Macrae and Conner, Ms. Yi and Mr. Herberts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the Severance Plan, which replaced the severance arrangement set forth in Dr.&nbsp;Macrae&#146;s employment agreement,
Dr.&nbsp;Macrae is eligible to receive the following severance benefits: (a)&nbsp;cash equal to the sum of (i) 18 months of his base salary and (ii)&nbsp;his target bonus for the year of termination, payable over 12 months, reimbursement for his
health care coverage costs under COBRA for 12 months, and full acceleration of his outstanding equity awards, and any outstanding options as so accelerated will remain exercisable for a period of 12 months following termination, in the event of an
involuntary termination during the <FONT STYLE="white-space:nowrap">12-month</FONT> period following a change of control of the Company (&#147;the Change in Control Period&#148;) or (b)&nbsp;cash equal to 12 months of his base salary, payable over
12 months, and COBRA reimbursement for 12 months, if he has an involuntary termination other than during the Change in Control Period. These cash severance benefits under the Severance Plan are identical to the severance benefits he was eligible to
receive under his employment agreement; however, under his employment agreement, only 50% of the shares subject to any outstanding equity award accelerated if the change in control was within two years following the effective date of the employment
agreement and 100% of the shares accelerated if the change in control was more than two years after the effective date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the Severance Plan, which replaced the severance arrangements set forth in Dr.&nbsp;Conner&#146;s and Ms.&nbsp;Yi&#146;s
respective employment agreements, Dr.&nbsp;Conner, Ms.&nbsp;Yi and Mr.&nbsp;Herberts are eligible to receive the following severance benefits: (a)&nbsp;cash equal to the sum of (i) 12 months of base salary and (ii)&nbsp;target bonus for the year of
termination, payable over 12 months, reimbursement for health care coverage costs under COBRA for 12 months, and accelerated vesting of all outstanding equity awards, and any outstanding options as so accelerated will remain exercisable for a period
of 12 months following termination, in the event of an involuntary termination during the Change in Control Period; or (b)&nbsp;cash equal to 9 months of base salary, payable over 9 months, and COBRA reimbursement for 9 months, if there is an
involuntary termination other than during the Change in Control Period. These cash severance benefits under the Severance Plan are similar to the severance benefits Dr.&nbsp;Conner and Ms.&nbsp;Yi were eligible to receive under their respective
employment agreements; however, under the employment agreements, only 50% of the shares subject to any outstanding equity award accelerated if the change in control was within two years following the effective date of the employment agreement and
100% of the shares accelerated if the change in control was more than two years </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
after the effective date, and (b)&nbsp;the base salary and COBRA reimbursement continuation period was six months under the employment agreements (instead of 12 months in the event of an
involuntary termination during the Change in Control Period or 9 months in the event of an involuntary termination other than during the Change in Control Period, under the Severance Plan, as described above). <B><I></I></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any of the severance benefits under the Severance Plan would constitute a &#147;parachute payment&#148; within the meaning
of section 280G of the Code, such payments are subject to reduction to the extent doing so would put the recipient in a better <FONT STYLE="white-space:nowrap">after-tax</FONT> position after taking into account any excise tax that may be incurred
under Code Section&nbsp;4999 in connection with any change in control of the Company or subsequent termination of employment, </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2013 Plan
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee of the Board of Directors, as the administrator of the 2013 Plan, has the authority to
provide that any outstanding options held by the Chief Executive Officer or any other executive officer or any other unvested equity award made to such individual under the 2013 Plan will vest on an accelerated basis in connection with certain
changes in control of the Company or the subsequent termination of the officer&#146;s employment following the change in control event. In addition, all outstanding options and RSUs under the 2013 Plan will immediately vest upon a change in control,
to the extent not assumed or continued in effect by the successor entity or replaced with an incentive compensation program that preserves the intrinsic value of the award at that time and provides for the subsequent vesting and concurrent payout of
that value in accordance with the <FONT STYLE="white-space:nowrap">pre-existing</FONT> vesting schedules for those awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Incentive Compensation
Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Incentive Plan is a performance-based cash incentive program for our executive officers. Pursuant to the
terms of the Incentive Plan as in effect in 2017, should a change in control transaction be consummated prior to the completion of a performance period that has been implemented under the Incentive Plan, then the performance period will terminate
upon the consummation of that change in control and each participant in the Incentive Plan will receive a bonus in the dollar amount previously set by the Compensation Committee at target level attainment of each performance objective; however such
bonus will be <FONT STYLE="white-space:nowrap">pro-rated</FONT> to reflect each participant&#146;s actual period of service from the start date of the performance period through the effective date of the change in control. Any <FONT
STYLE="white-space:nowrap">pro-rated</FONT> bonus paid pursuant to the terms of the Incentive Plan will reduce the amount of any severance payable to the participant based on the participant&#146;s target bonus pursuant to the terms of any
employment agreement. The 2017 Cash Incentive Program adopted for the 2017 year under the Incentive Plan is summarized in detail under the heading &#147;&#151;Compensation Discussion and Analysis&#151;2017 Compensation Decisions&#151;2017 Cash
Incentive Compensation. We eliminated the provision in the Incentive Plan providing for these payouts when we amended the Incentive Plan in March 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Potential Payments Upon Termination or Change in Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The charts below quantify the potential payments our named executive officers, other than Mr.&nbsp;Wolff, would receive under
various scenarios. The value attributed to the accelerated vesting of equity awards represents the intrinsic value of each stock option or RSU award vesting on an accelerated basis in connection with the identified triggering event, which is assumed
to occur on December&nbsp;31, 2017. The intrinsic value is calculated by multiplying (i)&nbsp;the aggregate number of shares that vest on an accelerated basis by (ii)&nbsp;the amount by which the $16.40 closing selling price per share of our common
stock on December&nbsp;31, 2017, exceeds the exercise price or other issue price (if any) payable per vested share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Quantification of Benefits Upon
Involuntary Termination in the Absence of a Change in Control </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The chart below quantifies the compensation each named
executive officer would have received had the officer&#146;s employment terminated without cause in the absence of a change in control of the Company but under circumstances entitling the officer to severance benefits under the Severance Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For information with respect to the compensation and benefits we provided to
Mr.&nbsp;Wolff in connection with his retirement, see &#147;&#151;Senior Vice President Employment Agreements&#151;Mr.&nbsp;Wolff&#148; above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:69.95pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Cash<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severance&nbsp;(1)&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;COBRA&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">612,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">262,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Ward Wolff (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;257,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Cash severance upon termination in the absence of a change in control is payable in a series of successive equal monthly installments over a period ranging from 9 to 12 months. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Wolff retired effective February&nbsp;28, 2017. The Severance Plan did not apply to him and amounts disclosed represent his actual entitlements (see &#147;&#151;Senior Vice President Employment
Agreements&#151;Mr.&nbsp;Wolff&#148; above for further details). </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Benefits Upon Involuntary Termination in Connection With a Change in
Control </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The chart below quantifies the payments our named executive officers (other than Mr.&nbsp;Wolff who retired during the year)
would each have received had their employment terminated without cause or with good reason in connection with a change in control under circumstances entitling them to severance benefits under the Severance Plan. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash</B><br><B>Severance&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B><br><B>Bonus (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accelerated</B><br><B>Vesting of</B><br><B>Equity</B><br><B>Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>COBRA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">918,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">367,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,725,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">122,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,370,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">140,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,925,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;343,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;120,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,242,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Cash severance upon termination in connection with a change in control is payable in a series of successive equal monthly installments over 12 months. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Target bonus represents the amount of severance benefit that an executive is entitled to payable in a series of successive equal monthly installments over 12 months. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Benefits Upon a Change in Control (No Termination) </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The chart below quantifies the value of the accelerated equity the named executive officers (other than Mr.&nbsp;Wolff who retired during the
year) are entitled to receive under the 2013 Plan upon a change in control of the Company in which their outstanding equity awards are not assumed or otherwise continued in effect, terminated or cancelled in connection therewith. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:28.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accelerated&nbsp;Equity&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,725,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,370,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,925,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,242,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The chart below quantifies the cash award for the 2017 year the named executive officers are
entitled to receive under the Incentive Plan upon a change in control of the Company. This benefit was eliminated by the March 2018 amendment of the Incentive Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:28.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive&nbsp;Plan&nbsp;Award&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander D. Macrae</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">367,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Y. Yi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">112,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward R. Conner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">140,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Curt A. Herberts III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;120,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Benefits upon Death or Disability </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the 2013 Plan, if a named executive officer&#146;s service with us is terminated as a result of death or permanent
disability, or a named executive officer dies or becomes permanently disabled during the three months after a termination other than for misconduct, the period of time in which an option may be exercised following termination shall be the earlier of
twelve months following the date of such named executive officer&#146;s death or the expiration date of the option, whichever is earlier, rather than the standard three-month post-termination exercise period provided for in the 2013 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pay Ratio Disclosure </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under SEC rules, we are required to calculate and disclose the annual total compensation of our median employee, as well as
the ratio of the annual total compensation of our median employee as compared to the annual total compensation of our President and Chief Executive Officer, Dr.&nbsp;Macrae (our &#147;CEO&#148;), for our last fiscal year (&#147;CEO Pay Ratio&#148;).
To identify our median employee, we used the following methodology: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To determine our total population of employees, we included all our employees as of November&nbsp;15, 2017 regardless of their full- or part-time schedule or anticipated employment duration. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To identify our median employee from our employee population, we calculated the aggregate amount of the 2017 base compensation of each of our employees excluding the CEO using a reasonable estimate of the hours worked
during 2017 for our hourly employees and actual salary paid for our remaining employees, target 2017 bonus, and the grant date fair value of equity awards granted in fiscal 2017 (using the same methodology we use for estimating the value of the
equity awards granted to our named executive officers and reported in our Summary Compensation Table). </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In making this determination, we annualized the base compensation, target bonus and other cash incentive compensation of those permanent employees who were employed by us for less than the entire fiscal year.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Using this approach, we determined our median employee. Because the median employee we initially identified had anomalous
compensation characteristics due to the employee&#146;s commencement of employment in 2017, we substituted another employee to serve as our median employee who received substantially similar compensation as the initially identified median employee
during 2017 but who had been employed for all of 2017. This individual was directly adjacent to our initially identified median employee, based on the determination method described above. Once the median employee was identified, we then calculated
the annual total compensation of this employee for 2017 in accordance with the requirements of the Summary Compensation Table. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal
2017, the median of the annual total compensation of our employees (other than our CEO) was $169,202 and the annual total compensation of our CEO, as reported in the Summary Compensation Table included in this Proxy Statement, was $1,795,856. Based
on this information, the ratio of the annual total compensation of our CEO to the median of the annual total compensation of all our employees was approximately 11 to 1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The CEO Pay Ratio above represents our reasonable estimate calculated in a manner consistent
with SEC rules and applicable guidance. SEC rules and guidance provide significant flexibility in how companies identify the median employee, and each company may use a different methodology and make different assumptions particular to that company.
As a result, and as explained by the SEC when it adopted these rules, in considering the pay ratio disclosure, stockholders should keep in mind that the rule was not designed to facilitate comparisons of pay ratios among different companies, even
companies within the same industry, but rather to allow stockholders to better understand and assess each particular company&#146;s compensation practices and pay ratio disclosures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Neither the Compensation Committee nor our management used our CEO Pay Ratio measure in making compensation decisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Report<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy
Statement with management, and based on such review and such discussions, the Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis, as contained herein, be included in this Proxy Statement. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Submitted by the Compensation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Committee of the Board of Directors</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mr.&nbsp;Roger Jeffs</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dr.&nbsp;Steven&nbsp;J. Mento</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ms.&nbsp;H. Stewart Parker</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The material in this Compensation Committee Report is not &#147;soliciting material,&#148; is not deemed
&#147;filed&#148; with the SEC and is not to be incorporated by reference into any filing of Sangamo Therapeutics, Inc. under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general
incorporation language in any such filing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Compensation Plan Information </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table provides information as of December&nbsp;31, 2017, with respect to the shares of our common stock that may
be issued under our existing equity compensation plans. There are no outstanding options that we have assumed in connection with our acquisition of other companies, and there are currently no assumed plans under which we can grant options. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="95%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Column (A)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Column (B)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Column (C)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:65.10pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Plan
Category&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities&nbsp;to&nbsp;be</B><br><B>Issued Upon</B><br><B>Exercise
of</B><br><B>Outstanding&nbsp;Options,<BR>Restricted&nbsp;Stock&nbsp;Units</B><br><B>and Other Rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;Average</B><br><B>Exercise Price of</B><br><B>Outstanding<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Securities</B><br><B>Remaining&nbsp;Available&nbsp;for</B><br><B>Future Issuance Under</B><br><B>Equity
Compensation</B><br><B>Plans</B><br><B>(Excluding Securities</B><br><B>Reflected in Column A)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Equity Compensation Plans Approved by Stockholders (1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,203,628</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,601,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)(6)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Equity Compensation Plans Not Approved by Stockholders (1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">836,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)(8)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#d6fff9" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8,367,628</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,437,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:2.00pt solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The equity compensation plans approved by stockholders consists of the 2013 Plan and the 2010 Employee Stock
Purchase Plan (the &#147;Purchase Plan&#148;). In November 2017, the Compensation Committee approved the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
amendment and restatement of the 2013 Plan to reserve an additional 1,000,000 shares of our common stock to be used exclusively for grants of awards to individuals who were not previously
employees or <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of the Company (or following a bona fide period of <FONT STYLE="white-space:nowrap">non-employment</FONT> with the Company), as an inducement material to each such
individual&#146;s entry into employment with us within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules, or Rule 5635(c)(4) (such awards, the &#147;Inducement Awards&#148;). The 2013 Plan was amended and restated by the Compensation
Committee without stockholder approval pursuant to Rule 5635(c)(4). Accordingly, for purposes of this table, information with respect to Inducement Awards and the shares reserved for issuance under the 2013 Plan therefor, are included in the row in
the table above with respect to equity compensation plans not approved by stockholders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Includes 80,172 shares subject to RSUs that will entitle the holder to one share of common stock for each unit that vests over the holder&#146;s period of continued service. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Excludes purchase rights accruing under the Purchase Plan and shares subject to outstanding options granted under the 2013 Plan as Inducement Awards. Under the Purchase Plan, each eligible employee may purchase up to
2,000 shares of common stock at semi-annual intervals on the last U.S. business day of April and October each year at a purchase price per share equal to 85% of the lower of (i)&nbsp;the closing selling price per share of common stock on the
employee&#146;s entry date into the <FONT STYLE="white-space:nowrap">two-year</FONT> offering period in which that semi-annual purchase date occurs or (ii)&nbsp;the closing selling price per share on the semi-annual purchase date. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">The calculation does not take into account the 80,172 shares of common stock subject to outstanding RSUs. Such shares will be issued at the time the RSUs vest, without any cash consideration payable for those shares.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Consists of shares available for future issuance under the Purchase Plan and the 2013 Plan. As of December&nbsp;31, 2017, 835,674 shares of common stock were available for issuance under the Purchase Plan, and 3,601,633
shares of common stock were available for issuance under the 2013 Plan (of which 836,000 were available for issuance as Inducement Awards under the 2013 Plan). The shares available for issuance under the 2013 Plan may be issued upon the exercise of
stock options or stock appreciation rights granted under the plan, or those shares may be issued as stock bonuses or pursuant to restricted stock awards or RSUs that vest upon the attainment of prescribed performance milestones or the completion of
designated service periods. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2017, the maximum number of shares of common stock reserved for issuance under the 2013 Plan and the Purchase Plan was 20,397,808 shares and 2,100,000 shares, respectively. The number of shares
of common stock reserved for issuance under the 2013 Plan is reduced: (i)&nbsp;on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-1</FONT></FONT> basis for each share of common stock subject to a stock option grant or stock
appreciation right award, or pursuant to a full-value award made under the plan before June&nbsp;12, 2013, and (ii)&nbsp;by a fixed ratio of 1.33 shares of common stock for each share of common stock issued pursuant to a full-value award made under
the 2013 Plan on or after June&nbsp;12, 2013. In addition, the 20,397,808 maximum number of shares of common stock reserved for issuance under the 2013 Plan includes the 1,000,000 shares reserved for issuance as Inducement Awards in November 2017.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">Consists of stock options granted as Inducement Awards under the 2013 Plan. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Consists of shares available for future issuance under the 2013 Plan at December&nbsp;31, 2017 as Inducement Awards under the 2013 Plan. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Report of the Audit Committee of the Board of
Directors<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The information contained under the heading
&#147;Report of the Audit Committee of the Board of Directors&#148; in this Proxy Statement shall not be deemed to be &#147;soliciting material&#148; or to be &#147;filed&#148; with the Securities and Exchange Commission, nor shall such information
be incorporated by reference into any filing of the Company with the Securities and Exchange Commission, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, or subject to the
liabilities of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit Committee has reviewed and
discussed the audited financial statements for the fiscal year ended December&nbsp;31, 2017 with the management of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit Committee has discussed with Ernst&nbsp;&amp; Young LLP, the independent registered public accounting firm that
audited our financial statements for the fiscal year ended December&nbsp;31, 2017, the matters required to be discussed by Public Company Accounting Oversight Board (PCAOB) Auditing Standard No.&nbsp;1301, Communications with Audit Committees,&#148;
or any successor standard. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit Committee has received the written disclosures and the letter from Ernst&nbsp;&amp;
Young LLP required by applicable requirements of the PCAOB regarding Ernst&nbsp;&amp; Young LLP&#146;s communications with the Audit Committee concerning independence, and has discussed with Ernst&nbsp;&amp; Young LLP its independence from the
Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based on the review of the audited financial statements and the discussions noted above, the Audit Committee
recommended to our Board of Directors that the audited financial statements be included in our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December&nbsp;31, 2017 for filing with the Securities
and Exchange Commission. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Submitted by the Audit Committee of the</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Board
of Directors of Sangamo Therapeutics, Inc.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mr.&nbsp;Robert F. Carey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ms.&nbsp;Saira Ramasastry</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mr.&nbsp;Joseph S. Zakrzewski</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The material in this Report of the Audit Committee is not &#147;soliciting material,&#148; is not deemed
&#147;filed&#148; with the SEC and is not to be incorporated by reference into any filing of Sangamo Therapeutics, Inc. under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general
incorporation language in any such filing. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since January&nbsp;1, 2017, there has not been nor is there currently proposed any transaction or series of similar
transactions to which we were or are to be a party in which the amount involved exceeds $120,000 and in which any director, executive officer, holder of more than 5% of our common stock, or any member of the immediate family of any of the foregoing
persons, had or will have a direct or indirect material interest other than compensation agreements and other arrangements, which are described elsewhere in this Proxy Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition to the indemnification provisions contained in our Seventh Amended and Restated Certificate of Incorporation, as
amended, we have entered into separate indemnification agreements with each of our directors containing provisions that may require us to, among other things, indemnify them against certain liabilities that may arise by reason of their status or
service as directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POLICIES AND PROCEDURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Consistent with the requirement under Nasdaq listing rules, the Audit Committee of the Board of Directors is responsible for
reviewing and approving all related party transactions as defined under SEC rules and regulations. While we do not have a formal written policy or procedure for the review, approval or ratification of related party transactions, the Audit Committee
must review the material facts of any such transaction and approve that transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To identify related party
transactions, each year we submit and require our directors and officers to complete director and officer questionnaires identifying transactions with us in which the director or officer or their family members have a conflict of interest. We review
the questionnaire for potential related party transactions. In addition, at meetings of the Audit Committee, management may recommend related party transactions to the committee, including the material terms of the proposed transactions, for its
consideration. In making its decision to approve or ratify a related party transaction, the Audit Committee will consider all relevant facts and circumstances available to the committee, including factors such as the aggregate value of the
transaction, whether the terms of the related party transaction are no less favorable than terms generally available in an arms&#146; length transaction and the benefit of such transaction to us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The members of the Board of Directors, our executive officers and persons who beneficially own more than 10% of our
outstanding common stock are subject to the reporting requirements of Section&nbsp;16 of the Exchange Act, as amended, which require them to file reports with respect to their beneficial ownership of the common stock and their transactions in such
common stock. Based upon (i)&nbsp;the copies of Section&nbsp;16 reports that we received from such persons for their 2017 year transactions in the common stock and their common stock holdings, and (ii)&nbsp;written representation that no other
reports were required, we believe that all reporting requirements under Section&nbsp;16 for such year were met in a timely manner by our directors, executive officers and greater than 10% beneficial owners. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HOUSEHOLDING OF PROXY MATERIALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The SEC has adopted rules that permit companies and intermediaries to satisfy the delivery requirements for Notices of
Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other Annual Meeting materials
addressed to those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This year, a number of brokers with account holders who are our stockholders
will be &#147;householding&#148; our proxy materials. A single Notice of Internet Availability of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected
stockholders. Once you have received notice from your broker that they will be &#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke your consent. If, at
any time, you no longer wish to participate in &#147;householding&#148; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials, please notify your broker or us. Direct your written request to Sangamo Therapeutics,
Inc., Heather Turner, Secretary, 501 Canal Boulevard, Richmond, California 94804 or contact McDavid Stilwell at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">510-970-6000.</FONT></FONT> Stockholders who currently receive multiple
copies of the Notices of Internet Availability of Proxy Materials at their addresses and would like to request &#147;householding&#148; of their communications should contact their brokers. In addition, we will promptly deliver, upon written or oral
request to the address or telephone number above, a separate copy of the Notice of Internet Availability of Proxy Materials or the full set of proxy materials, as applicable, to a stockholder at a shared address to which a single copy of the
documents was delivered. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended
December&nbsp;31, 2017 is available without charge upon written request to: Corporate Secretary, Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, California 94804. Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> is
not incorporated into this Proxy Statement and is not considered proxy soliciting material.</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">THE BOARD OF DIRECTORS OF</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SANGAMO THERAPEUTICS, INC.</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: April 24, 2018 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Appendix A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>ANGAMO</SMALL> T<SMALL>HERAPEUTICS</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2018 E<SMALL>QUITY</SMALL> I<SMALL>NCENTIVE</SMALL> P<SMALL>LAN</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>DOPTED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL> <SMALL>OF</SMALL>
<SMALL>THE</SMALL> B<SMALL>OARD</SMALL>: A<SMALL>PRIL</SMALL>&nbsp;23, 2018 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL>
<SMALL>THE</SMALL> S<SMALL>TOCKHOLDERS</SMALL>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">1. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>T<SMALL>ABLE</SMALL> <SMALL>OF</SMALL> C<SMALL>ONTENTS</SMALL> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Page</B></P>
<P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_1">G<SMALL>ENERAL</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-1</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>2.&#8195;&#8195;&#8194;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_2">S<SMALL>HARES</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-1</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>3.&#8195;&#8195;&#8194;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_3">E<SMALL>LIGIBILITY</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-2</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>4.&#8195;&#8195;&#8194;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_4">O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>PPRECIATION</SMALL> R<SMALL>IGHTS</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-2</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>5.&#8195;&#8195;&#8194;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_5">A<SMALL>WARDS</SMALL> O<SMALL>THER</SMALL> T<SMALL>HAN</SMALL> O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>PPRECIATION</SMALL> R<SMALL>IGHTS</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-5</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>6.&#8195;&#8195;&#8194;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_6">A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL>; O<SMALL>THER</SMALL> C<SMALL>ORPORATE</SMALL> E<SMALL>VENTS
</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-7</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>7.&#8195;&#8195;&#8194;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_7">A<SMALL>UTOMATIC</SMALL> G<SMALL>RANTS</SMALL> T<SMALL>O</SMALL> E<SMALL>LIGIBLE</SMALL> D<SMALL>IRECTORS</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-8</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>8.&#8195;&#8195;&#8194;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_8">A<SMALL>DMINISTRATION</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-9</B></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>9.&#8195;&#8195;&#8194;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_9">T<SMALL>AX</SMALL> W<SMALL>ITHHOLDING</SMALL></A><SMALL></SMALL></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-12</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>10.&#8195;&#8195;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_10">M<SMALL>ISCELLANEOUS</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-12</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>11.&#8195;&#8195;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_11">C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-15</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>12.&#8195;&#8195;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_12">A<SMALL>DDITIONAL</SMALL> R<SMALL>ULES</SMALL> <SMALL>FOR</SMALL> A<SMALL>WARDS</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> S<SMALL>ECTION</SMALL>&nbsp;409A.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-16</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>13.&#8195;&#8195;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_13">S<SMALL>EVERABILITY</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-18</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>14.&#8195;&#8195;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_14">T<SMALL>ERMINATION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-19</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.60em; text-indent:-3.60em; font-size:10pt; font-family:Times New Roman"><B>15.&#8195;&#8195;&#8201;&#8202;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#appatoc573774_15">D<SMALL>EFINITIONS</SMALL>.</A></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><B>A-19</B></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-i- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">1.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_1"></A>G<SMALL>ENERAL</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(a)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Successor to and Continuation of Predecessor Plan.&nbsp;&nbsp;</B>The Plan is the successor to and continuation of the Predecessor
Plan. As of the Effective Date, (i)&nbsp;no additional awards may be granted under the Predecessor Plan; (ii)&nbsp;the Predecessor Plan&#146;s Available Reserve will become available for issuance pursuant to Awards granted under this Plan; and
(iii)&nbsp;all outstanding awards granted under the Prior Plans will remain subject to the terms of the Prior Plans; <I>provided, however</I>, that any Returning Shares from the Prior Plans will become available for issuance pursuant to Awards
granted under this Plan. All Awards granted under this Plan will be subject to the terms of this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Eligible Award Recipients and Plan Purpose.&nbsp;&nbsp;</B>Subject to
the terms of the Plan, Employees, Directors and Consultants are eligible to receive Awards. Only Eligible Directors will receive Awards under the Automatic Grant Program. The Company, by means of the Plan, seeks to secure and retain the services of
such persons, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common
Stock through the granting of Awards. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Available Awards.&nbsp;&nbsp;</B>The Plan provides for the grant of the following Awards: (i)&nbsp;Incentive Stock Options; (ii)&nbsp;Nonstatutory
Stock Options; (iii)&nbsp;SARs; (iv) Restricted Stock Awards; (v)&nbsp;RSU Awards; (vi)&nbsp;Performance Awards; and (vii)&nbsp;Other Awards. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(d)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Effective Date.&nbsp;&nbsp;</B>The Plan will come into existence on the Effective Date. No Award may be granted under the Plan prior to the Effective Date. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">2.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_2"></A>S<SMALL>HARES</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share Reserve. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the adjustments in Section&nbsp;6(a), the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed the sum of: (A) 8,800,000 shares, plus (B)&nbsp;the number
of Returning Shares if any, as such shares become available from time to time, plus (C)&nbsp;the Predecessor Plan&#146;s Available Reserve. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to Section&nbsp;2(c) the number of shares of Common Stock available for issuance under the Plan will be reduced by: (A)&nbsp;one share for each share of Common Stock issued pursuant to an Appreciation Award
granted under the Plan and (B) 1.33 shares for each share of Common Stock issued pursuant to a Full Value Award granted under the Plan. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The number of shares of Common Stock available for issuance under the Plan will be increased by: (A)&nbsp;one share for each Returning Share subject to an Appreciation Award and (B) 1.33 shares share for each Returning
Share subject to a Full Value Award. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Incentive Stock Option Limit.&nbsp;&nbsp;</B>Notwithstanding anything to the contrary in Section&nbsp;2(a) and subject to Section&nbsp;6(a)
regarding Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options is 17,600,000 shares. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Shares Not Available For Subsequent Issuance.&nbsp;&nbsp;</B>The following shares of Common Stock will not become available again for issuance under the Plan: (i)&nbsp;any shares that are reacquired or
withheld (or not issued) by the Company to satisfy the exercise or purchase price of an Appreciation Award or a Full Value Award (including any shares subject to such award that are not delivered because such award is exercised through a reduction
of shares subject to such award (i.e., &#147;net exercised&#148;)); (ii) any shares that are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with an Appreciation Award or a Full Value
Award; and (iii)&nbsp;any shares repurchased by the Company on the open market with the proceeds of the exercise or purchase price of an Appreciation Award or a Full Value Award. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(d)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Share Reserve Limit.&nbsp;&nbsp;</B>For clarity, the Share Reserve limit in Section&nbsp;2(a) is a limit on the number of shares of Common Stock
that may be issued pursuant to Awards and does not limit the granting of Awards, except that the Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy its obligations to issue shares pursuant to
such Awards. Shares may be issued in connection with a merger or acquisition as permitted by, as applicable, NASDAQ Listing Rule 5635(c), NYSE Listed Company Manual Section&nbsp;303A.08, AMEX Company Guide Section&nbsp;711 or other applicable rule,
and such issuance will not reduce the number of shares available for issuance under the Plan. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">3.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_3"></A>E<SMALL>LIGIBILITY</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(a)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Eligibility for Specific Awards.&nbsp;&nbsp;</B>Incentive Stock Options
may be granted only to Employees of the Company or a &#147;parent corporation&#148; or &#147;subsidiary corporation&#148; thereof (as such terms are defined in Sections 424(e) and (f)&nbsp;of the Code). Awards other than Incentive Stock Options may
be granted to Employees, Directors and Consultants; <I>provided, however</I>, that Nonstatutory Stock Options and SARs may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#147;parent&#148; of
the Company (as such term is defined in Rule&nbsp;405) unless the stock underlying such Awards is treated as &#147;service recipient stock&#148; under Section&nbsp;409A because the Awards are granted pursuant to a corporate transaction (such as a
spin off transaction) or unless such Awards otherwise comply with the distribution requirements of Section&nbsp;409A. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Ten Percent Stockholders.&nbsp;&nbsp;</B>A Ten Percent Stockholder may
not be granted an Incentive Stock Option unless (i)&nbsp;the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant of such Option and (ii)&nbsp;the Option is not exercisable after the expiration of five years
from the date of grant of such Option. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">4.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_4"></A>O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>PPRECIATION</SMALL> R<SMALL>IGHTS</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">Each Option and SAR will have such terms and conditions as determined by the Board. Each Option will be designated in writing as an Incentive
Stock Option or Nonstatutory Stock Option at the time of grant; <I>provided, however</I>, that if an Option is not so designated, then such Option will be a Nonstatutory Stock Option, and the shares purchased upon exercise of each type of Option
will be separately accounted for. The terms and conditions of separate Options and SARs need not be identical; <I>provided, however</I>, that each Option Agreement and SAR Agreement will conform (through incorporation of provisions hereof by
reference in the Award Agreement or otherwise) to the substance of each of the following provisions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(a)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Term.&nbsp;&nbsp;</B>Subject to Section&nbsp;3(b) regarding Ten Percent
Stockholders, no Option or SAR will be exercisable after the expiration of ten years from the date of grant of such Award or such shorter period specified in the Award Agreement. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Exercise or Strike Price.&nbsp;&nbsp;</B>Subject to Section&nbsp;3(b) regarding Ten Percent Stockholders, the exercise or strike price of each Option or SAR will not be less than 100% of the Fair Market
Value on the date of grant of such Award. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value on the date of grant of such Award if such Award is granted pursuant
to an assumption of or substitution for another option or stock appreciation right pursuant to a Change in Control and in a manner consistent with the provisions of Sections 409A and, if applicable, 424(a) of the Code. Each SAR will be denominated
in shares of Common Stock equivalents. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Exercise Procedure and Payment of Exercise Price for Options.&nbsp;&nbsp;</B>In order to exercise an Option, the Participant must provide notice
of exercise to the Plan Administrator in accordance with the procedures specified in the Option Agreement. The Board has the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to
use certain methods) and to grant Options that require the consent of the Company to utilize a particular method of payment. The exercise price of </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an Option may be paid, to the extent permitted by Applicable Law and as determined by the Board, by one or more of the following methods of payment to the extent set forth in the Option
Agreement: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by cash or check, bank draft or money order payable to the Company; </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pursuant to a &#147;cashless exercise&#148; program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either
the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the exercise price to the Company from the sales proceeds; </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock that are already owned by the Participant free and clear of any liens, claims, encumbrances or security interests, with a
Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (A)&nbsp;at the time of exercise the Common Stock is publicly traded, (B)&nbsp;any remaining balance of the exercise price not satisfied by such
delivery is paid by the Participant in cash or other permitted form of payment, (C)&nbsp;such delivery would not violate any Applicable Law or agreement restricting the redemption of the Common Stock, (D)&nbsp;any certificated shares are endorsed or
accompanied by an executed assignment separate from certificate, and (E)&nbsp;such shares have been held by the Participant for any minimum period necessary to avoid adverse accounting treatment as a result of such delivery; </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iv)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if the Option is a Nonstatutory Stock Option, by a &#147;net exercise&#148; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of
shares with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (A)&nbsp;any remaining balance of the exercise price not satisfied by such net exercise is paid by the Participant in cash or other
permitted form of payment, and (B)&nbsp;shares of Common Stock will no longer be subject to such Option and will not be exercisable thereafter to the extent that shares issuable upon exercise are reduced to pay the exercise price pursuant to such
&#147;net exercise;&#148; or </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(v)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in any other form of consideration that may be acceptable to the Board and permissible under Applicable Law. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(d)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Exercise Procedure and Payment of Appreciation Distribution for SARs</B><B>.</B><B>&nbsp;&nbsp;</B>In order to exercise any SAR, the Participant must provide notice of exercise to the Plan Administrator in
accordance with the SAR Agreement. The appreciation distribution payable to a Participant upon the exercise of a SAR will not be greater than an amount equal to the excess of (i)&nbsp;the aggregate Fair Market Value on the date of exercise of a
number of shares of Common Stock equal to the number of Common Stock equivalents that are vested and being exercised under such SAR, over (ii)&nbsp;the strike price of such SAR. Such appreciation distribution may be paid to the Participant in the
form of Common Stock or cash (or any combination of Common Stock and cash) or in any other form of payment, as determined by the Board and specified in the SAR Agreement. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(e)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Transferability.&nbsp;&nbsp;</B>Options and SARs may not be transferred to third party financial institutions for value. The Board may impose such additional limitations on the transferability of an Option
or SAR. In the absence of any such Determination, the following restrictions on the transferability of Options and SARs will apply, provided that except as explicitly provided herein, neither an Option nor a SAR may be transferred for consideration
and <I>provided, further</I>, that if an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Restrictions on Transfer.&nbsp;&nbsp;</B>An Option or SAR will not be transferable, except by will or by the laws of descent and distribution, and will be exercisable during the lifetime of the Participant
only by the Participant; <I>provided, however</I>, that the Board may permit transfer of an Option or SAR in a manner that is not prohibited by applicable tax and securities laws upon the Participant&#146;s request, including to a trust if the
Participant is considered to be the sole beneficial owner of such trust (as determined under Section&nbsp;671 of the </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Code and applicable state law) while such Option or SAR is held in such trust, provided that the Participant and the trustee enter into a transfer and other agreements required by the Company.
</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Domestic Relations Orders.&nbsp;&nbsp;</B>Notwithstanding the foregoing, subject to the execution of transfer documentation in a format acceptable to the Company, an Option or SAR may be transferred pursuant to
a domestic relations order. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(f)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Vesting.&nbsp;&nbsp;</B>Subject to Section 10(a) the Board may impose such restrictions on or conditions to the vesting and/or exercisability of
an Option or SAR as determined by the Board and which may vary. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Options and SARs will cease upon
termination of the Participant&#146;s Continuous Service. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(g)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Continuous Service.&nbsp;&nbsp;</B>Subject to Section&nbsp;4(h), if a Participant&#146;s Continuous Service terminates for any reason other than for Cause, the Participant may exercise his
or her Option or SAR to the extent vested, but only within the following period of time or, if applicable, such other period of time provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate;
<I>provided, however</I>, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section&nbsp;4(a)): </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;three months following the date of such termination if such termination is a termination without Cause (other than any termination due to the Participant&#146;s Disability or death); </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12 months following the date of such termination if such termination is due to the Participant&#146;s Disability; </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;18 months following the date of such termination if such termination is due to the Participant&#146;s death; or </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iv)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18 months following the date of the Participant&#146;s death if such death occurs following the date of such termination but during the period such Award is otherwise exercisable (as provided in (i)&nbsp;or (ii) above).
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the date of such termination, to the extent the Participant does not exercise such Award within the applicable Post-Termination Exercise
Period (or, if earlier, prior to the expiration of the maximum term of such Award), such unexercised portion of the Award will terminate, and the Participant will have no further right, title or interest in terminated Award, the shares of Common
Stock subject to the terminated Award, or any consideration in respect of the terminated Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(h)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Extension of Exercisability.&nbsp;&nbsp;</B>Except as otherwise
provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service terminates for any reason other than for Cause and, at any time during the last thirty days
of the applicable Post-Termination Exercise Period: (i)&nbsp;the exercise of the Participant&#146;s Option or SAR would be prohibited solely because the issuance of shares of Common Stock upon such exercise would violate Applicable Law, or
(ii)&nbsp;the immediate sale of any shares of Common Stock issued upon such exercise would violate the Company&#146;s Trading Policy, then the applicable Post-Termination Exercise Period will be extended to the last day of the calendar month that
commences following the date the Award would otherwise expire, with an additional extension of the exercise period to the last day of the next calendar month to apply if any of the foregoing restrictions apply at any time during such extended
exercise period, generally without limitation as to the maximum permitted number of extensions); <I>provided, however</I>, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section&nbsp;4(a)).
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(</B><B>i</B><B>)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Continuous Service for Cause.&nbsp;&nbsp;</B>Except as explicitly otherwise provided in the Award Agreement or other written
agreement between a Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service is terminated for Cause, the Participant&#146;s Options and SARs will terminate and be forfeited immediately upon such termination of
Continuous Service, and the Participant will be prohibited from exercising any portion (including any vested portion) of such Awards on and after the date of such termination of Continuous Service and the Participant will have no further right,
title or interest in such forfeited Award, the shares of Common Stock subject to the forfeited Award, or any consideration in respect of the forfeited Award. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(j)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Employees</B>.<B>&nbsp;&nbsp;</B>No Option or SAR, whether or not vested, granted to an Employee who is a
<FONT STYLE="white-space:nowrap">non-exempt</FONT> employee for purposes of the Fair Labor Standards Act of 1938, as amended, will be first exercisable for any shares of Common Stock until at least six months following the date of grant of such
Award. Notwithstanding the foregoing, in accordance with the provisions of the Worker Economic Opportunity Act, any vested portion of such Award may be exercised earlier than six months following the date of grant of such Award in the event of
(i)&nbsp;such Participant&#146;s death or Disability, (ii)&nbsp;a Change in Control in which such Award is not assumed, continued or substituted, or (iii)&nbsp;such Participant&#146;s retirement (as such term may be defined in the Award Agreement or
another applicable agreement or, in the absence of any such definition, in accordance with the Company&#146;s then current employment policies and guidelines). This Section&nbsp;4(j) is intended to operate so that any income derived by a <FONT
STYLE="white-space:nowrap">non-exempt</FONT> employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(k)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Whole Shares</B>.<B>&nbsp;&nbsp;</B>Options and SARs may be exercised only with respect to whole shares of Common Stock or their equivalents. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(l)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends</B>.&nbsp;
&nbsp;Dividends or dividend equivalents may not be paid or credited to options or SARs. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">5.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_5"></A>A<SMALL>WARDS</SMALL> O<SMALL>THER</SMALL> T<SMALL>HAN</SMALL> O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>PPRECIATION</SMALL> R<SMALL>IGHTS</SMALL>.
</B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(</B><B>a</B><B>)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Restricted Stock Awards and RSU Awards.&nbsp;&nbsp;</B>Each Restricted Stock Award and RSU Award will have such terms and conditions as determined
by the Board. The terms and conditions of separate Restricted Stock Awards and RSU Awards need not be identical; <I>provided, however</I>, that each Restricted Stock Award Agreement and RSU Award Agreement will conform (through incorporation of the
provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
of Award. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:23%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(1)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the extent consistent with the Company&#146;s Bylaws, at the Board&#146;s election, shares of Common Stock subject to a Restricted Stock Award may
be (i)&nbsp;held in book entry form subject to the Company&#146;s instructions until such shares become vested or any other restrictions lapse, or (ii)&nbsp;evidenced by a certificate, which certificate will be held in such form and manner as
determined by the Board. Unless otherwise determined by the Board, a Participant will have voting and other rights as a stockholder of the Company with respect to any shares subject to a Restricted Stock Award. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:23%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(2)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A RSU Award represents a Participant&#146;s right to be issued on a future date the number of shares of Common Stock that is equal to the number of restricted stock units subject to the RSU Award. As a holder
of a RSU Award, a Participant is an unsecured creditor of the Company with respect to the Company&#146;s unfunded obligation, if any, to issue shares of Common Stock in settlement of such Award and nothing contained in the Plan or any RSU Agreement,
and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between a Participant and the Company or an Affiliate or any other person. A Participant will not have voting or
any other rights as a stockholder of the Company with respect to any RSU Award (unless and until shares are actually issued in settlement of a vested RSU Award). </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Consideration. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:23%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(1)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A Restricted Stock Award may be granted in consideration for (A)&nbsp;cash or check, bank draft or money order payable to the Company, (B)&nbsp;past
services to the Company or an Affiliate, or (C)&nbsp;any other form of consideration (including future services) as the Board may determine and permissible under Applicable Law. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:23%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(2)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise determined by the Board at the time of grant, a RSU Award will be granted in consideration for the Participant&#146;s services to the Company or an Affiliate, such that the Participant will
not be required to make any payment to the Company (other than such services) with respect to the grant or vesting of the RSU Award, or the issuance of any shares of Common Stock pursuant to the RSU Award. If, at the time of grant, the Board
determines that any consideration must be paid by the Participant (in a form other than the Participant&#146;s services to the Company or an Affiliate) upon the issuance of any shares of Common Stock in settlement of the RSU Award, such
consideration may be paid in any form of consideration as the Board may determine and permissible under Applicable Law. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Vesting.&nbsp;&nbsp;</B>Subject to Section 10(a) the Board may impose such restrictions on or conditions to the vesting of a Restricted Stock
Award or RSU Award as determined by the Board and which may vary. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Restricted Stock Awards and RSU Awards
will cease upon termination of the Participant&#146;s Continuous Service. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(iv)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Continuous Service.&nbsp;&nbsp;</B>Except as otherwise
provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service terminates for any reason, (i)&nbsp;the Company may receive through a forfeiture condition
or a repurchase right any or all of the shares of Common Stock held by the Participant under his or her Restricted Stock Award that have not vested as of the date of such termination as set forth in the Restricted Stock Award Agreement and
(ii)&nbsp;any portion of his or her RSU Award that has not vested will be forfeited upon such termination and the Participant will have no further right, title or interest in the RSU Award, the shares of Common Stock issuable pursuant to the RSU
Award, or any consideration in respect of the RSU Award. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(v)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Dividends and Dividend Equivalents.&nbsp;&nbsp;</B>Dividends or dividend equivalents may be paid or credited, as applicable, with
respect to any shares of Common Stock subject to a Restricted Stock Award or RSU Award, as determined by the Board and specified in the Award Agreement; <I>provided, however</I>, that any dividends or dividend equivalents that are credited with
respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of the Award Agreement (including, but not limited to, any vesting conditions). Any dividends or dividend equivalents that are
credited with respect to any shares or share equivalents will be forfeited on the date such shares or share equivalents are forfeited to or repurchased by the Company due to a failure to vest. Dividends or dividend equivalents may not be paid or
credited to Awards except in accordance with this Section. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(vi)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Settlement</B><B> of RSU Awards</B>.<B>&nbsp;&nbsp;</B>A RSU Award may
be settled by the issuance of shares of Common Stock or cash (or any combination thereof) or in any other form of payment, as determined by the Board and specified in the RSU Award Agreement. At the time of grant, the Board may determine to impose
such restrictions or conditions that delay such delivery to a date following the vesting of the RSU Award. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><I></I><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(b)</FONT></B><I></I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Performance Awards</B>.<B>&nbsp;&nbsp;</B>With respect to any Performance Award, the length of any Performance Period, the
Performance Goals to be achieved during the Performance Period, the other terms and conditions of such Award, and the measure of whether and to what degree such Performance Goals have been attained will be determined by the Board. In addition, to
the extent permitted by Applicable Law and set forth in the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Other Awards</B>.<B>&nbsp;&nbsp;</B>Other forms of Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or
stock rights with an </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exercise price or strike price less than 100% of the Fair Market Value at the time of grant) may be granted either alone or in addition to Awards provided for under Section&nbsp;4 and the
preceding provisions of this Section&nbsp;5. Subject to the provisions of the Plan, the Board will have sole and complete discretion to determine the persons to whom and the time or times at which such Other Awards will be granted, the number of
shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Awards and all other terms and conditions of such Other Awards. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">6.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_6"></A>A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL>; O<SMALL>THER</SMALL> C<SMALL>ORPORATE</SMALL>
E<SMALL>VENTS</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(a)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Capitalization Adjustment</B><B>s</B>.<B></B>&nbsp;&nbsp;In the event of a Capitalization Adjustment, the Board shall appropriately and
proportionately adjust: (i)&nbsp;the class(es) and maximum number of securities subject to the Plan pursuant to Section&nbsp;2(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of Incentive Stock
Options pursuant to Section&nbsp;2(b), (iii)&nbsp;the class(es) and number of securities to be granted pursuant to the Automatic Grant Program, and (iv) the class(es) and number of securities and exercise price, strike price or purchase price of
stock subject to outstanding Awards. The Board shall make such adjustments, and its determination shall be final, binding and conclusive. Notwithstanding the provisions of this Section&nbsp;6(a), no fractional shares or rights for fractional shares
of Common Stock shall be created pursuant to this Section&nbsp;6(a). The Board shall determine an equivalent benefit for any fractional shares or fractional shares that might be created by the adjustments referred to in this Section&nbsp;6(a).
</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Dissolution or Liquidation</B>.<B></B>&nbsp;&nbsp;Except as otherwise provided in the Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Awards (other than Awards
consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#146;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of
Common Stock subject to the Company&#146;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Award is providing Continuous Service, <I>provided,
however</I>, that the Board may determine to cause some or all Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Awards have not previously expired or terminated) before the
dissolution or liquidation is completed but contingent on its completion. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Change in Control.</B>&nbsp;&nbsp;The following provisions will apply to Awards in the event of a Change in Control unless otherwise provided in the instrument evidencing the Award or any other written
agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the Board at the time of grant of the Award. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(</B><B>i</B><B>)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Awards May Be Assumed.&nbsp;&nbsp;</B>In the event of a Change in Control, any surviving corporation or acquiring corporation (or the surviving or
acquiring corporation&#146;s parent company) may assume or continue any or all Awards outstanding under the Plan or may substitute similar stock awards for Awards outstanding under the Plan (including but not limited to, awards to acquire the same
consideration paid to the stockholders of the Company pursuant to the Change in Control), and any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to Awards may be assigned by the Company to the
successor of the Company (or the successor&#146;s parent company, if any), in connection with such Change in Control. A surviving corporation or acquiring corporation (or its parent) may choose to assume or continue only a portion of an Award or
substitute a similar stock award for only a portion of a Award, or may choose to assume or continue the Awards held by some, but not all Participants. The terms of any assumption, continuation or substitution will be set by the Board. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;Awards Held by Current Eligible Participants.</B>&nbsp;&nbsp;In the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue
such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by Participants who are Employees or Directors and whose Continuous
Service has not terminated prior to the effective time of the Change in Control </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(referred to as the &#147;<B><I>Current Eligible Participants</I></B>&#148;), the vesting of such Awards (and, with respect to Options and Stock Appreciation Rights, the time when such Awards may
be exercised) will be accelerated in full to a date prior to the effective time of such Change in Control (contingent upon the effectiveness of the Change in Control) as the Board determines (or, if the Board does not determine such a date, to the
date that is five (5)&nbsp;days prior to the effective time of the Change in Control), and such Awards will terminate if not exercised (if applicable) at or prior to the effective time of the Change in Control, and any reacquisition or repurchase
rights held by the Company with respect to such Awards will lapse (contingent upon the effectiveness of the Change in Control). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;Awards Held by Persons other than Current Eligible
Participants.</B>&nbsp;&nbsp;In the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar stock awards for such
outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by persons other than Current Eligible Participants, such Awards will terminate if not exercised (if applicable) prior to the
effective time of the Change in Control; <I>provided, however</I>, that any reacquisition or repurchase rights held by the Company with respect to such Awards will not terminate and may continue to be exercised notwithstanding the Change in Control.
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iv)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Payment for Awards in Lieu of Exercise.</B>&nbsp;&nbsp;Notwithstanding the foregoing, in the event a Award will terminate if not exercised prior to the
effective time of a Change in Control, the Board may provide, in its sole discretion, that the holder of such Award may not exercise such Award but will receive a payment, in such form as may be determined by the Board, equal in value, at the
effective time, to the excess, if any, of (A)&nbsp;the value of the property the Participant would have received upon the exercise of the Award (including, at the discretion of the Board, any unvested portion of such Award), over (B)&nbsp;any
exercise price payable by such holder in connection with such exercise. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(d)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Appointment of Stockholder Representative.</B>&nbsp;&nbsp;As a condition to the receipt of an Award under this Plan, a Participant will be deemed to have agreed that the Award will be subject to the terms
of any agreement governing a Change in Control involving the Company, including, without limitation, a provision for the appointment of a stockholder representative that is authorized to act on the Participant&#146;s behalf with respect to any
escrow, indemnities and any contingent consideration. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(e)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>No Restriction on Right to Undertake Transactions</B>.<B></B>&nbsp;&nbsp;The grant of any Award under the Plan and the issuance of shares pursuant
to any Award does not affect or restrict in any way the right or power of the Company or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company&#146;s capital structure or
its business, any merger or consolidation of the Company, any issue of stock or of options, rights or options to purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or
the rights thereof or which are convertible into or exchangeable for Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding,
whether of a similar character or otherwise. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">7.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_7"></A>A<SMALL>UTOMATIC</SMALL> G<SMALL>RANTS</SMALL> T<SMALL>O</SMALL> E<SMALL>LIGIBLE</SMALL> D<SMALL>IRECTORS</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(a)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>General</B>.&nbsp;&nbsp;The Automatic Grant Program set forth in this Section&nbsp;7 provides that Eligible Directors shall automatically receive the grant of certain Awards at designated intervals over
their period of Continuous Service on the Board. For the avoidance of doubt, Awards granted under this Automatic Grant Program are subject to all the terms and conditions of the Plan. Each Option granted under this Automatic Grant Program shall
(i)&nbsp;be a Nonstatutory Stock Option, (ii)&nbsp;have an exercise price equal to one hundred percent (100%) of the Fair Market Value on the date the Option is granted, and (iii)&nbsp;a maximum term of 10 years. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Initial Awards</B>.&nbsp;&nbsp;At the time an Eligible Director is first elected or appointed to serve on the Board such person shall, upon the date of his or her initial election or appointment as an
Eligible Director, be </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
granted an Option to purchase 30,000 shares of Common Stock and a RSU Award in respect of 5,000 shares of Common Stock (each such Option and RSU Award an &#147;<B><I>Initial Award</I></B>&#148;).
Initial Awards of Options shall vest monthly with respect to 1/36th of the shares over the three year period following the date of grant, subject to the Eligible Director&#146;s Continuous Service through the applicable vesting dates, so that the
Option will be fully vested on the third anniversary of the date of grant. Initial Awards of RSU Awards shall vest annually with respect to 1/3rd of the shares over the three year period following the date of grant, subject to the Eligible
Director&#146;s Continuous Service through the applicable vesting dates, so that the RSU Award is fully vested on the third anniversary of the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Annual Awards</B>.&nbsp;&nbsp;On the date of each Annual Meeting, commencing with the Annual Meeting in 2018, each person who is then an Eligible Director and who has served as an Eligible Director on the
Board for a period of at least six months shall be granted an Option to purchase 15,000 shares of Common Stock and a RSU Award in respect of 2,500 shares of Common Stock (each such Option and RSU Award an &#147;<B><I>Annual Award</I></B>&#148;).
Annual Awards of Options shall vest monthly with respect to 1/12th of the shares over the one (1)&nbsp;year period following the date of grant, subject to the Eligible Director&#146;s Continuous Service through the applicable vesting dates, so that
the Option will be fully vested on the first anniversary of the date of grant. Annual Awards of RSU Awards shall fully vest on the earlier of (i)&nbsp;the first anniversary of the date of grant or (ii)&nbsp;the day prior to the next annual meeting
of stockholders, subject to the Eligible Director&#146;s Continuous Service through such date. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(d)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Vesting Upon Change in Control or Hostile
Take-Over.</B>&nbsp;&nbsp;Each Option and RSU Award granted pursuant to this Automatic Grant Program shall automatically fully accelerate vesting immediately prior to the effectiveness of a Change in Control or Hostile Take-Over, subject to the
Eligible Director&#146;s Continuous Service through the date of the Change in Control or Hostile Take Over, as applicable. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(e)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Vesting Upon Death or Disability.</B>&nbsp;&nbsp;If the Eligible
Director&#146;s Continuous Service terminates due to death or Disability, such Eligible Director&#146;s Options and RSU Awards granted pursuant to this Automatic Grant Program shall automatically fully vest. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">8.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_8"></A>A<SMALL>DMINISTRATION</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(a)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Administration by Board.</B>&nbsp;&nbsp;The Board will administer the
Plan unless and until the Board delegates administration of the Plan to a Committee or Committees, as provided in Section&nbsp;8(d). </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Powers of Board.</B>&nbsp;&nbsp;Except with respect to the Automatic Grant Program, the Board shall have the power, subject to, and within the limitations of, the express provisions of the Plan:
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To determine from time to time (A)&nbsp;which of the persons eligible under the Plan will be granted Awards; (B)&nbsp;when and how each Award will be
granted; (C)&nbsp;what type or combination of types of Award will be granted; (D)&nbsp;the provisions of each Award granted (which need not be identical), including the time or times when a person will be permitted to receive cash or Common Stock
pursuant to an Award; (E)&nbsp;the number of shares of Common Stock with respect to which an Award will be granted to each such person; and (F)&nbsp;the Fair Market Value applicable to an Award. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for its administration. The Board,
in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement in a manner and to the extent it deems necessary or expedient to make the Plan or Award fully effective. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To settle all controversies regarding the Plan and Awards granted under it. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iv)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof will vest, notwithstanding the provisions
in the Award Agreement stating the time at which it may first be exercised or the time during which it will vest, including in connection with a Change in Control or Hostile Take-Over. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(v)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To prohibit the exercise of any Option, SAR or other exercisable Award during a period of up to thirty days prior to the consummation of any pending stock
dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other change affecting the shares of Common Stock or the share price
of the Common Stock including any Change in Control, for reasons of administrative convenience. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(vi)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To suspend or terminate the Plan at any time. Suspension or termination of the Plan
will not impair rights and obligations under any Award granted while the Plan is in effect except with the written consent of the affected Participant. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(vii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To amend the Plan in any respect the Board deems necessary or advisable, provided that stockholder approval will be required to the extent required by Applicable Law.
Except as provided above, rights under any Award granted before amendment of the Plan will not be impaired by any amendment of the Plan unless (1)&nbsp;the Company requests the consent of the affected Participant, and (2)&nbsp;such Participant
consents in writing. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(viii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;To submit any amendment to the Plan for stockholder approval. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ix)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to
provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; <I>provided however</I>, that except with respect to amendments
that disqualify or impair the status of an Incentive Stock Option, a Participant&#146;s rights under any Award will not be impaired by any such amendment unless (A)&nbsp;the Company requests the consent of the affected Participant, and (B)&nbsp;such
Participant consents in writing. Notwithstanding the foregoing, (1)&nbsp;a Participant&#146;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a
whole, does not materially impair the Participant&#146;s rights, including, but not limited, to, an amendment that imposes reasonable restrictions on the minimum number of shares subject to an Option that may be exercised, and (2)&nbsp;subject to
the limitations of Applicable Law, if any, the Board may amend the terms of any one or more Awards without the affected Participant&#146;s consent (A)&nbsp;to maintain the qualified status of the Award as an Incentive Stock Option under
Section&nbsp;422 of the Code; (B)&nbsp;to change the terms of an Incentive Stock Option, if such change results in impairment of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under
Section&nbsp;422 of the Code; (C)&nbsp;to clarify the manner of exemption from, or to bring the Award into compliance with or qualify it for an exemption from, Section&nbsp;409A; or (D)&nbsp;to comply with other Applicable Laws. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(x)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company
and that are not in conflict with the provisions of the Plan or Awards. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(xi)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To adopt such procedures and
<FONT STYLE="white-space:nowrap">sub-plans</FONT> as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Administration of Automatic Grant Program</B>.&nbsp;&nbsp;The Board shall have the power, subject to and within the limitations of, the express provisions of the Automatic Grant Program: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To determine the provisions of each Award to the extent not specified in the Automatic Grant Program. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To construe and interpret the Automatic Grant Program and the Awards granted under it, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this power, may correct any defect, omission or inconsistency in the Automatic Grant Program or in any Award Agreement, in a manner and to the extent it shall deem necessary or expedient to make
the Automatic Grant Program fully effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To amend the terms of the Automatic Grant Program or an Award granted thereunder, except that rights under any such Award granted before amendment of the
Automatic Grant Program shall not be impaired by any amendment of the Automatic Grant Program unless (1)&nbsp;the Company requests the consent of the affected Participant, and (2)&nbsp;such Participant consents in writing. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iv)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Automatic Grant
Program. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delegation to
Committee. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(</B><B>i</B><B>)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>General.&nbsp;&nbsp;</B>The Board may delegate some or all of the administration of the Plan (except the Automatic Grant Program) to a Committee
or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including
the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however, to
such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Committee may, at any time, abolish the subcommittee and/or revest in the Committee any powers delegated to the subcommittee.
The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated. As of the Effective Date the Board has delegated administration of
the Plan to the Compensation Committee. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> Compliance.&nbsp;&nbsp;</B>The Committee may consist solely of two or more <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Directors, in accordance with Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> In addition, the Board or the Committee, in its sole discretion, may delegate to a Committee who need not be <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Directors the authority to grant Awards to eligible persons who are not then subject to Section&nbsp;16 of the Exchange Act. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(e)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Effect of Board</B><B>&#146;</B><B>s Decision.</B>&nbsp;&nbsp;All determinations, interpretations and constructions made by the Board or any Committee in good faith will not be subject to review by any
person and will be final, binding and conclusive on all persons. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(f)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Cancellation and <FONT STYLE="white-space:nowrap">Re-Grant</FONT> of Awards</B>.<B>&nbsp;&nbsp;</B>Neither the Board nor any Committee will have the authority to: (i)&nbsp;reduce the exercise price or
strike price of any outstanding Options or SARs under the Plan, or (ii)&nbsp;cancel any outstanding Options or SARs that have an exercise price or strike price greater than the current Fair Market Value in exchange for cash or other Awards under the
Plan, unless the stockholders of the Company have approved such an action within twelve months prior to such an event. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(g)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Delegation to an Officer.&nbsp;&nbsp;</B>The Board or any Committee may
delegate to one or more Officers the authority to do one or both of the following (i)&nbsp;designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by Applicable Law, other Awards) and, to the
extent permitted by Applicable Law, the terms thereof, and (ii)&nbsp;determine the number of shares of Common Stock to be subject to such Awards granted to such Employees; <I>provided, however, </I>that the resolutions evidencing such delegation
will specify the total number of shares of Common Stock that may be subject to the Awards granted by such Officer and that such Officer may not grant an Award to himself or herself. Any such Awards will be granted on the form of Award Agreement most
recently approved for use by the Board or the Committee, unless otherwise provided in the resolutions approving the delegation authority. Notwithstanding anything to the contrary herein, neither the Board nor any Committee may delegate to an Officer
who is acting solely in the capacity of an Officer (and not also as a Director) the authority to determine the Fair Market Value. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">9.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_9"></A>T<SMALL>AX</SMALL> W<SMALL>ITHHOLDING</SMALL> </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(a)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Withholding Authorization.&nbsp;&nbsp;</B>As a condition to acceptance
of any Award under the Plan, a Participant authorizes withholding from payroll and any other amounts payable to such Participant, and otherwise agree to make adequate provision for (including), any sums required to satisfy the federal, state, local
and foreign tax withholding obligations of the Company or an Affiliate, if any, which arise in connection with the exercise, vesting or settlement of such Award, as applicable. Accordingly, a Participant may not be able to exercise an Award even
though the Award is vested, and the Company shall have no obligation to issue shares of Common Stock subject to an Award, unless and until such obligations are satisfied. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Satisfaction of Withholding Obligation.&nbsp;&nbsp;</B>To the extent permitted by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any federal, state or local tax
withholding obligation relating to an Award by any of the following means or by a combination of such means: (i)&nbsp;causing the Participant to tender a cash payment; (ii)&nbsp;withholding shares of Common Stock from the shares of Common Stock
issued or otherwise issuable to the Participant in connection with the Award; (iii)&nbsp;withholding cash from an Award settled in cash; (iv)&nbsp;withholding payment from any amounts otherwise payable to the Participant; (v)&nbsp;by means of a
&#147;cashless exercise&#148; pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board, or (vi)&nbsp;by such other method as may be set forth in the Award Agreement. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Withholding Indemnification.&nbsp;&nbsp;</B>As a condition to accepting an Award under the Plan, in the event that the amount of the Company&#146;s withholding obligation in connection with such Award was
greater than the amount actually withheld by the Company, each Participant agrees to indemnify and hold the Company harmless from any failure by the Company to withhold the proper amount. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">10.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_10"></A>M<SMALL>ISCELLANEOUS</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><B>Minimum Vesting Requirements</B>. No Award may vest (or, if applicable, be
exercisable) until at least twelve months following the date of grant of the Award; provided, however, that up to five percent (5%) of the Share Reserve may be subject to Awards that do not meet such vesting (and, if applicable, exercisability)
requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Source of Shares.&nbsp;&nbsp;</B>The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market or otherwise. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Use of Proceeds from Sales of Common Stock.&nbsp;&nbsp;</B>Proceeds from the sale of shares of Common Stock pursuant to Awards will constitute general funds of the Company. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(d)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Corporate Action Constituting Grant of Awards.&nbsp;&nbsp;</B>Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate
action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g.,
Board consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant
documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or
related grant documents. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(e)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Stockholder Rights.&nbsp;&nbsp;</B>No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to,
any shares of Common Stock subject to such Award unless and until (i)&nbsp;such Participant has satisfied all requirements for exercise of the Award pursuant to its terms, if applicable, and (ii)&nbsp;the issuance of the Common Stock subject to such
Award is reflected in the records of the Company. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(f)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>No Employment or Other Service Rights.&nbsp;&nbsp;</B>Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in
connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or affect the right of the Company or an
Affiliate to terminate at will and without regard to any future vesting opportunity that a Participant may have with respect to any Award (i)&nbsp;the employment of an Employee with or without notice and with or without cause, (ii)&nbsp;the service
of a Consultant pursuant to the terms of such Consultant&#146;s agreement with the Company or an Affiliate, or (iii)&nbsp;the service of a Director pursuant to the Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate
law of the state in which the Company or the Affiliate is incorporated, as the case may be. Further, nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award will constitute any promise or
commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or service or confer any right or benefit under the Award or the
Plan unless such right or benefit has specifically accrued under the terms of the Award Agreement and/or Plan. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(g)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Change in Time Commitment</B>.<B>&nbsp;&nbsp;</B>In the event a
Participant&#146;s regular level of time commitment in the performance of his or her services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a
change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board may determine, to the extent permitted by Applicable Law, to (x)&nbsp;make a
corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y)&nbsp;in lieu of or in combination with such a
reduction, extend the vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(h)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Incentive Stock Option $100,000 Limitation.&nbsp;&nbsp;</B>To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options
are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply with the rules governing
Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding any
contrary provision of the applicable Option Agreement(s). </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Execution of Additional Documents.&nbsp;&nbsp;</B>As a condition to accepting an Award under the Plan, the Participant agrees to execute any additional documents or instruments necessary or desirable, as
determined in the Plan Administrator&#146;s sole discretion, to carry out the purposes or intent of the Award, or facilitate compliance with securities and/or other regulatory requirements, in each case at the Plan Administrator&#146;s request.
</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(j)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Electronic Delivery and Participation</B>.<B>&nbsp;&nbsp;</B>Any reference herein or in an Award Agreement to a &#147;written&#148; agreement or document will include any agreement or document delivered
electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#146;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access). By accepting any Award the
Participant consents to receive documents by electronic delivery and to participate in the Plan through any <FONT STYLE="white-space:nowrap">on-line</FONT> electronic system established and maintained by the Plan Administrator or another third party
selected by the Plan Administrator. The form of delivery of any Common Stock (<I>e.g.</I>, a stock certificate or electronic entry evidencing such shares) shall be determined by the Company. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(k)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Clawback/Recovery</B>.<B>&nbsp;&nbsp;</B>All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing
standards of any national securities exchange or association on which the Company&#146;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law. In
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including but not limited to a
reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a Participant&#146;s right
to voluntary terminate employment upon a &#147;resignation for good reason,&#148; or for a &#147;constructive termination&#148; or any similar term under any plan of or agreement with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(l)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Securities Law Compliance.&nbsp;&nbsp;</B>A Participant will not be issued any shares in respect of an Award unless either (i)&nbsp;the shares are registered under the Securities Act; or (ii)&nbsp;the
Company has determined that such issuance would be exempt from the registration requirements of the Securities Act. Each Award also must comply with other Applicable Law governing the Award, and a Participant will not receive such shares if the
Company determines that such receipt would not be in material compliance with Applicable Law. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(m)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Transfer or Assignment of Awards; Issued Shares.&nbsp;&nbsp;</B>Except
as expressly provided in the Plan or the form of Award Agreement, Awards granted under the Plan may not be transferred or assigned by the Participant. After the vested shares subject to an Award have been issued, or in the case of Restricted Stock
and similar awards, after the issued shares have vested, the holder of such shares is free to assign, hypothecate, donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the
provisions herein, the terms of the Trading Policy and Applicable Law. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(n)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;<B>Effect on Other Employee Benefit Plans.&nbsp;&nbsp;</B>The value of any Award granted under the Plan, as determined upon grant, vesting or settlement, shall not be included as compensation, earnings, salaries, or other
similar terms used when calculating any Participant&#146;s benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend,
modify, or terminate any of the Company&#146;s or any Affiliate&#146;s employee benefit plans. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(o)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Deferrals.&nbsp;&nbsp;</B>To the extent permitted by Applicable Law,
the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may also establish programs and procedures for
deferral elections to be made by Participants. Deferrals by will be made in accordance with the requirements of Section&nbsp;409A. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(p)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section 409A.&nbsp;&nbsp;</B>Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan
and the Awards granted hereunder exempt from Section&nbsp;409A, and, to the extent not so exempt, in compliance with the requirements of Section&nbsp;409A. If the Board determines that any Award granted hereunder is not exempt from and is therefore
subject to Section&nbsp;409A, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section&nbsp;409A(a)(1) of the Code, and to the extent an Award Agreement is silent on
terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common
Stock are publicly traded, and if a Participant holding an Award that constitutes &#147;deferred compensation&#148; under Section&nbsp;409A is a &#147;specified employee&#148; for purposes of Section&nbsp;409A, no distribution or payment of any
amount that is due because of a &#147;separation from service&#148; (as defined in Section&nbsp;409A without regard to alternative definitions thereunder) will be issued or paid before the date that is six months and one day following the date of
such Participant&#146;s &#147;separation from service&#148; or, if earlier, the date of the Participant&#146;s death, unless such distribution or payment can be made in a manner that complies with Section&nbsp;409A, and any amounts so deferred will
be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(q)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Data Privacy</B><B>.</B><B>&nbsp;&nbsp;</B>By accepting an Award
granted under the Plan, a Participant thereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of such Participant&#146;s personal data as described herein by and among, as applicable, the
Employer, and the Company and its other </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Affiliates and the Plan Administrator for the exclusive purpose of implementing, administering and managing such Participant&#146;s participation in the Plan. Each Participant understands that
the Company and the Employer may hold certain personal information about such Participant, including, but not limited to, the Participant&#146;s name, home address and telephone number, date of birth, social insurance number or other identification
number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Awards or any other entitlement to ordinary shares awarded, canceled, exercised, vested, unvested or outstanding in the
Participant&#146;s favor, for the purpose of implementing, administering and managing the Plan (the &#147;<B><I>Data</I></B>&#148;). Each Participant understands that Data may be transferred to any third parties assisting in the implementation,
administration and management of the Plan, that these recipients may be located in the Participant&#146;s country or elsewhere, and that the recipients&#146; country (<I>e.g</I>., the United States) may have different data privacy laws and
protections than the Participant&#146;s country. Each Participant understands that such Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant&#146;s local human resources
representative. Each Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Participant&#146;s participation in
the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom such Participant may elect to deposit any ordinary shares acquired pursuant to an Award. Each Participant understands that Data
will be held only as long as is necessary to implement, administer and manage such Participant&#146;s participation in the Plan. Each Participant understands that such Participant may, at any time, view Data, request additional information about the
storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, without cost, by contacting in writing such Participant&#146;s local human resources representative. Each Participant understands,
however, that refusing or withdrawing such Participant&#146;s consent may affect such Participant&#146;s ability to participate in the Plan. For more information on the consequences of refusal to consent or withdrawal of consent, each Participant
understands that such Participant may contact his or her local human resources representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(r)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Choice of Law.&nbsp;&nbsp;</B>This Plan and any controversy arising out
of or relating to this Plan shall be governed by, and construed in accordance with, the internal laws of the State of California, without regard to conflict of law principles that would result in any application of any law other than the law of the
State of California. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">11.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_11"></A>C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(a)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Securities Law Compliance.&nbsp;&nbsp;</B>The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Awards and
to issue and sell shares of Common Stock upon exercise of the Awards; <I>provided, however</I>, that this undertaking will not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable
pursuant to any such Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under
the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Awards unless and until such authority is obtained. A Participant is not eligible for the grant of an Award or the subsequent
issuance of Common Stock pursuant to the Award if such grant or issuance would be in violation of any Applicable Law. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>No Obligation to Notify or Minimize Taxes; No Liability for
Taxes.&nbsp;&nbsp;</B>The Company has no duty or obligation to any Participant to advise such holder as to the time or manner of exercising such Award. Furthermore, the Company has no duty or obligation to warn or otherwise advise such holder of a
pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award and will not be liable to any
holder of an Award for any adverse tax consequences to such holder in connection with an Award. As a condition to accepting an Award under the Plan, each Participant (i)&nbsp;agrees to not make any claim against the Company, or any of its Officers,
Directors, Employees or Affiliates related to tax liabilities arising from such Award or other Company compensation and (ii)&nbsp;acknowledges that such Participant was </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
advised to consult with his or her own personal tax, financial and other legal advisors regarding the tax consequences of the Award and has either done so or knowingly and voluntarily declined to
do so. Additionally, each Participant acknowledges any Option or SAR granted under the Plan is exempt from Section&nbsp;409A only if the exercise or strike price is at least equal to the &#147;fair market value&#148; of the Common Stock on the date
of grant as determined by the Internal Revenue Service and there is no other impermissible deferral of compensation associated with the Award. Additionally, as a condition to accepting an Option or SAR granted under the Plan, each Participant agrees
not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates in the event that the Internal Revenue Service asserts that such exercise price or strike price is less than the &#147;fair market value&#148; of the
Common Stock on the date of grant as subsequently determined by the Internal Revenue Service. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">12.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_12"></A>A<SMALL>DDITIONAL</SMALL> R<SMALL>ULES</SMALL> <SMALL>FOR</SMALL> A<SMALL>WARDS</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> S<SMALL>ECTION</SMALL>&nbsp;409A. </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(a)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Application.&nbsp;&nbsp;</B>Unless the provisions of this Section&nbsp;12 of the Plan are expressly superseded by the provisions in the form of Award Agreement, the provisions of this Section&nbsp;12 shall
apply and shall supersede anything to the contrary set forth in the Award Agreement for a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards Subject to <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangements.&nbsp;&nbsp;</B>To the extent a
<FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award is subject to Section&nbsp;409A due to application of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement, the following provisions of Section&nbsp;12(b) apply.
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award vests in the ordinary course during the Participant&#146;s Continuous Service in
accordance with the vesting schedule set forth in the Award Agreement, and does not accelerate vesting under the terms of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement, in no event will the shares be issued in respect of
such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award any later than the later of: (i)&nbsp;December 31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> of the calendar year that includes the applicable vesting date, or (ii)&nbsp;the
60<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day that follows the applicable vesting date. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If vesting of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award
accelerates under the terms of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement in connection with the Participant&#146;s Separation from Service, and such vesting acceleration provisions were in effect as of the date of
grant of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award and, therefore, are part of the terms of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award as of the date of grant, then the shares will be earlier issued in
settlement of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award upon the Participant&#146;s Separation from Service in accordance with the terms of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement, but in no
event later than the 60<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day that follows the date of the Participant&#146;s Separation from Service. However, if at the time the shares would otherwise be issued the Participant is subject to
the distribution limitations contained in Section&nbsp;409A applicable to &#147;specified employees,&#148; as defined in Section&nbsp;409A(a)(2)(B)(i) of the Code, such shares shall not be issued before the date that is six months following the date
of such Participant&#146;s Separation from Service, or, if earlier, the date of the Participant&#146;s death that occurs within such six month period. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If vesting of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award accelerates under the terms of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT>
Severance Arrangement in connection with a Participant&#146;s Separation from Service, and such vesting acceleration provisions were not in effect as of the date of grant of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award and,
therefore, are not a part of the terms of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award on the date of grant, then such acceleration of vesting of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall not accelerate the
issuance date of the shares, but the shares shall instead be issued on the same schedule as set forth in the Grant Notice as if they had vested in the ordinary course during the Participant&#146;s Continuous Service, notwithstanding the vesting
acceleration of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Such issuance schedule is intended to satisfy the requirements of payment on a specified date or pursuant to a fixed schedule, as provided under Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-3(a)(4).</FONT> </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Treatment of <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards Upon a Change in Control for Employees and Consultants.&nbsp;&nbsp;</B>The provisions of this Section&nbsp;12(c) shall apply and shall
supersede anything to the contrary set forth in the Plan with respect to the permitted treatment of any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award in connection with a Change in Control if the Participant was either an Employee or
Consultant upon the applicable date of grant of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards: The following provisions shall apply to any Vested
<FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award in connection with a Change in Control: </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:23%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(1)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Change in Control is also a Section&nbsp;409A Change in Control
then the Acquiring Entity may not assume, continue or substitute the Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Upon the Section&nbsp;409A Change of Control the settlement of the Vested
<FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award will automatically be accelerated and the shares will be immediately issued in respect of the Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Alternatively, the Company may
instead provide that the Participant will receive a cash settlement equal to the Fair Market Value of the shares that would otherwise be issued to the Participant upon the Section&nbsp;409A Change of Control. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:23%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(2)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Change in Control is not also a Section&nbsp;409A Change of Control, then the Acquiring Entity must either assume, continue or substitute each Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT>
Award. The shares to be issued in respect of the Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall be issued to the Participant by the Acquiring Entity on the same schedule that the shares would have been issued to the
Participant if the Change in Control had not occurred. In the Acquiring Entity&#146;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash payment on each applicable issuance date, equal to the Fair Market
Value of the shares that would otherwise be issued to the Participant on such issuance dates, with the determination of the Fair Market Value of the shares made on the date of the Change in Control. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards. The following provisions shall apply to any Unvested
<FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award unless otherwise determined by the Board pursuant to Section&nbsp;12(e). </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:23%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(1)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of a Change in Control, the Acquiring Entity shall assume, continue or substitute any Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Unless otherwise determined by the Board,
any Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award will remain subject to the same vesting and forfeiture restrictions that were applicable to the Award prior to the Change in Control. The shares to be issued in respect of any
Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall be issued to the Participant by the Acquiring Entity on the same schedule that the shares would have been issued to the Participant if the Change in Control had not occurred. In
the Acquiring Entity&#146;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash payment on each applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the
Participant on such issuance dates, with the determination of Fair Market Value of the shares made on the date of the Change in Control. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:23%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(2)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Acquiring Entity will not assume, substitute or continue any Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award in connection with a Change in Control, then such Award shall
automatically terminate and be forfeited upon the Change in Control with no consideration payable to any Participant in respect of such forfeited Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Notwithstanding the foregoing, to
the extent permitted and in compliance with the requirements of Section&nbsp;409A, the Board may in its discretion determine to elect to accelerate the vesting and settlement of the Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award
upon the Change in Control, or instead substitute a cash payment equal to the Fair Market Value of such shares that would otherwise be issued to the Participant, as further provided in Section&nbsp;12(e)(ii) below. In the absence of such
discretionary election by the Board, any Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall be forfeited without payment of any consideration to the affected Participants if the Acquiring Entity will not assume, substitute or
continue the Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards in connection with the Change in Control. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:23%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(3)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The foregoing treatment shall apply with respect to all Unvested <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Awards upon any Change in Control, and regardless of whether or not such Change in Control is also a Section&nbsp;409A Change of Control. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(d)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treatment of <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards Upon a Change in Control for <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors. The following provisions of this
Section&nbsp;12(d) shall apply and shall supersede anything to the contrary that may be set forth in the Plan with respect to the permitted treatment of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award in connection with a Change
in Control. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Change in Control is also a Section&nbsp;409A Change of Control then the Acquiring Entity may not assume, continue or substitute the <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award. Upon the Section&nbsp;409A Change of Control the vesting and settlement of any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award will automatically be accelerated and the
shares will be immediately issued to the Participant in respect of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award. Alternatively, the Company may provide that the Participant will instead receive a cash settlement equal to the
Fair Market Value of the shares that would otherwise be issued to the Participant upon the Section&nbsp;409A Change of Control pursuant to the preceding provision. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Change in Control is not also a Section&nbsp;409A Change of Control, then the Acquiring Entity must either assume, continue or substitute the <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award. Unless otherwise determined by the Board, the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award will remain subject to the same vesting and forfeiture restrictions that
were applicable to the Award prior to the Change in Control. The shares to be issued in respect of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award shall be issued to the Participant by the Acquiring Entity on the same schedule
that the shares would have been issued to the Participant if the Change in Control had not occurred. In the Acquiring Entity&#146;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash payment on each
applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant on such issuance dates, with the determination of Fair Market Value made on the date of the Change in Control. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(e)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the RSU Award is a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award, then the provisions in this Section&nbsp;12(e) shall apply and supersede anything to the contrary that may be set forth in the
Plan or the Award Agreement with respect to the permitted treatment of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any exercise by the Board of discretion to accelerate the vesting of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall not result in
any acceleration of the scheduled issuance dates for the shares in respect of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award unless earlier issuance of the shares upon the applicable vesting dates would be in compliance with the
requirements of Section&nbsp;409A. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company explicitly reserves the right to earlier settle any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award to the extent permitted and in
compliance with the requirements of Section&nbsp;409A, including pursuant to any of the exemptions available in Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(j)(4)(ix).</FONT> </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the extent the terms of any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award provide that it will be settled upon a Change in Control or Change in
Control, to the extent it is required for compliance with the requirements of Section&nbsp;409A, the Change in Control or Change in Control event triggering settlement must also constitute a Section&nbsp;409A Change of Control. To the extent the
terms of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award provides that it will be settled upon a termination of employment or termination of Continuous Service, to the extent it is required for compliance with the requirements of
Section&nbsp;409A, the termination event triggering settlement must also constitute a Separation From Service. However, if at the time the shares would otherwise be issued to a Participant in connection with a &#147;separation from service&#148;
such Participant is subject to the distribution limitations contained in Section&nbsp;409A applicable to &#147;specified employees,&#148; as defined in Section&nbsp;409A(a)(2)(B)(i) of the Code, such shares shall not be issued before the date that
is six months following the date of the Participant&#146;s Separation From Service, or, if earlier, the date of the Participant&#146;s death that occurs within such six month period. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(iv)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The provisions in Section&nbsp;12(e) for delivery of the shares in respect of the settlement of a RSU Award that is a
<FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award are intended to comply with the requirements of Section&nbsp;409A so that the delivery of the shares to the Participant in respect of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT>
Award will not trigger the additional tax imposed under Section&nbsp;409A, and any ambiguities herein will be so interpreted. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">13</FONT>.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_13"></A>S<SMALL>EVERABILITY</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If all or any part of the Plan or any
Award Agreement is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of the Plan or such Award Agreement not declared to be unlawful or invalid. Any Section of
the Plan or any Award Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible
while remaining lawful and valid. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">14.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_14"></A>T<SMALL>ERMINATION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier of: (i)&nbsp;the
Adoption Date, or (ii)&nbsp;the Effective Date. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">15.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="appatoc573774_15"></A>D<SMALL>EFINITIONS</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in the Plan, the following
definitions apply to the capitalized terms indicated below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(a)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Acquiring Entity&#148;</I></B> means the surviving or acquiring corporation (or its parent company) in connection with a Change in
Control. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(b)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Adoption Date&#148; </I></B>means the date the Plan is first approved by the Compensation Committee of the Board. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(c)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Affiliate</I></B>&#148; means, at the time of determination, any &#147;parent&#148; or &#147;subsidiary&#148; of the Company as such terms are defined in Rule 405 promulgated under the Securities
Act. The Board may Determine the time or times at which &#147;parent&#148; or &#147;subsidiary&#148; status is determined within the foregoing definition. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(d)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Applicable Law&#148;</I></B> means shall mean any applicable securities, federal, state, foreign, material local or municipal or other law, statute, constitution, principle of common law,
resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body
(or under the authority of the NASDAQ Stock Market or the Financial Industry Regulatory Authority). </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(e)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Appreciation Award</I></B>&#148; means (i)&nbsp;a stock option
or stock appreciation right granted under any of the Prior Plans or (ii)&nbsp;an Option or SAR granted under the Plan, in each case with respect to which the exercise or strike price is at least 100% of the Fair Market Value of the Common Stock
subject to the option or stock appreciation right as applicable, on the date of grant. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(f)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Automatic Grant Program</I></B>&#148; means the grant program
in effect for Eligible Directors under Section&nbsp;7 of the Plan. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(g)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Award</I></B>&#148; means any right to receive Common Stock granted under the Plan, including an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, a RSU Award, a SAR,
a Performance Award or any Other Award. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(h)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Award Agreement</I></B>&#148; means a written agreement between the Company and a Participant evidencing the terms and conditions of an
Award. The Award Agreement generally consists of the Grant Notice and General Terms and Conditions. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Board</I></B>&#148; means the Board of Directors of the
Company. Any decision or determination made by the Board shall be a decision or determination that is made in the sole discretion of the Board (or its designee), and such decision or determination shall be final and binding on all Participants.
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-19. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(j)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Capitalization Adjustment</I></B>&#148; means any change that is made in, or other events that occur with respect to, the Common Stock
subject to the Plan or subject to any Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other
than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in
Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a
Capitalization Adjustment. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(k)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Cause</I></B>&#148;<B><I> </I></B>has the meaning ascribed to such term in any written agreement between the Participant and the Company
defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events that has a material negative impact on the business or reputation of the Company: (i)&nbsp;such
Participant&#146;s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (ii)&nbsp;such Participant&#146;s intentional, material violation of any contract or agreement between the Participant and the Company
or of any statutory duty owed to the Company; (iii)&nbsp;such Participant&#146;s unauthorized use or disclosure of the Company&#146;s confidential information or trade secrets; or (iv)&nbsp;such Participant&#146;s gross misconduct. The determination
that a termination of the Participant&#146;s Continuous Service is either for Cause or without Cause will be made by the Board with respect to Participants who are executive officers of the Company and by the Company&#146;s Chief Executive Officer
with respect to Participants who are not executive officers of the Company. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such
Participant will have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(l)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Change in Control</I></B>&#148; or &#147;<B><I>Change of Control</I></B>&#148; means the occurrence, in a single transaction or in a series of related transactions, of any one or more
of the following events constituting a change in ownership or Control of the Company; provided, however, to the extent necessary to avoid adverse personal income tax consequences to the Participant in connection with an Award, such transaction also
constitutes a Section&nbsp;409A Change of Control: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(i)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a merger, consolidation or other reorganization approved by the Company&#146;s stockholders, unless securities representing more than fifty percent
(50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the
Company&#146;s outstanding voting securities immediately prior to such transaction, </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(ii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a stockholder-approved sale, transfer or other disposition of all or
substantially all of the Company&#146;s assets in complete liquidation or dissolution of the Company, or </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(iii)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the closing of any transaction or series of related transactions pursuant to which any
person or any group of persons comprising a &#147;group&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-5(b)(1)</FONT> of the Exchange Act (other than the Company or a person that, prior to such transaction or series of related
transactions, directly or indirectly controls, is controlled by or is under common control with, the Company) becomes directly or indirectly the beneficial owner (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the
Exchange Act) of securities possessing (or convertible into or exercisable for securities possessing) more than fifty percent (50%) of the total combined voting power of the Company&#146;s securities (as measured in terms of the power to vote with
respect to the election of Board members) outstanding immediately after the consummation of such transaction or series of related transactions, whether such transaction involves a direct issuance from the Company or the acquisition of outstanding
securities held by one or more of the Company&#146;s existing stockholders. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing or any other provision
of this Plan, (A)&nbsp;the term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-20. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
domicile of the Company, and (B)&nbsp;the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall
supersede the foregoing definition with respect to Awards subject to such agreement; <I>provided, however</I>, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing
definition shall apply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(m)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Code</I></B>&#148; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.
</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(n)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Committee</I></B>&#148; means the Compensation Committee and any other committee of Directors to whom authority has been delegated by the Board or Compensation Committee in accordance with
Section&nbsp;8(d). </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(o)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Common Stock</I></B>&#148; means the common stock of the Company. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(p)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Company</I></B>&#148; means Sangamo Therapeutics, Inc., a Delaware corporation. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(q)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Compensation Committee&#148;</I></B> means the Compensation Committee of the Board. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(r)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Consultant</I></B>&#148; means any person, including an advisor, who is (i)&nbsp;engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for
such services, or (ii)&nbsp;serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a
&#147;Consultant&#148; for purposes of the Plan.<B><I> </I></B>Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form <FONT STYLE="white-space:nowrap">S-8</FONT> Registration Statement under the Securities
Act is available to register either the offer or the sale of the Company&#146;s securities to such person. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(s)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Continuous Service</I></B>&#148; means that the
Participant&#146;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an
Employee, Director or Consultant or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#146;s service with the Company or an Affiliate, will not terminate a
Participant&#146;s Continuous Service; <I>provided, however,</I> that<I> </I>if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, such Participant&#146;s Continuous Service will
be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of
Continuous Service. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#146;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)&nbsp;any
leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii)&nbsp;transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a
leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#146;s leave of absence policy, in the written terms of any leave of absence agreement or policy
applicable to the Participant, or as otherwise required by law. In addition, to the extent required for exemption from or compliance with Section&nbsp;409A, the determination of whether there has been a termination of Continuous Service will be
made, and such term will be construed, in a manner that is consistent with the definition of &#147;separation from service&#148; as defined under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h)</FONT> (without regard to
any alternative definition thereunder). </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(t)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Director</I></B>&#148; means a member of the Board. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(u)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Disability</I></B>&#148; means, with respect to a Participant, such Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical
or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Section&nbsp;22(e)(3) of the Code, and will be determined by the Board on
the basis of such medical evidence as the Board deems warranted under the circumstances. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-21. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(v)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Effective Date</I></B>&#148; means the date of the annual meeting of stockholders of the Company held in 2018 provided this Plan is
approved by the Company&#146;s stockholders at such meeting. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(w)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Eligible Director</I></B>&#148; means a Director who is not an Employee. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(x)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Employee</I></B>&#148; means any person employed by the
Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#147;Employee&#148; for purposes of the Plan. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(y)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Employer</I></B>&#148; means the Company or the Affiliate of the Company that employs the Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(z)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Entity</I></B>&#148; means a corporation, partnership, limited liability company or other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(aa)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(bb)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Exchange Act Person</I></B>&#148;<B><I> </I></B>means any natural person, Entity or &#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act), except that &#147;Exchange Act Person&#148; will not include
(i)&nbsp;the Company or any Subsidiary of the Company, (ii)&nbsp;any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any
Subsidiary of the Company, (iii)&nbsp;an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv)&nbsp;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially
the same proportions as their Ownership of stock of the Company; or (v)&nbsp;any natural person, Entity or &#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner,
directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#146;s then outstanding securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(cc)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Fair
Market Value</I></B>&#148; means, as of any date, the value of the Common Stock (as determined on a per share or aggregate basis, as applicable) determined as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(i)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value will be the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest
volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ii)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If there is
no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(iii)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the absence of
such markets for the Common Stock, or if otherwise determined by the Board, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(dd)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Full
Value Award</I></B>&#148; means an Award granted under the Plan or an award granted under the Prior Plans that is not an Appreciation Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ee)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><I>&#147;General Terms and Conditions&#148;</I></B> means the written summary of the general terms and conditions applicable to an Award and which is provided to a Participant along with the Grant Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(</B><B>ff</B><B>)</B></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Governmental</I></B><B> </B><B><I>Body</I></B>&#148; means any: (a)&nbsp;nation, state, commonwealth, province, territory, county,
municipality, district or other jurisdiction of any nature; (b)&nbsp;federal, state, local, municipal, foreign or other government; (c)&nbsp;governmental or regulatory body, or quasi-governmental body of any nature (including any
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-22. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
governmental division, department, administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and
any court or other tribunal, and for the avoidance of doubt, any Tax authority) or other body exercising similar powers or authority; or (d)&nbsp;self-regulatory organization (including the NASDAQ Stock Market and the Financial Industry Regulatory
Authority). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(gg)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Grant
Notice&#148;</I></B> means the written notice provided to a Participant that he or she has been granted an Award under the Plan and which includes the name of the Participant, the type of Award, the date of grant of the Award, number of shares of
Common Stock subject to the Award (if any), the vesting schedule for the Award (if any) and other key terms applicable to the Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(hh)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Hostile Take-Over&#148;</I></B> means a change in ownership or control of the Company effected through either of the
following transactions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(i)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
change in the composition of the Board over a period of <FONT STYLE="white-space:nowrap">thirty-six</FONT> (36)&nbsp;consecutive months or less such that a majority of the Board members ceases, by reason of one or more contested elections for Board
membership, to be comprised of individuals who either (A)&nbsp;have been Board members continuously since the beginning of such period or (B)&nbsp;have been elected or nominated for election as Board members during such period by at least a majority
of the Board members described in clause (A)&nbsp;who were still in office at the time the Board approved such election or nomination, or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; text-indent:15%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ii)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
Hostile Tender-Offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ii)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><I>&#147;Hostile Tender-Offer&#148;</I></B> means the acquisition, directly or indirectly, by any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common
control with, the Company) of beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the
Company&#146;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#146;s stockholders which the Board does not recommend such stockholders to accept. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(jj)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Incentive Stock Option</I></B>&#148; means an option granted pursuant to Section&nbsp;4 of the Plan that is intended to be, and qualifies as, an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(kk)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I><FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director</I></B>&#148;<B> </B>means a Director who either (i)&nbsp;is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from
the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation
<FONT STYLE="white-space:nowrap">S-K</FONT> promulgated pursuant to the Securities Act (&#147;<B><I>Regulation <FONT STYLE="white-space:nowrap">S-K</FONT></I></B>&#148;)), does not possess an interest in any other transaction for which disclosure
would be required under Item 404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> and is not engaged in a business relationship for which disclosure would be required pursuant to Item&nbsp;404(b) of Regulation <FONT
STYLE="white-space:nowrap">S-K;</FONT> or (ii)&nbsp;is otherwise considered a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; for purposes of Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ll)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I><FONT
STYLE="white-space:nowrap">&#147;Non-Exempt</FONT> Award&#148; </I></B>means any Award that is subject to, and not exempt from, Section&nbsp;409A, including as the result of (i)&nbsp;a deferral of the issuance of the shares subject to the Award
which is elected by the Participant or imposed by the Company, (ii)&nbsp;the terms of any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(mm)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;
<B><I><FONT STYLE="white-space:nowrap">&#147;Non-Exempt</FONT> Director Award&#148;</I></B> means a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award granted to a Participant who was a Director but not an Employee on the applicable grant date.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(nn)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I><FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement</I></B> means a severance arrangement or other agreement between the Participant and the Company that provides for acceleration of vesting of an Award and issuance of the shares in
respect of such Award upon the Participant&#146;s termination of employment or separation from service (as such term is defined in Section&nbsp;409A(a)(2)(A)(i) of the Code (and without regard to any alternative definition
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-23. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereunder) (&#147;<B><I>Separation from Service</I></B>&#148;) and such severance benefit does not satisfy the requirements for an exemption from application of Section&nbsp;409A provided under
Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(b)(4),</FONT> <FONT STYLE="white-space:nowrap">1.409A-1(b)(9)</FONT> or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(oo)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Nonstatutory Stock Option</I></B>&#148; means any option granted pursuant to Section&nbsp;4 of the Plan that does not qualify as an Incentive Stock Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(pp)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Officer</I></B>&#148; means a person who is an officer of the Company within the meaning of Section&nbsp;16 of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(qq)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Option</I></B>&#148; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(rr)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Option
Agreement</I></B>&#148; means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an Option grant and which includes the Option Grant Notice and the Option Terms and Conditions. Each Option Agreement
will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ss)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Optionholder</I></B>&#148; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(tt)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Other
Award</I></B>&#148; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;5(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(uu)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Other Award Agreement</I></B>&#148;<B><I> </I></B>means a written agreement between the Company and a holder of an Other Award evidencing the terms and conditions of an Other Award grant. Each
Other Award Agreement will be subject to the terms and conditions of the Plan. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(vv)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Own,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Owned,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Owner,</I></B>&#148;<B><I>
</I></B>&#147;<B><I>Ownership</I></B>&#148;<B> </B>means that a person or Entity will be deemed to &#147;Own,&#148; to have &#147;Owned,&#148; to be the &#147;Owner&#148; of, or to have acquired &#147;Ownership&#148; of securities if such person or
Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ww)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Participant</I></B>&#148; means an Employee, Director or Consultant to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(xx)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><I>&#147;Performance Criteria</I></B>&#148; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such
Performance Goals may be based on any one of, or combination of, the following as determined by the Board: (i)&nbsp;earnings (including earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii)&nbsp;earnings
before interest, taxes, depreciation and amortization; (iv)&nbsp;earnings before interest, taxes, depreciation, amortization and legal settlements; (v)&nbsp;earnings before interest, taxes, depreciation, amortization, legal settlements and other
income (expense); (vi) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (vii)&nbsp;earnings before interest, taxes, depreciation, amortization, legal settlements,
other income (expense), stock-based compensation and changes in deferred revenue; (viii)&nbsp;total stockholder return; (ix)&nbsp;return on equity or average stockholder&#146;s equity; (x)&nbsp;return on assets, investment, or capital employed;
(xi)&nbsp;stock price; (xii)&nbsp;profit (including gross profit) and/or margin (including gross margin); (xiii) income (before or after taxes); (xiv) operating income; (xv)&nbsp;operating income after taxes;
<FONT STYLE="white-space:nowrap">(xvi)&nbsp;pre-tax</FONT> profit; (xvii)&nbsp;operating cash flow; (xviii)&nbsp;sales or revenue targets; (xix)&nbsp;increases in revenue or product revenue; (xx)&nbsp;expenses and cost reduction goals;
(xxi)&nbsp;improvement in or attainment of working capital levels; (xxii)&nbsp;economic value added (or an equivalent metric); (xxiii) market share; (xxiv)&nbsp;cash flow; (xxv)&nbsp;cash flow per share; (xxvi)&nbsp;share price performance;
(xxvii)&nbsp;debt reduction; (xxviii)&nbsp;implementation or completion of projects or processes; (xxix)&nbsp;employee retention; (xxx)&nbsp;stockholders&#146; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-24. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equity; (xxxi)&nbsp;capital expenditures; (xxxii)&nbsp;debt levels; (xxxiii)&nbsp;operating profit or net operating profit; (xxxiv)&nbsp;workforce diversity; (xxxv)&nbsp;growth of net income or
operating income; (xxxvi)&nbsp;billings; (xxxvii) bookings; (xxxviii)&nbsp;and other measures of performance selected by the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(</FONT>yy)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Goals</I></B>&#148; means, for a Performance Period, the one or more goals established by the Board for the
Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the
performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board (i)&nbsp;in the Award Agreement at the time the Award is granted or (ii)&nbsp;in such other document setting
forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1)&nbsp;to exclude
restructuring and/or other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects; (3)&nbsp;to exclude the effects of changes to generally accepted accounting principles; (4)&nbsp;to exclude the effects of any statutory adjustments to
corporate tax rates; (5)&nbsp;to exclude the effects of items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles; (6)&nbsp;to exclude the dilutive effects of
acquisitions or joint ventures; (7)&nbsp;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8)&nbsp;to exclude the effect of
any change in the outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination or
exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9)&nbsp;to exclude the effects of stock based compensation and the award of bonuses under the Company&#146;s bonus
plans; (10)&nbsp;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to expensed under generally accepted accounting principles; and (11)&nbsp;to exclude the goodwill and intangible asset impairment
charges that are required to be recorded under generally accepted accounting principles. In addition, the Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define
the manner of calculating the Performance Criteria it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Award
Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(zz)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Performance Period</I></B>&#148; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#146;s right to vesting or exercise
of an Award. Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(aaa)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Award</I></B>&#148; means an Award that may vest or may be exercised contingent upon the attainment during a Performance
Period of certain Performance Goals and which is granted under the terms and conditions of Section&nbsp;5(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(bbb)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Plan</I></B>&#148; means this Sangamo Therapeutics, Inc. 2018 Equity Incentive Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ccc)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Plan
Administrator&#148;</I></B> means the person, persons, and/or third-party administrator designated by the Company to administer the day to day operations of the Plan and the Company&#146;s other equity incentive programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ddd)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Post-Termination Exercise
Period</I></B>&#148; means the period following termination of a Participant&#146;s Continuous Service within which an Option or SAR is exercisable, as specified in Section&nbsp;4(g). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(eee)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Predecessor
Plan&#148;</I></B> means the Amended and Restated 2013 Stock Incentive Plan </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(fff)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Prior
Plans&#148;</I></B><B> </B>means the Predecessor Plan and the 2004 Stock Incentive Plan (together. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-25. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ggg)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><I>&#147;Predecessor Plan&#146;s Available Reserve&#148;</I></B> means the number of shares available for the grant of new awards under the Predecessor Plan as of immediately prior to the Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(hhh)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><I>&#147;Prospectus&#148;</I></B> means the document containing the Plan information specified in Section&nbsp;10(a) of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(iii)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Restricted Stock Award</I></B>&#148; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;5(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(jjj)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Restricted Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award
Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(kkk)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>RSU
Award</I></B>&#148;<B><I> </I></B>means an Award of restricted stock units representing the right to receive an issuance of shares of Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;5(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(lll)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>RSU Award Agreement</I></B>&#148;<B><I> </I></B>means a written agreement between the Company and a holder of a RSU Award evidencing the terms and conditions of a RSU Award
grant. Each RSU Award Agreement will be subject to the terms and conditions of the Plan. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(mmm)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Returning Shares</I></B>&#148; means shares subject to outstanding stock awards granted under the Plan or the Prior Plans and that following the
Effective Date: (A)&nbsp;are not issued because such stock award or any portion thereof expires or otherwise terminates without all of the shares covered by such stock award having been issued; (B)&nbsp;are not issued because such stock award or any
portion thereof is settled in cash; or (C)&nbsp;are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required for the vesting of such shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(nnn)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT></I></B>&#148; means Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act or any successor to Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> as in effect from time to time.
</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ooo)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Rule
405</I></B>&#148; means Rule 405 promulgated under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ppp)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><I>&#147;Section</I></B><B><I></I></B><B><I>&nbsp;409A&#148;</I></B> means Section&nbsp;409A of the Code and the regulations and other guidance thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(qqq)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A Change of Control</I></B>&#148; means a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the Company&#146;s assets, as provided in
Section&nbsp;409A(a)(2)(A)(v) of the Code and Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT> (without regard to any alternative definition thereunder). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(rrr)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><I>&#147;Securities Act</I></B>&#148; means the Securities Act of 1933, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(sss)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Share Reserve&#148;</I></B> means the number of shares available for issuance under the Plan as set forth in
Section&nbsp;2(a), subject to adjustment pursuant to Section&nbsp;6(a) in connection with Capitalization Adjustments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(ttt)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stock Appreciation Right</I></B>&#148; or &#147;<B><I>SAR</I></B>&#148;<B><I> </I></B>means a right to
receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section&nbsp;4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="font-family:Times New Roman; font-size:12pt">(uuu)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>SAR Agreement</I></B>&#148; means a written agreement between the Company and a holder of a SAR evidencing the terms and
conditions of a SAR grant. Each SAR Agreement will be subject to the terms and conditions of the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-26. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(vvv)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to the Company, (i)&nbsp;any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation
(irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and
(ii)&nbsp;any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="font-family:Times New Roman; font-size:12pt">(www)</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Ten Percent
Stockholder</I></B>&#148; means a person who Owns (or is deemed to Own pursuant to Section&nbsp;424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(xxx)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Trading Policy</I></B>&#148; means the Company&#146;s policy permitting certain individuals to sell Company shares only during certain &#147;window&#148; periods and/or otherwise restricts the
ability of certain individuals to transfer or encumber Company shares, as in effect from time to time. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><B>(yyy)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT>
Award</I></B>&#148; means the portion of any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award that had not vested in accordance with its terms upon or prior to the date of any Change in Control. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt"><B>(zzz)</B></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award&#148;</I></B> means the portion of any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award that had vested in accordance with
its terms upon or prior to the date of a Change in Control. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-27. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Appendix B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANGAMO THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>2010 EMPLOYEE STOCK PURCHASE PLAN </U></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(As
Amended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) </B></P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">I.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>PURPOSE OF THE PLAN </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman">This Employee Stock Purchase Plan is intended to promote the
interests of Sangamo Therapeutics, Inc., a Delaware corporation, by providing eligible employees with the opportunity to acquire a proprietary interest in the Corporation through participation in an employee stock purchase plan designed to qualify
under Section&nbsp;423 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman">The Plan shall serve as the successor to the Corporation&#146;s 2000 Employee Stock Purchase Plan,
and no additional offering periods shall commence under that Predecessor Plan after November&nbsp;1, 2009. The Predecessor Plan shall terminate upon the completion of the purchase date under each offering period in effect under the Predecessor Plan
on April&nbsp;30, 2010. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman">Capitalized terms herein shall have the meanings assigned to such terms in the attached Appendix. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">II.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>ADMINISTRATION OF THE PLAN </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman">The Plan Administrator shall have full authority to
interpret and construe any provision of the Plan and to adopt such rules and regulations for administering the Plan as it may deem necessary in order to comply with the requirements of Code Section&nbsp;423. Decisions of the Plan Administrator shall
be final and binding on all parties having an interest in the Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">III.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>STOCK SUBJECT TO PLAN </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The stock purchasable under the Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares of Common Stock purchased on the open market. The number of shares of Common Stock
reserved for issuance over the term of the Plan from the Effective Date shall be limited to Four Million Six Hundred Thousand (4,600,000) shares. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Should any change be made to the Common Stock by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares, <FONT STYLE="white-space:nowrap">spin-off</FONT> transaction
or other change affecting the outstanding Common Stock as a class without the Corporation&#146;s receipt of consideration or should the value of outstanding shares of Common Stock be substantially reduced as a result of a <FONT
STYLE="white-space:nowrap">spin-off</FONT> transaction or an extraordinary dividend or distribution, then equitable adjustments shall be made by the Plan Administrator to (i)&nbsp;the maximum number and class of securities issuable under the Plan,
(ii)&nbsp;the maximum number and class of securities purchasable per Participant during any offering period and on any one Purchase Date during that offering period, (iii)&nbsp;the maximum number and class of securities purchasable in total by all
Participants under the Plan on any one Purchase Date and (iv)&nbsp;the number and class of securities and the price per share in effect under each outstanding purchase right. The adjustments shall be made in such manner as the Plan Administrator
deems appropriate, and such adjustments shall be final, binding and conclusive. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">IV.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>OFFERING PERIODS </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares of Common Stock shall be offered for purchase under the Plan through a series of successive offering periods until such time as (i)&nbsp;the
maximum number of shares of Common Stock available for issuance under the Plan shall have been purchased or (ii)&nbsp;the Plan shall have been sooner terminated. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise specified by the Plan Administrator prior to the start of the applicable offering period: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each offering period shall have a duration of twenty-four (24)&nbsp;months, and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;offering periods shall commence on the first business day of May and the first business
day of November each year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">C.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The terms and conditions of each offering period may vary, and two or more offerings periods may run concurrently under the Plan, each with its own
terms and conditions. In addition, special offering periods may be established with respect to entities that are acquired by the Corporation (or any subsidiary of the Corporation) or under such other circumstances as the Plan Administrator deems
appropriate. In no event, however, shall the terms and conditions of any offering period contravene the express limitations and restrictions of the Plan, and the participants in each separate offering period shall have equal rights and privileges
under that offering in accordance with the requirements of Section&nbsp;423(b)(5) of the Code and the applicable Treasury Regulations thereunder. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">D.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise specified by the Plan Administrator prior to the start of the applicable offering period, each offering period shall be comprised of four successive Purchase Intervals. Purchase Intervals shall run
from the first business day in May to the last business day in October each year and from the first business day in November each year to the last business day in April in the following year. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">E.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The initial offering period under the Plan shall commence on May&nbsp;3, 2010, shall have a duration of twenty-four (24)&nbsp;months, and shall have four successive <FONT STYLE="white-space:nowrap">six-month</FONT>
Purchase Intervals. The Purchase Intervals in such initial offering period shall run from the first business day in May each year to the last business day in October in that year and from the first business day in November each year to the last
business day in April in the following year. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">F.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Should the Fair Market Value per share of Common Stock on any Purchase Date within an offering period be less than the Fair Market Value per share of
Common Stock on the start date of that offering period, then the individuals participating in that offering period shall, immediately after the purchase of shares of Common Stock on their behalf on such Purchase Date, have their participation
contribution election transferred from that offering period and automatically enrolled, if necessary, in the offering period commencing on the next business day following such Purchase Date, provided and only if the Fair Market Value per share of
Common Stock on the start date of that new offering period is lower than the Fair Market Value per share of Common Stock on the start date of the offering period in which they were currently enrolled. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">V.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>ELIGIBILITY </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each individual who is an Eligible Employee on the start date of an offering period under the Plan may enter that offering period only on such start
date. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The date an individual enters an offering period shall be designated his or her Entry Date for purposes of that offering period. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">C.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each corporation that becomes a Corporate Affiliate after May&nbsp;3, 2010 shall automatically become a Participating Corporation effective as of the
start date of the first offering date coincident with or next following the date on which it becomes such an affiliate, unless the Plan Administrator determines otherwise prior to the start date of that offering period. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">D.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To participate in the Plan for a particular offering period, the Eligible Employee must complete the enrollment forms prescribed by the Plan Administrator (including a stock purchase agreement and a payroll
deduction authorization or other authorized form of contribution allowable for that offering period) and file such forms with the Plan Administrator (or its designate) on or before his or her scheduled Entry Date. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">VI.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>PAYROLL DEDUCTIONS </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For each offering period, the Plan Administrator may allow contributions to the Plan to be effected in the form of periodic payroll deductions or one or more other forms specified by the Plan Administrator prior to
the start date of the applicable offering period. However, all contributions, whether in the form of payroll deductions or other mode, shall be made solely on the basis of the Participant&#146;s Cash Earnings or Base Salary (as determined by the
Plan Administrator prior to the start date of the applicable offering period and to be in effect for all Participants in the offering period) for the offering period up to a maximum of fifteen percent (15%) for all offerings in which the Participant
is enrolled or such lower percentage as set by the Plan Administrator prior to the start date of any applicable offering period. Unless the Plan Administrator determines otherwise prior to the start of the applicable offering period: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Participant contributions for each offering period shall be solely in
the form of payroll deductions, and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the payroll deductions that each
Participant may authorize for purposes of acquiring shares of Common Stock during any offering period may be in any multiple of one percent (1%) of the Base Salary paid to that Participant during each Purchase Interval within any offering period, up
to a maximum of fifteen percent (15%), unless the Plan Administrator establishes a different maximum percentage prior to the start date of the applicable offering period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The rate of payroll deduction or other permitted form of contribution so authorized shall continue in effect throughout the offering period, except to the extent such rate is changed in accordance with the
following guidelines: </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">(i)</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Participant may, at any time during the offering period, reduce the rate of his or her payroll deduction or other permitted
form of contribution to become effective as soon as administratively possible after filing the appropriate form with the Plan Administrator. The Participant may not, however, effect more than one (1)&nbsp;such reduction per Purchase Interval.
</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ii)</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Participant may, at any time during the offering period, increase the rate of his or her payroll deduction or other permitted form of contribution (up to the maximum percentage limit for that offering
period) to become effective as soon as administratively possible after filing the appropriate form with the Plan Administrator. The Participant may not, however, effect more than one (1)&nbsp;such increase per Purchase Interval. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">(iii)</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Participant may at any time reduce his or her rate of payroll deduction under the ESPP or other form of permitted contribution to 0%. Such reduction shall become effective as soon as administratively
practicable following the filing of the appropriate form with the Plan Administrator. The Participant&#146;s existing payroll deductions or other permitted contribution for the Purchase Interval in which such reduction occurs shall be applied to the
purchase of shares of Common Stock on the next scheduled Purchase Date. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">C.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payroll deductions shall begin on the first pay day administratively feasible following the Participant&#146;s Entry Date into the offering period
and shall (unless sooner terminated by the Participant) continue through the pay day ending with or immediately prior to the last day of that offering period. To the extent the Plan Administrator authorizes other forms of contributions for an
offering period, those permitted contributions shall be collected in the manner specified by the Plan Administrator for that offering period. The payroll deductions or other permitted forms of contribution so collected shall be credited to the
Participant&#146;s book account under the Plan, but no interest shall be paid on the balance from time to time outstanding in such account, unless otherwise required by the terms of that offering period. Unless the Plan Administrator determines
otherwise prior to the start of the applicable offering period, the amounts collected from the Participant shall not be required to be held in any segregated account or trust fund and may be commingled with the general assets of the Corporation and
used for any corporate purpose. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">D.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payroll deductions or other permitted form of contribution shall automatically cease upon the termination of the Participant&#146;s purchase right in
accordance with the provisions of the Plan. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">E.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Participant&#146;s acquisition of Common Stock under the Plan on any Purchase Date shall neither limit nor require the Participant&#146;s
acquisition of Common Stock on any subsequent Purchase Date, whether within the same or a different offering period. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">VII.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>PURCHASE RIGHTS </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Grant of Purchase Right</U></B><B>.</B><B> </B>A Participant shall be granted a separate purchase right for each offering period in which he or
she participates. The purchase right shall be granted on the Participant&#146;s Entry Date into the offering period. Unless the Plan Administrator determines otherwise prior to the start date of the applicable offering period and subject to the
limitations of Article VIII below, each purchase right granted for an offering period shall provide the Participant with the right to purchase up to 2,000 shares of Common Stock in the aggregate on each Purchase Date applicable to all offering
periods in which the Participant is enrolled for a maximum of 8,000 shares of Common Stock purchasable in any single offering period. The Participant shall execute a stock purchase agreement embodying such terms and such other provisions (not
inconsistent with the Plan) as the Plan Administrator may deem advisable. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman">Under no circumstances shall purchase rights be granted
under the Plan to any Eligible Employee if such individual would, immediately after the grant, own (within the meaning of Code Section&nbsp;424(d)) or hold outstanding options or other rights to purchase, stock possessing five percent (5%) or more
of the total combined voting power or value of all classes of stock of the Corporation or any Corporate Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Exercise of the Purchase Right</U></B><B>.</B> Each purchase right shall be
automatically exercised in installments on each successive Purchase Date within the offering period, and shares of Common Stock shall accordingly be purchased on behalf of each Participant (other than Participants whose payroll deductions or other
contributions have previously been refunded pursuant to the Termination of Purchase Right provisions below) on each such Purchase Date. The purchase shall be effected by applying the Participant&#146;s payroll deductions or other form of
contribution for the Purchase Interval ending on such Purchase Date to the purchase of whole shares of Common Stock at the purchase price in effect for the Participant for that Purchase Date. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">C.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Purchase Price</U></B><B>.</B><B> </B>The purchase price per share at which Common Stock will be purchased on the Participant&#146;s behalf on each Purchase Date within the offering period will be established
by the Plan Administrator prior to the start of that offering period, but in no event shall such purchase price be less than eighty-five percent (85%) of the <I>lower</I> of (i)&nbsp;the Fair Market Value per share of Common Stock on the
Participant&#146;s Entry Date into that offering period or (ii)&nbsp;the Fair Market Value per share of Common Stock on that Purchase Date. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">D.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Number of Purchasable Shares</U></B><B>.</B> The number of shares of Common Stock purchasable by a Participant on each Purchase Date during the
offering period shall be the number of whole shares obtained by dividing the amount collected from the Participant through payroll deductions or other permitted form of contribution during the Purchase Interval ending with that Purchase Date by the
purchase price in effect for the Participant for that Purchase Date. However, the maximum number of shares of Common Stock purchasable per Participant on any one Purchase Date under all offerings in which the Participant is enrolled shall not exceed
Two Thousand (2,000) shares, subject to periodic adjustments in the event of certain changes in the Corporation&#146;s capitalization. In addition, the maximum number of shares of Common Stock purchasable in total by all Participants on any one
Purchase Date shall not exceed Two Hundred Thousand (200,000) shares, subject to periodic adjustments in the event of certain changes in the Corporation&#146;s capitalization. However, the Plan Administrator shall have the discretionary authority,
exercisable prior to the start of any offering period under the Plan, to increase or decrease the limitations to be in effect for the number of shares purchasable per Participant (and the corresponding maximum number of shares purchasable per
Participant for that offering period) and in total by all Participants on each Purchase Date within that offering period. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">E.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Excess Payroll Deductions/Contributions</U></B><B>.</B> Any payroll
deductions or other form of contribution not applied to the purchase of shares of Common Stock on any Purchase Date because they are not sufficient to purchase a whole share of Common Stock shall be held for the purchase of Common Stock on the next
Purchase Date. However, any payroll deductions or other permitted form of contribution not applied to the purchase of Common Stock by reason of the limitation on the maximum number of shares purchasable per Participant or in the aggregate on the
Purchase Date shall be promptly refunded. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">F.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Suspension of Payroll Deductions/Contributions</U></B><B>.</B><B> </B>In the event that a Participant is, by reason of the accrual limitations
in Article VIII, precluded from purchasing additional shares of Common Stock on one or more Purchase Dates during the offering period in which he or she is enrolled, then no further payroll deductions or other form of contribution permitted for that
offering period shall be collected from such Participant with respect to those Purchase Dates. The suspension of such deductions or contributions shall not terminate the Participant&#146;s purchase right for the offering period in which he or she is
enrolled, and payroll deductions or other form of contribution shall automatically resume on behalf of such Participant once he or she is again able to purchase shares during that offering period in compliance with the accrual limitations of
Article&nbsp;VIII. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">G.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Termination of Purchase Right</U></B><B>.</B> The following provisions shall govern the termination of outstanding purchase rights: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">(i)</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A Participant may withdraw from the offering period in which he or she is enrolled by filing the appropriate form with the Plan Administrator (or its designate) at any time prior to the next scheduled Purchase Date
in that offering period, and no further payroll deductions or other permitted form of contribution shall be collected from the Participant with respect to the offering period. Any payroll deductions or other permitted contributions collected during
the Purchase Interval in which such withdrawal occurs shall, at the Participant&#146;s election, be immediately refunded or held for the purchase of shares on the next Purchase Date. If no such election is made at the time of such withdrawal, then
the payroll deductions or other permitted form of contribution collected with respect to the Purchase Interval in which such withdrawal occurs shall be refunded as soon as possible. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ii)</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Participant&#146;s withdrawal from the offering period shall be irrevocable, and the Participant may not subsequently rejoin that offering period. In order to resume participation in any subsequent offering
period, such individual must <FONT STYLE="white-space:nowrap">re-enroll</FONT> in the Plan (by making a timely filing of the prescribed enrollment forms) on or before his or her scheduled Entry Date into that offering period. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">(iii)</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Should the Participant cease to remain an Eligible Employee for any reason (including death, disability or change in status) while his or her purchase right remains outstanding, then that
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchase right shall immediately terminate, and all of the Participant&#146;s payroll deductions or other permitted contributions for the Purchase Interval in which the purchase right so
terminates shall be immediately refunded. However, should the Participant cease to remain in active service by reason of an approved unpaid leave of absence, then the Participant shall have the right, exercisable up until the last business day of
the Purchase Interval in which such leave commences, to (a)&nbsp;withdraw all the payroll deductions or other permitted contributions collected to date on his or her behalf for that Purchase Interval or (b)&nbsp;have such funds held for the purchase
of shares on his or her behalf on the next scheduled Purchase Date. In no event, however, shall any further payroll deductions or other permitted form of contribution be collected on the Participant&#146;s behalf during such leave. Upon the
Participant&#146;s return to active service (x)&nbsp;within three (3)&nbsp;months following the commencement of such leave or (y)&nbsp;prior to the expiration of any longer period for which such Participant is provided with reemployment rights by
statute or contract, his or her payroll deductions or other permitted form of contribution under the Plan shall automatically resume at the rate in effect at the time the leave began, unless the Participant withdraws from the Plan prior to his or
her return. An individual who returns to active employment following a leave of absence which exceeds in duration the applicable (x)&nbsp;or (y) time period will be treated as a new Employee for purposes of subsequent participation in the Plan and
must accordingly <FONT STYLE="white-space:nowrap">re-enroll</FONT> in the Plan (by making a timely filing of the prescribed enrollment forms) on or before his or her scheduled Entry Date into the offering period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">H.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Change in Control</U></B><B>.</B><B> </B>Each outstanding purchase right shall automatically be exercised, immediately prior to the effective date of any Change in Control, by applying the payroll deductions
or other permitted contributions of each Participant for the Purchase Interval in which such Change in Control occurs to the purchase of whole shares of Common Stock at the purchase price per share in effect for that Purchase Internal pursuant to
the Purchase Price provisions of Paragraph B of this Article VII. However, the applicable limitation on the number of shares of Common Stock purchasable per Participant shall continue to apply to any such purchase, but not the limitation applicable
to the maximum number of shares of Common Stock purchasable in total by all Participants. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman">The Corporation shall use reasonable
efforts to provide at least ten (10)-days prior written notice of the occurrence of any Change in Control, and Participants shall, following the receipt of such notice, have the right to terminate their outstanding purchase rights prior to the
effective date of the Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">I.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Proration of Purchase Rights</U></B><B>.</B><B> </B>Should the total number of shares of Common Stock to be purchased pursuant to outstanding
purchase rights on any particular date exceed the number of shares then available for issuance under the Plan, the Plan Administrator shall make a <FONT STYLE="white-space:nowrap">pro-rata</FONT> allocation of the available shares on a uniform and
nondiscriminatory basis, and the payroll deductions or other permitted form of contribution of each Participant, to the extent in excess of the aggregate purchase price payable for the Common Stock <FONT STYLE="white-space:nowrap">pro-rated</FONT>
to such individual, shall be refunded. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">J.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>ESPP Broker Account</U></B>. The shares purchased on behalf of each Participant shall be deposited directly into a brokerage account which the
Corporation shall establish for the Participant at a Corporation-designated brokerage firm. The account will be known as the ESPP Broker Account. Except as otherwise provided below, the deposited shares may not be transferred (either electronically
or in certificate form) from the ESPP Broker Account until the <B><I>later</I></B> of the following two periods: (i)&nbsp;the end of the two (2)-year period measured from the Participant&#146;s Entry Date into the offering period in which the shares
were purchased and (ii)&nbsp;the end of the one (1)-year measured from the actual purchase date of those shares. Such limitation shall apply both to transfers to different accounts with the same ESPP broker and to transfers to other brokerage firms.
Any shares held for the required holding period may be transferred (either electronically or in certificate form) to other accounts or to other brokerage firms. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><B><I>The foregoing procedures shall not in any way limit when the Participant may sell his or her shares. </I></B>Those procedures are
designed solely to assure that any sale of shares prior to the satisfaction of the required holding period is made through the ESPP Broker Account. In addition, the Participant may request a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stock certificate or share transfer from his or her ESPP Broker Account prior to the satisfaction of the required holding period should the Participant wish to make a gift of any shares held in
that account. However, shares may not be transferred (either electronically or in certificate form) from the ESPP Broker Account for use as collateral for a loan, unless those shares have been held for the required holding period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman">The foregoing procedures shall apply to all shares purchased by the Participant under the Plan, whether or not the Participant continues in
Employee status. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">K.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Assignability</U></B><B>.</B> The purchase right shall be exercisable only by the Participant and shall not be assignable or transferable by
the Participant. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">L.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Stockholder Rights</U></B><B>.</B><B> </B>A Participant shall have no stockholder rights with respect to the shares subject to his or her
outstanding purchase right until the shares are purchased on the Participant&#146;s behalf in accordance with the provisions of the Plan and the Participant has become a holder of record of the purchased shares. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">VIII.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>ACCRUAL LIMITATIONS </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Participant shall be entitled to accrue rights to acquire Common Stock pursuant to any purchase right outstanding under the Plan if and to the extent such accrual, when aggregated with (i)&nbsp;rights to
purchase Common Stock accrued under any other purchase right granted under the Plan and (ii)&nbsp;similar rights accrued under other employee stock purchase plans (within the meaning of Code Section&nbsp;423) of the Corporation or any Corporate
Affiliate, would otherwise permit such Participant to purchase more than Twenty-Five Thousand Dollars ($25,000.00) worth of stock of the Corporation or any Corporate Affiliate (determined on the basis of the Fair Market Value per share on the date
or dates such rights are granted) for each calendar year such rights are at any time outstanding. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of applying such accrual limitations to the purchase rights granted
under the Plan, the following provisions shall be in effect: </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">(i)</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The right to acquire Common Stock under each outstanding purchase right shall accrue in a series of installments on each successive Purchase
Date during the offering period on which such right remains outstanding. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">(ii)</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No right to acquire Common Stock under any outstanding purchase right shall accrue to the extent the Participant has already accrued in the same calendar year the right to acquire Common Stock under one or more
other purchase rights at a rate equal to Twenty-Five Thousand Dollars ($25,000.00) worth of Common Stock (determined on the basis of the Fair Market Value per share on the date or dates of grant) for each calendar year such rights were at any time
outstanding. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">C.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If by reason of such accrual limitations, any purchase right of a Participant does not accrue for a particular Purchase Interval, then the payroll
deductions or other permitted form of contribution which the Participant made during that Purchase Interval with respect to such purchase right shall be promptly refunded. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">D.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event there is any conflict between the provisions of this Article VIII and one or more provisions of the Plan or any instrument issued thereunder, the provisions of this Article VIII shall be controlling.
</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">IX.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>EFFECTIVE DATE AND TERM OF THE PLAN </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Plan shall become effective for the offering period commencing on the
Effective Date; provided, however, that (i)&nbsp;the purchase rights for that initial offering period shall be subject to the </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provisions of Paragraph E of Article IV and (ii)&nbsp;no purchase rights granted under the Plan shall be exercised, and no shares of Common Stock shall be issued hereunder, until the Corporation
shall have complied with all applicable requirements of the 1933 Act (including the registration of the shares of Common Stock issuable under the Plan on a Form <FONT STYLE="white-space:nowrap">S-8</FONT> registration statement filed with the
Securities and Exchange Commission), all applicable listing requirements of any Stock Exchange (or the Nasdaq Stock Market, if applicable) on which the Common Stock is listed for trading and all other applicable requirements established by law or
regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Plan shall serve as the successor to the Predecessor Plan, and no further offering periods under the Predecessor Plan shall commence after November&nbsp;1, 2009. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">C.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless sooner terminated by the Board, the Plan shall terminate upon the earliest of (i)&nbsp;the last business day in April 2020, (ii) the date on which all shares available for issuance under the Plan shall have
been sold pursuant to purchase rights exercised under the Plan or (iii)&nbsp;the date on which all purchase rights are exercised in connection with a Change in Control. No further purchase rights shall be granted or exercised, and no further payroll
deductions or other forms of contribution shall be collected, under the Plan following such termination. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">X.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>AMENDMENT OF THE PLAN </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board may alter or amend the Plan at any time to become effective as of the start date of the next offering period thereafter under the Plan. In addition, the Board may suspend or terminate the Plan at any time
to become effective immediately following the close of any Purchase Interval. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In no event may the Board effect any of the following amendments or revisions to
the Plan without the approval of the Corporation&#146;s stockholders: (i)&nbsp;increase the number of shares of Common Stock issuable under the Plan, except for permissible adjustments in the event of certain changes in the Corporation&#146;s
capitalization or (ii)&nbsp;modify the eligibility requirements for participation in the Plan. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B><FONT STYLE="font-size:12pt">XI.</FONT></B></TD>
<TD ALIGN="left" VALIGN="top"><B>GENERAL PROVISIONS </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All costs and expenses incurred in the administration of the Plan shall be paid by the Corporation; however, each Plan Participant shall bear all costs and expenses incurred by such individual in the sale or other
disposition of any shares purchased under the Plan. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing in the Plan shall confer upon the Participant any right to continue in the employ of the Corporation or any Corporate Affiliate for any
period of specific duration or interfere with or otherwise restrict in any way the rights of the Corporation (or any Corporate Affiliate employing such person) or of the Participant, which rights are hereby expressly reserved by each, to terminate
such person&#146;s employment at any time for any reason, with or without cause. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">C.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The provisions of the Plan shall be governed by the laws of the State of
California without resort to that State&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">conflict-of-laws</FONT></FONT> rules. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Corporations Participating in </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>the Sangamo Therapeutics, Inc. 2010 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Employee Stock Purchase Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sangamo Therapeutics, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>APPENDIX </U></B></P>
<P STYLE="margin-top:30pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman">The following definitions shall be in effect under the Plan: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">A.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>2018 Annual Meeting</U></B> means the date of the annual meeting of stockholders of the Corporation held in 2018. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">B.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Base Salary</U></B> shall mean the regular base salary paid to a Participant by one or more Participating Companies during such individual&#146;s period of participation in one or more offering periods under
the Plan. Base Salary shall be calculated before deduction of (i)&nbsp;any income or employment tax withholdings or (ii)&nbsp;any contributions made by the Participant to any Code Section&nbsp;401(k) salary deferral plan or any Code Section&nbsp;125
cafeteria benefit program now or hereafter established by the Corporation or any Corporate Affiliate. However, Base Salary shall <B><I>not</I></B> include (i)&nbsp;any overtime payments, bonuses, commissions, profit-sharing distributions or other
incentive-type payments received during the Participant&#146;s period of participation or (ii)&nbsp;any contributions made by the Corporation or any Corporate Affiliate on the Participant&#146;s behalf to any employee benefit or welfare plan now or
hereafter established (other than Code Section&nbsp;401(k) or Code Section&nbsp;125 contributions deducted from his or her Base Salary). </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">C.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Board</U></B> shall mean the Corporation&#146;s Board of Directors. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">D.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Cash Earnings</U></B><B> </B>shall mean (i)&nbsp;the regular base salary
paid to a Participant by one or more Participating Companies during such individual&#146;s period of participation in one or more offering periods under the Plan and (ii)&nbsp;any overtime payments, bonuses, commissions, profit-sharing distributions
and other incentive-type payments received during such period. Cash Earnings shall be calculated before deduction of (A)&nbsp;any income or employment tax withholdings or (B)&nbsp;any contributions made by the Participant to any Code
Section&nbsp;401(k) salary deferral plan or Code Section&nbsp;125 cafeteria benefit program now or hereafter established by the Corporation or any Corporate Affiliate. Cash Earnings shall not include any contributions made on the Participant&#146;s
behalf by the Corporation or any Corporate Affiliate to any employee benefit or welfare plan now or hereafter established (other than Code Section&nbsp;401(k) or Code Section&nbsp;125 contributions deducted from such Cash Earnings). </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">E.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Change in Control</U></B> shall mean a change in ownership or control of the Corporation effected through any of the following transactions: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; margin-right:7%; text-indent:14%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a merger, consolidation or other
reorganization approved by the Corporation&#146;s stockholders, <U>unless</U> securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter
beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Corporation&#146;s outstanding voting securities immediately prior to such transaction, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; margin-right:7%; text-indent:14%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a stockholder-approved sale, transfer or other
disposition of all or substantially all of the Corporation&#146;s assets in complete liquidation or dissolution of the Corporation, or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; margin-right:7%; text-indent:14%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the closing of any transaction or series of related
transactions pursuant to which any person or any group of persons comprising a &#147;group&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-5(b)(1)</FONT> of the 1934 Act (other than the Corporation or a person that, prior to
such transaction or series of related transactions, directly or indirectly controls, is controlled by or is under common control with, the Corporation) becomes directly or indirectly the beneficial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; margin-right:7%; font-size:10pt; font-family:Times New Roman">
owner (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the 1934 Act) of securities possessing (or convertible into or exercisable for securities possessing) more than
fifty percent (50%) of the total combined voting power of the Corporation&#146;s securities (as measured in terms of the power to vote with respect to the election of Board members) outstanding immediately after the consummation of such transaction
or series of related transactions, whether such transaction involves a direct issuance from the Corporation or the acquisition of outstanding securities held by one or more of the Corporation&#146;s existing stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">F.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Code</U></B> shall mean the Internal Revenue Code of 1986, as amended. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">G.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Common Stock</U></B> shall mean the Corporation&#146;s common stock.
</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">H.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Corporate Affiliate</U></B> shall mean any parent or subsidiary corporation of the Corporation (as determined in accordance with Code Section&nbsp;424), whether now existing or subsequently established.
</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">I.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Corporation</U></B> shall mean Sangamo Therapeutics, Inc., a Delaware corporation, and any corporate successor to all or substantially all of the assets or voting stock of Sangamo Therapeutics, Inc., which
shall assume the Plan. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">J.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Effective Date</U></B> shall be May&nbsp;3, 2010. Any Corporate Affiliate that becomes a Participating Corporation after such Effective Date
shall designate a subsequent Effective Date with respect to its employee-Participants. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">K.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Eligible Employee</U></B> shall mean any person who is employed by a
Participating Corporation on a basis under which he or she is regularly expected to render more than twenty (20)&nbsp;hours of service per week for more than five (5)&nbsp;months per calendar year for earnings that are considered wages under Code
Section&nbsp;3401 (a); provided, however, that the Plan Administrator may, prior to the start of the applicable offering period, waive one or both of the twenty (20)&nbsp;hour and five (5)&nbsp;month service requirements. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">L.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Entry Date</U></B> shall mean the date an Eligible Employee first commences participation in the offering period in effect under the Plan. The earliest Entry Date under the Plan shall be the Effective Time.
</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">M.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Fair Market Value</U></B><B> </B>per share of Common Stock on any relevant date shall be the closing price per share of Common Stock at the close of regular hours trading (i.e., before after-hours trading
begins) on date on question on the Stock Exchange serving as the primary market for the Common Stock, as such price is reported by the National Association of Securities Dealers (if primarily traded on the Nasdaq Select or Global Select Market) or
as officially quoted in the composite tape of transactions on any other Stock Exchange on which the Common Stock is then primarily traded. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value
shall be the closing selling price on the last preceding date for which such quotation exists. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">N.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>1933 Act</U></B> shall mean the Securities Act of 1933, as amended.
</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">O.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>1934 Act</U></B> shall mean the Securities Exchange Act of 1934, as amended. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">P.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Participant</U></B> shall mean any Eligible Employee of a Participating
Corporation who is actively participating in the Plan. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">Q.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Participating Corporation</U></B> shall mean the Corporation and such Corporate Affiliate or Affiliates as may be authorized from time to time
by the Board to extend the benefits of the Plan to their Eligible Employees. The Participating Corporations in the Plan are listed in attached Schedule A. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">R.</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Plan</U></B> shall mean the Sangamo Biosciences, Inc. 2010 Employee Stock Purchase Plan, as set forth in this document. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">S.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Plan Administrator</U></B> shall mean the committee of two (2)&nbsp;or more Board members appointed by the Board to administer the Plan. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">T.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Predecessor Plan</U></B> shall mean the Corporation&#146;s 2000 Employee Stock Purchase Plan. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:12pt">U.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Purchase Date</U></B> shall mean the last business day of each Purchase Interval. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">V.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Purchase Interval</U></B> shall mean each successive six (6)-month period
within the offering period at the end of which there shall be purchased shares of Common Stock on behalf of each Participant; provided, however, that the Plan Administrator may, prior to the start of the applicable offering period, designate a
different duration for the Purchase Intervals within that offering period. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:15%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:12pt">W.</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Stock Exchange</U></B><B> </B>shall mean the American Stock Exchange, the
Nasdaq Global or Global Select Market or the New York Stock Exchange. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g573774new01.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Electronic Voting Instructions Available 24 hours a day, 7 days a week! Instead of mailing your proxy, you may choose one of the voting
methods outlined below to vote your proxy. VALIDATION DETAILS ARE LOCATED BELOW IN THE TITLE BAR. Proxies submitted by the Internet or telephone must be received by 1:00 a.m., EDT, on June 11, 2018. Vote by Internet &#149; Go to
www.envisionreports.com/SGMO &#149; Or scan the QR code with your smartphone &#149; Follow the steps outlined on the secure website Vote by telephone &#149; Call toll free 1-800-652-VOTE (8683) within the USA, US territories &amp; Canada on a touch
tone telephone &#149; Follow the instructions provided by the recorded message Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. Annual Meeting Proxy Card 1234 5678 9012 345
qIF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q A Proposals &#151; The Board of Directors recommends a vote FOR all the nominees listed, FOR Proposal
2, FOR Proposal 3, FOR Proposal 4 and FOR Proposal 5. 1. To elect eight (8) directors to serve on the Board of Directors until the next Annual Meeting of Stockholder to be held in 2019 or until their successors are duly elected and qualified; +
Nominees: For Against Abstain For Against Abstain For Against Abstain 03 - Stephen G. Dilly, 01 - H. Stewart Parker 02 - Robert F. Carey M.B.B.S., Ph.D. 05 - Alexander D. Macrae, 04 - Roger Jeffs, Ph.D. 06 - Steven J. Mento, Ph.D. M.B., Ch.B., Ph.D.
07 - Saira Ramasastry 08 - Joseph S. Zakrzewski For Against Abstain For Against Abstain 2. To approve, on an advisory basis, the compensation of the Company&#146;s 3. To approve the Sangamo Therapeutics, Inc. named executive officers, as described
in the Proxy Statement. 2018 Equity Incentive Plan. 4. To approve an amendment to the Sangamo Therapeutics, Inc. 2010 5. To ratify the appointment of Ernst &amp; Young LLP as Employee Stock Purchase Plan (the &#147;Purchase Plan&#148;) to increase
the our independent registered public accounting firm number of shares of our common stock reserved for issuance under the for the year ending December 31, 2018. Purchase Plan by 2,500,000 shares. B Authorized Signatures &#151; This section must be
completed for your vote to be counted. &#151; Date and Sign Below NOTE: PLEASE SIGN EXACTLY AS NAME APPEARS HEREON. JOINT OWNERS SHOULD EACH SIGN. WHEN SIGNING AS ATTORNEY, EXECUTOR, ADMINISTRATOR, TRUSTEE OR GUARDIAN, GIVE FULL NAME AND TITLE AS
SUCH. Date (mm/dd/yyyy) &#151; Please print date below. Signature 1 &#151; Please keep signature within the box. Signature 2 &#151; Please keep signature within the box. IF VOTING BY MAIL, YOU MUST COMPLETE SECTIONS A - C ON BOTH SIDES OF THIS CARD.
</FONT></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g573774new02.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED
ENVELOPE. Proxy &#151; Sangamo Therapeutics, Inc. + PROXY SOLICITED BY THE BOARD OF DIRECTORS FOR THE ANNUAL MEETING OF STOCKHOLDERS, JUNE 11, 2018 The undersigned hereby appoints Alexander D. Macrae, M.B., Ch.B., Ph.D., Kathy Y. Yi and Heather D.
Turner, and each of them, as proxies of the undersigned, with full power of substitution, to vote all shares of Sangamo Therapeutics, Inc. Common Stock which the undersigned is entitled to vote on all matters which may properly come before the 2018
Annual Meeting of Stockholders of Sangamo Therapeutics, Inc., to be held at 501 Canal Boulevard, Richmond, California 94804 on June 11, 2018 at 9:00 a.m. PDT or at any postponement or adjournment thereof. THE SHARES REPRESENTED BY THIS PROXY CARD
WILL BE VOTED AS SPECIFIED ON THE REVERSE SIDE, BUT IF NO SPECIFICATION IS MADE THEY WILL BE VOTED FOR ALL NOMINEES, FOR PROPOSAL 2, FOR PROPOSAL 3, FOR PROPOSAL 4 AND FOR PROPOSAL 5 AND AT THE DISCRETION OF THE PROXY ON ANY OTHER MATTER THAT MAY
PROPERLY COME BEFORE THE MEETING. (SEE PROXY STATEMENT FOR DISCUSSION OF ITEMS) PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ACCOMPANYING ENVELOPE. CONTINUED AND TO BE SIGNED ON REVERSE SIDE C Non-Voting Items Change of Address &#151; Please print
new address below. Meeting Attendance Mark box to the right if you plan to attend the Annual Meeting. IF VOTING BY MAIL, YOU MUST COMPLETE SECTIONS A - C ON BOTH SIDES OF THIS CARD. + </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g573774g06d72.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g573774g06d72.jpg
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MA2N3N^(Y859<63KW10D4"&2P%-(5.!E^#"H.R/\ )I.+4@C9'$"0D'BVYD[
M;;'X\YEKC6^HM(RJ],72,:XKK2SJZ6'/7J1JN<7:VKBVF8ZX1JI:FV4K2 J2
M7BG8[E*0,K:;LYI/:51FW!J5)IALFRFWJ_4ZV-B6JAP%S4-<?K:'3=3-'$+I
M-WHIF&J>Y2;$&Z,J!'*G$]N)<$+DI.<P-*5UH2=E@(\4*]=OS*B-N[GW;[]V
M6ZNE"+470I-:1(.E7QIZ/>.NKN!9-(=DVLZO1 ;+,!@OA,>&)KLM("&DNEIQ
MI :+R]98=J#L_8$6F<TAM&6,_P ;KYS>V27."2/*@C:GN,IS%DE9 (%&"')S
M>8XD*&ID#4THU[@R)\>&<TZ4L019F+B 0"H GF.?D\A]P'R$]_DS;)VM](UL
MR! G:AJXTNS9CR(32Y*3UT>6H(B2"XCB::8E+(1&>>6VV^KDTI9WSN:JZU.&
MS<\DK 9,FBM8)7%=2NW[;LM];USR@@E:0HM()]>RF%L$6XR-U&I<&YN9X^A.
M3JG1>M**"H3D@./*BM7 -]MR2$I'=N3W#<\A\.2:QU4WI.NBR1!?M;&TM(=)
M2U4=UMARQM9ZEB/',ET%J*R$-NNO27$J2TVVH\*E%*3>=L:S5H7BJC]3[Y#M
M&IM1^=(@FKI)7CG!;NCTI;C$H4B9RK+#Y+E:UCD12G!S!(6US-3*3"%:,].0
M<E&(4H6?&XT\'#SWWW21[AY?W984VK+8^&4ZRTX=((IXS,Y=HNS:L:"3#="R
MM;5MV>$AN1%4CADQG6@M(4A:5*2L#+;D&CNW$7L"/56^:_V,DG\N9)!(HI&R
MV;QY5)VF*(SU\F/CRAO.5('D]@2IS!NZ!N5J7% /))"E*6H4)RC8AQ!!4%#8
M=Y\V_GRZC=(.BI=;*MX^I*M=;"D1HLR47^K1$>F.):B)DI=2AQA,E:@&77$)
M:< 4M*RA*E"MOG9][IQIKD3V]ZW6<@9XI$_EP]N@V8!R F*ED*5*MV1*DZDX
MEX+:TR10>^)F8;@M822LF/*9"#(<B=8@[#B',[#W_-[GN;]_DRWC])>@I3L5
MB/JJI<>F3/!\=H/E+BIA4A"&7$*0E3!=6M"8ZWPTW(4K9A;AWRW%&E&V":LS
M[D.H6Q,5BGA;18HYD!F\,U#@CVW)G=#+4W@3C%2M@ U+$CBYN21.<F9$2DE4
M]#;R3 CRZQ&_#Q#??AV]W?;;W]_CRZ3K[1BK9-&-1UGA94]ZK["7^%X6,=U3
M#D)?$D(1)+R%M--+4E3[B5(8#B@1G2?=.MGXS5S;=+_24Z:JP=D\:6I):K;0
M 2!;YDI)11%U7H\'Y=6EHDZM2D3L#NZH$3:[FK$0$"H_*Q+X5UB"KAXAQ<QM
M[W?[G+RY4CZYTC+MW:&-?U[ULRJ6VN$ATE9=@(4N:RVYP]2\_$0A:I+#+CCK
M*4++B$\"]KGDF@^Y$/(:E,HUXL9B)>YTT5HVC<FPA-DZ;R%?AKCS$: :O T9
MD@<L@0,*Y:%.V/*PTE.VK51IY(!P#K9Y!:3L">_R#O\ BRTB](^A9RGDQ-3U
M<A4>N?M70TZM?#7QF^NDR 0C98C-;N2&VRIYA 4IUM 2HBFU'J=/IU/6EBL!
M(_U/7Q%V(:$L.SG.->6&^M[!5 <C53(\,YCPPC4N3.G:7%>])/*:(EH:D"]U
M<UJ- C./Q$K&W+91X>)(W]</)Y^_D ?.=LJW>M*VNK7I%:N-<V:J!S4=94LR
M^H=M:Q):2B0P^&) 0T\MYIMA?5+4^\XVRTVMQ:4Y3T&GVQ4B@#[;T*JF92ZH
MF@N5.2:?-S4 "-YB\.7J4#]+6II&K&\N,=:!I3LO3NUHW!K9C"%9*]>6-$JR
M6+B >$J 5RY>_P!P/D!/OY5<UOIB+8QJ2?<085V^8;2ZUUXE;$R<VAR/">>"
M.H:E/!:>H9>6T\^%(4VV0XC?67D^;9CC&.,8XQD^WX/=^<U=/]A)_P#Y A?+
M:5_!C^N/_:K/,/HI?XIZ=_M$?\-FY[4N6&>'<<8QQC'&,<8QQC'&,<8QQC'&
M,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8S
M4FV]PH% )<;4E?,$GV!O_P  6=BF*B)0.KS'RE..B5TLZ4N"Q#"ZECPS!$Y&
MYSI\:U9Y!P#F=I>!Y"0*=*"1Q$A*?9*\ON #FH^X![Y&;G2Z)L;*$+JRDQ--
MZ;XBDWMTIQEB24GQV:F&VAR?=20.+9FNCO(2I)2^\QZ[-)+GLB=9"<;N#L^"
MEVTXO)Y&JNESDI.L(P@P/A26ZQ[]7)TLNRI,3FC3*RX>AIUE/&#/BCTZ@P6<
M+>]+='6JM6E"ZBJ6F$H[&VLB8E<D#DHMK4E2I/">2DQ&Y;B?PD)'/.8=(_HF
M.@'H,#L5*F-3:G83N$W##-U;*<V!"H6C8C_@JI0YL'8S^J[!X.)/((5XF:8(
MMP()3F7!'J/KC6=,#79. OL1];_EU;<@R;G.1+WR8/!A[HXK3\YR-1B2NLP$
M,8ABRK'D8A9] T'H>J:.&WM2V\RV>'"I42#^\(*3Y6U.'K9;Z1Y'&UPE'?F@
M9\^^E+]T4Z4M:+<BZ<B-U5>@E,9^\?-J^RE/)MR#2Q1"T[4D#8=G3"L6D@ )
M<(VVP!.=EK]L@9V9E;<X=$ZC(LFMA#VI9V,7>]&>C QY;64/H]'Y*#'0/7'U
M9SCG7JG0NCZ,)\%Z<J8ZT;<+ZHJ),L;?_P Y+Z^4?A>.YYGGGCK4W3)TIZP4
MX=0Z\U+-:=WXX35D]75IW[_^%UAAUP\PVBC8<ARS!XA"&(0A"R(0LY$(0LYR
M(0LYZY$+.>N<YSG/7.<^G.?3GFU@   #8#D .0 '< ,YJ25$J4222223N23S
M))/,DGF2>_/G&0QQC.9.H4)#BU*4\Y,H)%@91Z<T9)Q0PYZA&6:6((P"QGTX
M$$6,XS]6>2K0AQ*D.(2XA0V4A:0I*@>\*2H$$>X1ME1IYUAQ#S#KC+K9XFW6
MEJ;<0H=RD+00I)'G!!S8N!;>[)UN,G$:MZ7&(R,AP!JD2[$N:<%8Z=2"V^3E
MNR=*4/'7&?$0I3 ]<C+,+,Z#QI-QT;:&O KMVFZU+BM]Y$)GP;)XCW+4]7F,
MMQ0\G7%Q)VV4DIY9US2_3[TPZ/4WX'U]?K8;V @V\KP_ "!MNTB)=)GM,(4.
M1[,&%C<E"TJ\;,J)-C*'L60E2>[*#3PBR^N?![$:JOCI2MQ(CA9Q_MJ]5'W-
ML%*S,Y_+/22%[6,IF," -A4 %@H/'=0>AX9*5O:6NUM*[TUUVD/L*/?PHG1F
MDN-)&P"0N&^H\N)X;;GV]T8?NE6M:5EBEZ1J)F]HSP-OI@H;LZ_JQRW7I?43
MLJ*%JY*6_66M4XV02PV"0E,@U37U?K&W^5*JL.-[_5:VE8/<XFY!C]1;F0QI
M!G 1&#1G 8*UMSQ D&0=]8TU@Z/*K/=1O3ZJ%C)WGW4>C=0Z5>ZF]JI$ +44
MLRP!(KI!YD!F8R7&2HIYEKK.N0-NL:0=QGO?0/2OT!].<3M&D=01=*7O5AR1
M"0N7+J&W%$ ]OI9H.J-/-*=5U:93:;JKW2HM.): 4-ZJ/V7J'8-([!K^0*"I
M5%S0))U6<M:UT/M2O'(7=P)MG%?OQ2.1,1N#<Y)(7&)#69SR 1K.Z.*;NGBU
M52%)[QR/<H<TGWB.1_;?,]J#2MUII;)LHR50Y8*ZZVA/-SJ>S:'_ (M?91E+
MBR$[;*4V%A]H$!]EI?BC/?)<US'&,<8QQC'&,<8QQC'&,<8QQC( _P (M_,Q
MK?\ O"1G_ M@\NHOKU?U?\QGHCT,G_,2;_96S_Q&FSQ9\OL]\8XQCC&.,9N)
MIIL!"]>W^_'2;()(O3VCJC>U'1X,:1-RXU++K-CZ1J8%SN%R=V@*>/IE) Q.
MRQ(->X)R<A$D:UP\Y+Q(M)5P[>1:5'W@>>:/KK3<_4L;3C4!R*VJHUEIW4$D
MRG'6PN%4R5O26V2TR\525I4 RA8;;4K<+>;'/,K4GMY7];4+K55KLBG WNH.
MT"9-K)6:T(6HQF70-ICT#:0(F4U1(42E9,RCXX\93(5R!N:P$*R,X?BQ*%!9
M,JD**ED;<VB@;^RW4?BYYAK_ $59VNH]5V[*Z\1[OHUD:.AAYQX/MV+TFQ>Z
MQ\)C+2W!4F4QQN-N..E2%?O<A*"K>V-]J;K_ ()+>7!JLB&RFJ-A=L;@J1P8
M:;I*=2.5,NPDY>YS'4YDPL-U=<4Q+F5:YD,TM7L3!/6YWBZ?" K"U22B&DI%
ME?<-B%)0E7C* '" #R&W$"-]ARY_#OSN7T0:E*E,-/5<Z'<Z9T9273<B]OZ^
M+#D:9KV*^4H0:QEGP["?;:4_";D2:YUF6KK#U:5.!<9.G.RT0HJ>6P1:L9?I
M)4.PM/SRD+6008QJ03%EC<Y/;W $G@Q;EXNQCD$;=FE$J;FQR,2M*M,)2D.&
M3@10RZSB"H)X2 I*@H;CD2-^1\NQWY[9UG7&E)VH:VF53RX\6[TS=UU_3N6
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M(P:<ANQ$N!3<I7'9NNJ0U6P4M3'>./,8?$=?*F=/QQC)]OP>[\YJZ?["3_\
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M!UVS9X9;I'L17L)16-.(<TM<8[D"6OS8BL:L76P8FT69XF9!G&75J@F"F<Q
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MJR1ZB-?Q0R?V=*$,%A!:@]&F=%Q0UKO)7)*66:>PP6-)Q@<Y>_  <F"H)1>
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MG^PD_P#\@0OEM*_@Q_7'_M5GF'T4O\4]._VB/^&S<]G#W&HY)DP4<D8&60)
M#P8!*]M2%V3!,Q]0PD+R%!01X_0+ <9Q^C/+$$CN)'O9XA:==97UC+CC3@!
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MT*'<I*@%)(]P@@Y(I*D*4A0V4E12H'R*2=B/@(VSI\FR7'&,SB/6VZRT=!N
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M\*TH4GS;O%402LM$-*1P:-(6 Z2+KU>)PK3^'-72":%R*,QI:ZNZM4<>><L
MDBJ9M+)P,*9&F;RDJ0@@DO .>I/0Y.?OG6:">9;H% >9*#< _I<'D\N>'_W6
M"SL[C6NA7Y\IR2U >U/"@I4$I;C0Y%?I&<PPRA"4H2@J<>=)YK6M:EK4HG?-
M<.>HL^1N.,9$;VC 1XVG?C<]?!'U?KV)/G]&0$T%6R0_NY_3C"U,JP+I]0\#
M#GTXSSEL;^$L@>\7E[O_ -5O-6G?S;H4DCW-CY<^E.B"#HC1:D^M.DM. >^B
MHB-K_P#[B%[^[N,S-I3,*#<=/]YM<[@OZ*T#(KPD.KCK!'V81&R)8T+R*KED
M^D<I 85743E*Q,,@A>U)BL+"TN#CW(H1/A2R%0B=/U-&MD:BTM<UU2_;,U;-
MZW*:CR(4=Q!GQXC+'.9(8202AQ1X2K8(.^Q*=^M:=?K%T6I*J?9L5CMDY2KC
M.R&);S:A"?E//;B*P\H;!2 .()W*QMN K:0NKMZM0X*]L% QFTBE+366B2W7
M2N]JY*TW!6+"[VJ_68FL28ITRNOD!]XUM7SZBP7&6N6MK41(D!B%0%8W8:5>
M#U6GSM*ZBE-/6[\$AR=JI-S,H&%UTYUN U"5#C%29:TU<V8RK=]<=:RRL+!2
MX7$\*=IA:DHHSC=8S-!1#TTNIB7;R+"&VY-=F"4^$F(A5E$BNHV90^EL/(*2
M"@(5NJA6!O=4\ZC/:*0%'LHQL2JQ*KU82Q!]8$U^QJ'[ .U-I'!NO%A"N<P2
MB:+I5;$#)8:D>9?/$T>!::!"D42@I)'@*3B:L/2MA$?T=+52N.B'.O52&G55
M+\FH;L5-KJW>%'41DL5\LO6#<>(IXP%K4&"IX@&E*U)!DLZKBIMVVE2X-*EA
MUI-HTQ:.5Z5HL6N-P/22_-B]7!<?DI:$U*0I\!KB(S)?W:&ZM2J41"2QZY(*
M^UM*]L=,K2C,$/:-C7V:41#*:DK&XS%X'&94%-4E*&15A3.T+61VE&V7!LEJ
M7 7)B2_% *,8VIT?>L,2&'JV4U-CT&I(#\H.4S4:UDV3#J(S8D,%5A9A]U3<
ME+UFN-V)Q)2HGBX<R%GJJE?>9>:L([D1^[H)C,53=L[(K8]>ZTJ0X6G]H->6
M6@N.IJO1([6A7$D>+Q9J'*^TG=7".]J@[-FSMA$S^U;TI K4YU0/%A-[R51T
M'O.ZI$N9( [$I$YE=19GA4P;1?)Q2JBYBIM?ES46WJC%+NCSL3&BT(=T&VNC
MAF) J[0Z@;6W#6V;2555C*'9:"HB9(<E1E_?TI?"5M(<*TA+:LP3^KG%-:T6
MBXE"5.LJT4BTN2DN"NC65B\IN*L)!B,MQWT?>B6>)#JD<"BIQ.;!W1VC=&67
M:6XOE2_G"4UH[[?Z 67K@V.C382B/-<)K*2FK[QD,+8%T="5"\I2.ZODB<:!
MC=Y8L/4*TR5\7*5(S,16Z-M(4#3G5U*&)K>G=6PKEQ#D-+SDJ<P$5;,EY+V\
MGB5XC*N-UN.D!*E-(2-LG8ZKKIDS4''9J>AN7NF)E2A:)1:1'ANJ58NQVE-;
M1]ALMT<+:WU*4H)<4HDVPL[1JKHI,(N?6.PK[%V%X[:.V=BK*%&$UAL!;]JQ
M*YE#UB5]D8$C(B/?HB_,Z9Y-<8"H M=5>$Q076+94E(0XKIT;.?C/B=3LOO-
M]&L"GA=>J&\6;UB/)2IIDJ=4&9#3BF@B6.%">(]6^$E>4CJN&P^T8=HZRTYT
MA3K:661*:ZVE>?CJ2ZZ$MI+L=U"7"N*0I:N$<;&X3E2J;>K5*$VYKG)/.JV-
M#'7&V_:D60Y'EPZ:&(V*$7O6LI8J1=PMY,4.RH22UU6MR%*UI$JE8SA,#F1(
M&E*6:,%.PTM?R:ZY8[ MQZ9I[0L) ,F,%.RJJ:P[9M\9D#94="5J4XI24N;?
M>5N*(&3P=24L:=5/=M0AN)>:SF+/42.%N/90WFZY? &3NE]:D)2A(*F]_OJ4
M ';N:=;:MMT)]&8B_P!B6;9FST8J;M)87*+&1QNP+7MNC7*V"(JKI^U,'A;W
M"4S4F,M*&5'I$D)72-\C;,>N#A$A( %.*74>GUUJM4R&H<&%1OV&BY+$)3\2
MOK[1NO+Z;&!L5HCQ2^XI@*5*2RT\X$DJ6?&R:AO$6 TVP[+F2[EF%JV,],2S
M+G3ZU<Y+*H$W?A6_)#*$OE*8RG7&FRKDD#8ZO]J\4_M>N/9K1R9VE*;CFS17
MVQYCY/YRPS>+RV2HC[D3HF)V6,=F(VRPP,GB#3EGB3Q+FQN=)%&V5O>A(DA:
ML*4G.Z!+2[G6CT: Q6Q7)E,&HD5Z*_'84*TJ=;0[!4Y#+G&YUDAN.M;;+SJV
M@I7#N<-K8.HJ=(LR)KT^2W%MB[*DMR67WDFP"6EJ;F)1*#? WU;"WT(6ZRVA
M?"D'A&[FNG:A:MQ^YM7:YNB:X=]?*\U?U0?&.=!CTO4&T#MI2U4J(C+0)6XF
M/'OBQHES$H<*^EAS$T/+8N4^0%S>J+1 <7DC6+G0UZ]6WDVMC=7;S+R_:=B]
M=& MM/V=@)$<J67DM)<CNI1,CAUQM:1UJ5I*N!L[#4ZQIFK"EB6,CK*N)34;
MC<GJGR:N\KH/4/<*0T7%-OME<5\MMN(4>J4A02%N##%8;:50;I/J;5D3W$UI
MI.>5:OV4-LF-7UJH_7PJ,#8-[2.7P<Z-NBZC;(:V8HR-J/*#H4SN*7*SRHV$
MN8!K&OP"+)3M/SQJ:_GR-.75I$G(I1">JK]JJ2##JV8TH/-HM(:W#UR>!LN(
M5P]6LHV2YNJPAW<(Z=HX3%_45TF&JW,MFSI7+)1[59.OQBTM=;+0V"T>)8;4
MGBXT!>ZD;)UI=)+J]M#K!4.M<\VOA5'3[42Y-D,QV>/U9V,KJB^*QNN?I9BK
MF\73P^*JGJ*OS>O:B_(L.D<<83#F%:C2A&E4%J$C5FD,WM'>6%U$H)-I$U#6
MTH>BM3H:;"IG5D149,5\R'TM2&EH<)=DLO.@/)43NG93F(6]37-/!J)5W'KI
M5%/MNIDNPY:H5G#L929"I+(88+C#J%-CJX[K+6[2DCQ5!24:N=HG?E87M<M?
MHZ77/,@JR@]>Z=UJA<XD+4<PO=C-=2,:AO-G;@Q*LB6M'EYQ<%N4*)PSAQ"U
MIT)R\A"K..;TN=T?4SJNNF*LT-LS[:XLKJ3%9<#K4)=@Z%B(AU/B.=4A">)2
M/$ZQ2P@J2 M6&U59P[*?%37J<=A5E7 J(\EU!:<EH@M%!DK;5XR.M6I7"E?C
M\ 25!*B4IS+V< 1_(+8@ST^"Q*:)*SCIZ/#F-EX&%"Z_HS@DA3C'U=<"SZ?1
MTSN-1_&B#[E%>$GW.WZ=&WQE/Q9YO]$,0.C! />K7.G D>7?P%K$[_ D*'FY
M^Z-]^^=#SPSCC&2H:ED"RX]G83G&>IFTFTS[C&.G>\40:E6 S#,QGZ\%86N*
M8H?3T9&8 (OKQT\4=/B@K73@'>BBK$*_K&1)7\?"H'WL^V_[G\VIKT,O2>ZK
MDF1:-);W[B5:ITD.7DW_ 'D\1RY%*MML] '.'9WG'&,<8QQC'&,<8QQC'&,<
M8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8S\Y;M"=:;-U
MIVDMV/SR.NB)FDD_ELK@LH,1GA9)9%Y$^+7EK6M;CW/%%"I.E6EI7=&6:(]O
M<"3R308+\"8;E&UA: 0>>P!'F.W[;>?/IQT5:LJ-5:,HEU\IE<NNJH%?:0@X
MGM,*9#C-QG0ZUR6EIY31=C.E/ ZRM)!X@M*=(.5,Z1CC&.,8XQCC&.,8XQCC
M&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQEZ5[74YMB8,D!K>*O4RF$C6D-[.P,*
M$Y<N5'GF *P(0"@Y F2DY'@Q6N5#)1(D^!J59Y"<LPP,"0D;D[ >4YC;:WK*
M*ODVEO-CU\"(VIQ^3)<2VA(2">%._C..KVX6F6PIUU9"&T*6H)/Z36K57.=)
M:VT34#VH)5/5:U/!86\*4V<B3G.L?CJ!N<3",YQC.21+"#O!9SC^)W>8I:@I
M:E#N*B1[V?*[5%JW>ZEU#=M(4TU;W=K9M-KVXVVITY^2TA>Q(XT(=2E6Q(X@
M=N69ZY+F"QQC'&,<8QQC/-W<#$-+I:S,&0=\^A]W-KJA5"QC\HM"X6Y:<I8S
M1AQCJ62>P&L R<YP# B3T8^G4X/7T7Z'>8&]3WD(JV[91-2DC?URH<N,V1[J
M@)BSMW[!1[@<\M?NG569NG] ZK0DE$E>D7B0-^ 7.A&VY!)'<!.H%MK.Y'6D
M)WWV&1Y\]>Y\=,<8R+OM)F<::TZIDN0YS\KZ-CZD\W&.I?C46F]@0(";(_J\
M.4SQ5F/,*S^664K3#SCN&EB%S):.JM]0L=R46J76]^6Z9=973%J ]B9+\A(/
ME*%>4$9]$>BB:)_1CHA[?=QFKG0']COPKK[ZWB,H/F5V%J&LCR!Q/>-B8Z^5
M<W_-O-5M5 ;#I+=G4RLUFI*BJ BK-*[AMIYC[O,!,!<J? 1B%1V/0UB-2N4H
MEDP?QC0LC7AP:48PI%IBAT(- F3+->OKXTZJ^+&@N6EK;/N1ZZO;>;C=;V=H
MORGGI+H4AB/&9V6ZYP.*'$D);(*BG.TM*+5,Z3(F-UU;5LMOSYSC3CY;Z]SJ
M8[+4=HA;S\AW=+:.-M/BJ)6" %5:S]0T8+ JF&ZF6RU;G$7/'UCU#D5911U:
M+29UK0L5HWR.V/4!B]_D,!=6\"(YV*-<G!2UN$= .0I7#+448I#3@ZA5V2?)
MU!7N::-:\EN0N<^AR XAQ*5-/0K$(99EMK*@V0A 6AXAE2.L(3D\RB3VJ%'H
MYR-0"P:4XPF&PM$UM2%*2XU+@<3KL5:.$K!6HH6S]]"N $Y9IVE&VZ>S'BF3
M-=+<S:C%%29RY00J%O!\B!"U#NVQ\B5I4)"<P3E'3GQW;FDMX;<JT W!1XH$
M_)Q1X"[D:FT^8+=D+BO[ Z^8J)9DMADR0VX\8ZEDC@>#32W"VOA7P)XMMB":
M!T]>"8NO-3/[:VR)*HPCN%[LY<0T'TI )6T77$-AQ'$@K/#ON#MW9UHQN)6<
M8FDUG^MEOQ*(UV>@(F<E>H8ZI&5CPY%H#4:LYQ$3E,I;# .C;X1W0&*FM,-<
ME+4K"3#RP"DBZITY.?C1HEU72)$P+,9EN2VIQW@*@I(1ONESQ%[-K"7%!*BE
M) )R:3IN^ALR)$JHGL,12D2'G([B6V^,)*5%>W"4'C1NXDJ0.)(*@2,I]@:6
M;9U3!7*SK'UXMF&5\SK&M"ZR]_ASLA8F\U[+2#:#E:XPCP9#>Y&+DB)&[&=&
ML]T/ T 69=.J/$\34NGY\M$&%<5\F8XE:T1VI+:G5AHJ#@2D'<K0$J4IL??
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M,7(OL%LD+/4<6L8B-,T)>V4T"9"SMDHR?'51A3<H&O)PI>>0C:0U!$99?0B
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M",,,&$LLL <B&,8\X"   AQD0A"%G 0AQC.<YSC&,=>0)"05*(2E()4HD
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MM^=?QI_TX^Y;T?[8-2_+J_L['TC'<#U64'^YIO\ &W'96_.OXT_Z<?<MZ/\
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M+4I^PZ5?&6-V4PACSS(87$K":$@79F>,*HC.6<A^B[KE0QN#DF($Y-2DE5E
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M%*W&9#/$D28KS\9:DH>4<W+0>M;+06HHM[7I#[02J):5RUEMBVJGUMJE0'E
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MT0H6S+ PLN=*]DJ0*O* 1K:Y4U1>PK1<37FM2'N7VE)YQ?%@IH"Z^4'N//\
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M1"17]D5'#ADH;:E===I=#'9@Z[P!PO%23N!;6ZFH.:PF4)BFP:R?H7"XM-;
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M@UY^1"$(61"SD0A9R(0A9SD0A9SUSG.<^G.<Y].<Y].<^G/+K/2@&W(<@.0
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M[(\1S,>6&)*.YQI"@0-<^7N5L<8QQC/Z  9HP%E@$888(("RP!R,8QCS@(0
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MCS(T>6POU[$EEM]E6W=Q-NI6A7PI.7M?96-3*;G54^;636N;4ROE/PI36_\
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M) P+/Y):E2XDD&8_A@Y\%C.<:[.]$9:+"A7::K8BOP53[-Z>.[D5-Q6("O\
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..==5QON\#8==6&VPG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g573774g06r49.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g573774g06r49.jpg
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M 0$! 0$! 0'_P  1" "J D # 1$  A$! Q$!_\0 'P !  $$ P$! 0
M      <&" D* P0%"P(!_\0 -Q   @(" P  ! 0$!@,  P #! 4#!@('  $(
M"1,4%1$2.'<6%SFS"B&&M;:W(B,D&!DE-%%A_\0 '0$!  $$ P$
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MJF2'(MB0)/%8!@<F,RWK/.3O[Y>O:.%SU#%D_*[@92K8S#L,IEEFQ)$T>L(
MS2M*7,!_2 E$H(^W#.(HZNVU'G<AC+-WHI8L+#KE\!&.E*8&!GI*2$6$QBP)
M?)3$PR!ZI'5+5/X=C:?V/Z&\X;(O&>OM?^6Z]LG:>W-G9(Y&YXVE=?Q M ;2
M@KD9 WW-Q=$;VKF(UG9>'<<3S(OY9GT&81-19WPJ-KX3.T*D7;NXGT,=C,?#
MH4!9:])K.N^Q(E"U5')L YG3,3*>CD.N#'R3MPYS.1QME_EJ^*79MW+4KZRB
MC7@2%JU1,=9O!BI .KTZ^>"Z9&:<N^LOAT1!ZUV%KST!Z *HC"\MJ=M;4]LU
MW2HO0B!0)7R6:O8E,[56#K5[JL,FO0*B<!O95;<+,C/.'$_.$N(*HJ7]\2=^
MC>PN%&X%-5K'9*M>MSA'M)XK91M=Q'M%5A:^MHFNNQ1P/$]N)&3\G5=MP-6S
M7R&0E!/--RHVNB,BL(7)!91TL\J:B/I"1-HF//,07!0,@^SO+WB_SIK+6#;7
M^R?2]HV5O;2>N=^:J66^DZR74F"DWJP$!Y@WQFFM<[M390TJ=Z1@"B6OUO;/
MI5!DWS%(+F%H=J[AW5G+^07=H8"O0P^6O87(LK6\@RW-NF@3ZZ:VU12RN36I
M&3<Q+.WW)[4$(P53F\5A,;5JG7LY1MJ_1K9"H+DU11"+#)CIL$#>L&0L&3TK
M%@]?1'7Q,S'!\.GP?2O92C<3NTV/8'4^L&NJ5?5-UCC2!;#@DV.^:*'>S737
M83)<CBI6N!5G;2QA ?.:$!R239$JX!\)2NV^=XV]K,Q:JZ*73D%Y)GFLAYLD
M2Z@A;58]2Z*V.FW>)D+09Q"Q*(B!:1=(]=N8%&:"Z;6V.:IU![-7L0SHLL,#
MM,.R8KA%: ZFP/O2/,\C$<SCTV=5TE'V5L*E5JVK;_7*A>+75T%[3X=1J+HE
M0/CU2NV*X^IR<<%UB!$@;A88DDXXC&1]8D3X]=2Y7M0L-MT*5JQ692?9J5K#
MJ;9Y;4:Y(,96;/2/+$&4J.>D?>"?=CX:MVTH$6;*%.&PM+W*6\/R'@MA #@]
M9]U@Q!CZSZ%'K.L[77PD_-C3<U9\T*-B>N@=JV_7:>XK]EEZ1J;SSHE-<Z[R
MOT4%AN"VR+W8R\;##M47-DM'Q@99PB9%_C)C-WA[_P!2LZO%/S[:.V3QU6\V
MJR@&6LISC05>BD1(JLKFDC+GN#'<*97$ET^DQJ_?Q1Q9W58P+.8&VVN#AM%2
M2>- CK>8B&.%@F(Q^1/(QP7$<_7J!=8?#UT4;Y8T%OS8./M/83[=;+<R^9-Y
M-TQ5]O(*I_*;8QM(P(=G,6Z4I</9Q<!#T,LG9/3.05Y\K$>(##J2:R&]LP&X
MLUA:7XJ4DX@,4<-W)EK&,=9]I4 MR*06IPF5<NH'1'3VX)//,G/%!5V[CRQ.
M/R%GVW99>*Z,AB*2KBT^4LDB),B("&&Q$$N?7JF&?"!CFG_,_D;PYOFR[QI#
MC8'L*DV_2]6W?M5HI;:SU8NECUAJ,W\WVQJ*7<9F0&U)%DL,+>M$!"I0GL1H
M/WV*&'&;/VS^YMVX9&(MJI;8MULM8Q&.6Q60R)Q.0R8?G%D-05GCH9!2JP)D
MTTR!]F9GC7GB\/@<@V\@[&92ZDJ];(#K5 F*M,OR3@G246I&8@UR(@+.1ZXB
M.9CKRWX_\_>JO2>R4M9VCLJ@>1=7T.*]6?;6RZ_5$]\5PDC5VNKU;18E:V&I
MAL'.R'DXB:*!D;F;5ELY>6$#'J:(>NW%N?-;<P-!K\=0N[FR%R:=?&T'V&TV
M$)/>;%L<I%DEJH)$FR2P@++('F5\25-BL-CLMD[(*M6J^'JUXL-MVEI"P,3"
MUB!"!,2)'99(A$$74H9+T+F(\ZD>!I9MX>\]'[*L3JO//'/G7T-N=84J"#[P
MN;+3Y==_A6(N([K/(:M75-8!7N! W>)^ )06466/>>?7.]O>41B-G9>@A3T[
MHSF$Q3!89<U5Y07^8D9#CJL5&I),P7(28GSS'&NB<!S>S]&RQBSPV.R-T)$8
M^F*F2^US!?!3P9#.8][ID9B?75SEI^$.,DN/@@E3L*P/M1>M(=65_8UD$!42
M6'4.R-@U%?>(Z_.-%WF']"XKK+HZI3,HL2"<5+7H[KK'-=(7 5_$PG5=Y"VB
ME.3VU.1?1KD;83DZ%*R=.7B4\%UJ>OHLPN9$9:KH]>Y RK=GP#L 06&,I9?R
MB[+!$.Y3LV4B_MS$>[TFL^I,E',]!P7Q&2PUWNO05*\7*J#$2EC5FUV&O#E3
MXX83DP)6YBV(B;"/_P!>,LT8V,DF.'_ACGEWUC_X]=<RE3?-FI5LD,"5BNAY
M#',P,M4+)&)GUXB2XCGUXU93UPI[E1,S"FL7$S\9@#D8F?[YXYU2G*C7EIQI
MIQIIQIIQIIQIIQIK.C_AY_U^&_L-L;_>J1S$'C;^A@??-'^3<U?GAU^D!?=]
MG^97UO'\^1M9TU\[#XG_ /4#]8_N^_\ [8G)-'YH/U?\SK:MX._*_9'W#5_>
M>KVJ5\-3S6V"\B5BR6WU_-L7U?J;5FP0;!KC352N^GJ$?LV:9;@-;GW;Y4\7
MK4+$6<]Q+T!/]!7,AVA1L<?9&0_G+CY/B%\ 11Q)3!3 _9'U\_OUCO(^+N[D
M,WU<J4=B#B=DYO-8ME;+9^]CL]DU8<1=)4:L5G5VNLJ,55X[@]VWU)!<STP5
M+:^^&QJ,?4FT=@[-=>H=F-==>NMH^6\%/D;5%>VE(QCURK".QOY*UNW7%+ZZ
MVF[,AZ,Z/)CAE*3"]1R9E23="<75$1 1R$'[Y<?'ZN?3U_\ ]ZK,KXN9PLYA
ML7AZ^S<0C*[%PV\Y?OG-VL+"IRSF+G%@Y"&@VV@>@NWV@DA"P<S$! ZB@_P=
M1;]0=L631##>0ENUSZ;T'I+^7&]J0DI5X"J^]4*I(D?6ZMIC&4R5Y)MZ=BD5
M"QL)Q3:K]K,EB@9DS11=N[,2/5T\2!%R,\QR,S/$3\..F/\ SS]FIM7B7DL9
MD\'4W*K;9T,ML_<VXO:VV\C8R&.9<VW9?8L5J-RP"AL5HP0IL..5":[O>6,D
MD!*9SW1\*K6VK-T[11+]O6JRZ*UQX_VIZ0_F/ N1XL&=RU?<G&M&6L(\L8_M
M/U\E]7#+<LH\<I?D%=_)SDSCREQZB^9&/2.J3$>/7X%$3$_^-6WM_P :\MFM
MO86RW!4JFY,MOO"[3]DDVQ*E8_,T$9=.9XDN_P!J,8XG1!3$=0>]$041J":%
M\.>.Y>#;)ZADO9@>XOL5_P!L:^TO@&-GU:_/^I+34*=LO8,\^6/W$29&TL#0
ML;#\.A35JJ"07ZGZN>0+O+>&P''N^@R7V%,3,1]GV?Z_9JY<GXKS0\2Z>S1Q
MJV8'S6+P>4W!+3B:6Y\Y3OW\1BQ"/HCBPFJE9SS)K<XQ/H[8PRI-0^(O.K7R
MMHST#M=QZT</-VVS9=6"KGG35%4V4)7L]?V7!'@6[B:N4[,:)I"4+*+B-TPF
M*(B.A@@P^3%U)P3#@R$>CTB)]Z9CXQS_ *:I,[XB[K1O3<>U\)7V0BOMZCB+
MK+>Z\W=Q!VHR=2;$KKDE#TF22 Q.3[0@,K(BGJGBNW/PV=!:;LOO;^?.Y=I,
MJ#XS9>;HA6^GJC43+9: O171O2Z!I7;<_ 7+G%9)(1A.!<7\'6'>+<F/&3+H
M0+OCO$4+Z!CEG7Z%,\>Y]DQ_WU&U_%O<^?I^&?XL[?PRLGO]6[9-&>O7ETJ;
M-J=OO&FW1K,<VO<$;+*YS5*?5 %Q'<9%EGK?R_3M)5[1.W]/;#;;.T'Z3JUH
ML&MK!:*Y#4[FK;4&P1U>_4ZUI0V+5=]TK+@@*#-DM.R!.R)EP&B^4)B69Z+.
M2DA*.D@F(F(]8]?6)C]>L@[&WE?W%:W+@<]BD8?<^T;M.KEZE.V5Z@Y&3JS<
MQE^E8-26]FX@&%"7+ABH 9,NHY!=E?/360M.--.--.--;R/P!OZ?BS]W]E_W
M$O(ZQ^=G]0_NUKE_"=^:#?N'$?NLZRC^D/T[[Z_9?:7_  =[RP/$[Y;>(7[#
M[L_H-_6(MC?IML_]J=O_ -6J:U*HXY)I(XHH\Y99<\8XHH\<LY)),\NL<(X\
M,>N\L\\\N^L<<<>N\LLN^NNNN^^^:>1$C(0 2,S*! !B2(B*>!$1CF2(IF(B
M(B9F9XCUUL>(A 2(B@1&)(B*8@1&(YDBF>(B(B.9F?2(]9U>+Z0\KP:-IE*L
MRNT26@N0^*F;5#ZA@Q@HNS)*JBM^%:AG'_'HF&94V)SBDE[[DQ^WY?-[QEDS
M@@S5XG>$B]@X3!92IEBRSBL!A-VH@%PO ;I+$4,R.+!B_P ZME2VT@(_?B*\
M]7!D2UXPV-XAGNW*96A8H#CUBDLIMUG4<GEL".0MXTKQ@<^X86*P00CP,][W
M8D1@SBGT1J9?I799-%6-S'8L%=J3OH\Z"$8C*6QUU>[G@[B'RRCZC&E-R@BR
M_'\V<>&.6?\ Y=]\M#Q)V?7V-NAN JW'7TKQN&O18L+6IDGD\96O&N07,CTJ
M-\K">>2$8F?69U<6R-R/W7@0R]BLJHP[V1J]E)F80-*XZJ)]1\%U&*X(H^$3
M,Q'IJX)CY%J-?LUM86>]NU&I=;:JUKL2[6$=.(RLT[790\6"*I5Y;U.(#D8T
M:?4B!''S8C"X08Y&=9=2?,PR1:\&L-CLKF;&5W!>I[/VQM';&Y<[DETDVLHR
MWN=8CC\/C:T,37EUJU#$H?89"UP$2Z)Z^1LM'B5DKM#&IH8BI9W)G=Q9W"8J
MD=EJ* 5\&<S;R5UW2QT*KU^AC5)'K9)3"YCIZ9HT;2^BKQ=-+J]7;(NLJO95
MZ!I=DK%VK8:V^5*,LP>&)Y"6JR-J;0 Z&63(7"(SHB"3"+\\9/4A6($&K8^P
M,]G-CU-I[GSAU-T9]&#R>*SN+15W!AQ:Y8!?!U0GXBW7L 92H0=W%D(P4-ZG
M17E&;JW?B<7NFQN#!XD;&"Q#<I1OXJ\U^(R)+69'4)5CM9&NY)0,')+Z#&2X
ME?"^[[EV\@9T)]O]8W?FDJ]::Z#V7KMZ#")F#>:^UL2].OG)DZ[DPC^3@46(
MQZ#S_P#6V7SXPY9B90R2R&=\&)V_D/$6K<R+VU-K;:3NC;>0K@DJ^>QMO)(I
MUC:?O"/;AK4V>Q/ W*S("23($5+B?$R,Q3V:^M32NQG<VS YNFTFP[$W:]%U
MEPK'W9GKE:V([L3S7<'5PV#@;(>8&UEC3C33C33C33C33C36SA\/3]'^H?\
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MK(*/616809HF%S(Q,"$Q,K*>F.K')4O1=%K_ (-W+Y=*7VJ:_; W_KS:*)O
MO5=U*&N5*O'J& S0Z1Y@W&<SD$QR!BBI#@\X>L^YF,&>/6&5]6<'<?O'%[A%
ME:*=+#7L<Y1&WS)/LO6U9+"$RHE0(S!$3@.)XX7,>NK;3DJZ]OW<5(NFQ8R%
M>VLX$.S"E+D"@B[G7#)F>8B (>/B<3Z:_.K?1='I/B3U3YO;+;1/>MWWS1=G
MJ3)>"KFJP*_6;ILQ?Q6 \AT*U$+*@/AQ4QKTC2$B7&3$N<''K'/-D<%;M[LV
MYGELK#3Q%/,5[*S-L63.^E2TR@!22B$9"99)N7(Q^2)SZ:5,DA&"RV,,6S8O
M6*#4D(A*A&JPB9#"DX."F)CHZ0.)GXR.KQ=;_%?L6B=>^"J=J4S8?VCSZ@V7
M7/1VMG!(R[6NWDUZOT[J()<($^98,3P:LP9CJ[&[1JF59?31S+HS0<BL2;7O
M^&Z,Q=WE:R0T>[FW4'X*^H2._BW4Z4*DV$:5R '9!9,0ES%V$C,,D#Z9&9K;
MM;0KX!-,K/1CEVE9*L<P-:X%BQ)Q P+"ZB%1% -, -3)Y&)&2Y_ ?O'RSYWH
M7IJM^5]0-=F'^EMW)GSI1ZVH"=]3%&B$2LFP*:"6-7-LMW%DLRO:#5B6.T9'
M?2,*\(I.<YFOXOP@Y/9VX<Y=P%C<635CPP.(:E3-LW6IM-S+F"EMT2?C%*17
M9CU@,J6'4MY,!4"B?>X'/XK'5\HO%4SM%D[P,,,O7 T!CUC+ KR*KAFUH6B(
MH,BZ27 R?+(U6K;XI&EKIM.H[<O>H[-@PW)Y+O7D+V]4*""FK21E5&A\,%0O
M.CF+2T/S9K0K0C+X)P;C H'!'3 HA&9D4GWH6D5X>96ICK.,IY2O(8O<M/<V
MTK-TFV'+LK BM5,NM==(178XF2)U2:1DXW$L9CLE[GNJDZTFV^FV"NXA^'SJ
M:X@I9)(HA-B@1M84N%<#$B^ @8 5P91/<BP[T+:/#@&J*KK/RU2MM66Z1WAE
M<;GOS=T2>LVC)'.IQ6+-8UBF4JSNJSG789>HG3%V[CR>8NAIL%<L:QE-!!>.
M$K[N/(V;^X;>-15FHNK4PV(EMBOW89W&9"Q;MUU6._,<J6E/">R42R)8N"F
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MKY2\>/D]XA?LY;_B5K5P\Z;%1ZCWCK+95E&:&(:9:0G;05+ *2UG$'QEQSP
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MZ/4>@]O%MVF.V/9M/B;4Y76YZ!7L*F-KR61=5QD!(Y"SK9?6$JMY(/G*XPS
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M+K4SK6!L/IE7SN4<%^7C36(]A:CKR^3;! L#M3YD'6(M.--.--.--.--8/\
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MH$F-K54R&8-@RX65@@&(Z2_/@C':$03"!3SEQYP=<W\[B<8TD7[@5FA2=D2
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MERL5FJ6:O>?L!94RLC$!7;+/)Q48=A3DV(:3DLE: 6V2(Q6R0D/Q6N=&37W
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MN5DX%62\%:S1E$JVAP;4-(QV,";0X+(6#!7NK>&57)&F#8>43!UASQU1S_\
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MD=PDM2)IDCK]NY*YE\35R5VHFD5U:[-=27/;S4>I;4DV+%6HQ3O?(#7T&$P
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M0QC["9X0#RD8]%]0CRC=8$13YP2Q29^ZMV;>>8K1DEN,\,O<("E-ILLPK2$
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M/K8[*8.[@V.C#R'0NWEFY0;';#)POJ3#2JPA(H1("LP!4B<,K!W8@)I=O%F
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MM%P4BQBV6 &7 :<V=RP7Q_D(F!5B$&Y2CVSNKQ!/<V#PF,BME,?8QV$PF"R
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M?;*]: T E.L#%1$WGS=V!H?7Y1TR7.@#>%FV^K$H?CE3OE^V(Z$U+OG!J(N
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M%[LO:GJK3Z4F=A;(%05K\D8GRWR9L9+4\<ADMA'7RS5%A'#/G+U)%B_&0_\
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M385?/4[$6ZI/VT3.\4'4?!RI4PJ5Q*$J$U?#8E]FCS"8(!18Y3<.DNB.>8^
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MN%H3\2L6OA18W*%=]L;;PS*"_(D];]V5%W,,[N'<56E#5G*GSWX-%A31Z#5
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M.OF:5V#[D!]1)W(+#-XO?6(S&:#"4UV(M'CL?E8[_ET$5+)8^,BBPI)O[UA
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MME,>1LRN2IU4&5YYE6:W'(<NA+I6N6+""<??-4$9"PR@"D5B-.>0*RJC2M1
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M5(YB#QM_0P/OFC_)N:OSPZ_2 ON^S_,KZWC^?(VLZ:^=A\3_ /J!^L?W??\
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MECZ-6A,HC31PY"D?;'.OL&*LOGMCR4^O!?E1SZ3Z<<\?;^KCU]?C$:FH\/\
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MFKDT%^SIHGMI&TU8IU/S&.K8:K=#)5TI4]K'$Y61";DV++[#'-8P+$M1,)B
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MU<E2[OYBXI;F**??2])=JRER^!U79';>/R63H9AAW*V1QZ7U5V*-ME4WTK)
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MKIY;,1/2M,+\M'OG9U?L.M;,$_\ FL]3H)ZM3^CQ!S@QZX5,[R,3G!D89P,
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MU;:W,^(2X-U^^Q8QC%6&5U-45B1N5UP,+KJL=4UHB#20'ZZKLE0JDO+DI2D
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M[&XRG;5C=M9'/5)I6&FIC:.Y6[=&KYWWU7JQ%V+#K]9*%I,;5<5N)7<BLI^
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MZQM/9VFR$NF+E=;):JF7L>N^:+T)%3+;<U;])=J;2=@;.("#>MHFF;;6\-N
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M0M<)V@TH3)6Q$DRA+!/#GQPG$,%FQRA(&FPPF@EPRCEPQSQRQZ\TN584MZ&
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MK$6QOTVV?^U.W_ZM4UJ3\T[ZV/Z[N"X^1<2WC#)S5AFA+BF&,,G88Y[* \D
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M2HKL$V*8'2MIF) 76(\:62C6BI+JFVL"SH!?>$/5FJQ.)RTW%HD[-*7=F=8
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MR%-G>J3A+",N C-U;TUUW6+&U2A3AM6!9?%AR:P&-"WA QN01YFIW'5LL-=
MU7CT.]HK;0(IA!J8TD!,I?W%RE4A6E8P)G-O_L3?VOMQ^V=0[;KFRU]GUH.D
M\R?4D$+K&%U2<JG2M>)]@*WBUK7P<NIA'R1\49$DQ=AF0=_,&FG[(P@[FMKX
M6[B]IY/&OH'7OD[<'2(L0?FXLV[S:3$L4\_0DN2(=WLF)>A#''5J.S60KW<W
M3MJLBRK"\7S,BR/+]I%<+ ,$UC^2P&24!UC,>L3//&LA=#]2>'%&Q[3DVNNI
M,:#9_B$^G+TQA,UBR8C$>6K_ .<6E?HH<(V>ORS@*J9LZ0;#&D+XQCUK:7%R
M:C%$QE81V/=V]N]M&MVJN3\[7V1M^FN0R  0[BI9Y;K92471 [(8^"GS9R0,
M3':%Q%PN;CKY7!!9;UOI^7;N+)N*"JD43B;&,-:1B/+R0I*UQP@>"!D]R5C'
M):M;HF]//E+G^'ZVI.R]4UBA4^R>6&'I#7[^AV4S9=.VGHW=SRY;#VW7+$'2
MF"W)7>*Y8YBCFJ.S3V"R(5:*D$+BHZ^G4J[CN8C-VAWJJW0R-BY9K[B# W47
M:XT+6.R^)35I8QZ#MK9#*CZ\""G5X17<QUL3&7M:R)1?QR9V\:+515=+,262
MKLKMFRBU1O,=8MK9""'I>MLD1K;+&K!:)&86L!FVL^B_&C,!DPLVQ]:PLU]X
M^)J*7"^I%J8-+BMWVN&:>>VH)0]%9PD*,'>,Y@4UA-535!K^,L@R\J3K+*(L
M8+=2R6%>C?E9T_#^1E-NL"ZIX8R7FUF)7%D+>U(@<(!D6E^D$81JO7DL*<&3
M+-6#&QNB"[B&D;QOC!8XAF$'$K[GO#+""4G'/ S,3JE''I+R-!YFVA1DNP:R
M)2[UYA\.U)3HU76K<OMO6Q-4[?KUM]%+&1P5/P2P6*U8IW;N6WD6;$.W$G)R
MBV?60H?8=4K!;E+<&/N.I6"M4]P;NLMR['U3K>1R>+?6P;%@=KNDBMW4IBJ-
M>2JB#1%?O%U^+,GAXQEI 6%0A^+P2 H"IP.\Q4N+=DA(A3T0QL ;)=+>'203
M)SP/3Z;#TCY &]3/1YIM#6;SJ^4[/#JESI .T-?[7H>N-K; U.YKJ!(U;4K!
M%6K5I!<H?$5:BPI)*N938=FT0]B3%?TR(_S#!;G+;B9CVS7SJ6X\[%6T>.NX
MVY>QM+)*>YRUVY=8K9=C4Q8N2Z+ VO9UP 'R37!V+)8>,J<3-!F.8%L5/0-J
MO;KU;=BH:EK,TPM3J @<I1 2J4Q:KD119!96,>7=JZDU_=_>Q+N]P+Z[M'RE
MZ4U?JIHX2FK"[I9KO9:T725W:A$K-%KACY:I))FZ+B7H$LWX"$&"Q]P8YW;N
M''9.[4V:*J<F_'[DP.0R*U.!@5*]2O8&VSNN8!/!+&B,2,FYL>\(%/5Q!8JW
M4KOW!)V(%=K$Y.K4-@$)/:]BY0/0 S"R8(R4]72L)])*/3G(/AZ7\!=;FU?8
M1"J6!00/7VH[U0PYJ6TF'U#Y=0^;5%6V51;2MCKA4OR'.Q8H CJ:$.X_B2S(
MWUU[Z)$>CN[-9?L'>GLK(H*+1W#VQDZEPHM+B<GN%V=;9H7*QR\8ZE42(@M'
M*NQ7<FI[I)E5:X8R>WO.U6#*!0.8IV$1*"F*>*7C05:0T>U/H=F($D#!]QJS
M?[T'#&]>J6W2N\2*V/2;'HR&]H?$7H6G["VNZZ5ZH&TU8VWHL 34]J66M\@J
ME%7OX*G<D-0K9A3VM#P(GK*KI[.OLOVFOM.UBMEL1%B;:,P5-V[<):I8Y/<R
M995"L&PLE6.LAUFX:2LU76GB*7S+DKL-KLK]UR^%.I7I7"6T/,KP>139N'TU
M(IM+)#%1PM-:JXGVGK2HB-40MA*!H,Z%G:[Z+VCJ*D>NFUKV%H3JG;%QVGJ+
M9M,NFH?0-)N.FJSJK\=?V:OEIJ=2]5F*;UVYI@IS?M@DO=>&D:6&/,5,)"KP
M ,N#!8_)V]LJKTLSYJC[.R>/MU,IA+=7*V,C_;:[Q;:MY$&T^U:(%=#J;RA:
M)ZFE+),(O)6J:,P;K..[-CS=.TAU/(H=274_L[5R"452!_<2)'U+>H>IGNK&
M @9G7;7I?S)8)_8%Y1WK3U_V19O6&T[LG[V76MJRHMJ^7MB:VL-4J%-0]K:B
M RELVN+#8FE@7U5^16E -J,KUO@?2E4\,P"(QN SZ(VQ3=3RE*A7VWCJC?(6
M,;#L=N&C>19M6G==HUQ7OH0M!V418:=<'U23 VB Z^WD\6PLP\+%*Q9;EK3P
M\TNW*[>*L56*2A<@F#EM9C"8*F2I8M);>YU(&8XJAZYT K]3>#E[2VZJQ\W4
MC2&@S/19W\J%I>16[*1I:[TJZ2VMKW0)K_:R,VMBR#+'!F:U6P%DB/<X#C1L
MFD"UMK-,V[O(UULC[=MYC-#@P]I,'IQ-O+4[=2*RXNQ2KC"T08D<+LH$"3$@
M!=LN$Y?'CEL").J>S$T<>62+R@E$WD4GI?+CFO-AQ2;)&8CJ4R2%DP11UQYS
M?T9YGL/GAC4[+<]5L+JV^'A8J$Z&%UUB(Q8^FD>\P;)KJ#MHLH@<>39)K:,@
M2MO<#HZ\D'DF30, IB)1\_5>#SZ,X%BO5R(5%[XKW$D5[J6O;[L.:+T]MEPI
M[3;\B5A4A+VE$-(#B(*.IY+&,QQJ:^H3CVXVN<17X,\H%^&UHZA0/)A5CA1]
M7;".0@AF9C4.>'=P^<:)J#6"C;MGIBNQH?B&:3VF^"L%:9NCXM (*185.QII
M"1*XVB+KYQ[%>*PJ$14QCW+#*7[(7#!W+R3W;C,[;R>1;C*]IB'['RV.22+"
MU!.:=<0VB,"3U2+P!;""S(P*>8CNC,\:HL%<QJ*=4+C4 U>XZ5I@M41E[/"N
MP+,\PLX)9$0P2>9EG'/1/'.KA#]Y>+[J7K&)]L'7-?V)WH/W/K=1M("@N%RC
M5.T+;NM^Z\OV6PXUZDPE8)5VK6!*.M.:RG<':^S<AD=0*&*C',2%'$;JJ#D"
M12O.HQFMGWV8X[JC;D<?6Q*%;A0COVY"7'D0AUA-AJAO=HAY:#?>D3O81Y5H
M98K+?[/SM8+0US$*EIMYAXMC(6B"[8U"D%&H#*OUQ,0!A'$'OO0&CFGG'8C"
M)CYQ+W]8-B;^@V^BZU]?:U6]G)MG4RJ+];WO3ZZO5!*M@*UK9$C5A3UUIDJP
M]3N3 V[SJL1G1^;&71A<NO/40D<Z.%11PTXQWGJ5BQCVX^W9._3R;'VFLD<A
M7<I=EE>+!6:@#4AO4D870LR% L;9+JQLWV6,A%Q<5WJ5:"RE(U7T@6D!B:K0
M,DBV50IQ%8D.#+JNSOGKSQ]#<*S:$-ZU[,)0?8G@79];FK.N62UT'KN@:IKM
M?]+- I(*0L/+[)M41O3E><1(SM.0<!RP9B.$!-%;5/;.Z)JOKNIW8*[M?>>/
ML18OK-17KN2>[ K."N, .FM(=I@# 5H.1,ER3(F7?F,/#EN6^M(U\QM^TKM5
MB%@UJ]12\H0S"!(NIO/6,S)MZ8(8*!&8@:Y^O]0TU:[V,IME"W1LQ)\4:U;M
M"4F5EJ?/=?+C37_V/M!*QN-070XUEEG,57<ZT;+$4$SRRL02N4? 9W-,5=L9
M2T:J+:]S%4&^'=;$DP+"@&IN%=WN]Z JV63YA? V.^,2)+B$$R"ZDQ'OS%-(
M,L@VO>M!NIMX0)1E+\45?H[<DY(_1',ROM3/,']*(\<,GR:+N_R,DV'ZV!I=
MDJ8(59/II_CJU[N17&>LOZM7=YN-J;0I5IFJ:"P6(/K88301"+F0G$EMU"KD
M-%LA H[Q@(5ZW,3N9U';16T63-X6E[HKXEU6+";#\0K'8ZW7BT]"#\B:R<72
MTXJW'S<KB4I AZ5[^'79RXI8F!422PSKRWRIBEWSMVD-[*V-CS,%"XF5Q+JZ
MXKMF(843!WH7;OG?8?CZEUJNCU:E[BIVPDW8%8U?$]ZHMNHS:3;5B8'NJY:E
M/W&@W#7I]L KIC-7:&@VRDS>LR-,GC"H=#:\E\)C,W1W/;L/*Q;Q=JBWKL9"
M4^<K7%QC$ "GUF]%VK>76-XK9666/:JQ"X2%KJO4.1N8VQAD+5"D74V Z55>
MYV'5SFXPB-3@ZJ[JY-%<D#2BRLU2?62>FMC(Y?VK7TXTUG1_P\_Z_#?V&V-_
MO5(YB#QM_0P/OFC_ ";FK\\.OT@+[OL_S*^MX_GR-K.FOG8?$_\ Z@?K']WW
M_P#;$Y)H_-!^K_F=;5O!WY7[(^X:O[SU?N7Z1\B"^=-B4M=?:T/1+MYM\.54
M'1RRLVT&U]WS5.X:Y;O1BMB6'4(DT5AM<2=ZYEML]FQ$MY)R<DMGUD,%V)X]
M#.N)XGJ@SGJYCCB8]WZ_J^KT]/AK&*]I;Z/=>*R#<9<+)X[=OB-=;N-URBRE
M[-S>!MTMJ.4#+TO*K2)]:O%(*?71%;P6F8-G73MJ]0^95'K2)'F5J"T>4MCQ
M[]H#JX:[I=S'N=-TMOO(8FAPL0K975$->>>?&F>!%*4T9-V55%.%J3KC9!7B
M\0;F%ET<\%UC(E$3,<20_E?"9Y@H^/,^L\?9JJI;-W@_9$V8#/4][8@ML9.O
M0RN0H%0R&X=LP09,E,I6WE:K;H1$AD7Y&QT7WS2>Y<'6:PX7USOO0N'FW8YD
MO\M(=RB[3LXA%0W BN;#K8GG)IHB/4VO4*EA2E1L#BXZW:]'V)<L?.D(V%]-
M5;)*?9'JL2P^T@76,>O3TQ/(\1P?5U3/K/I$_JGT]./MN#*[8W-.[<0L?:Y8
M \+38%_!6<>J<5NQ.Y9S>5LO7D'+)%#+([51KJM>R<XQ3L0NK"G2#+L2_3GC
MYK?4K(F[T^=T$E^&XL=7=Q6K Q5D:HTJ ,I]/:OAA+K,Y)&1?T0,SJNX+YUV
MSD06*D')SU% N,Z]!\?">.6^GU]1<]!?Z^D_5.K)7L_?B,982&.R UV/\6FU
M\<BW52X,WN!AOV?F2(;8@'1W&#7MRX6X>TSOLBOR;0]PZ_\ FJH^==$WIX#3
M*[HG9FLOB9+5VO&]1P8WN]#F[BL:KSO70V M=:3].* 856(4K9C95^%*C!R.
M#+'%'DEZZ\%)F/K)1*?6)GB)Z8ZY^/U_7]<ZIEXS=U[=>Y<979D+>Y,/F/"!
MS<HB]*L;C## U7[KM,6=M >7R:PN%82JHV<A+.T:R,X'5)]>I/,0FJATBJ^:
MMBMBOS'\.Y2BE(UQV0<'OC76RQ?_ ,D6V38R@SY9V@/7>;:!M;RBIL7XI48]
M>;LS^L,(>W07/J)<=;>?6?R2CW?2)^'/U?5]FJ[\3=X,S16'XS-%1=O'Q5?9
M@<KTK/;66PY_BFB$+R8\4V97L$BB #-4P([2$JYDJ W?O#QYE3_2INDBM)RN
M[%Z#])'&5FU4^_KP]DZCVY4%(>J;!KD=!6@Q!FVL'D38ZH5NRFU<2BW,S^*L
MAQQ,R)9N1 ^1ZN?R0XGTY&1F9GGF>?7ZYCGF/3[-2>W=N[]B]M!6X@W%%>KM
M?:2UW*5[&-/$YS!7WLS57+':ML,D9BL2%7K=1=P\ECU^2ZR.!@91V7ZM\E99
MAMT%VU^5+2?07@+8=1_AS7IZ]X,EUWKX!)Z1; E14M:629-8>LON^# S,^T8
MB0%K,6(X0F<76%GZQ,%Z@R)F9].9GD?K_P#WZ]0V'V3O?AB+6.R@#D=K^)V+
MN^:RBV5BL97*,L;30T)OM  &KSV)4OM4^X2VRHV,&;'BME:EN/Q.KUM"Z[;I
MI6F+'N7<EG V98:9;;A61ZB\'NQ]&AQK4M=&LXK:#$Y$D1N,*Z?U2K-]OM,8
M3H-#\HSTZ9A,1 SU<#Z1,<\^G,_&8^V?J_[:R,&(SE#P=QN&QV#R"]P5,!@*
M;</5R%*A<*_7/'+R13<&V50T%*[-BRB;:O:%/NTI97.SU+O0)])>0UK+95BJ
M=_UIU8;1YT\'*%K(JC61B61N/7.Q*Q_/-M.;:-;!22VB.F*&Q36ZEKPC['$1
M!) 3(])R$@\Y!DQ',%^4R?C$^[,>[\)GTY^K_C6/@VEOIJ</4O8O+S5I;L\2
MGN4&1J) <!EL7<_%Q(KI9=D#3*^] )QZVL74D"@@BN'64CZ@]2^)->^A);]2
M]EZ^UG7E/Q MN;7N;"&BVR'N^^?[3K@T?5^%6&3T1@9BCJEG);_EHI Z>:O/
MF<3X5=&1V,1!P0,D8B8(OHXB/7X%$^O/,Q\8^OUYCTU$YW9GB)E-K1C,CB,K
MF+;_  PP6%QZIR5(HQFYZ666>8FZ;\DH/,W:8HYR0E8BU7258W2$$):XC'J+
M%@=C 1$9#B85U"7!B1A 5%U/GU&1#@5 ,5C%/A^$L>)(PY&.&774T$4G64>-
M7'PC]4:^LE=7:5U 2R[8=0%(R0%TQR!2!&$D,^DR!D,S'ND4<3.\+\ ;^GXL
M_=_9?]Q+R/L?G9_4/[M:Z?PG?F@W[AQ'[K.LH_I#].^^OV7VE_P=[RP/$[Y;
M>(7[#[L_H-_6(MC?IML_]J=O_P!6J:U>])V1/4-GU6R/UR)NG4S,R35=CE8"
MJS\.TC*&,3H]6,8<J9SSR11HG4(TN*1[DN;3]8CARYXZI=B9.EAMUXC*9&M0
MN4J9VVOJY,["JMB)H6@!/F*BGOIVF,(!H7@4<4;\UKC.%H,H^_=UT;62V_D:
M--URO9LC7!3Z(I983,6ZY2WLV&*580 B16ZI,&;52'U@Y-HQ-Y[';NBA*XSJ
M EK.>T<3U3K6^LJVX6&=M;9J@.DKU5J5_4 IXE;F=>Y@(#*S8$+R; .)@VD(
MF)8]RRYOL[RV G&6L*K+V,A@4>+>U]PVL;=JOFWF-H(P5:GEJG<K4PJ7CK75
M,2TK#*S,BM(W"8QUGJ/%:-M;N9=1DF8U53+-\/,[AT7JUA<5\=N-N6=9Q]CH
M;9*Q5%U4Q:N$@X*1MFM "">D>6787GIJSC".L* &[$U3T<$CV=@C9Y(JTXM-
MX$9Z6^OD&32,XHU56@L((1 BLJ6F V56!C",0MS#3^A[D\.+=H4V,GCD9YN'
M\3$8_=0T;14,7=RV>3:V-Y@E42L@-3$KR-=#4U&LP=?*5:\ EM64TNHX3>E>
MN34T;KL2O);';;P!6D#<OUL=B6(W5V8.U""*QD2IN:#+ #E'4;#I)@/AMGBK
MVT=/V+6!-8O5]15J]M=E;DLJ>QTU$V6U&G-;-240*>QS5J*J?,(KCLM0WKT0
MRX6)TEE;"OXUD!40I@/3&;LV9D]J-Q6?W#C\7N"WNC>N5IY/"T+=7#X2WE,%
M0KTLF>+'$03,;>=3N8X5UE#?HG;5D8J@T%/1WO;?W+2SZ[^(PUR_AZ^"VQ0M
M4<I;0_)9.M0RMM]FD%^<CP%ZJNS6N$;V%5M1792)YK)BF]4K:^IS-%AT1O:*
M\T8+/-!%:'62*#IRX]G"[9RLX P3:5#GG$7'6YBY V&)G2N"0LH;J?$@HF.7
MR=N_9[]@)V_=RN-MV:GA<>+54*D]CAW4G=Y96NI%PL?,@X<8;B38%\55DYJH
M9#7,$O0-N[C5NYN7JX^[70_?87S>-A0*+ GMV*#6-KC;B"5-X5PU,JFP8K ^
MB06$C)5;W?YK2[7I5H#9ITZ=5N\>SU0P=$RBRH6H(M)85XRMFP"+)2A\RKOF
M'%TC"P-[S:K&]AR[Z&:8,V]T8S?GAA2W=@LLFW1I4J>_%Y7#N70M@6WMF!L4
M<:_%O6FH;5R[.RD(H)A\E;JW,C,]JV-JY WMI[ZM;=RN/97M6;-C:A8_(J.V
M@HS&Y9W9-Y=]1L>*V"O$BPO.-E7%=]:E$=:)16C.O;0U"FU0R2J[B@K^#'R-
M;-;M*E]G>9-V>[2M@BM#74Y@%?*$*'LB6$+H%M,U^3B"*""5T-&J[P!M;&[K
MV;2VA:HU,WCL<-GP;S&V+>'BG?FY:WTW<:K3[S'5\:U3EY2B"/+VV6^B$*0A
ML*&I,(G[N W-:W&BU8Q=VYV/$C'9U&1FS3BLC:J\,==54%NNK8LZ%HF]ZN-?
MJ[K&M7+"L=3:D$VOH #=NOV )>M\=.#PN'0L95>M9-AJPK#2V=2RHMG6S)NU
M>2[&Z K3XA5$+KZEYD5;I& LIYQ1,FG=_AU7WWMRPAVV!V4L+MY0MQF7;DL2
MJSL8L/. RM4Z,TYK1G*]5X)IA>AM^6Y@K*CL6&LH&[<WF[:N:2U6=G<["K5&
M2N[C@I9!B=U1DAR]!XVHL0^<6VPDF62J]NIV\:*3!2EA!J7:U/M&EMDJ=DDI
M K]/F<74'574 )F9LZVN4VJJ*K8*VHKP=5:5=@N#)E2.0I1G=5:JGS.;+KNP
M]9-;"H[NPN5V-NBGN=M!&X6$]N&O8FI7HVGLJXS"8FEB<CBZ>-3B;>)LUD-.
MC>02KV(MU,A:9(SD8*U=UK;N3H;JP5G!+MMPXPD,E5R%AUFND'WLID;.0I7[
M-QF0KY!+VK&W5<+*N1K6*=</_LYBO9MS".LHZ<::<::V</AZ?H_U#_K_ /[0
MNO-J'X-_R8V;_F+_ '7G=?!/C3\S-R_X-_0,5JJ/;WZ2]]?M^S_NC<^L/"KY
MB;1^^$?PLU\I>/'R>\0OV<M_Q*UJ#\V0:TQ:<::<::<::<::<::<::<::<::
M<::<::<::<::<::<::<::PII$CBRN5-=KRL]V^?,@DZ5,K%F.9M6K(F,->N7
MA#X2$%FFES1#C#0X9RS3281QXY99==<QFYJJZFO>P%)2LVM:PH!:U+&3-AF4
MP(@ Q)$4S$1$3,SQK:6M9M,%+ C8PA  ")(C,I@1$1CUDBF8B(CUF9U? 5\.
M?T@%5=SG24]^=L/2.SZ3K"PZCKU3LUFN3PZ[KK&>&ZJD:)<;@]2K?X4<1,#P
MXI 9<(H3%9K$.3.:*T@WS@CLXH(M("CEL?;R",FZS7KU5!48@#39EQA*6L\R
MJ0 Y@XF9!@ <1$SD[;R4*NEV6%9HVD564UI:US">+2@U0L2ZP#LGU%$2,\1(
M$0S,Q:*)J[9A]::W,'7=Z-J"//N-W:A*D_(K:?/%B,GRP:/(5^:P#+%N8&KR
MZ+*B[Q9%B@Y?@41#%G<I9"@%A=4[U,;3O5-8K*1L-CH)O*TR<,/Z,"9[HS[@
MD?Y,3,1$5;1*-PUGDE?H;82R5A/5 >^<#TC[\P/K,>],#\9B-5GM3SGNG2]V
MKFN=AZ]LR.[VU'4'M?K62=C,U:Q7=0J<I%@ L8O<ASW&-R"N9)P<235;WN=$
M9'$U%(%CI<=G,5E:C[U&]7=4K.M)>^&A"US4:U36&4EP"9E1L6TND&)Z7!,K
M(2GVMXV]2>JM9KM6]RTL6KH*3.'@!K$8B/>9P8B0#R0'RLH@XD8X#?./H5:[
MKU:8Z'W,!8[<6[ JE?,U?=QG=G/K77?=C"KZF9'@>Y,08X]Y.QEPY,ZK'K\Q
MV$'7^?.0SN$8E]@,QBC16%)V7AD*A)KA8_,$]D.D%"__ /I)A##/^B2UP6-R
M(FM18^Z+'$8I655\&TE?G16$KZC)?_7 Q,A_U<:\[^1.[_FF0?R<VI\]>C3V
M8^'^7MM^:%6[$L,=(+ 7']H_..E>)ES%LH:3=8 LEB\X\.>800B6/T]KXG@2
M]J8[I-S:X%YVMP;T,!3D#/=X)R6L6MJXY-;# #&"(8GKY"]S,>2M\BL&E'EW
M<BI@D:V3[GHLP$C Y]TA$BB9B)G76CTSMGONN2$:SV&$';$D=IKK BBVSL1U
M4<C0E^=M3Y0IYI'-:A+8@CR.%,9H?9!@HT<F9!0\4G:<ICOIX&_2(JSO+/ ;
M=;J39Z#.*S8EL0JQ(+,H4V0/I BF($2F.(I6_HN:MD1<N'+*4.X-/4(]X. F
M35$D,=800\E$1/,Q$W2:^\#;.V?ZG8^:J?.[8+UFP>M<G[A)U=LI-24;DI6<
MU3R7!=8*\ILE-Q:P+RL8 GZX5EWU#*2,(8'A]1E;UW>6/Q^W0SUJ$@9T?/!B
MQR./;;<H6 ML532]J+7;DQY-!DOF8$B YZ=2M?;]JUE2QB)80C8\L5V:EI:%
MG($82X6+!J.N!G@6#!3QS$2/KJT5CKB]K4)=OFI]HRI(K>='W=\:\XQJ,K*
MLD'Z2.Q9!]*>R9"1"(L!OJ_G]RPRQ?+^9'GCC<H7J9N&M%JOYLEPWRG?5YF
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MGQ)Z^)6E&6RZL\WK>ZIORH[SIMCNE7I56=HG"W?"C:.PQ?XPIS ?L^J[7KZ
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M^7%F]Y'(2VT<B3Z8(L0B6MD3","3SL\F7?:%\2<P4QUQ$>GQCICIB8G[>/\
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MV/ZAG)(E?+E\ENV/I^?21=7C "/^9#3T--["R1P?62/.F8$1#)XQ@EG%SXE
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...--.--.--.--.--?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g573774g23x22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g573774g23x22.jpg
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M 0$! 0$! 0$!_\  $0@!B0)> P$1  (1 0,1 ?_$ !\  0 !! ,! 0$
M       '!08("0,$"@L! O_$ &40   & @ " @P%# X&!P4)  $" P0%!@ '
M"!$2E1,4%1@9(597EM/4U0D6%S%5(C)!4E18DY27MM'2"AHC-CA14V=U=G>1
MDM8D)S,Y0K0E-#=Q=(&U-6&AL;,F0T1'8G*CI<7_Q  = 0$   <! 0
M         0(#! 4&" <)_\0 8!$   8! 0(&"@P)!PL#! (#  $" P0%!A$'
M$A,8(3%6U!05%T%155>5EM$(%B)487&1DY33U=93@9*AI+'!TO C,C928K7A
M)#,U-T)R='5VL[0E@K8F-++Q1$9F<X3_V@ , P$  A$#$0 _ /?Q@ P 8 ,
M& # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P
M 8 , & # !@ P 8 , & # !@ P TT\3G$M;[?<9NIU>:>PE,@GKB*(E&.%&J
MLTNU4%%R^?+HB155)18ANUFXF!)%("#T!6%10_SE]DA[(K*V,KM,#P:UD4%=
M0/' N+>N7P%K8VK:2[,CL3D_R\")7NF<32(IB2]*9D+<?5'-II/7NQ_9%1.T
M4'*,G@-6LRU;*57P)B>%@1(*S/L9UV*?\E+?EMD4C_*4NLMLN-)2TETEK/$$
M9R;'QC,2@B/C$1D'?C__ )LY0/:;M(/E/:#FYF?*9GEE]R_IX]U]I6&]$L9\
MPU75 [N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78
M[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6
M&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*
M=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5W
MW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[
MN37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR
M@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\
MPU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78
M[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6
M&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*
M=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5W
MW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[
MN37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR
M@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\
MPU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78
M[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6
M&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*
M=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5W
MW7P]I6&]$L9\PU750[N37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU750[
MN37TQ*=8._78[IFTCR@YOZ5WW7P]I6&]$L9\PU751?\ 0-S;$UO,-I:NV64(
M5)8AW,:Z=KNHV01 P"HW=M%SG24(H',.?1 Q#<E""!RE$-[P3V0VU#";:--<
MR>WR6L)Y!SZ3([*7:Q9<8U%PK;#\YR1)K7S3JIJ3#<;W722IYJ0SPC#FLY/L
MEPG)(#T9-+7TTTVU%%LJ>&Q ?CO:'P:W6HR&69C1'H2V9*5D:-2;6RYN.HWM
MZSO++9-$K=U8I]@2G8\CA5MSZ7:KQ(YVSYMS'ZH2HNT5B)F-R,=($U! .EGU
MUQV]@Y/0TV1UBE+K[RLA6L,UD1.)8G1VY"&WDD:B0\T3G!O(U/@W4+09F:1P
M';UDJEM+&HFI2F7639,&023,T&[&=4TI39F1&IM>[OMJT+>;4E6A:B^LS(QX
M8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & #
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M(HO;6&P2&)4-BR<@EV"_(.)*8?0_#6\RY&>8)3[SZ7EGE)GFXV\, & # !@
MP 8 , & # !@ P 8 , & # !@!O$X-A$= U+F//DZFP#_N[J./%GV?V 'KL:
MV>Z\O_H#1?)(D$7R%R$/G1M5+3:+EVG)_P"JJ/Y8[!G\I\IC*3/81Y\& # !
M@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 ,
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M & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@
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M<(EC8>T:MF+5LR9H)-6C-!)JU;($*FBW;H)E21123* %(FDF4I"$*  4I0
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MWD(T,BU(Y<S5AF@P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 ,
M-Y/!TLJMH"G J<QP15F44@,(CT$BRKHQ2%_B*!CF$ #Q<S#_ !Y]H]@CSCVQ
MS9XMU:EJ3CD5DC4>IDW'6ZPRC_=;9;0VDN\E)$7(0^<NU)M#>T/+DMI)*3N'
MG#(BT+?=;:=<5\:W%K6H^^I1GSF,G\]=&@A@ P 8 , & # !@ P 8 , & #
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MM24V<!*"1NF2B<-1J+=(CDG-?&4# !@ P 8 , & # !@ P 8 , & # !@ P
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M5K(N):3?1&5':MIM3CSM8E]27?\ ZC*#)M8J'^$-%?&6:3=)^.^K '*@]*#
M!@ P G'AB_A*</7]N.IOS]@,E7_,5_NJ_48U#:#_ $"S?_I#)?[FFCZ:^8D?
M*X==V[:1[1R_?NF[)BR;K.WCQVLFV:-&K=,RSARY<+&(B@W02(=5994Y$TDR
MF.<Q2E$0 (.Z,GN_QJE?0>F#<A*B<'$=.[:2^P9<H]A>P>M%PY"5N8&\Q?41
M_P!("/IIQ1M\W\WX3_,7K/\ 4?P\TO\ .\)%\FO^'ZQ.;9LW9-V[-FW1:-&B
M*39JU;))H-VS=!,J2#=N@D4J2***12II))E*FFF4I"% H &2B86+9MG5"KR
M02[UQ,VM1$J[>FU9BZLEL515\2+E:%B4W#B+CE3?4=VYL8R"0'ZIU)MTRF.6
M.A_B\)\A"!F1?"?@+G^06YT-OW3Z\['3T K_ ,"/<JX[+72-]NLH5]K^I.R#
MXC)II;*163$#$=,EO$1R%\/YB]9E^28<I_!^<_47YQ<U7UG3ZF^4F6,>K(V=
MPB*#RX6-Z[L=N>(F'I';'L,PL[D6T<)Q,=*&CU6<*TZ0IL8YJB!4RC,S^+P=
MX"(B^/PGRG\HOW("(8 :V^)#@YG;/9I&]ZO!FX7FECO)JM.7"3%0'ZGU3AY&
M+KB1J9-R8#*JM5%$CD6,(-P.0W13X\V]>QA7M$N'LRPR? K,BE-M(MZVR-UF
MNMEQVD,M3694=F0N'8< VVR\A<=<:9N-NK<BO$^[)Z#V6[:DXC7HQ[(HLJ;4
M,+6JOF0N#<F0$NK-QR,ZPZXTF3$X5:W6U)=2_'WEMI0^V;2&<21X2]^AXOB$
M\_\ )['>U9S#Q0MLWO"@\_Q/VI(_E(>U=W_9U[[M?-,CUAWIF_?()Y^.QWM6
M.*%MG\7T'I!$_=#N_P"SKWW:^:9'K#O3-^^03S\=CO:L<4+;/XOH/2")^Z'=
M_P!G7ONU\TR/6'>F;]\@GGX['>U8XH6V?Q?0>D$3]T.[_LZ]]VOFF1ZP[TS?
MOD$\_'8[VK'%"VS^+Z#T@B?NAW?]G7ONU\TR/6'>F;]\@GGX['>U8XH6V?Q?
M0>D$3]T.[_LZ]]VOFF1ZP[TS?OD$\_'8[VK'%"VS^+Z#T@B?NAW?]G7ONU\T
MR/6'>F;]\@GGX['>U8XH6V?Q?0>D$3]T.[_LZ]]VOFF1ZP[TS?OD$\_'8[VK
M'%"VS^+Z#T@B?NAW?]G7ONU\TR/6'>F;]\@GGX['>U8XH6V?Q?0>D$3]T.[_
M +.O?=KYID>L.],W[Y!//QV.]JQQ0ML_B^@]((G[H=W_ &=>^[7S3(]8=Z9O
MWR">?CL=[5CBA;9_%]!Z01/W0[O^SKWW:^:9'K#O3-^^03S\=CO:L<4+;/XO
MH/2")^Z'=_V=>^[7S3(]8=Z9OWR">?CL=[5CBA;9_%]!Z01/W0[O^SKWW:^:
M9'K#O3-^^03S\=CO:L<4+;/XOH/2")^Z'=_V=>^[7S3(]8=Z9OWR">?CL=[5
MCBA;9_%]!Z01/W0[O^SKWW:^:9'K#O3-^^03S\=CO:L<4+;/XOH/2")^Z'=_
MV=>^[7S3(]8=Z9OWR">?CL=[5CBA;9_%]!Z01/W0[O\ LZ]]VOFF1ZP[TS?O
MD$\_'8[VK'%"VS^+Z#T@B?NAW?\ 9U[[M?-,CUAWIF_?()Y^.QWM6.*%MG\7
MT'I!$_=#N_[.O?=KYID>L.],W[Y!//QV.]JQQ0ML_B^@]((G[H=W_9U[[M?-
M,CUAWIF_?()Y^.QWM6.*%MG\7T'I!$_=#N_[.O?=KYID>L.],W[Y!//QV.]J
MQQ0ML_B^@]((G[H=W_9U[[M?-,CUAWIF_?()Y^.QWM6.*%MG\7T'I!$_=#N_
M[.O?=KYID>L.],W[Y!//QV.]JQQ0ML_B^@]((G[H=W_9U[[M?-,CUAWIF_?(
M)Y^.QWM6.*%MG\7T'I!$_=#N_P"SKWW:^:9'K#O3-^^03S\=CO:L<4+;/XOH
M/2")^Z'=_P!G7ONU\TR/6'>F;]\@GGX['>U8XH6V?Q?0>D$3]T.[_LZ]]VOF
MF1ZP[TS?OD$\_'8[VK'%"VS^+Z#T@B?NAW?]G7ONU\TR/6) U_P2;9L4PV);
MF;>GP!%B"^>.G;5V^.B4P"HDR8M5E%#K')S!,ZPHH 8?JE2^/EO."^PRRV5;
MQW\^LJNIHH[R')4*IF+L+:P0A1*.,TZAE$.$T\1;BY:I#[S1'_)Q%J]TC6<G
M]D50L0'F\5ASI]HZVI+$B?'*) B+41D3SB%.*DR%MGHI+"6FVW-/=2$ER*V^
MUBN150KT/6(1#M:*A&*$>R2\0F!)$O(5%# !0,LL<3K+G I0.LH<P%+SY!]'
MX<.+7PXE?!8;BPH,9B'#C,IW6HT6*TAB.PTG_9;990AMM/>2DB[PX^D2'Y<A
M^5)=6_)E/.R)#SA[SCS[ZU.O.N*[ZW'%*6L^^HS,5W+D40P 8 , & # !@ P
M 8 , & # !@ P 8 , & # !@ P 8 , / U\-I_O$]R?T=2?S889DV/\ -(^+
M]ICZ&>QT_P!6%=_S2Y_\U8U.95'N@8 , & &=6K>,&E:CU'.UNI<.U;8;PGM
M/;)T4^W@VO$^@QDJ'M)5="PR$_J\\<XBY:^-(!X[KL+94+)&1C9F+1T^K,D_
M9).#4S09J(S4>Z2B5NZ%_.+FT5_5^#0_CTY!YY;X1/NKJ/+F9/*<H(]Y59$W
MCZZ^,IQJQJ$I5%:C6Y.)=8KER4(E/Q5177EKWT-RVFW%)%V<3?P@C[B+UK8Z
M>CJ2)H-NVO=M<;&X@;XRN$K/EV=;M6:_4U_5UH2LO8MDUH4,HV<O)^8BTI*Q
MKOI]8CA&39LTC,E8(:W3(][4DD9)+330E'J>I]_P=XM.\++$]FK>+VL6<JZ?
MLH5/ M*O&ZYR$S&[4PKBR392TR);;SB[%\EH1'8=-J*AN,1I4RMPR<3>&E_A
M(4M+%<P4+J-XYHD3JS7M H]8:;!+"':251);YBW/KR]3IS]&[57;U_V!:K?L
M2GIL8!2102J=?1GTV%59**P4UO<IJY=3/737G,M-",^0R(B(CY=.4].46-]L
ML5?;LA^[0FQ?N+.RL):ZTY!+:FG"8A-U[9SFE0)E)6UL.%5SC<D$TI4R2J.;
MDMPBU<Y6'KP8 , & $X\,7\)3AZ_MQU-^?L!DJ_YBO\ =5^HQJ&T'^@6;_\
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ML<=G9MT:SCZ)0_> .+=F7CG&?I%K]DAX1&"\UTMZ4,_<V..SLVZ-9Q]$H?O
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M]#/8Z?ZL*[_FES_YJQK!RJ/= P 8 =ID0JCUHF<H&(HZ;D.4?F,4RI"F*/\
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M=%),R,M2Y#Y2YR&72HE)2I/*2B)1'\!EJ7YARY*(A@ P 8 , & # !@ P 8
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M84V?8QU-V=LR^U)LR25F?9C<],M4:>E"2FPUOJAR2+5YA7*8QRVEM"^;HO\
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M@FD _P#RAUKZ$UT?_@,=RQJ?A/Y3#0O 7R$/P=!Z-'QCIW6 B/C$1HM9\?\
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M;3_>)[D_HZD_FPPS)L?YI'Q?M,?0SV.G^K"N_P":7/\ YJQJ<RJ/= P 8 ,
M/T#& ! !$ -RZ0 (@!N0\PYA\P\A\8<_F'QX#0N0].4N8_!KX Z0\NCS'H@(
MF O,>0"(  CR^;F(  "/SB !_%@-"UUTY>;7OZ>#4?O2,/1YF,/1#D7QC]2
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MB E,40Y@("'B$!#Q@(>(0\89[&//1^X , & # !@ P 8 , & # !@ P 8 ,
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MDF1<P@N7&;>C1UOMI?F$ZJ*T:BWWTL(2X\;9?[1-H4E2M.9)D8KN60N P 8
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M$OF*WGW"@K/9_7B <BI6%<SB:IJ(%^,"DE6RN)NNS?SO][]?P_ ?A\/>$O\
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M^U[>/;Z3T)^42?\ \BX[);_M?)_B'&BP'Q-F/T"D^\(?M>WCV^D]"?E$G_\
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MS[<F.YH?)O,R&6GFSYTN-I47*1"L9:BN& # !@ P 8 , & # !@ P 8 , &
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M*?/_ !\ D+("(8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & #
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M*6.#-K@4ONDUP1OHE&WP9*W.#.4TW)-&F[P[:'M.$0E11./'-?"&PR;F]O\
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MT2(W:LV;5(B#9JV02*5-%NW13(DBDF4I$TR%(0H%* 9 1':P 8 , & # !@
MP 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & $2[.TCKG;J")+
ME" X>M4Q29S#%464NU2,(F%)-V0IP41Z0B8J3E)=-,QCF3(03G$VHYA@>(9]
M7HK,OH8-Y%94I<?L@G6I41;A$EQ<*?%<8G0U.$E).G%DM<*2$$YODE)%GL?R
MC(,5E*FX_:R:Q]Q*4O<":%LR$I,S0F3%?0[%D$@S,T<,RO@S4HT;IJ/7'X>
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MOUQ'>Y\<4_8CT:G^D5[U\.[MM+\=1/,]9U8.\)TQ])7?KB.]SXXI^Q'HU/\
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M!GK\1<A?%_'*?P@1:?&?*?Q_QS"_L@(A@ P 8 , & # !@ P 8 , & # !@
MP 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , &
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M?P_$.FRY3U[Q<WK]7P?&)MR F# !@ P 8 , & # !@ P 8 , & # !@ P 8
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M !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8
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M45D5:VX(JDJD<#$434(8Q%$SE$IRB)3 ("(9YCM=_H9)_P".@?\ >'H>R_\
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M4+^R B& # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , &
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MI!2C;-LR2ZLN$W#6I"24>Z>Z9"279PH;,YYU]M1UT1^;*8:6VY);88:4\M7
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M/M'\^)S/O5CG]'J+_DU7_P""P/D1D'^GKO\ YO9?^8\(8S,C$!@ P 8 , &
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MQE/K)7!2+MJO7@<+D:]D(BYF)%>1L4FD21E5TTAGWN\7Y_A/^.3F B[Y\_\
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MC+_1JYZD'MLQ7I-C_GFNZR'<F5^C)#\2<^KQW/L]Z$9?Z-7/4@]MF*])L?\
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M=97H2MQUM;:]T]=#W5DD]#T/0]-#T,00XVZG>:<0XG73>0I*TZESEJDS+4O
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MNYN<M.^7-\)>#U?C+P:2GR<O>,^7U^O^-9OR43!@ P 8 , & # !@ P 8 ,
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MK2%?@G[@>DX>P\8[7, <@,LY9(+*B ?8YG.8>68D^<_C,?)8N8OB(5C("(8
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MM;1.EMC^B]7#O4^&'^1;>F)O:\<7G8SY/:7].ZV'=:VB=+;']%ZN'>I\,/\
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MIQYYYQ;KSKBSU6XXZX:EN+49F:EK4:E&9F9F8K.5Q3# !@ P 8 , & # !@
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M;ELF??7S)2ZFI?;B1J]1J)F;8J;)]PY>Z9&N/$96POL?7<D.2$D]JRTMI[6
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MUGS0C)O$.6S^*<LI)J[1F6<S&2;-I,L+"UD4IYI.-D)Q"23EDB/0PR,IOT9
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M%J9)0[.C(U,M#-9Z'R&-]^?3D<7!@ P 8 , & # !@ P 8 , & # !@ P 8
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M4N+*2TM1QY"4J2I3+I)<22B,TD1D+4P+P, & %9KH]&P01A^8LS&#\X!\SU
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M1ER75N/&2GFB:62),)Y9$DG7(JEM*2Z22WV'V=[5TG#&7^>[CR\, & # !@
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M1IA4Y^S.J;E)16G8227V1)-"&4RU$\XZY(<B+F*KU2G%23B</HLISS31L 8
M, & # !@ P 8 , & # !@ P 8 ;#O@]8UX:XWZ7!$W:"-99QQU^0] ';F50<
MI)=+ERZ1D6BQ^7/GR*(\N6?0KV#=?*;A;1[5;2DP94K&*^.^9'N.RH#5[(EM
M(/F-3#5C"6X7.12&_".3/9-2V%2</@I<(Y++%W+=:(_=(8E.5;,=PRY]'7(D
ME*3[YLK\ VM9WL.6@P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8
M, /$I^R&?X<M=_L*I7YP7',A&_S?_N/]@[J]BY_0>]_ZLD_W-2C1%EP.E@P
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M6G)>(EXKD24USAFY0_VESI4.@4DXBF <UK!0679SG.'9Z)&LV[B5.Y#YN0_
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MXXYVR7Q=F_F:I^\ <73/??F,^<;#[(#PA-*\@;'UG'^IQQSMDOB[-_,U3]X
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M<<<[9+XNS?S-4_> .+IGOOS&?.-A]D!X0FE>0-CZSC_4XXYVR7Q=F_F:I^\
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M@WV''&7-#W%GH>D@9GABPP 8 , & # !@ P 8 , & # !@ P 8 , & # !@
MP 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@!!\S&2.J9
M61N558NY*ARSM:3O])C6ZKIW"O7)S*O]@4F.;E.JLNJ<QW=VJ3),QYX.S66
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MBA-[^54MQ)EP%2NWA6D?%DHO2,X#C<>4\4 X^J9JU>.6RC8>M&J_M$E-6=7
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M@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 ,
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MAMY^0VRVA^3P12'4I(G'B92:&>$41:KX-*C2C77=(S(A5LM16# !@ P 8 ,
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M9VT.;0P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P
M8 , & # !@ P 8 , & # !@ P 8 , & # !@ P ZSS_J;O\ \,O_ /2-@!IE
MO7[ZYG_Q9_\ YYI%]_I)W_<;_P#Q&?J__M$_[Z_UBTLPPR(8 , & # !@ P
M8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & %T4O]\\/_XQ/_YY
JF*+_ $DS_NN?_@8Q]I_]FY_O-_\ YD-SD=_[/8_^#;?_ $29O U\?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g573774g82k09.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g573774g82k09.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1*84&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 \     !  $#P     $  3A"24T$)@
M#@             _@   .$))300-       $    >#A"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M 3A"24T#]       $@ U     0 M    !@       3A"24T#]P      '
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))300>       $     #A"24T$&@     #-0    8
M         '\   %V          $                          0
M       !=@   '\                      0
M   0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   '\     4F=H=&QO;F<   %V    !G-L:6-E<U9L3',    !
M3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M!V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I
M;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M    26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   !_
M %)G:'1L;VYG   !=@    -U<FQ415A4     0       &YU;&Q415A4
M 0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .
M8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       )
M:&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=
M  EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.
M;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M      QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
M     #A"24T$*       #     (_\        #A"24T$$0       0$ .$))
M3004       $     CA"24T$#      (^P    $   "@    -@   >   &5
M   (WP 8  '_V/_M  Q!9&]B95]#30 !_^X #D%D;V)E &2      ?_; (0
M# @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,
M# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@
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M)+Y5224_522^54DE/U4DOE5))3]5)+Y5224__]D .$))300A      !5
M 0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0
M;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X0DE-!"(
M     2Y-30 J    "  ' 1(  P    $  0   1H !0    $   !B 1L !0
M  $   !J 2@  P    $  @   3$  @   !X   !R 3(  @   !0   "0AVD
M!     $   "D    T  6XV   "<0 !;C8   )Q!!9&]B92!0:&]T;W-H;W @
M0U,V("A7:6YD;W=S*0 R,#$X.C T.C$Y(#(P.C0S.C,V   #H $  P    '_
M_P  H ( !     $   %VH , !     $   !_          8! P #     0 &
M   !&@ %     0   1X!&P %     0   28!*  #     0 "   " 0 $
M 0   2X" @ $     0              2     $   !(     3A"24T#_0
M    "           _^$!,$U- "H    (  <!$@ #     0     !&@ %
M 0   &(!&P %     0   &H!*  #     0 "   !,0 "    '@   '(!,@ "
M    %    )"':0 $     0   *0   #0   #P     $   /      4%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3@Z,#0Z,3D@,C Z-#,Z,S8
M  .@ 0 #     ?__  "@ @ $     0   7:@ P $     0   '\
M!@$#  ,    !  8   $:  4    !   !'@$;  4    !   !)@$H  ,    !
M  (   (!  0    !   !+@("  0    !              /      0   \
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ML_ G-#5"1'1U@<'_Q  4 0$                     _\0 %!$!
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00- T#0- T#0- T#0-!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g573774g91g84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g573774g91g84.jpg
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M 0$! 0$! 0$! 0$! ?_  !$( 1( V0,!$0 "$0$#$0'_Q  ?  $   <  P$
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M7%6N-,BS$L2VTZ3D60<5YTF9"4[N@YEI$2M U:"]&W*ID1(4 * % "@!0 H
M4 * % "@"L6A]\[3XV;0BNW=/RTM$9C%"K(BW<#7KELT+-6KE-=T!D#-%5-
MS'2Z6&3$P&?X+,G[)95!=+*V75M'6M5 NH+]=8QVY$:0VI!I6E)J;4I)DEUE
M1D9M/-F>DVZC)2%$1D8[];9S:B8S.@/N,2&%I61H49)623(S:=21D3C3A%HN
M-JS2I)F1D.H!Z8&'_M>7^KM_\%4<V)_^S_L__H7)U_\ _#_N_P# Y3M7T%)P
MH 4 * /ULBME=*V*2M[N+]1"UD\[W6OU]T^HE:UO^\OV2UT_^#J_\=KX_P#J
MMU*9EN[N]O\ O>SN]K<W0R/<W-_>]_V-SM[NX/2V&=\<L[897PPOC;/.V-[X
MX7SZO66RRZG4QOEUN76VO>U\NMOU.KU+TS]CV3 >4TE%L[)I)YJYWZM[8)X9
M9YWZENK?J8XVO>_4MZ]_6]:WKT,R+=,\B[9[@$1GN$69]HMT>5$E4<NL6342
MSM:U[X*89896M?\ ROUN5K7ZE_\ IZWKUP1D>Z1D9>]NCDR,MPR,C]_<'YUR
M. H _?%JYR2NOBW7R1M;*]UL4E+I6MCU>NO=2V/66MCU+]=?J]2W4OU?\JXT
MDYY9EGVLRS^(<Y'EGD>7;R/+XQ^%<C@7>Z8Y(PB%:LRU%MW1C3>$(";4QW5#
M1UY\9U^D-G+F-,8F9'3%4.',.I; )*+"1S$O'!KN'2#%4-:X>:"L7[[!77K*
MEE29_HC76BJN4[ ]#)+FQ&IAJBI?5(;7&)UQM,>6RMQ[6WG$R6<G/SD9S029
M3M?;1H\/8,ZN38QVYOHC'1LIR*2))LI8<0^:&W%/Q7D-LZXTA4=W-LM"0@E*
M(Z^'ND5DC_5VB8^"B.S8T<X^H:80@ZB6[WI'0SB3:4DXZ5ASI?23G7B?;I1]
M9I=)9/TR,'#7+-F_R<.^U<D'42S@YE$ZU>=D07VK<[(Y1'6)1;$Q9L+CN--V
M:9AZ"$Z69'L+)62D9)TLTR3N*GE0ZUMIB8RY5IKTQ\K%2ZPWJ]Y#[;CE<<4M
M):M'=+99*+\E6DK1,E42WMREA^R->&-9:NTOZ4,;FVZ%=_[&L0V(_P!CO#>P
MD@4@CX5C&7#J-1:T4@L=83"77& 7N$I/KK&[9EY@3Q'L\,).JHI$*8W.G67H
M@_%K"J(6A#3"2U#-UIYU3Z4OO[(E/+CQ]-Y)L-$363<9!K49Q]E<QY<5R'"K
M]@,R+ [.7IRU2U.2B;=::2RI3+.L1FDR']!I6ONF;F:WU:*2%F=;(( * % '
MFUKWO:UK7O>]^I:UO7O>]_\ *UK?];WH 7M?&]\<K7QRQO>V6-[7M>U[7ZE[
M7M?U[7M?UKVOZ]KT ><<<L\L<,,<L\\KVQQQQM?+++*_K6MCC;JWO>]_6M:U
MNK>@#W[ O>W7615ZWJJ8]7L>?4ZY+&^:MNKU.IU4\+7S4M_GAC:^674M;JUQ
MF7;+V/IW"^,][MCG(^T?L_1NG\1;_:'ICAGGUW68Y9=;C?/+K<;Y=;AC_GEE
MU+7ZF-NK;JY7]:W_ %O7(X'K0 H 4 * .HQ5%Q= <N>KT"EX4 * % &>*)<L
M]1Q'6_'R%9<O1\EDHC36VQ"6Q2,2WJ+-\6]O3GCF\U9KICKP8'U$T90G5>M;
M#A(8])]2.YEL.:3PT1VHN"[*,9=;^52,/V$B;;RBP\IAARRKW%0D2*IQJ^KH
MMR4^:J8MRP4J5/FZ:W6H]@F-"C16D0"=,G%C]*8NX,>)51_1Y#SS=?/;*4IB
MS0Y2SY52N%%3$0B"E,:%#T4-NO0%2)4B4M4XVLT)% -X<S(%(PW-8?JL^C%%
MYORVT_O'1AN.PG*'3<\ZBKW:*\JV$ZF0@,TD(EPW*/HM)XR#D1UDO'7AY^YC
M@MF7<253.7J\.2V7,,KGLG(*+A^QJ[1MZ3LF,TE],$H\,H[CBF7$FVA^.^ZR
MTHGDM(2\M3:6,HNROXSR,0IA.$P<B]@V5<XU'-B0ZIE4TWI1R$-DZV9+6R\R
MTZZDV5.J-I"7#>,Y'VUS5ED@YS0/<$?W[M4M"M.D=>:MA>VG,HV C.3FG84\
M:,9+("I%\NC/'.6SE5Y=-I.%*8]MN%9>0 YBVX])J&:]FOPS'9PO+KGJB W)
ML43)\FO2Q$5%:LI*5*99;0DCBIV"11XK#J/R2*.AW7%+-3JNO.Q"^[B2-/:L
MYJX\!<6%'G&_**2Y CFE#SJUK,I2MF&;\EYM?Y1F^IK0)!);*L1?>G$S<3/F
MU/>0&PD]E;0GTKY#):$(3\7N0S.!4;:Q4H4XWN(C*,H]*!HV/7F;E,)E#"Y#
M5MXFS29JG74IC+U6/QR.;J\05R\,Q*B'L*!$8ISMD1'*UN*X\J0A%R4A@G6'
M%O;&2;NR6TS]D*-1-)COIUY_OKLJ2>G$4FTE%,F2GK0JQ<I%@Y)0TEA:ZE3#
MVM/(2UL@R;V.XJ%K"22;JGV5&TS</"(QPBW:GR6G,*UAHT#JG7\XWZT$EB8"
M>BW#_4(;C_+#NB2T<R>GL'L*E^6U\'!*3%-B,XXSF>#J)PJ+XF287.(XPTI_
M$]8=)%E3[1VPEQ:E3C;;L1:4V+MO&:M6W]%HT28Y0#2AE$-3RHQID27S:;=)
M\Y2.SAVP3<28T.N:A19-F2%K:E(-4!NKD.UBV=)W2CR#FD:GERR:3(TF([.N
M*;..*6']U='3'$3C#2H/6T:5EW&#>, 9R*2Q_<$E7%FI!$=49Z_C^P!*^J&=
MV&R<I$%V8QRG$,*;%#J*26R)V:-XSZ%8A9!FLQB\II=F[-?*/>5<M3+#M<R2
MVV9%@4MZ(X5@K2A:R["5L62W#=+6,VHJGM<-WINV&%&B<37-1&3?IK&,EUYN
M>\;;KK$(XK4EM4).C,UUJ6DY,=<MK\]DY()G1UJT+3W+,K#^'&S./<@W/MT<
M&D6]]$.F.LXQ+YLQ&N]$VC_(9'D)'@N#=WA$1 N5E)G"59%&7JK-K,BKAD3?
M#2]@SQPRV&QP^W)Q'"MVJVN6XS56J537XT5:TVNO4YU#SIFDY#BX[<:43+Z2
M4J,V2T(6WKJ27!0+M;%!,JW;"<EMVRK%)ALOR$H56ZU:E:--D2MCMH?7(C&Z
MRHTID+-*U(<UM1IO&.;>Z/ >*WA#88\TF#4VAJV<1H=+0&H-_N(F/AS+DEHF
M::EA"H>1C4)CAO4=J..;6_::6#U!D(-2Y'73$AM-6S8M)<]<:K\8+<K),E-H
MZ4&?%?7'=L:@I"Y"J6UC6$DG65G&.J78/0-8CK)<EJ.<Q:(!:3;)3SD["J6[
M&/'.N:.9!DLH?;@VAL)83;UDB#&-MU&R"LD069NO/I-$9U\HB%S3T5NG3OD[
MM_A*AJ?<D+XX$XJS+["U_JH208PB+;,$QJ32V!<D-D2#$JUPF< A-@^?I./(
M"LY;N1R-DWK=<.L<F)YD_E)[N4==B<["NDW*'U-PY<]Q"Y3\)Q]B/+IH3.MJ
M.-+DZYE8HEDE25GFE1.$U':4AAKJ7$[#Q0I\>J6RER5%A-K3'9EH9>?C6TMW
M7$[(BQM;_P#3U1C,C062B-LW'W4K><*\B=%R;6&D(Y*N2<N#<?@NO>,NN=L<
M'8W!9H\<'C<!V'%"&\YTW*.F(W5$95FS)A+]CB=FQ*7.]P/Y#($8,2!C03DH
M13%3VC$ZS>8I8[MN[,O)E?BAZ5%23+4N'(15130E:Y[Y15KCPG(,B.FN2RR<
MM#JW4MH')VM:]#KFG[>0W5MQ:>)-PXU&D*4XY&E,*LI*5J2B"R<A*'Y;<QA\
MYZG7BC*;0T:U"<!FS.C,"S>-.9/&=+3!5U(=-"]@E83K7?HW4W[!O-_RWTR"
M,)B\I9AIH/F,>XWO8\.D;QT(00(2=JB]A3:12EBO)2777!QL[&?2R_9QB2S9
M+AMR9M2NPV6FHC["1*?84[&7'>NDO+923AJ0PHTRE,L+)A'W3,P@W(9-YFOD
M&;M>B4Y'B6B(.QE6C^S%QV'DMR$/M5"F4.J-!$MY)*C$Z\DWW(_J0ET><EBI
M7;4OBVB8T"CY+AX VJ&/1#=+MNDB7-\L,=W1G54>C:I"08SJ4ZOB6K<!4N7S
M7AHZ8>AQ(Q)P!MVX,-_C8(Q@P^W7QW[1]UU&(W8#K4BM29FVUA_T+?GO/DAG
M8K$Z1/-<8M&2N-IH;8>:232OK!7A9YER=(9K6FVET+<UIQBQ-.3CMV5BS!:9
M-;I27X3$+0?,SCH?T5N/M.J-PJ>6V%T8+&*:*S&0.-O2037\I5FC>2);;(21
M2<X\5]F#\Q&S18N!A0)QK)^4CO7I>%G8=LZ38QN/L;V>-H4&<D6(SN;#QPJ1
M:DN6^EMV9'*,IDZ]#)1?1Z"LG(2URW7FE,429K<EJ3!8U]Y7Y*I3J4*7U=E8
M.2Q6Z$9E2VXKYR"=V<MTY/H+,3K<Q"8S;;A/71Q7(SD>8\3+2<EE';-26_B+
M3;HW9+J[>*7H;!X3/))$M>'8:\!PS:K\FSV"XX\Z<O-XI#HJZB5@ >-C>0C/
M:M\"^6WX W8L"3W-,'L^)XQ$>QR;C8S9G59Z<J3$8D3&I*79,!+:H97%EL:1
M)?3(UYQ]=.JO_-E73#6M"?SL&1LA:\%R,)O0K(M&/&DO1XKL=3<>:MPI9U5?
MLEAA@X^M-LHM4S?SFSXI(0M1DU-8UA":TFMX]'1$;["#ZE)ZG$J2K4+>-JRI
MAK?>;8<1+03EGJS8<7] $76NQLEA<R/Z6$2-46[ND62%3:/1\9,=KG[LT)<<
MC&ZO&,@H;E@BP<)BP4\3"IM6:TMRL/SX;^O&F8MB3&:LG&2<3FV;D9YYR/7L
MZ1QVI%RQPHQLIN"N"C7X)-&^F)9)0M<:\A2V-:(XB'H\AVN;=T#R<)$AIM$B
M<YD3[DC/=E]&>=+^C\EQC!P89W.C(I'Z+1/>I+=A,V_YJJR:2SL[+G;->)E-
M$DN'BSB/J0N[UQM%U/%\'*\5L?[:E:W;3"QJTC6F=?;6W6FRSK<BK16-M(PS
MK#$1J.E92&[5&(R2]LK1*"40M%,C6=&.76.7A!Q>N/$RXA=@3KNFS9+L5N*Q
M";STEU]25,+K54)FT<?2.:J2>D;.NYO'0^*;SXNQ/EOP8W;#F,=UG']>R$>;
MWNG"XQ.6X4&^B7(K9JT5+M@Y%,T8+D5=%(:M>DW '(JJ1(=ER(8WE%S:.,H_
M5WDC#^*:R2MZ:],94U5'*?BFXZB12P"?;4XV;;;:"M3GI0ETFR0G+0_,:T8C
MF+*G8O,-V+"&8;<5U+ED4=F23;:F+:8;#A-K)QQQ7H:4)2S;-PUJST_S^N$+
MU=M\[>(,XA4,C4;E9@ W49<JMJS5BRCT_ N,=Z<I.*._<I(S3?1\4RR6!L-W
M[)AVGL6;9TM'GT9CO;A+!Y W9)ZMK-=A7$465*??CMNF2J&!%6IZ(Z7H517]
M3K*C2ZXK)U57"DV.D:2>2^]HHT9:4)+8)V)**2Q'::><:3E=3I*4M2FC]$KF
MDLS=22FD)S:38RX]>22/6E,LZ2R5%4M1V)\D-WZ'AC"#WX8$84&>RG3L@UAR
M02#:YF(>\EFQIC%K2^8Q!38V!)(5KF0*-;(ZT8B[1R9Q!^-F3TB$!-9*&2RV
MJEJ[62N5Z9$2G$Q[%F=2F[,C.:Q&:7(V-'D%#-!N3625G.6YKT:2A<9*'75,
MN9:W;6-;'1&]+ZH[:GZ]V%;ZW%D-Z](<2SK\A@Y>EH1'<LH:4$S(84B0I;32
M76R/&C6ZC40H 4 * .HQ5%Q= :=7(C_#R\THEM26-=""89M/4KHP_?0@VO/8
MW$SX^/NG2BHT+*14M>A[XG!C?/!DZ=B7!,:1[!B026:9NLQS2QM/JOX:D0(Z
MK9R3!L$MH3*:*(](:6\E.2W&'(Z7/S2S+22EPD+1GH&2B3IJK_:ZEF(&)KZ:
MQ$>9!-Q2HSJI3++J6E*,T-OH?4V>NH+)*E(-:%Y$HC2:C0FAO<$^DR[SD0^F
M357G74IMKX*[XR>;9_4"-VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-
ML_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!
MW!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUT
MVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7
M]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y
M$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/
M-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77
M!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YU
MTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\
M7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\
MY$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9
M/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(7
M7!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5Y
MUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL
M\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N
M\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\
M9/-L_J VL\7]PQ^<(77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(
M77!W!/I,N\Y$/IDU5YUTVU\%=\9/-L_J VL\7]PQ^<(77"M6@/\ #R\V)AL^
M+C]YBH9JG52)9BZFTB0G\9E9Y>/H.,%"0R+B(F]-9*GW[;'-JQ7+*C!;/-7M
MU=RMVOBR<QEMJOX9C07UU:Y,^>;:DQF3B/QVB=,C)"WW)"6\F4*_*439+<5E
MHDDL]),A6:EF(9$QE-BB/"A$M)R'BE,ON&T1D:T,ML*<S=46XDUFA"<](S/+
M1/>0_9D%_P"VH?\ [5_^2JO:^[[<_H\PL=K3?M?I5YQAAXK<3]-](5K=YS!Y
MC 26\Y5MK8&UKP*%RN52Q'7FD]:PS9DLU]$X-!(>%-B@*"N0Z*)&#\B>,7)L
MN7(NEG#RZF3E9Y^DWM_980FIP[AQU%7'KXD#9<F.Q'.99S9,&/+D2I<EUIQT
MRTY!MLLI4EIMM"2).XDD_GU+20,51%7]^TNQ?G2INQHS[SQ1*Z)'F/Q6(T:.
MVXALCT&"<==4E3CCBU&:L\S5<QW(/HV/DE:Z_P!;,/.:H7;$QKX03/D1NH$Q
MZ1,(]XXGRG^N#N0?1L?)*UU_K9AYS4VQ,:^$$SY$;J ](F$>\<3Y3_7!W(/H
MV/DE:Z_ULP\YJ;8F-?""9\B-U >D3"/>.)\I_KA(TAZ-+HC8B0]"97HW0,8*
M]@3=>ADAG1$*0[66OGBBX[2)35LY[ K=-2R:W8^QJ7PSMCE>^.74YVP\:GO7
M\WY$?J!QZ1<(%OTD/Y3_ %P_$'T;?1"R<FW"1K2G'N0F7=ELF@@'/GI8FZLV
M04<N+MV#";N'2UD&R*KA:Z:65DD$E%<^M3PRRLVP\;=_YOR(_4!Z1<(=Y(?R
MG^N$X7Z)CHP[7O:_%S5=KV]:]KF9/:]KV_SM>W[55T3U5<2%N'B\B,MPR-^O
MW/\ L':+4XPX>Z6&4F1[I&34S=_[QX[DST8?R7=5>69/YU4VUL2>%Y?O%?\
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M?WV9^=2'\VM7@A<<+6G*,WRET>IE=P?!_4XW]% A51P[@4 * % "@!0 H 4
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M"XX6M.49OE+H]3*[@^#^IQOZ*!"JCAW H 4 * % "@!0 H 4 * % "@!0 H
MR ='M[(DY_@M/[<'5=7L(^/&,/V4;Z7@BN'9*<6</\NJZ/DC+17I6*;!0 H
M4 4)Y2>UEY%^ G;OW?R&I6BX;IN5:_RMD1EUP-;<F3_)71R[:O6*9#HP]$/[
MGOHOYWWE^(;:]4SU0N-]IXNKZ'@"V6!.*U;XRRZ5G#)/6EC;@H A)XI8&$+&
MLDDE\!(YX2426?,1:6:3)NHY5Q4)$UVPUCAV-/*^3M^Y;,D+?]XZ<((8YJX
M% M9[H,[)V27',$(ZCK[&-8E0.2^;9*7/%\?0-NX>-UVTH),9(#P*KGARQ:-
M!7$42NP%*L)L;=$'0T=D99%[_P!'\NUD?;[9$,2/,_>^G_F_[WOGNBY.L1D-
M:P[^^S/SJ0_FUJ\$+CA:TY1F^4NCU,KN#X/ZG&_HH$*J.'<"@!0 H 4 * %
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M&9Y+,SQAJKDD""9)Y*-R#A'.Z>6<LPRRPOEA>^%\L,,KX]2]\<;]6UJQN?\
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M@,QI&[ _Y\FW\723[9>UZG4W ]5R;!\E:'@_B'A^\Y8L_+7Q*-20APH 4 *
M% "@!0 H 4 * % "@!0 H S ]#A[,^UO!@C_ %6%JMO9+\6,/\O*Z/E"Z'83
M\><7?LFGIBO&P_5,1Z4!0 H 4 4)Y2>UEY%^ G;OW?R&I6BX;IN5:_RMD1EU
MP-;<F3_)71R[:O6*9#HP]$/[GOHOYWWE^(;:]4SU0N-]IXNKZ'@"V6!.*U;X
MRRZ5G#)/6EC;@H 4 6TSCCP1DVR2VSHMN/86LS1V-@8P7;1-O$W#-\QCK@FY
M'9J^CX LMBK@J6=WR[$HGC?KK>MZU9:6X1&DC(L\L]+V=_>,NT,<MTSSW_@_
MN1B+P;3LZB<G'GC7(7:,\&LL7F+B+21E!T0Q&[IBX:HY.E T7&D<<F2RR;YO
MV!XE:[ELE96RB-U$\QF7M4E[Y:7]U&.<O?/Z/[$- 7:G)_9#/9^QVB3:,72:
MSR7MDKYC'E\[IH2$BEAUU[%,;7RZW&W77M:UKWZM[6M_E7[?'U;=4&/'8CM6
M4,FF&6F6R.K@J,FVD)0@C,VLS,DI(LSW3WS'[A'_ .F?V*=M'8M)F&\5JEV3
M+5A*4C&ERVA4F8A,A]2$)<T4)-UQ1I06XDLB+<(2'ZJC9GP:+>2GOYK7VV\]
M47OG"YJ@]2/MZE_V)7@UBW^-KKK ]51LSX-%O)3W\UIMYZHO?.%S5!ZD/4O^
MQ*\&L6_QM==8'JJ-F?!HMY*>_FM-O/5%[YPN:H/4AZE_V)7@UBW^-KKK ]51
MLSX-%O)3W\UIMYZHO?.%S5!ZD/4O^Q*\&L6_QM==8'JJ-F?!HMY*>_FM-O/5
M%[YPN:H/4AZE_P!B5X-8M_C:ZZP/54;,^#1;R4]_-:;>>J+WSA<U0>I#U+_L
M2O!K%O\ &UUU@>JHV9\&BWDI[^:TV\]47OG"YJ@]2'J7_8E>#6+?XVNNL#U5
M&S/@T6\E/?S6FWGJB]\X7-4'J0]2_P"Q*\&L6_QM==8'JJ-F?!HMY*>_FM-O
M/5%[YPN:H/4AZE_V)7@UBW^-KKK ]51LSX-%O)3W\UIMYZHO?.%S5!ZD/4O^
MQ*\&L6_QM==8'JJ-F?!HMY*>_FM-O/5%[YPN:H/4AZE_V)7@UBW^-KKK ]51
MLSX-%O)3W\UIMYZHO?.%S5!ZD/4O^Q*\&L6_QM==8'JJ-F?!HMY*>_FM-O/5
M%[YPN:H/4AZE_P!B5X-8M_C:ZZP/54;,^#1;R4]_-:;>>J+WSA<U0>I#U+_L
M2O!K%O\ &UUU@SZ_X?G<4LV1R%W@-D*0=-N/TRW?(7&LW#92ZV4WCS>]E,EG
MCFV6'6*9?\-L<;]=U+]=U+=2^G8SU1,48RA1(5]+CR(\24<IE+,./&-+QM+:
MTC4RA*E%H+46B9F69Y[Y#3<9]B)J*]CM$AXCU,:FZK[2^DJI+%RSQ!86[2X"
M6CGDAMF6I2&G-D1VE&ZDM+1(T9Y*,;8%?G(_/ H 4 * *$\I/:R\B_ 3MW[O
MY#4K1<-TW*M?Y6R(RZX&MN3)_DKHY=M7K%,AT8>B']SWT7\[[R_$-M>J9ZH7
M&^T\75]#P!;+ G%:M\99=*SADGK2QMP4 * % "@#E][>]EG:'A$FO]2DZERW
MB^ OY#UMI>!JGDR!Y*T*=UR),* % "@!0 H 4 * % "@!0 H 4 * -C+_#=>
MV5W]X#6O]?1NNK*]8G_-_8Q5[LI>*V&N7W.CI W%JZ(I % "@!0!0GE)[67D
M7X"=N_=_(:E:+ANFY5K_ "MD1EUP-;<F3_)71R[:O6*9#HP]$/[GOHOYWWE^
M(;:]4SU0N-]IXNKZ'@"V6!.*U;XRRZ5G#)/6EC;@H 4 * % '+[V][+.T/")
M-?ZE)U+EO%\!?R'K;2\#5/)D#R5H4[KD284 * % "@!0 H 4 * % "@!0 H
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M1+GRGILR5(=5^4X](E/NNK5N)(U:"$H;2A":;UR)0* % "@#8R_PW7ME=_>
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M>KG[>'<E.$'Q,V[]:CE+^L=-L#%'=5?S#1?=H>D;#G<\[GJY^WB:H-T7_"*
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..'L"HE "@!0 H 4 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g573774new01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g573774new01.jpg
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M P,# P,# P,#_\( $0@$)0,T P$1  (1 0,1 ?_$ 8<  0 " @,! 0$
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MD3! 4*&QP6#1X7#Q@)"@P/_:  P# 0 "$0,1   !_?P
M
M
M                  'P^@                            T8])^AHEQ:
MBCMW]DNK5_-JW[OJO;Q]3,<.J@W:]'>/1\?37>];GN#3^*\O1S;7HQZUE]3S
MM5;#W-MZKYGKKZ'[GL5YO\_Z][W[+>>G^5P':?1YUJ_GFP?6T&U.E^/
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M6'<88S!+C$D!)&3$KPR9P,"<CU&4)B5T09;Z2ER[
M                 "FS^5V<WZ%,=SKCNPQ_FNG+?"?FXSW88_2'K^Z5X_PR
MG):B:8+^WC#\\64.66IJXRV!8\CRG[A7#^?><DV3=%/W>O&
M                        /A39K.R_&.9R<_2)C^J%P_F$G+\/Z1KQ:',O
MRAF?Z"7']@6'\K$Y<L?U%WBI)?Y_)R7@F]=QBIK3,M;5Z2OEA)_75>$
M                                :9+_ #VSE_2=C^;3+]=F'YE,OT$8
M_B8Y-SV/]*-XM"66L<NC#+8Y,,7 80JA827JF];&+5K/,K[33584NZ+']B[@
M                                     !K:NMB['ILLE)KKBMD)ES95
M( 46N;(D?@_.3^J>\6E*R8RY[2Q4\1$UN5*<6IS=)/0
M                          :TK_/S.3>MCIBR_H.O%Y2CUF)WGG/*9M)N
M5XN?3 +ML@           '3<TG&Y<F/Q1].)R.)] !].*\ICPN7.8\;ERF/&
MY<ICQN7*8\+EV3'A<N2=DPY                %*K0:[BL9"
M       ?FQZO].8S@TNMN]^SWWJ?F5>=[UW;CQ3'J^=K3N^LNCH>+I;O>QF'
M!I/#>;S\VW\^/6M;I>7I[9_0;GU'RG5;TOZ$VH\Q^=M>-Y]@O73?*:TVWTVS
M=7\YH;<?5-B]!\3U3]3^C]P?,_GG63=?7;HUW@OT)\[\$M#I^5
M                          _-GUGZ<QG!I=;=[]GOK4_,J][OK>V<<QZO
MG:T[GK+GZ'BJ7[_LI?U])X;R^?GW'GQZMK=+S%/;/Z#<^G^4ZK^F_0FU'F/S
MMKOO/K]ZZ;Y36NV^G6;J_G%"[CZKL7H/B>J?J?T?N#YC\\ZR[KZ[=&N\%^A'
MG?@F1X=96//MN^85YV-_QO+F<.G',^[NKJOF       @I6*@ #J/$
M  "^4D(          !4?<]7U8\$1[&\DW#JL5R=SE)[\>KB,^[(./H1_D[WN
MQX.M>.7/PF&:PZF!Y=E(>#3PKM^EFO4\S%.QNI-P:C#<VUS/#K(QS[:6];10
MCN>GGO4\U#NQNI#Q:ZTNKY[G..'\O?Q^78RG'T\)R=^2<?0P.?;M?KZ$
M  :YK/DUA7'D@/&30CY;25LL9+#,<7:FIBY$DQ%B>'81$]ACSTGP]8-@TK==
MDT &C7H/O$^ZGE8SV-WXKR37J^<AO<]7[.#3;EZ;Y&
M            !J@L6C6YE;ED:C,E>DQ+'LIF7P$AJ*Q>%4!$P+,*9)#4N(E'
MN(^8TD59HP$;#62 V90 :K[GZQ*.OI?!R=SSW/.\.JC?8WTYZ?F+EZ?D
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MMYR<+?!GW*6[OK,MQ:[D>7D[O/#K_+E?_2\A[E(7[)QMY2?+>Z<>1PZH
M U9VGTB <NQ\LPX7+OQX/%S;:1<6MGO#K*B[7HO9PZKP\G<R./#<?!I8YR=V
MRNKYZW>IY@ 4_P!OU&LFS^B93CU_+'KXO+L>[CZ7EYMI;76\_!N79QSFV60X
M=9X[E=_5\[#>QNYQU]'?W0\6    /SQ]%][A?/N-J=3\RV9UGSD  0#L^@G_
M %O/ZX;+Z#L?K?GU<=GT)+%ZWG]=-G]#V-UGSRM^SZ#Z&61<<FZVCR#&N.SZ
M(*%C]7SNNFS^B[$:SYU7?:]%8'5\[0&S^B3_ *OG;'ZWG:X[/H+'ZWGP
M     !5/:]+Y+EA^3N_3,<71PG+W^^<><X^C'N799KBU^#Y=AVS&;\&FA?/N
M+$ZV@E_%K !#>;;5MV-]F,.IC,^UUW+-\6OPO+L)!Q:W!\G?ZKEFN/HX7D[T
MXX-/%N799K#J6CU?.    #\G?9_KBNNWZ3=[SWPO<G1?%P !I=O/L\KX-%0^
MP]WL%KO!13FVO3AUY]QZW7/:?1[UUGSV!=GT7*<?W+L2+'JR/J>:]S&N^YZS
M'WE^L?BSWK>=HS9?0]B-9\V@?+M9SP::A-K]*EO6T$]ZWG\GAUMD-;\\
M      &K6T^CP'EV'EF/!EWS@\7-MI#Q:V>\.LJ/M>B]G#JO#GW,A.&YNOIH
MWR=VR>MYZV^IY@ 5!V_4:R[/Z'E>/7L.OC,^Q[N/I>7FVEM=7S\$YMG'N799
M#BUGC97?UO.P_L;V;=?17YT/%@   #\SO4?HZ"=C>;?Z7Y+M;J?EX  ZF7P^
M@  ^'T^'T4@  ?*^P %(5RDYH          *G[7IO%<L3R=SZN7X^CA.3O\
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MS@>?==./!ZSQ<G=E/#JXOS;*UNIYFJ.SZ.U>MYVI>YZNT^GY2[NKYR2<?0
M                T>96,E;+Z2OR7E^II6NQB>:,A6!-A$@2TNLC38=-;V7M
M3VGB+\2$K6QEBHUM!-P4        _)?U_P"J*Z[7HMX=!\4W,TOR   4[V?0
M5CV-W:77T>0QX\UCUO=CP1_D[LMXNA&,^W+>/H1SD[V3PZN3G'D)Q
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M,[3($F),5R",+-TQ1-# G29@A9)C(E1+?Z0XQ1#%NI($3LXD*)H1$Y'G-JT
M    'Y@>J_2\ [.^W)TGQ_;73_*@ !1_;]1C;RR[#I2CBULLX^B
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M]A*@    ?C?[O]JUCW?5;]^8_/&\?GO@X  U$V7T''Y<MF\.JF_!J+'X-*
M                    /ST99T\9VEN)#UK".-8HFA*"?)K4NQJ4*OPEA&"]
M4PI3<LG(W4P.B+%LAZQ4G1+$J19(F!7SDR2MEW\8Y<   _/?>?989S;3:76_
M/]EM?X8  5SS;>O.WZ:?=;09_#J2SBU@                      IXJE?>
M3@D*59+4:RU+2K,F%,X"LR:E%+,2?I-TS!7RX(E1\.])&1%>HSJ9 P1XU]:>
M\%4+M0@   TK]!]XBW/M]A=5\TOC6_.P !I=M/H_1$RPZEM];SUE\&D
M                 &NJZSK8)6\2\LA*@6?UC3VD.(*7.>,OY-)Y9S6UJ6V@
M                                         ^'2=X  !TGF/@(6=ID3
MP$M(@2XP9G08(SH     !ZSM                                !&,]
MS^=^S_5F4=/;K7_"=7NY]FOGK_,M3^]]P]6/!^EFI_'7K /SK9:_+4)O2FL<
MNUEE%QJI<MH&-=KL6GZ9,0
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M\SEL>B/B^Z=:SN+QP  'P 'E.HR
M                                                           !
M$SWGH/$2(Q)Z#I.1R,@
M     ?F*RK4UOF7Z)7#5B9;46:KRXLCQ-B4I2J_N_</4
M                            #B<3@=I5!:QQ!!2>'$':
M                                 #6%:<,T5T9PZ"WR0&ERV0D<7(I;
MI$B#+LDFHRY5+5,Z4<6&2XCY)BE5VL2I#V%.Q,:\9ZBWB'F]"
M                       >,]!U'<=9].T\IW'$ZCU'6##F4.9AS.'(  ^'
MD.X' [SI.\ Y                                  J0U<7SD"-ATKY9
M*>Z(K6!)N1PL8UH64IF#)&6-YD
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M8S!"ELM,61<^DJ(:38C!Z3O,2<B9&#/I= -1)<W6-+/3VEK
M                   %"&(.Q803A*ZEONS"%<+X2U$C:RQ,2>0\*YE(\O4"
M;) EFJ5RL?)BGC7/'I/"84VO3V'YX3*W+! 3:Q+%
M
M   !^1C+RJ                               /IV@         ZCX
M;A,=NT   &LV29IW  AZQ^!:%@@RRT]B#7N97+9GT %(RVC6=3D0Q9B@
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MLZ3X68:8LK=38ICVE6KTFMK+]$+A0$N*7QEDI)"Z[B
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MEP &.              (*>TEH  .H[0       #J.T
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M$SX4$N[3&GEN)(\O),L6,4FOZ!L0
M     !KV4O+ UV(LEZ0!:76X4A*V&GM!BSSGK-;Y<T;87&4&O"P5;$2$+M4Q
MJ%=M$                           'YBLOTZ8@   "@2-K'2BUDJ6&5N9
MPAAL242=YW$N,,6>4^?"Y2-E/%@$")*20\I6I*#@9(L\J\R)49L&0,R!&"6F
M(.HA![2SB3D (++-+("6B5,NP*5V3\P9@C#DZ)2466:8XMM-:EL<K$V!*T.L
M\9Q/46+%75<!KL;.&LQ*C$EK%9E@F#(@N,28GZ"H -(U_(Z9_II<?T98@
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M+D#K/:72E2+]29EH  U06,RXZMYF/4?GI,IV6)9LBFLRP.6#'Z'7$
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MU<?I,Q
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MBCE_3]CFS\Q&5HI&E_0]CK2M'+U%_)L<@
M
M    QII NPQ=::UKG"OB0DZ2#K"23GB-B4E(              !H=+;5;+I3
MQ3JY@P19!@#"'B/*;%)8X                     !X2A5S*7>:]KJ^MA)(
MR]DJ!8V>0D!?*3X               I8QBWXE8&FC*ZT[R='>E8KXCX;)I,
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M/EVB2%RU[6RJ:+LMZ&.CS+>%C!BCUVI31U=XD    UU6FS%$BCC6(,R80GQ
M2,$J+@(V>DI\DAA#*&?)85$7 4&2PN--:&4C3+&,.DW_ $]P !H:R]":SK^P
M3$?DW,[ZN,*7]'V.EBX):X-R$N] !\/S-66@PI+CZ"/G09XSA7IT'Z))E0
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M9Q7Y)RJUL!,:> ]1ZS*F$.9TEF'O
M
M
M
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M.31/84XN-+%($9HFA BVTBJP8LE,(N%,P;5(                    /A]
M !\/H   /A]        *6,82D@Y,S DN,*8@GI&C %BD .)(3"G$G9X#P'B/
M(9HC!V$S+ /0   ?#Z                                 ?GRL.+D(R
M8T\9YB=GC+Y20FM:U:9TM@JLQ<6_5.EDE:DH)<;O(    !YS\KF4[3&Q.:G9
M829<H%8211=A$H@]1?91)F3"&5+6*2.DNXJ@GA$S9-+V !01KPLA/&=Q9!/T
MD!HFRG"?">$+/06XE"RR2O>>0SY69E"?&!.1U&ZJ=@    !^?[+*'H,>90XG
ME(<8TEYF#X=9\.@Z#)'$^':=AR.1R   !U$?-^F-7FL#*+$Y.\',^GPX'6=A
MQ,29@A9*SO.1R/A]!Q/@.9Y4^$G-PTTT77Q9\>8]P) >XQ1%3T1F:Q9&2;%9
MQ/:ZSUF1/&?#UF/.TQA($]A]+_+J0   :2R[M6   "E"ZP   5(649$
M&EB[>IIDN[B=X            !HS+O-9HLN]*             #25ENTQ
M&DLN[5@   U.7;%   !J>NV"      :6+MZFF2[N)W@            &C,N\
MUFBR[TH             -)66[3$   :2R[M6   4&MCI-0  "#$!6]T
M TL7;U-,EW<3O             -&9=YK-%EWI0             :2LMVF(
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M%',\)BC$KF4EA'BRR/F#,(3DA9ECM(>ME)G0
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MV\I.'PWFS&/5QF78\"]DX9),(SESYJ8=)WS#A<XKEV)EQ:[Q9]GLQXK=X=0
M     -+%_ENG-X#^P.\%X'Y+^]_;'KX=3>.M\!6_8WFJOHOO.8XM7O;Y;\YZ
M2^G_ $/A^;;8-=]/*_FGNN>HF_\ M<#[?JK(X-=N+Y?\UT9L_H&N6[^PC>?R
MWYNC/8]!JIO?LD1Y]S;FM^?[3:7Y'BET>]5^DLW,-Y/+?F^8]70[9Z3XS!RO
MUD2>5?"08G!VEU(!YEU_V7T/8G6_.]<-I]-V"UGS:#]C>97'B[<>*MNWZ:\-
M?X.CMA[N]=?X36C9?1]E];\XHK8>[O/7^$Y P&7-3/8WDWX^G#>78]$PDF/!
MP3"Y]O.\?2Z[>3./Y]O(8=3IO)EYQ87+L9W#I]&7/UF(O+D<.KDIA@>7NR#B
MZ5O<.G'D/R-9_K>P]P   !I,O\KLYB_V%7KWB?DO[W]L>OAU-XZWP%;]C>:J
M^B^\YCBU>]OEOSGI+Z?]#X?FVV#7?3ROYI[KGJ)O_M<#[?JK(X-=N+Y?\UT9
ML_H&N6[^PC>?RWYNC/8]!JIO?LD1Y]S;FM^?[3:7Y'BET>]5^DLW,-Y/+?F^
M8]70[9Z3XS@2DEPQ"R3DO, 8XVR0#Q7/2_>_;=W=#\/H#8^^O_7>!U7VGTB?
M\?2F/7T&/RYK(ZOG:'V'N;XU_AOSY])^A_T"\W^>J,V'M[TU_AN8(%S;75?N
M^MO/K:&I.SZ#%W.<<6NR<XH1R[25\6LP^79S./#%>79>7'JR"<>;QXH3R=V3
M8=/HO+[9QQS/MXR<=P<.IK+GW4QX=7LMT_)#2EE^1LS_ $WN'Z(L0   *M-
MYD/TDN,J->-M]1[,>O*N'3QS/MUYW?6^G'@M_7^*J?O^S\V78\A<.O\ #\[:
MT[?J</R]^08<-I=#P\3Y]Q"NUZ3ZMK=#Q'AR[E?=OTV/S[,BX=//NKYSSK5'
M?]O]2W.AXCV<?4L_J^9Q1E0                          #7%=CD
M                                                        %%D<
M.*QHV^0                                                "OS''
MO,>6D
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M)Q>EA5Y([%E=XO"$TI4[.2IPF@VJ(EY%5')X:N=7!#U)6-0<;9T?5B!>_O"
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MQQ+DX(T,<>WYTD/LI.]0\B1<006L7+V1<3UM0%:@*U 7K4!>M0%:@*U 6JP
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M!(5R]%96_P 98VI2O?7%5*YD8S$W,N3\-:+7K5#K;(NM%KT^0UKD+D((1VU
M:=0&F-QILBK5JVJP AM< +_#KZIFO":]_C$=18]=%;O*&N6/I"!)O2O%"F8R
M]I' ):_/[TRF.3,X,)J*X(PO<BW-8K5*'4A;'3SY(K>M[L6Q@<7AI:VELVI
M8,-<O$O;W(PQ[BRPLEQ=9M)T<N1ND@4K"9C)1&S4QU'.([/I2Y2)[>"D[F@>
M^Z18Z<+IF\3N"ZG%9Z;?&:>RI(E<W>7C1\>2(E";,I,TOD+F;BO085=P'%?
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M=&R11][&&;PP5VY_8G>UY?$PJ43^Q.0!R:.%"[W:::I%'WZC)%'RG1-)8XL
MM?V)M5J5B-%8M2F.-32>-K"5LA8&Q.O?61K2D2*/JDR62QQ<X6E$:N?QO"]U
M,E$9)5!DT<&-/)(ZK;SY7%TJ_B./65%.K6H$Y/S$S#4RF,HUZ681)<4K>F=
ML Z-AHA." "A1(X\D3]\-'=HIC$0(;3.'B/42%@2$)GYC6@6R6.MB<E]9%)3
M;)8X\*$4CCSF?:91"Z$F;0Q2>&4QD82G-M/4)I3&%J4V7Q,A"9+HH2LXCCUE
M13JUJ!=\-&W722.MB<A^8U1+=)8X\*2IA$CS%S^Q-A!"Y$J&1(H^J&.9P\M"
MGDL<5KELECC:M$_,0"7&3QIH&C<6]P""5Q8U,?,H@E3JUR9$A_N&PW>BC0G%
M=;,&/2<CPG F-+XZA9D(D+O.LGPZTC5'L+AQ!BY$\!>0,<Y8%22)9#A3,QQ=
M7$I_E")2E9+&V/K1OL#B:8J*M4:DY;8W1 ]6C5L;SN4%9RG!>R1V6HR,/,<P
MC;JJA3KHO')&UKLNQMPDJE+$)*>RG,[BEF ,:2(]$6SS$"AD82B\E*$P0R+#
M+$M9G^8Q!3NS.N4L3^J8WLQ 9C.1M+ZFC+NABHX9,T4EQ$LO'FA3"I"Y318R
M+UC3.Q#E3IEB-S24%$K7UP&XQ(V7)$+-+D!JYB=7+ <VADE4.N,$2YME3GC)
M[7-@XY(GY'CV#N_?!\8>%<560F57 P1Y[5J$$9>4S''F210R4Y/3A,D4.C[X
MQS-[@;\[-S>%S/<8O%96CE[@T3@<[;H?*F!,;'791B9QB<A:UG#7><DLQ2.1
M- X-,";/4;4+L,/,0DMY;@Y"O:RT,.F*LMS8;R5K>H>$V7J8HN>HYB&-RAN?
MVO%[TU0Q9$)0_.;/$BK'((R\IF*$Q*4LL]DD.EZB22"-J%^&W2(27BW!Z%>U
MA01AU60YM99.T.D9.5,4@(C*M:QB:9&.@,ZU;)Y(A7$Y=CV-Y08>I9I<N2H#
M'0)R^-N3Z@?8(OB3VVK@KRFOES*1YLZFQ,K8F5L3*V)E;$RMB96Q,K8F5L3*
MV)E;$RMB96Q,K8F5L3*V)E;$RMB96Q,K8F5L3*V)E;$RMB96Q,K8F5L3*V)E
M;$RAQ&/&C21IG0';$RMB96Q,K8F5L3*V)E737%?8F5L3*V)E;$RMB96Q,K8F
M5L3*V)E;$RMB96Q,K8F5L3*V)E;$RMB90TMS [$RMB96Q,K8F5L3*V)E;$RM
MB96Q,K8F5L3*V)E;$RMB96Q,K8F5L3*V)E;$RMB96Q,K8F5L3*V)E;$RMB96
MQ,K8F5L3*V)E;$RMB96Q,K8F5L3*V)E;$RMB96Q,K8F5L3*V)E;$RMB96Q,K
M8F5L3*0QYY2I;1YY[G61YY4H53*Z'NB=F<R7I#'WE*2&//-FA7'GE0WJV1U4
M.!+,YEO:%@>$H2X\\@:%4>>3VY8QNJE:6S.8'Q"P/"6BH\\EM*F//)S8M8G9
M2ILS.=GU$PNZ4PB//)34?'GDUJ6L+NJ-NS.??J)B=DRA/'GDEL.CSR8TKF%W
M5"&S.8GU&QNJ98ECSR0VF1YY&T+F!X56-9G,Q\2,CJG<$D>>4[<.//(FA='W
MA44>S.9KVE9'0AS1QYY3H+QYYNSKH^\JDZEF<SGE*RNA#LBCSRF1<///<ZV/
MO*E(J970]W3,SH0\(H^\I4MH\\]SK(\\J4*IE=#W5.S.9+TAC[RE(#'GFS.K
MCSRH;U;(Z*'(EF<RWM"P/"4 (\\A:%4>>3VY8QNJE<6S.8'Q"P/"6BH\\@:5
M,>>3VQ:QNRE4%F<POJ%A=THR8\\EM2B//)K6M87=2=W,Y]^HF)W3'IX\\DM9
MT>>3&I<PNZH0V9S$^HV-V3*TT>>2&TV//(VE<P/"JC69S&^(V-U3KDL>>B&[
MA]VNU+&%>J+.9U9CLF9EI"],P+TZ.[ ONUJV!>I)/9UASJG9EA#DD8%Z9)W
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M&Q*N&Y15[Z@/<'%Q1-*)/)&)7>][!LF>6Q93U*V".F)U297:E*E.B3O$F8V
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MZ#_R[)?L)5_Y7./;<P_HZ@^AYC?2(OY?O<G]>*,_Y(>^8*^W_8<O7I=UE5E
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M%PTI\Q@MN*#_ ($OCS$Z'$$$IB53(SKG!]A,/DYZMF:%Y"^+QQU-[F:>]FZ
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MU:X*U@WK6#6N"KB"&K#!>_N?,Q_,;\K+_P!QE_?>)?RPQ\W$WI&?Z%Y\^_\
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M^'?_V@ ( 0(  04"_P N:( !%% #<H\HJP4X 7HTHNP$A98C3"P62$%%W&H
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MO6CVI-@Z+ #>OX+V_@#5P!M;5!<5]4(-0(#-4%A:H='\%Z_@#:Q&L;NW:<$
M1=0K16H"P@EA%7\ @_P6K5#HU07%J!&;;5$7J L+4#>OX+T(&N;NND1@"PE>
MR++.N#9'TI",/7-+V=Z"GUKU<O03L_\ HT-/J7HPO9W*+VHB2]J827M3>@)>
MDHXO9&%E[2Q1>TO0$VO>MG_T:,3:E'%[(=&%ZEO=@&W+MMA:MS[Z;'BM?:WU
M+J!:=O?38V^FR@5K[6^I=0*]]O?2$RX;V/%:A#U^J >I?>!5MA:NWOILH%:^
MUOJ74"O>YM].WOILH%:^V%J7/O>]S!:^WOI&;<=O9$& L5M2Z6B"*_6-+L8.
MR>U[E?F6GL.@AUT^C0F,(L"C_P"<2>UKF%V,$2"P!IB[ -2EVL;8FP@B)L$
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M2H3JP$%FC ,9!VP,,6"O0EQHK'J@F _S4B,!>^T!KA,!85AAL"XP[,1@+UM
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MOZ=2_P  7Z+>\V_S*Z.G1UM'PY;HMU?TJWY_@5NK^E?IT7Z+_A]JT=71TV_
M[5HZGZ:*_3IT5?\ P7T5HZ=%:.IHK1^!:*T=316CIT5H_$+=%NK^E6_/\"M^
M?4_2OTZ+]%_P^WL;?@=OST=3]-%?ITZ*O_\ E!T5H^)KU^GO-^I^ON-^C]:_
M7V5_P?3>M-__ , 6BM%:*T5HK16CIT5HK16BM%:*T5HK16BM%:*T5HK16BM%
M:*T5HK16BM%:.KHK16BM%:*T5HK16BM'1HZ-%:*T5HK16BM%:*T5HK1[/16B
MM'MM'N%_P"W1;WW]*_3WR_L;_@%NBWOOZ5^GOE_8W_ +=%O??TK]/?+^QO\
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M/_-E/Y.1?O:_J?BK[8QK]H!],4OIG_O]U]3GOU.8/4$'AO\ ZK,]*Y/]H&^
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M_]H " $" @8_ O\ BYN+@">(SQTI 7_XHZ<C1_G"9;+,JB4#$M^&^NJ.O-X
M4[U,#@#BWX+Z:Y!=8[Z04U6CJN^C932 %X#3W;JFW1@R7P$)6 'Z+PM<M2%
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MK0:@W0X>_J[S?YM(@^2L[E./NC[!'LT"[8T#O?\ JNOUT?CH>O\ 2,I_UH_
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M<UV)R$5-N@ACT"KRFF.M"&)SDQ11=W=E"0-#3>F"\W*34T88!8J''8X#EIA
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MVIATX4;?P^U3?#Z_7E7>_#7KRP3*CR)[7)6.:^#;Z^:ES:?%C[5*>?\ !X:
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MV'9D=M"*!R,',/ZQDO)[N-A[B9$T]DD@+9-2=0=QGRKF<,NR]S@F6U%J'@/
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M>+YW.<_=;B7LDC=LPW97C#E7,"I8Y)!9-'$QVXW%L!6,9;#W]M.87;KWR..
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M,$2F[I^+RYZ[9[.:ZYL':,#%Y;?2@O@KM35EQ!TT<+@/=7&&/N=9:[2T[77
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MW^[8C@%RP=<U6MPPKT=K6"6UK3(+KRQKKFM.]:@(;B&AVZT7(*:\0P"+?N8
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M+MS"^S][<4([1,=K +>-K@G,D;+!^3A7_BA_[1VC_0J(NU/I-H/Z34/3+_K
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M$0(B41K 6SA,"VU,,-U @3( ?>W%IIM!J))6, +AK9V \]C<&] K_P -U/\
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M'%K61C3C,Z?&[TQ>J3A6J[<T;;H]!(R.)LH43-D*7ZIOZ24>2Y0AK^\>%!-
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M;]&RNQ/LIOT4]=E_4Y/%J:[+^K_Y>HOM!_PG5^]OUEG[1)7]@_.K^P-^$*[
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M<!F8PJ@$H2,<]KM2+A?:<=XW*TN)2U<03@G-3I6NW"P#'B$+NY%>*&A-P];
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MO__:  @! 0$&/P+_ .XX_P#OZ?U[HA0;*?"$7BGO!D%'$F2(PR'A\>,:(9[
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MV0M%-F:':F@F75H2/G[-0QR!*1OTG*J+B'.L.*QD+ BQX4<<&3.K(B18KE4
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MP8+JN.RQF5TZ!*?)\J383ZR4Y6_7;/1.N#\QY!1/XY$'$2Q#$-)AV$J1!-&
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M[ANK3GMJOFRP:%%A3'J"3,ADE+3RF5Z2(!"!DC[]\=(JZ#"5OQNJ^&/L ?\
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M^C)<AI4MHY8E,()&\GG43H9J^3/(52Q8K'#L&N24U40F:>54]JXK[8)(X_\
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M*HV.*]S6HKL/"^TMY$IGI#:VR.2$Z;4!H2$+4!A:838ZLCO,_7NL(IM2Z\\
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MAK3@/%KA#$D-L$H1QI1FD0@G;V\]7=5Z18PK"VC,; D5=F\9@.+>5\R<^RF
ML"%C$5CI,XI'J\&TY$,]J>5>A9KY$PD$DJ;8>A/6/Z6RSLH+JZ=-3("2U<>*
M1_D4JC8\CG-1%7#Q/M;61*&RI#56)E@K+IH]"=\BI##TPF@(@"D76I6$4R+Y
M\\3*(SC306:6"V<B0K$E3SVKBOG22N ,0V%(XJZ=#6HQ$3+PQL6US=7@72JX
MYPV1HK@2H]2TR0:^1&!%#')%0Q=TWEUR"L:KU5$RP*3&L+$R#IP4J@E/CE86
M+"ERI-<\CTCL,IX ICPM5'(BBRU(KDS_ $NYDQ=WMSSSD#EP'B=@FAR^7*=+
MDME2O\-Z:EQ^W?\ AKPK[[Q<MM=>9RPE#KXY3<>Z,9(UY-J"E25\9.K_ (OL
M\?Z\QJ2[=:/L)L!;2/'J:&TN7=BD@D7=)V#";>11Y+CC,>&^<(_+FWKZ4%A3
M65<8C>.*WU190I36/AZ=:;>M/E4\,?\ -_\ E,3;FXF0:^LKH[Y4V9(4C11P
M#^,]WBJ_ B)FKEZ)UP,HU HRL:1BY%3-CVHYJY+DJ9HN/^;_ /*8<Y=C)J*Y
M<D(JY(F?1/;B#>UB/2#8,>2.D^%+KY>D9B =O0Y*,.!=8EZ.3PZXLN1W+M%7
M4@[F<2+%D3#C!K8-Q&QQ?*$0>O-V7@W-<<4C'DH\W-9*1>.MBQ9,CNW=GW[C
M$5GW/%'$\SB.Z)GB796,F%#@0(QIDR6=SV!C18XW%.8KU^*P8VJJXKJB*\AI
M%M0)R:"=M?.2O+4N*$+'NG.8T(I3UD-5 NR)IZY8_P";_P#*8_YO_P ICYF[
MJ>N^A?./9[:1V_I7?>G;G=_8M[NNFCQRZX_YO_RF)ES<S8-?5UXMZ9,/NH,(
M]36)GEFYSGO<C6M1%<YRHB=<(Y-C)R(J="^"]4Q_S?\ Y3$J?.D0HL*%'-+E
MR3.>P,>-'&XISE>JY-&(;555^#%75PR/D&N>/IRBODMKYR5YJAY #&1TY[&A
M%))W#5:%V1%;URQ_S?\ Y3'_ #?_ )3'_-_^4Q_S?_E,?\W_ .4Q_P W_P"4
MQ_S?_E,?\W_Y3'_-_P#E,?\ -_\ E,?\W_Y3'_-_^4Q_S?\ Y3'_ #?_ )3'
M_-_^4QY].K^\SR^EX]?TB\C2:SW<ED L3C,2RXC<3)[WM7JZ9*"Q1'.OM<WH
MN/\ JGW6?S(O?_@8O'5D3C$5 &@H;YM4LVG:]2#DJSO&S413N32NC3\5,_A_
M1\@D$#/_ .[ML"GE :./OR3R7A&(T)JR482.JD=U<K'9"?TZ=8L5:JTC GV%
MK5P;$ZUBQ)4NH=.;):T<>R//$UWIQ58I M1=/7+-,/XVF]WPZ]+!2Z6=K\=K
M5B(_<W%F,$]I5;IRVW(N>#58:VT*.-8)52;,0XA(4><L))R#.)LQ;,05&Y&[
MSHZ!UKEJ]N%F:)NPWD@N-.=MQ^A3JNU9Y=S_ -4/&BO0GQ]*?$Q*IH=;:V4^
M+9,K%9$]-&PIUJS6I7"+/LH0]N,$#F/U*U=Q,D1?'%C+CAFL'5PA3I33B$PB
M(]DMSP-:T[T4X'P2,=UT:D\KE3K@<KT>RK8QX\>5%+/)4N[D4EFXS0RNLYY&
M*C%15W$9X_UKI%KN=5GN^/\ [,Y:+=VT.LFQC#^<G6N:&VD1HR%,[)Z.1VM$
M&N7MQ[KK$')8'-[JNXA[XSBOZR/!9$M+*'2@/&8.)7%D0VN"Y&"<QKES5O7J
MN+6^J+DDJ79>Z*_Y).CSN<MY396-Z%H2QN55]$H]5%V1B%$4#?(S)K53-N.8
M@I_>+R+D4Z9[N^/\MLJ.5>3+F,DQME&W+LLYZF2*Z<8JC- W&M<U$51]$5#Q
M:[D7)9]5PGW9</Y'Q^N#R.=(B7%R$EOVC[1[3/\ 5!%<-6/;GD7/)V>E,>ZB
M]K>;77(.2>\ ?(D]X%/*NRSHPA!IYTP\I*C<5E"[CU@)HQZ6CZ>7'N(OW\EY
M-83.<5'-8?(!65Y.G09$6KJ94NK&*$<K@@?!()%1Z)N.=U<JKCW4T7-.8WM-
MQV7P#E_("V8^0S*N3:<B@7Y8H>[M^X9)ENJ:Y=X8G/5%]J*G3$.N2[E<HJKS
MC#J[U^PC+'F6\27#?#[^0 @([D.5CM6:L157S?3Q9SPCD^M^X3W7<@XX,KAJ
M]0<KEV4JG]0$Q47<?!XQ4:T_OD^#')..\<YG?<KH;SW(W',.1K)Y'(N5AWU8
M^)*K;!)"E*^O2[)K$>)FC"BS16Y8BP:6_MBUP?\ RQ\FMPN2\F24;;=\ CI3
M3-D9)*KS%>$3D\\=C=M%1&Y8L)-'?\CM+"[_ /+O,YE);:VLNU_[RQ"01LM8
M,>0YPH;XT>0_2P34;DWPQPZMX]S6XY-6SO==,N[B-,Y)*O(X;V7,JG%DD:20
M9L67)1550+]A]B-U+G[P)D.0:)+C?^72T-'DQC$CR %9RK-I F$YA1/;\+51
M<<FKX7/+>M]?]Q4/E,N[Y)=SI<6OY*2W!7+;,(_>=4L*$RC^08B"U(K6^5,>
M]+C5F'D=9:U-=PSDJQ$YV_F?&3!/9CALGUMD]YIP&6FI2FBG,1BJUCD1NG')
MH\?E')Y-+PC@'#K/C\6/R2<>+/FEJK<(IT\C3/\ 4U>,6:KGD5[LUSR3'N+]
M-OI%I=,]W/O#L;&#ZD:8:;90N-ZJY;B/O/=*,EA&<C-Y%74CLL3I7^TGDUMR
M?EONBY!?W_'GW4VQ!-L:^..QDV!?LS*!U=-;VNPU0-.%7#5'=<47S3M[&>D+
M_P MO(.00H[[219Q_7TL()R&V7%( AJDIB#$Q4S",>UX)E@8.)\WO.3Q^3^Y
M7E_)>6++Y!(N5KKF)4"/7WP"[SWTDN1..0.VQ69:?#-N*$P.<W4,_,_<%>7U
MQ<\@N9T^!7742'4O@7;1%4S:YE:DW3F%F;6)GDYV>=OQJR%<Q[0O&*F^Z<X^
M?/%;.+W#HGKU=(E*>RJ9]H0FIX7ET.9U1C<OZENT'S2_@L]1/IB1[OAX 1TS
M^Q"#,YE"E#8WX""&[Z6/P_Y+_.'@WY>8N^YO;&\^6@Z76$^DGK'\DG-!+37E
MVT:$]NXH\\NF?7]':&;81V#LI%K+>%6ETND%(OHY"9-^-!%.EZOIN9EB#>1.
MQ;9=_P @=;E4;E[ZNN9\V<#;<YCE#80G/$W4FG4S6Q5R5,,Y&EF1;3YQ%L'B
M<8RUOHY0>E+#9%RTI-2G:Q-S+[*WX.N'VL611@,(QI4"Y[<T>\8Q8) !I)O:
MB;'G5;9#D57D<]^WTTZLG8C1(UF0M8^/ 98LL"GD25D5L2QA1RPG*BM"/8LW
M^3HB*QN6(I;J3'L1+(!/M6M=* ^98>EV@)9FO$HGHU]A8ZV]4^3;DOP8M!4C
M*./0V]9!K7A(LP,N .'#EQ$[,( .C/3[81WF<GMP^-*KN,PV]I! LBB[M),T
ML0:CWI_<1@-5515=TS\SE_K6*7R'C-'=R0![<,BTK(DXP@:W$V1DD"(YH]QZ
MKEX9KBN]+X]35_I"SUJ^SKHL?TY;33ZDL/:&WM^^T)NZ<M>77%C*I..4M5)M
ME5;,T"MB123M2JYS9#A":I&*YRKI\,\6M?6\5H(,&\1[;B)%JH8063"(YKF3
M!L$C3CR>N35Z)GTPQ]+25=6]D"-5,?!A C/2MAO*2+!UC8UW:QR&>YK/!%<O
MPXL+BLXW20+2U1[;&PB5L0$N8TBZBM.<8FO>A7=7_KEZKBH9&HZH#*!LEM&T
M4&.-M0V8-P9;:Y&C1(B21.5K]&6I%ZX@T<_BM!+IZPBEKJP]7#)"@D<YSW.B
M1W"VX^MSEU:<M6?7 @ $,( C8((1,:,0A#:C!B&-B(Q@V,3)$3HB8LS0:JOA
MFNI"RK@D>( 3[22YJM<>>YC$645S7*BJ_->N+*+3<9HZN-<;B6H(-9$C"L&E
M:]CQRV#$UIQ.81R:7>7)R].N&PHO%Z($1E7,HVQQUD5!)3V$ATN?6:=O[AF2
M7J0@_BO>N:X-Z<&+36Z4$CCU7>1($,DVG@E:FR&(AQ.&L2.=C'["_).T=4P/
MD=]9\:DGKZ*30UD3BO&1<:BD2?-CS;&XM!!.\1[6:^*Q';;6,3$J18TU9./-
MJWTDPTJ%'.253D+W!*L[R,<XL!Y_,HE\FKKEA9#Z>L>=U3Z"XKX4=[W4BNUK
M4.5PUU5ROZ[/Q/I8L:6NXK00JFW14M*Z-5Q!1+!%16Y3!-$C9"(B]-6>GV8U
M4U-65CNQA5NN##!&<M?7(]L"&KA,:Y8T-".VV^#<URPD^HXM0UDULB7+;+@U
M4.-);(G#V996F$)I&ND!\KNOQ>F+235\9HJ\]VTC+<L2KA@?8C-GNBEJ,2;P
M2JY=35\KE\<1?1^/4]8L*')KXBPZ^,!T:#-E=[+B!<P:.9'DS/E'M\'/ZKBU
M%4\7H:T5XTH[@<*KAQV60C->PH9C1":A@O:1R:%\O5>F(9&TM6CZZL)2P'=C
M'SB4YFC8:KC_ "?R4 K M1PD\BHU.F)2<:X]3T7>O0DOTJOC0NX<W/3O* ;%
M>C-2Z4\&Y]/ZEN8O:*_8GG'J_P!F<&TU:5\?47\DC/F?XQ1LS^#'W$[_ ,)*
M_P#*K%R[94.P6$GX*1^+ZMQDA?B M+/O,M/BNC1]//\ 1SKAMW.>B<X=QQM.
M;M7UKJ\RBC)VXTBI*'+B[N^CT+^UKJ145<!FI,Y,RPMHM!M/N+7C(1V#IK@G
MF!XT06OLK"5'U(#NF]$<G@[J@8 ;>Q&NR6KDFMX<%EC423\OI:G>G[3C09<R
MMK[')AVKLEU,>J>.&UM7.O+(M9R!I9$*[B1VSI]2RDNIDF'&FA3*<*>M80D5
M^VQ["(C5U-5,J27'L#&@I8W-O/>*"62V5Q]>3GIJ\!"! ]L-@JY3'1Q%']RH
MF>+=Z<BO9S(/*^*4X8\TT(HG0[4W')$O4@H('*9Z3B#:N:9#=\/7$'DH^0RI
M$ODM9<J:!IBNB5A4H;6TBGJ0H%"@=1FA-&36XFYFNOS98M8MHY4DT-'!':Q6
M-1&>J"EV^]-!Y&KLVD$03#]FAZ)[%Q4B9/M7DM <)EE94NKP3U7D!.73)@()
M)^F(+)D4 TUN1- 4]N><  I=O%MK.1$K@2YXPV=O#?(>^5*/)%4@DBDDB0@D
M^PL<G1,2KAAU'4R.&0-:-%DM-R:<R^;'DKK&KVC=95JQ'M?T:11_3Q84+;%P
M(\".>Z%:JR,^4>/<ADAIJT@WL<UJ5M@*0Y[]/G& *?7.Q5SR(C23JZ%,>UOQ
M6ODQAF<B?217_P!9J.-Q-@#V")9\JOA%"PZ_,WBX@FNQC:Y%VSS%EL8-Z=<T
M7+$Z*V-92)$:=PN%"$ <95NDYWH]#F5:NE,0D3[+NN?H5FP_HN29\PJVU_(^
M,6=1QKD5[56L^KK)7>1:"0.%+GPZ<MHR3DAC->!DUL5)(O,U<L<[=+K+3DH:
M?E%345$.FB5\<L6%*X=4WLF39S)DN%7Q(K3F*JE.9/,]HVY],%MF5MY9\(-[
MON.<O1L"N@K+H03;:XB6MG;O+,"1PHPHPT405,[Y-[F-5$5<<NB3HTSD)$YF
M&CXA3T@:\<T\!O#:GDDTJGF2H$5P8[)!"*0I45=;6-S543 KWW>R('>W<"')
MII=RPC8L04LH4D2)49B.<^3 C*1=E?*XS-*KEFN.1S 2X7(^3CO.5TO$+V/7
MCAP[NJXW$[VQY:6 TAHJ0J<(I#7.8J@*43&I]DQ2\FA$5UC(F<&;+VX8I))(
M+BUJ8]F&/%=\GW$J/)>T>66ESDRP+8XSRF1R(W(K;C#.'ACUK[WU&DB#L;-[
MGI9^E)#C5QQE4O<Z5W&M3-<'LHT>V/%C\#L.?O\ M8(BI75<X];.K'"-)&]E
MQ'FQGC<-?DT5OQ\7S24/)"Q..1:DUG:#CUS:T4F_B5,JEK^Y/9"1LF=ZNUN;
M](A:'.>YK<E7U=:FTJ=))0GPIPXQI#EBJJ*6&6LDSX=E%.G4)8Y",)[.N+:F
M]$O./VE5$@63X-X.".02NLWR60Y"C@SIKH9E=$=KCGVCCZ:F]<<8I*"!:@JB
M\]L.+VM[)@1"U-PM136YK6NJR-D&GLD1+&.-$?LL0NV]!J[)<3QV/'>34IJT
M_&NYCV0*QL@-9RJV6FKK>4&/9G?!"&;EW 3:)06N15'BY)!#*&&FO[/CKS2&
MC:.9+J'L!-/#VRD5\1DI7"1SM*J\;NF*FA!RRKF4,X=ER*QIDXR(,FHXS$4<
M.($EOWY'R9=A:&08UVV>49'?6Y+>U=-76L_D,3AUGR59D&)$EP./1VI(B5ME
M;ME20J0!+$2_)B89^@;G*W2F*&DLN/\ (7GMXT&/&N61Z\-9:7DB@];[&N$6
M>&?(85K%'OL!VK)'R:O3 K=L2V/%+Q2EY4N@<%G;CY!<LH:JJED/.$")8GL=
M:.UO0 FA>YQ$1.JW;JBWK-'>(^OF! >8Y8:N1SH2ULB=$LP2=.8"1R$89%\N
M+BL]&N:"TI15DJ57W38"2>RN&2'P#JE?.GM 5R17H0!58<*]'-3""E M8\A*
MCFML>.0,3=B_,:=*@64$^4Q42=,+"(L9J9H1J=5;CTF3 MX$9#DK37DL<)*J
M/?QJ3YP3:$VW-).29"KT=K(@5 IF*-KU7$JQI@3^-S(<[@MEJY#'KE9+X;R;
MDD6N6Z"@9<T8HYX:&1R%VSQUR5S4Z8]VQJ8$J%Q?E+>:D.VQBQFR;.%3PXCZ
M6TCZ2&-#AS"$<42.T$()R*YJ?U%?;EO;A?ZE(U"#SM\ 0US^*R$G$I?;-3]9
MNDR^''_7EY_XC/\ R*Q?=O-FS/EH&I9G(5OU'\G*RT.6FI^VU>U,B:OI9?HY
MLYT> .]9#-<3'D>1Q11#(2*>PVGO<$.XT3F.>UJ.RS^'%G)B+7+5JV'#L4WK
M(FVAC-)7HD8KW' KSCS"\;47-OE7IAI*J+6RZHD27 5Z?+C?&-(0\X,EQW.(
MXCI(]1-WY36G7$691PXNP\GJ$6:)Y9#S/)&+$21W1B$,=.T.YC=3E1&NZ8G1
MHU;&#'LA/!-"-N0Y "/ED>)S,\D&Y\XRY)DGRBX<Q(8M+Y,&8[XRZI-8V*R
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MI/ARZ?H[>M2,)T>!339$>0Y[LY%U @,MCURHU<D&E9)&_/QSU8A0Y42A]4N
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MV,]Y0U[QQW39K:IXUV._<9(H)54U59NZGL<K=;5\V+#CG>!CS)Y)DU+*OAN
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MIO+)]A7W5["O'<?A0JGD%H&/0+>P##@\@!6HP*"E-8C4:UQG"\FK%/NS^5V
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MWU13E5*IE195A:-C&H.&LKO1UXX[U\RCW!Y?3Q73I"43)])'HHE="%83W1)
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M8PEMR;CUA>3SS7Q*29*''?'@/>B" 51N1HT:J*I$XH&IJ#4U4?E/%:N[D3Y
MVV?<7G%9G(C4CZ@T'4,  O"CI"%83=;DC-.;L7E8L =KQ]A^ U@LYP89ZNQY
M6^U@QG!CI!*6P#,L1A0RN*W99YF([JF+>975.QZ55UCWI(F9L^<4NN+-L: K
MFQD4:TS]H92]<W$^(FGK1SK^NB2ZZUXY[LS6?:S1@2KF\RMK^M990@)6[L[O
M%#'>4#B,;'8Q4:YZ_&L#>B2*D08L"QKCN=*,";7V?>=MJ-(KH F6(.SS.(2G
M$U",TE?FN7&8LRF';'E0N(1[*\+9BA/+;\P@6<BMT5@*U1[#)5?H.Y'LT-?J
M:UV2MQQV-;\>[N=)X_4V5Y.KC2G"!*NZZTLZT@@"J'11P'1Z]G<N*<;H[CHC
M&F1CW8IC3.& BQK"KXA?3GLY&V06OI^:\A7C]2X8DJ!I,GL>YA2BU,:UFI-:
MJB9U?H/'6113>7<:@BE3I$O8FT%M:VM>9JF+3B!&N,ZM'.8%90V",BH17(J)
MZ>*D]1AUU96W?(YJV#(9*^JMKIU'%?6Q'1C>K3&G$0CQJ\"(,?1RO<UN.9<R
MB4D.M-50^3DH&&L^^28E L^*^?,8V"!(R=U!>YH?.KV(F;FY].35H*@D&SJ>
M+V6J]C/-.#!Y1!XE%Y&7<$2G'6)6_;>V(KC:WF;DH&L<URW[0\7D3 5!B084
MONY$9EA.@\BJ>,S133%J4KZW>F6FY&T'D*\87:T$N2862ZD$L2EJN2!Y52,M
M1;,6;1\LHJ<MG5V:U6_9KV=CJ$)S(S7:U1^ES<3CKQ535Y#7L;C9VW(VR+@_
M&>35W%[=DZ*L'^!VNE6&Y'57&UL9Y]M51,0JPW%"OLAV%K$OXT";+L$A!J^3
M!XRZ14OCTRK9J0INXR.D)K0C<FK7I:HZZ'QUMRQM7!MIAW6S:YP@S^10N-A"
M 3H,I#G678,=U<-NA'=<\D66Z9QUH9E?%*^='';H8#9D;W@$X%* "0M>-QHZ
M''W#"*QJN;Y58B]<3J^LH85=:U_,^,TJP+6PE!L#5%IR<E&:42+(IA#&R:@6
M[<B,^;':V1\?<9H5G;0V6E!#X3-O[F"Z8""0 XW(*R&:QB/=#DEF3 Q)+D9'
MU"&_VN1=.=M5CI),2#$]3?76NJ604ME1<DHY;)F[718T2460S=",1I.H/QE8
M]JMP,WS-<9LNSY8"N%'M9,J7.J^%V/I=Q,9'AT<E13Y$MS6Q8[LAOZ[AA=,[
M>V3C#'TP;8W'Z*6ZY1LNRN8_(HG&C,L*D=<:?70N]DJ]"!;+?M#\S&O>QCFV
MMI6SZ^G],XVMU'EE&&/QYUE=\OIBVK&FJHUC*CEGTX&:BN&UP##>C&.UHXZS
MN(S@18%$RSM5">3)DU\XO$W<Q%#*U*ID!L7T]1@<9\ACTE$1-K1\ICWH&N!@
MJIE$"$6L@19(+0%7W'#(5NBBF]C#=,UR3[B[H^CE5J9MRQ7OY71M&85'33IM
ME'M12!R?6>(V5]3&<P=='8";=3J.1&<!OD"5X]+B([I"D2XW92I$2,:3#W-[
MM)!0L>:-O:![NP15;JTMSR\$_2+8C9M8QKYQG(PG-..0B-1?8^')X9-D1G?W
MKRD5/AQ]WU/\_N*_D%BVW3Q3ZRQ,NUOJN\TZ6'^.ZLHJ1(V>?@]":O9EEU_1
M'K)C*_(;S\AD1"R&L*/N"R5/:E;NM,P)"/*BD7R>+?#IB6\$VD?7M)6I,FMY
M!N[#XY%=4C?9>HN/%09,]EB$:F?@F) (:59^.R&RRRBCDCDPCYN<Z9)D3MTF
MX1KV*KBN)J:K?'IAKJ0L>1!*:0;N8TOOVR)!#O648DU2G?).X^>MSGN=GT_K
M?6@.6*'F'+*EK!"9N.F3*VC9*G9D8W6T$2(^:;2]VE'/>K455Z8I^#7<*N=(
M!WMO6PBAG]I%6T=964QDBR%E#!ZPD2458IS92F!?Y'-;B?<TU9$G;TJ:&R.2
M+8P)9B625-D5)0I:1918DP,.$>/J10[31N%Y<6A?0XG\-21S)QQ'E#>LL$PD
M]DB$8,EKZPJ6!7&58JAS,Y7+YE5<1.-NK(OHT#MGP(<8A8W9.BN7MI$21%,*
M7&.-^?RK'H]55>O5<0N3VM#'C-I$I*NN+!A6,LP7"D=A1@C5U<AGR9(S3U&-
MVT\F153/)5Q7'#13Z9DDQ;F*PG%.7MDQ&\7$M6ZRD12U[Y=;65@KAR-<1K(_
MR[W)U5RXK.,1*>02U'%JA5>SQ[D)ZU:N'73JZKE M&Q'U9:@,"_.%)&ZH/EU
M:KL\)$] C,"Z%65C$27/85(U,\YJI@3I,20,\'?(@RM<AD&Y6:M'3$"X'0U[
M+2I% % .+<8L1E8 L.N5@&%0&Y%BO<%CU;KV_)GIZ8&6371"<VCUD:\!***4
MY61(ASUM?+?YFP3/AR3OVFNS>QSM3<EZXD5ZS!6$RTN+:\MIR10P!SK6ZF%E
M2GB@#(9D834R&P>I^3&=57#8L"DAB#')4JP:$D$VGT-C)N:9J;AWN8VNL)I"
MB;X-UY9:<DQR";32:VOB,Y+%XU;%C+),PW(3*#MJ>"BJ;=2.ZTZ!B_(@5Q.C
M=),B6LNL@UM92,J)SCY2')%^;3#,IGL8QQ"D)!22YHFM1SGJ_+)5RQQ=T.&"
M/(FK.IJ<)(-^(D)Z6$FI/#MXL@?\$D!:7!(@.^:-1$D;05;JRQ8N>R-)#QZ5
MQ[@\@==#L[,K)?'WCY!1T<,%>.2><6G+\OD)'J)6.UKY'(BS:ZF@FK[^15\C
M9(CEEM&<H#OMZJ9#5#M="$.1+>9@P[8]17+I\SLZVUN*>)/L*AS70))D?K%H
M..4-A$8]K)012@M*QA4>QA6H]$U=<'X^*O VFDBGA/7^90%%:DD%L&/1SE<K
M91)9%=U^NP5R<>BJIZ=:$VLLLB%K'0A5KQ/0DAR..2O"P#C_ '0X34:K\DQ=
ML#!!6S.0/@+9SA#>??#$MJVUDA2*0Z1@^J/K6-D.&C'$7)S]3D3'I[*"&D3L
M9E:X2ND/4D*PL!6TX1BO,XQG2[$#3/>YRO<]/'%K8.X]!69=N:^S-\M]L/;-
MCV2N1F[MQW&L(@C%VT9O%8CGZE3$>:>BB$DQ;.7<"+F=JK83Y@;&68S6F1DE
MAI\<9E&1'"W6-<C<T3#I5G61YDA\:-"<4NYJ6+$L@7$8/E>U-(K.*,R?WS<1
MSS./0CEC2)TH+U60W*196OKDPCT89J&W+C[91'ZD87S-RQ9-7C\3*V/'DS<B
M2T^5BV2W .T5)"+7#':N61HC[3-Y5=EFN(=C>4L6RF0&M'%.?=S&)DD<S8<U
MA&,-'=*"Q[AO1S'*U,T7+%E<5E6")96[GOGR1J55*I3OE&T#>1P8R2)1%*1!
M-8A"KK=F[KB)!F440T6#.GV,469V(.5:RBS+-5<,S'D#8R3.<<+E4)?KFJB)
MBXG&X[!?+OV:+0_R[7GS/'EN(+29$A'?+B",X@-LCBB:]55S47$FJ=Q^"^OF
M542DEQ7H1XY-9!ERI\6,;617$VYLTI=:KK<1ZJJJN"7DFDAFLS0WUYCO1ZL-
M%)$)7O::+K[,I%@%<#<<Q2;#E'GHZ8GUM-3@A0K1J,L0L?()WB)%2"F^4YBF
M>J1&H//5GI1$Q#IJ>+#HZ;YP4MY=0@PN\);MX^0!ZRO9*E25=71@EBC3R(Y$
M#J8U&ZU7])L;(')Z.*&;++(''/P#CU@8+7KT&2=(^7E.;^O?U7'X7\=_\,^,
M8L63K:OM5FDC/&L#C=9QU [#3-<A&UW24K]Q,E=\7+IX_H[F]'"&\%BMW0)$
M#N+9NJ"U*UT$Q%>;MNQ]4ALDHU$UHAE7%+:CH+8 J6%Q6'-&2.-LV<6%<PYI
MEC16F<\P:P$<GF=IS4WESZXYLL6ND5YKVU]0@5I6QFRW ""I%)>\.X^.R39O
M@%?MO7KK37XK@K)+9G6RL2 )8B &Q/&?*>H3SF@8)%.5/KG-0CFY*[K_ %OX
M#R*)#AJVI!;CMY:[0ICXTJA/$KP:]&[($V7(=Y<\F:U7VXB C5,"BH;&!QN1
M*VK1DGYLR>.<;Y11MHXXFA82R$9]V%6';I:C&$U)GISYLDZOJXW(+RJ@UM;4
MEGNF5SGT?#*_C,8TR7$2.]@+67"<32W)XPN:BKJSRY1P[T.+%9R&TEV,9J6U
M9'96@T<6VX+8M3#C0 ]V6/-5=C2P2L3J12:\/O*BAKMMTCGD=T6/9#A(6IN.
M4\?E\9C_ &(C&1ZRK#+*P.G2)V;$R4BKAP(5.0-G\XJV2E9ZN^K.:%0<M$53
M1K=! +!-85U?O!>C4<-2)EX9XJ)U7Q#<*SC/,N,GA\AY\^Y/$??6-+,AV4JZ
MF@FS)\1.S)F!J:AM1&IBBLHD)+\'&O=?7<.1@I.Q(L+0-O4-7:'LG(P3HP'D
M1<E3II7+QQ EU4.)8"]%?50)4JR6"3A5VZWASF\OA#T/=)D-B T?(Y'^3:SX
MA'X9R L6*%9C_>5ZU,%):Z1.'=<O@6O%4.U/LK05HRJC?".YRM3XRXNKR93T
MXY56'CT&D!"M]+.21J/WAQN6(9-]BK3O)3PV!5IG.SDJ[P'E@EG.K*]EH(P[
M"KRM&'=5SB^]VPY=)=%D:!Z#,XW+T;B(BNS</P5<<DFW:*G>ZPNF,FP"BY!(
M==V]BRY+%BP0RTDMAS6#4DLQ#^(_L8V+CG,*#45 W6/-Z&]XP-J10CB0HD?A
MX+$H,A(E<9[:J4W)N2O3_"QRI:6AC+>P9,^NX_&LY2-@6CQ,!VEF9Y "0<5#
M%<JLZY[*HCNN>*-'50XQ+)D"-RN9,OXLZ=&F5OO A<XF\E<6-$ .>:_<,K&@
M$C.V?MM^(WIRIE33Q2U\_G-'?QZFMM6<=ES*N+Q&/4RT@6<=C%I)R77RKG-5
MBE"U[=7RBHM;2W<:(PU+44=<V=".-P+$H*F*R<04,<<'8BC3$<)B?7M;J1&H
MNE/[%1C3-4&QK$5?')J(U,\D1,^GZ0]_CI:YV7PY)GC]H^H3^[C]H^H3^[C]
MH^H3^[@O&5E@;=AJ&7KXCP2V-])?*="[MDES$C$:V2S2Y$=J;[4ZXB7E))#+
MJYZ%=$DK'EQ]Y@3DCO>T4E@C(Q2B72JIYDZIT7!S5LR#-%&F2J\Y *1[&38)
M5!+CZO!7QS-5KLO!R989/MY(8L1\R#7M(@)9\Y=G+%!A#T 81Z;LH[6ZLM+<
M\UR3'[1]0G]W!KBZE AUP"Q E/L2SZ23I88,5NU':0J[DJ0QOATSS7IA558Z
M(G5577DB?"O7$>SJY<*=7S&;D66!2."<>IS-P3_KV*YO1?!<?M'U"?W<?M'U
M"?W<2*@<R"^SB18\V5":KW&CQ99#"C&,U/L;3OCOTY]5TX_:/J$_NX_:/J$_
MNX_:/J$_NX_:/J$_NX_:/J$_NX_:/J$_NX_:/J$_NX_:/J$_NX_:/J$_NX_:
M/J$_NX_:/J$_NX_:/J$_NX_:/J$_NX\^G5_>YY?2\>O]@=O+CNT'BUD^2!^E
M':3 BE(-VER*UV3V^"],45Y;^]7CE V^BDDQ(UC05Z$5H2;14:]!M:30JIGD
MB?&QQ2S'[P:7D]-=<MK>/'2MHX(6_+$U26]QMN5%03<NF2IJQ$%6\/N.3-DB
M*\IJQPVLB.8YK6C+K:[S$1V:?J8OF2KZ-RRR'4E.D*LJH,,_%$>)QP7=FS;=
MOPV)Y=*]%Q4 6_KIO)C4@I4Z(%XDD=X.&TLQ5C#1&#VR9YM1,DQ5\DM?>?Q_
MCL>V+-#%#8T%?FY\&22.1&D0;6O7Y/5X=$7$:_@^\FBY)7>OUM-(96T5>W(D
MM[%>Q3;;]+FB<GT_-@W^*)_Q5_0<?Y;QJ(:59&B7_ Y+([7*78Y;7/'5R7:$
M5R#K;B,PGP:G83CT(W)F\NI;+W?57NU!%6X;0R>)Q8M6#D9S,C?P.2,=6S'V
M#Y/G1^62Y9X=51BVD&EB>\#WE"Y+W<CFC Q[9'M7A#B&IT)8$(2%K+'V\PGD
MY*957% RU?:S[/=X ^S/#BS!7)GLM:E\N2R*UG>@LM**Y4RUM+]/%ASKBQ+^
M9Q;C_.;FLXS&L)%LKIE)R?C@:MSD;</[^3"@<SV71U-F[-29=<\XM"]TJQL(
M+>$!F%<XTR3)FCY)1%L#N>NX4FH^MWTFX!8'/R)Q;CWL>]3B\UKK.X;$^:IJ
M^Z6)##%[A(L6,DAB$$5C6O0BYH[HW+@L.#,N*R)'XK+#7$=\\]Z)[RF<C>RQ
M'!AU(W=S:QX>P@@2$[+:<33USQ[RKI\WD;+AOO(XWQV"2'96P Q:B3.X>>Q)
M51&&0(4,9[_E&MS:UN6?CB?2J>S#P6K]YO+(I%L+#EQ Q@NXM32^/!/84SY/
M(20VVTB0^/YG#=*T[BX63?'MI'(K?W7<0DBF3&7(&63@(>-:FD1Y'VL"6(88
MNL9LGM*YZM34Y_\ 8C?_ ,2VO[Q/CW:^D3*5CJNILF2V6%F*&]KI4L2BTM5K
MU7H!<_#'N[I;"37&G-]ZU;,<VOFCF,0!U=H74U&KXIUZ8Y(>=,J)/$)]J>0I
M9-N<\^I8D=[846-&>1(T)A3JW6Q?[6)%K4RN6"Y)+%"A)3S8?:<8L.WR'$B\
MC30I74<HB)OZW:=..,TC>,\1@2K?B%C9V,ZGKA#*":(+T*&MF"TYP'JWVHJN
M3VXX/$J9=0.16V/(321V-B*&J,D3Y#1Z45'N55RPE59RJLLR3[PJ.<-E=/'-
M3MU9'#F[2C%1=85]F#?XHG_%7]#M:V;NG7MZDW-&>6O1GJTY^WZ-.2X;*..D
MGLLXL-DV2" >8%XBQWV$,3VAGI&,%KQH1%1KOU5S^CFO1$\5QJ541OCGGT^K
M^D*JJB(B9JJ]$1$\55?@PK6O8YS4:KFM<BJB.ZM543JB.3PPKD(-6H[0JH]N
M2/SRT*N?1V?LP]5>Q$'U(JN1-"99^?\ 6],(J*BHJ9HJ=45%\%1?@_L&L!K%
M6<CX4IBPFOVG3$<!Z+%0G[6LCXN?LSQ;5_+>'1>%V%46.'M)]Y;3B'<4;WDR
M6,]K6["(WX<]>&6E)[I#W$&KC1[P7((W(948 '1\YFOMY!3*O:H)']<T7X,5
M?':NK2AF>]N)\Z9]FZ46P2+)IU'/T$B$VFG4S0JS,;@M;GGI7%[27WNZG\HY
M=*J>RY#*;;1JTDKCQG;< #XD=G:A8@%1NH>1%\57$^9RGCSZRNXY*E\:K+:3
M.^1XA"(-!1^*D#&8C[(CG+I[A^M_7XV!0&<-CW=GKRG0!7=M#+ &\ Y$<I'/
M(=CTD-+TRQ7MJ:VO]:=%#9/K1V%T0\(@VA*4;WND,$18AGZ5]BY>&#?XHG_%
M7]!%<%]5\T/1I"3!O0_K*WG=,[=P51.W['M,\\USU?VLA&#Q^-9\]9S#D!9C
MS"N(_(7B)*FMHY,"7%AO;*XNV@>-KV$,.)MMT?9,TQS,#K6QMT;QD!85HM<&
M#-#=6-',+:545D>#&$]U9)02M8HW%"\VT]7.;BEAOM)TP#T+"D5<BN P4>BA
M\<ARJSD:RQP8\CN+*P<UKG.)LD4[AM8C@KE+XO&;+'6KR$?' W+*B,1([;RR
M%R*!;->^(H#"J.(1Y$1RKFS?5JOS?UQ)I],FM,D*T6/8+30]'?<,IY]9:-?O
M0U"H^2<K/#*/X HY!Y)TQ(/R.),KZE\<EE5Q25*L[EW+)D*-PVC,4413"+7=
MC,WR*J(F\U2NR1,JZ*>WF5YK._@19TX=%&?.I7'XMR6SMJK:E\?BUP10[&OC
M-'K[@P7.T%([4W-*^<(I8]K[MR<VG27TL=([(X^%SJ^SXR<1(BC[B9RQ0R-M
M?E=E[F)Y>F.6\?DD=8P!\,$:!5!IXCJ^J[>)QHHF6==*IXT\+WK)*@C(>7#F
M*[(:,V\<L9!M)#K"(G)&RZ9W'P;'#6P.3U5;Q23'EOA(MM\X:F20JH0AD(GG
M9H1F+V#%N)TTG%*_WDS@(^CJ][DY^/3ZP%!$E;4$36:F6;LTBH-QMI$3JJKB
MM(_EQ ))#S<U991Z.)9R;V;30>,'I*F2GS>AQ?EKBP/%4D8#&O:Y!Z]U-2<H
M0<F0"VA5O*R'XLE$)\7C<"LH8\SCG(06+X;B3B6EH[;TD*41=U6M8U1*N.;C
M%S*SFVG><)(KY=; BOD5AN-V!C.JS#X[94]8YUF+93>$@B*-6*]#$UKQ-85I
M><;&>,Y_*+9O$'V-I7VSN,1+JEJ3U)84F+JM32OE6!_;&;#2L>O3E*09-BLR
M-'Y:B43N+;<>AKZN#$-Q;D$>26$0DN3>2"9."0QV.W58UK5"JXM^/6%M8W,&
MXG\RX0%#T4&(B,[CB\.KMED5\".Y"$;R&2U5SV5"'HFIKGKS>+Q&NG2[V=5>
M\E@IGHUU3<LH3Y(^+%LK 1C4?(ZF=LM'2OSWA:AJS+)R8Y!Q_@O&GUM-/)[O
M&BLH43DT0GJ3+9 =M=P;2'&ALOXCR.)(,'<?M(W<?GGE8<CYA4VJ<=Y-R[A_
M(^90%K[ K&51:[F4:M#.B "XQZJ#81X#I+-+D:FG6FG%TD0$N+QQW+KTG#H\
MP$J*HN-.='[;MHTUHY4>O)/[AT=CFMR"YN299?V#6DX*-4T.NFRA(1%5BDCQ
MB%8CT16JK=3.O5,<$K;L/&XK><0[0_*K*$.)%LZ\U;HD0MB:<AU@J=X4:[>U
MJ]O1,5M.&7;VG'7SHY..D;*E6-D7DTAKF@C\I(P;(SN#;:9%:UNK)<<=XG9F
M[<W,85A:6\JH.01*&74B[A(/#I+V(^HIY#VY$$K7J]O3-,>B+/N*J9#9&(V_
MII<6M#<N(S895CN6;K[,\=79N!EY')B5QWB9^76#8\R0V_CSROFEEVL*4YI9
M8!0T^V48)N:$(S6BXY#9P+&TS) !\WHO(['1R($\:* KN2QUAG**$1XOM?2N
M:BRQP^?6$/&Y=7 XW32H="9!)*A-)E9SR1H@!SI+'&:J.,[)JIEJ3^H8-N:.
MUUC71YL2%)5Y$< %DL5TT36(]!NWUA"\454T]/;_ &'W_P#$MK^\3XXG5RDB
M5/+N65QGUUFD:7*E%)7R-^81K$*R+FD5FE=;F=%Z8B-D^_>5(CUTH#9%:_BI
M1L.&&5K2PG%8%SF-(P:LU)G\.*2=#OR<.F#BV7S*F1HK;5_**<PMR;9L83MV
MU2,"Q6[1_.J+FF*"*R_![M[#CU_,M 1(T&=>.9*80K&2D(H1"1QWKNY>;+PQ
MRB;.YPE7R9_)"EJ^8+42Y$R=5/T=V1L)@UCA;9^;-'>9FK!TX3R8M?"Y26DK
M7VL.*TBN:" (:KV\X0WKLF8[]9G\./G3QV3(9?<.M&^[^:P79*2X@09*&L[P
MII2A%$65O9J!K7Y>QWZ&'LK5?-+T>7WR$W_6/6^Y#V?;Y?(=EVNO5GUU?VL:
M@#1/>E'YM93)A$"7U;T4=E,(\D@KF[CN*NXAMM"F?:J[;:U-[%!9OY!E:S?3
M)%C93&U=4\B3H9II84>02FF4E4YIE:P+I0=MR-03B(0B/Q.E'Y!909K^S *@
M=25,8L"KE,X[VO(9LJ8UX*!9+[ F[(E$DPA[BM8-S@+G732VYMB'.XY!/%;!
MKRBMAVW.>2<=E29<OTN(9SAU$&.1CX[(K%?\IITNTX?%BWUE7%?)H)<1 A@'
M[.,/B?O '(DPA3(4@2H:4-HWN>A&ZG^&>G*KBV4F.(4J+'=)J5V6$=!?Q.!:
M-N 0A5*S0;UR=S-\LSM=*J%&;K>MFRS1 ^\23SVN7CDXP"=T*I]0JFU>Q/TZ
M(W'B5#B".FI(SR[S'_*NR7B<J9!JJP%A5<E6OFU-<>-874QTW=-7<KE.?D4X
M(0^Y!FU=QS'Y*W1D^R"3DQJY[>0EK;*N;4P7,XOQD=K71XO)4F'AE[1TV$;5
MNS-^,_N=3&(D=^*?N;(LB7#MZF5QVI2M !.8PP$Y H.0$1L9LL?==H#/8>*.
MS/JSY8>7)S^IQYUC&A!-43!=M+>.T+4-F2*\Z@IZNN78F:4V=!#Q]Q1E=K;@
MK2L+' LH<ZO_ (+!W0X'*X,^=QGMWEBO4=C3U\5['$;Y]PJ:NN6*LHKF5/JK
MNR9#D -&A*$O;^[B@GML^[%$%*[M9L11KYT#DJIHU^;%Q5/L'5U?2VL%MK>,
MAP_M2CY38PB54L;Y48T8;J>$&6 A7M>-BZ2%1<L,C%L$),DFJG4[G5P1&N*7
MN.2@/=-C]OT%.CUL<I'(B#&XC=.E"-1:"Q=R!4M)2P#V-E+;5U93I+@2IQ(<
M8Q::71UI&GT,#W(FL(UFRI4*1'XF6,:\LH06PN33H\ M%4B<Q./TG'[.O <9
MH<HX33I<\S9+=TGD\@U:YNM9]9 N94<,N>.(U[X=,:52Z><5E$5HJ]*XOI[U
MJI9-+9QI12(C3Z!-72OHXN4RY4Z/:RE!32HM823=2YGO)NJVPB'*VO8<8XU"
MUIFM$HU$CMW/9;IQQVMG<GE5U))I.-395\>MJM5 V96\HT5PG'KR1]B1+IXK
M$?):8NIRMU:BLTENMTBS'LD0DHEJ8[(\8@^ 5_(EL/N5]GW(K-Y7;;GO9H^3
MT*Y,\2I%A-CV6U;S(L&?&*&2V5!$T"L>^9$K*FNFD&=Y&;D8+0JC$^N1W]@M
MM+&C'$C5D^0-"MUC5X8I2-0C.FMBJWJGM3%%>EY![K:0%A&(>K%;!) D"&CU
M$9H$=Y&]?C;:Y=4QQJ7-E^[:[J;SE%=0E+05W=OURBYR/EW(T+7H)KO:JHY4
MZ8Y3R#DYYT'C];;R PJN)*)77EC'F)LA-QH9]H!H$>0]JG4;D:C,\"X'9#@<
M;*.3+D\DD<K"&LDRN.VQWZ0TDJ0J2&VVR74USV(Q$ZHJX!%I"J&J@0;V',F\
MBFP#UTF<-'C!(ARE(H'Q"M1-"KDKL>[=P+W@3^41N03R2+"K,!*&-FU.R+.0
M*]P*,T62.5V7FSRQZ'P<\6?<7<Q.3\CY$JK:<29.,HV7=='F1%>^),-H1\<#
MF]!JBJOZ+Q3/_P!/Z)6O:US5\4<B*B_JHOZ.PDQAO21:RDESC%.>00Q6A''&
MU'2"$44<(1(C!,TC9[&IFOZ$ED@D[XL0,$A]3\W18YI!PBT:MM$864]<\L_-
M_81?_P 2VO[Q/CW8/X_7CG-KZBT;*5\R'%VUDRPJ++NC"UZMEWAX98]W55>1
M6PYW^UFND;+3@D)LFU[;MR,0H^NGPSSQ97L*T,L_@<@5-/@=H]HNXLYT5JYR
M#(S5M-ZHH]2+CE=S(A1^4Q8G&K U7SZR8@KF58Q0O:Z Z 1&2([*E6Z1D5,G
M(WIC@?$!4T"KF\CX?$OY/)XP&OLF'B!:0PMIV3"),5/.Y7)XXY1[OKN=ORK&
M#4PN.69JQ2R0V$X'=%(!H4>&.0;2HFISFHJ)XXB3*Z0;B4:)R.KH4KJH\=\?
MDL=Q&!^<]@HG.6/86 AHUXO8C?T,- I5?-+T>7WRDW_6/6^Y#V: R^0[+M=>
MK/KJ_M8Y3RH,/CL$AN3\@B#OPTQB\H@0IG/'PK"RG2#J2-*B0*O<*U-O0C1L
M5V;&NS6YC/-;R:UAQU-EVF8[:)6Q/>P*!:NCPAAC2=0T:Y=EK1R-"*Q$1[<$
M=66WSGJ>]E#K[M*^"[OXG'XE/R>^=KKXP89GDJEL((WB:UNZ)N2;K55>*V$Z
MR/#//6W-,8(8 C/ZIPKE1Z^KD,<%53(I!1TRTO<3+KKTK@=6VX:HX8W/%<V
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MHB8D3)16@BQ %DR3$7)@0 8XIBO7V-&-JJN(EA!..5"GQ@3(<D2ZA2(LD33
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MJT;FE->G4B.TZO#/K_8W_P"G^WC7I;KRTZLDU:?'3GXY9X^QL^/N?%;]D_\
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M$,;IOV8Q6[:(-3$U(ZQE.778T<FP*-BD2.T\NI]VT@B"&]SM#&E._2GLSP*
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M^JBQ)G'X4:[+&9)]5*R6"P>4BR6C K2#42]%UR+B/<"G1ZUE'5N44..Z/RN
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M12@/GP@Q9$N&TC5D1@35.V(8PD76,<E8I-"K\;0OP8!85LH$Z#*9N1I<4C3
M.S-6ZQ$8JM>W-,0H!Y<<,VR[GL(I"M:>9V8T-*[<:KJ+VXG:GY>"8C5Y)(63
MI@9,B+%<]$.<$-0-E%$/XSV1UE#U+[-:?#@=6LH"6)8A9XH*D;W)(4<P8YI3
M0YZU (\AC7.\$<]/T._*...'< '<,]&,W91QQHX]3NFLT@S6-3VN<B?H3QQG
M$\\;;[D+",<4&\W6+>&BZA[K.K<_%/H%D'(T0 #>4Q7KDP8QM5SWN7V-:U,/
MBQYL4\@;"$>$)AD(Q@91815<UCE5-J8!XG? 1BM\4^@4YGH,(1O*4CNC6#&U
M7O>[Z36IA!5=M7V)'5\*V1D*4*2OIEEN>GSODG.^UINT[;=X/TKE]$<N&<4F
M,9-0C@>A!$:BJW-CVYHY-2?1%(CD:4!QM*(K%S80;TU,>U?:US5^CS">GO/O
M:2/6\^Y=00:Z%1<3D CU]1:/!#8A9E*62]6!73FYSE7+QQ^>7E'\V^$_ZBQ^
M>7E'\V^$_P"HL<ANP^^'DAC4U';6H@DXYPI!E+7P)$M@R*VBU(Q[A9+EURQQ
MFQFEWYD_C]--EF5K&*:3*KHQSE5@VL&W<*]5R:B(GL_J;WD>MPX%?LNMX_''
MP)9E=,HMD*09<][7O?%E&>]Z/1N2M3ZWX0P ?-KBKW0KWD7;@-.N(7(I]>2J
MCP>/1)%NL"6R7/$==;0M4N>C;\'9V#&WD>A%+--4UM<-;,BP7P+/GLR/7:))
M@@::>Z,C<\T<H@.:SS:5;65!8D:,6<>LKS?:I%6)8W_9\D@C5'/^)"X<*;KS
MZJ8:*OP8#5P>2+7.,?B9(,9X!RDAL)5^\-)LP4-YAI)0KXC6NU)HUZ,\]+<4
MT.6M>*/-CUXSUZ.KA&*R1Q$%^2YB!=8/NU1T\BL;\@L1 (J:]Q,7S*X\*+#J
MK21.EQUA.DELVI;<=K%CN,63]JZXTXGF&B>=&9=-2.WR<AA-/47-C)T1!0'U
M$L;N+\X+6UO=QK!YBB-,I6(D:8*-/&7XS7?)JAX,B=6VU_&D-(.,D1L4\Z _
MW?6')ED,KPG<9(@K>/M:V^+6*S/6N(;F\J@<N *+#''!!BI$B6LU.7\2<[82
M/*>"18P@V.G6#4QK5:UZ:MQ%B0X/(JB22=$CVA;:+4B,RLD'XW?W,GCBQ^[<
M%309%2'J1=YH39/35I=@D&PE1%#+IV6$.# %$***K(=&<K9)FS?5X,MC[-VI
MLF/L&:YB@+T<CAPH5]4E/:6SX)'AK!&=Q7:Y>:A%'D"23]L29]<QSV[VE=T#
MG(FA<D+:S)L"Q@Q(X[CD%=$@Z)?&P>L2*0E*5S"O)W:*1AOE40F<0WUCD1MU
M4V%I744CRR)I4 K77-KVO#1R:B$\DK,!XWJ+OL/F7,:Y9(_5*!(G5M3'D6HX
MDB7);5%?Q(?K=C7HV1'%/(1&R1PV!UV#0.24]51JL5&M]U\M>2QJ@DF[1#\A
ME(TD-6DH^4NW7#F2&!<.2YJ;:%>K6YM\<DQ5UD\,<#STT7E4M61GC8M+85,*
M/# '6]RL,_D2REZYNV0HB_#BWG Y"DKTF=>,EPI &2-4-_O"CP053OE_M+;K
MI&H;\M:-</+R='7+;5\7((8DID,2UW<51SS[B*6O,.%.ER6#$. Q/MMH9&ZT
MGERR1O'P295?.?/K..7':[-76^K,Y-(EH6NA,/8^IE)4! U@G1@G5Q5S-DU4
MR"9.9\<<]]++Y$21Z6Q!#M 5T"8'@RN6;VY)$A\HBY-=WS1#R5-7FQ<NF<B@
M<>!.B\Z)!:2$,!POX[/'3QN. F++$8EG*:=YG$8B&1PTT-R1^+2,276UL=UH
M6O*21Z40G$HX.5@H63Y,<=@26HSPR9N=/''8DA[',S%FF.*NK[H!9]YRF95/
MO7Q^^&^,>YOE=,B1S'5JYBC)LHYSF,;DG5J8KNYFU1'VM75WGJ#H<"!#KEGT
MEQ,95.]2N(48@C2:O6CW'WU&A48BKEIN OE409 X\4\,#%ANBQV]]QZ/,CR)
M\FU":NM&LM7C&EA&!#.5PW,/H1Z+7OKWQ;)Q(>@T E7&@E/-^;5S;(X01<CG
MV,AQ)<(62QAEA*-5:T[W.16R@P;CC=P",6<X%^(,*'72R1>/\<M U;UF<@#'
M5[Y5N;<V"$D;0\F#UM>O]07E.*BGGC\@YEQ'D@+L;H7I,6OIA<4]29-<^6V4
M*6-W''HP:"=N;K,OKM,^%'@WP!ODS5?)//?#LY1Y-=,"99"COIL224)5'IGQ
MTBI)<[5M-<S/#JXR6&V.T"G#XH.0(,]4&7S*"A)3HI;0<V;#GQI&R-&MD.1K
M'B5K&OZT,FNKIKHL&1QHS;",0SAI';?$7D(GJMW!B5Z-JU3<3M)19C':45J#
MP28V3V,Q7>[M(EM\YH%9!JH]9:VDWDK;NL);1C2A3:&7MC1\<R.4N3<L\\<-
M#!MH%.>GI@0?4F\I@D@#276\G'(;/'\Y.RCI#MI<17"' ,\J(A5*FE&XXVM/
M,?3FJ"VTBX#=<^KYLZZ(O':@=W$A2DNI$BEC<KGQCQQ$&?SN>I<A-=EB#\U^
M301M^:E]%>R'R:N@FCSY=IQ L 3M-B/3,9#B2M+D5=&EW7KUAR8/((9N/T5W
MR)4@+RZ&65<\6D\KXO/ATL:P-<+.1JH,\QK"$R*D50OZ/R4,>JCVI;$5-Q67
M5V$>8HZFE?\ .:U=9S+&/W8F$;+JH[A_8C;K4V\O-B/"O07G9/F1UO@EDE@"
MF60./<H',L&&!R.RE3A2;61#U&;VXC.0:H)-#LK.G05FSDT+B@:LQ'E:.1(O
M#\9BG<2+.;(749DJ5I4FIJH9J_2<ML6GK;:3&-(OH21_6;$Z.H3_ #;-%8(/
MK,:21@Y*3C-",H2E=N,UMW<':\=C GQ&0@<<-()K!5[GO#GV"S$IG7$V,]8-
M L=[1&*91B8@D=FF6**6%A8')*>=!CB@2;!3NM;24:112!=R4SW6#;%9[Y8M
M2J]WE541R=)P*^+R"1.@]VI;E;3[6N^/Q05WHM5#:6PR2T0L;P5@])&E57Y&
M\YK^ZA6T2.QMV>H!/G+E&6RNYJBWH,>::/W"U#V9(Y';37:4R7%AWL2VM.-5
MMT-H:^OL'=W=4%J>?=V"-'WH"%],LY,,&VY[7/CQ'(W-KLG/>2MN"K,'1FMG
M!+ZG)EMCT%G75<8FWR*G?)G44O:0S]_2A58?Y5&JJ3S6D>T,(U.ULNTLGZM4
MU@:)@!13Q+<L"?',HI+D8L(983VO3=>TO6VCM=9K7I$OXE>Y+-$*YO'85C\T
M"L7NM;37DKD"[F:Y_:+=?UN+&;%J+&+*K[,\BMD-L%&,YI?O%+<&EA1D]4.%
M_'9*(J%3PW&:<U7.GDUE;-<""3CY!V$8I7#[?U63Z\)SG7<*)7HD$C4(WLY)
M9C'(FI$'TL7R(=F='<9XQ-=$+/?.D3>2!KIR7S NES"HV9),,#7+J:-SLOIX
MY%$N*.+%6_6-RN/*@O9VT \]I&FX41SCF(UO&W-1 .:W9<PKLL6*OI;T:&+1
MS$KVJ<P"VXX?(P622Q$YEZK/'W1XJ+/%+BNW6BD(+0/+'"I42MG2I4+;=*A!
ME$+7"FN-4O>DR:&UJIT4P6!+M3OMD:,W&$"[=1%@L)47<ND,&NE<IJ(-D]9-
MC('.Y-Y "]1"GR"RX1""$\;7@&C>NC3BJ$XMDL50U8I[UM4(1@N31 4_(6F>
MLG,\GC,2G&='IGJ-)<YBN557!#S!3QCL*/78K+L"3&ON67EHX2Z223[9&51A
MM30B-VT:WZU,J&VLQ6:3QSHL2P)(M#&&E*GN\B@,,D?O"1G,7E8<U\JO4Z:_
M#K]'G_\ O:]X7\LKBKY;6.?8\8JMT?,>.BBA)+=5&5JNY!6F1O<NETNG4\.K
M00&KP5,\3KVGE=O[N*H1JFM58K4+RZX5PUF6PRG'W$>JJE9LAT:=XBN5?#2G
M.OQ.Y/\ R+-QPW\5>/?R1$_J=,T1<ES3-,\E^%/@7&2M:J?31/9U3_TX\$_^
M_IC/),_ARZ_5QGI3/+3GDF>GX,_@QX)]3"^1O5=2^5.KOUR_3PA]D6^C$&AM
MMFZ@T550:$RU:$5R]/# FCC1V-!JV6L"-J"UNUOVD1J(/6],UR\5PNV (]1'
MF=H$QNHI?LI5THF9"?7+XKAQA@"PSV,&\K!L:1XQ?8V.>B:G,'GT3V8[:!%&
M$2G-)=XD>XYY!I1"/*17D>N\=VG-?*BY)DF#*T 6K(=KD*@F)OOR1NHV2?*.
MTIEFN&J0 2*Q^ZQ7B8Y6DT[>XU7(N3]'3/QRP=%BQU26J+*10#5)*HB-13^7
MY94:F7FSQL% $@?_ %)!,>+_ ";D5N)]JQ"NFV(H@#D+(.9K(\%"]O'BA(]P
MH@$>=[U:-&H][U<N:X>[9%J(N9%VV9D7R]7KEYE\J>/P8*X01#<=^X9PQM8X
MQ,D;N%5J(I'Z4\5ZX1=*9M^*N29MS\<O@Q\1OQM?Q4^/^N_POIXZM1>N?5$\
M?A_5P[RM\_Q^B>;V>;X<>"=/#Z6-LP1%&NE=!!M>S,;D>Q=+D5/(],T^!<'<
M^+'>LIB"DJX(W+(&U%1HSJK?E6-1>B.S3!1$C#1"Q5A*0/VO(;%5KF[09(%'
M(CHQ'KH5CFJQ>K<EP4,<))&_,98&-8R#64DDP0 10G4\UYB(X$>,QK,LM.7P
MJJK^GRZF=#L QX$N?$ESV0;&4UO8T5#?.DC%$@F4D0<:Z7>)GI @=3ER>F&5
MCRJZ8:=,BC[&+938HF LYE9&?/F-@,CP'RY$)[&[BHQQ&JC'/3)52'8?*V-8
MPIQF])ES&PC+ -8+%#/%$,$-I)K8[BLCM?OE&G1JYIG&>*>63'ER>V',B5]C
M*@-7?C1-\TX$5\4$+O)C [SW(+=U-S\C]+(@I<M2$,,+2/I;@<5=Z1(@@-WA
M(#8R13V$4D9A=6VX[%8BYX@%C/<ZOD-D'ERY<2= )&@MIS6\&<"%*ACDSHUF
M,.D#AID1>C=3DTX[R I%8TQ8QA28IX4N+) [2:-+ARQ!DQCC7ZU[47)47P5%
MQD:II2BE3K>%"!7W[I5M'](NTJ7FNJYU6'L 2&^9KF$*B$5C%^/J27M&F2'Q
M2C$T,:GM9![#=.>*PM0$4)S[>+W,4C%-'W!(K%S=EDN'G9->HVU@K M@E98]
MHV,Z&VR#&)-[/92>L.0A&Q5=O^?)&:ERQ(O=^0R%$,L62,L"<*P!-0XXR0"5
M;XZ6*3R2#,8P6WK>KVZ474F -/W,,TJRGP1,=!LG-CC#?S>/UY;8JPF,I26D
MV$K!CD[:[N;$S5,-I9DQX9JI'4CEAS5A1N\9+)#299)'6OB.EM@FVT(1JN4:
MXI:^O9/DNN)4J-K)6V,-8:!JG6\:3(#*AB*V)8QD10%72,B9JB^5V&Q),P!)
M<8ACC ^&<I0FA70^-$*-O;N5AF6\MH6JGF77J;Y.N(2AWRUD\P6#L%A6T;MH
MSZJ]MW6<P<NM T56^/2*HC(]6$8KGYHUO6PN&RBQX54CW6/?PIM?)AL9&',1
MQH4R.&8C31#,(/R?*-<FG/!BK--'6*&2>9'F5UC$F0V1#Q(QTEPY$5DF.1A)
MX?(YJ.<PB.1%;UP]VU.BS$2X7MY5;;(".E9.MX(26,T=<04$5@^E,HM75VAS
M6ZG)DHXBN(X0ZFQL9TT42R?%8>O+0@= K2+ :VWD./>-&K YE85$8K-3LDC7
MD<4V9&D7%=2J$4&:V;&ESKD%(8<J"Z-WD<T"25=P;V([-NGVI@4TS9T>8Y(B
M+6!J[>7*.6:Z<P*50QUZ%N0JM9(^4CM>Q-E^:],1KM9#I4:PCOD5;8<:9,+/
M:V"6QUL!$CR)+ #B!5Y2*S2)J>;+ S3)!(AO2XUA)8D2>>,TY84.::LB3F1.
MVL;*,.>/, E<;S?%\<GDD%D##L1"!CMJ[I]UN%?=),;)IDK.[ R".C,YZ]=+
M6.5Z-30KR,'/.]!Q'S-Y*NU[<K!P(EJX$>1V>U*GI73Q&[<:N-I?\7#8^W9H
M+T^7+(9]3:,.*9%N(=)Z*Z L+N_53S9K48'+6[-N2+J1<4\> IYTBVLJF"H^
MSL0-@)9V1JW^$3/A**OFB+$/E&.HBN<%R986NGR3@,P3RD-Z?/? $K(4FR[<
MMB.,Z$R8^##(5H=>XYK>B=4S$C9<P331UDH6346\4+$[0]B,!RR(0V FR*V.
MZ2(#\C%!D]K51S<PMW;)IC22171"T5T.9$425[GGL(CX"2($-&VT9=XK6BR.
MWKXY?0Y__O:]X7\LKB%PZ&T]3Q"9%[SEO(@G&R7,A[SA?-:J:Q^^ ]@C<Y!E
M1&M N2*JJK5LN*0X9I/N^FB-=<:E(9"?-B6\S?4N-GWBK(=#.8JGBN\VG-S5
MSZJG.OQ.Y/\ R+-QPW\5>/?R1$_L"O)Q+.2UEU'M@K&:$&45US04_'Y91E7S
M$RCT@GM1W@]7>Q>E78,M#M=5V9[,3DAQ&S6ND6TFUD1(]F-HY88$[N=F2!RE
M$8+4R:Q^;EE\EBV$>'+E:)*$)20)\Z+9QZ<E-$DP[&2NX"*(.V1P=.;BBZ$:
MUSVNKJ^/>';45*Y5L&;!'8.KQI:1+C5".22-@YKY@7M?(<,A>W)MMT:4=C:'
M/*1PX]*)B."QJ/=1\AL>1!U+K\O<FG[3OUK6YX@AY)<O/9-I*^J)L0HS01@P
M:@T.)&V]9!2W1)LLA2$=Y9'Q=#&X[<<N&X)23Y4N/ IHE3$?.F&CJ(L8,<A'
M1PQ8P-M&O<9[]6IQ%R1,2JH6T,\VP+/E6HH48<Z1N<A=R! F(U-16L(NVFI5
M\J9X>*-/8,6^!6B](KT;,B!F39G9WSPH&1>#4DMG1Y&#SC"<YCG:U?'A%MY*
M@CT@Z1"BKZV/-D1P0VQHX9QP!8*PK@2!MDMC'$]K9">56C^3Q(I RF12'MPW
MHY=?60( 8EC%GQ+"&H*\(]ET<!8 VJA7$(1F>;_#(KB7TPS+&;'GWPUAPV):
M&A<EG<GB-"YK=5<-DNP<%Z-U*\"(G1_G6Q-*E26LLWTBR C0:)HI>_:T;'JF
MI.Y;8.U+[,DRQ77![R3.L*\D5FX^'%"(]=#II=."&\(LM!5[UYWE1>I5Z-1F
M3$=R59LQIUN8]OVC4#VR;%<^,L+XFYVQK/1/=US[D:>SIB/"=9S$"*LJ:<N0
MH^H\*MX]?\;(G5N0S2X7(".U==!&-Z*F:+=T+I#$;>:=Z375E=4]N\,2/&CF
M"",%PR'&^,A54NYJ(JID@\F),E'Y%+[ZW[D=U(' AM9+C&?1J*/% NM(*1QT
M AH[,CG->_/S*U6L*^Y.U FMW@(*!"%8@CV\ZWGR( [,2,DO@'?;N8<)=P9F
M#9DC':G.- 6ZD.K^TLA089X$(XHTJTL::X/(D:FHL\"65,CD"[2FV9[%5?*K
M1T,>;'C'';1;MLR'418D1DZ+>@O6-%4@(T;8N['0>E2N(K.KB.=YL5@TL!O/
M3PJN)"6PJP6,%RUQ+O,DRO><226R 7I&Z4>Q6.8UR.]F*&NK;3TR5Q^(:!&G
MMK8A1OC3*U]9.:M<'LX@G%8_<'HTL$1J>5S,V+*<"PB:3P3!8^1QRIG2^[DU
ML.LDNF2YJ'[RK,**Y5B:1_9WIN:=*-B2>/RI4^V ,D,3@)! *OC&%R57 A0K
M>60/I:.O&A$)9"OB,$QS=[)1.B5Q[F7%EC8I"R(.2:9)^,UW'9(V$7;(^,K(
M*JOV-SVO5OE\<+']1R$Z3,F+%;50$K4-(NJF] )E?EM]C&EU>C;57*0)%17:
M_E,0UB6Y(\=DZHLK"'&K*V-'G3*6RF64798 0VP .?,T/:U'.<T3%U:MQQ#6
M\FUD,4GV(:Q@'+#;Z+.I218,DRN6) ,R>X[QL:CGR.KG*WR8DV0[$L0\J,%B
MR@P*Y;6-*CT#N/ DU]L0+I,!K8V@NEGFWAYM>UJO:Y!LM.W_ (6]718=3!BO
M@2>UIHF_1R69SZJ9M4Z9EWB[F\3=0GE5J-,;?)F]5+MM%FCB.<QNAO1-MBHW
MZ>7T.9UTGW:\ZMDG^\+F-Y#GT\:B)!D5UK:O-"*-\R^AGS()-74:=%3'YH_>
M=^X^,?E1C\T?O._<?&/RHQR2DB^Z;WDCDW%#<5<<AXG&T P]A7R(@GF4?)2/
M032%35DURY>S'%X,P3@2X?':2)* _+6&1'K8P3"=DJIJ&1BHO_N4G0/$>&N"
MABH%7+&U*%".02N_[U)U5F6/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X
M7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^
M5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0
MX7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-
M^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P
M0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6
M-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/
MP0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]
M6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>
M/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7
M]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5
M>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X7]6-^5>/P0X
M7]6-^5>.G#^&?_FWY5X_ SAWU ?E5C\#.'?4!^56/P,X=]0'Y58_ SAWU ?E
M5C\#.'?4!^56/P,X=]0'Y58_ SAWU ?E5C\#.'?4!^56/P,X=]0'Y58_ SAW
MU ?E5C\#.'?4!^56/P,X=]0'Y58_ SAWU ?E5C\#.'?4!^56/P,X=]0'Y58_
M SAWU ?E5C\#.'?4!^56/P,X=]0'Y58_ SAWU ?E5C\#.'?4C_E5C\#^&?\
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MCU:-ER]^ABKU=EI3$6?8S9L6'-T]G(?S;EKQRT<U'HZ/LW1'&9H<BZD3)$7
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MKO9BO  XB$AR;(<@3'M>2.I;"44#3(G5CB!5')GXIUQ>U]4)#6$ZN-$CC4C
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MR>*^[[C?)X\>Y"QK%<L>]LK%SFN\'N>SX4Q;1N3TC(H.85$;E4J5%DRK"/\
M.=THS;QEHX\&(.OLY\>P!]KINMTQ'9/7)<3V4M6>AF&]^<:QB6L.DC$?#HA4
M\=&6@P& L<U6*1K1%<BA1ZK[<4Q;.-RE^P_WG"EVM=[O(?*BSC3_ '@LL(I3
MU1H$J)6CN(;%D#(-K?+T;Y5P$,6GLYL";P6SJI*Q(A=8^_YEP SHOD;\A*]/
MBG(C?%&A<OUN.11.241;6TB^];@HXT\M=W+KCC]*7AE<3D M8W_(3*FMUS%3
MRHYI$=X8]X@FU?(V!M)%PE/%A\!!+IIHC<"B5T4H^7]@^76IW85&@Q%:S4Q&
MY>=<>A6T&R23:!]TK(MW348JF/7T]?+,:6V8&"/R<DXQ;&<0Q3D5Q(^VJ(W)
MZ8IK/D=-R&NGK*]Y?JQJ/@@.:#=-G<BH2A>.!-@S  A7 X1#@,C456)DBY*N
M+Z\2C;&C2>'<4[2Q?5CBZK#O^4.L1M)M-5D](YQ;[4\R(YJ.]F)E,M,].3$]
M[P.8"YBHXOIX>+AF1Y+BOOU+\F6/2A?5]DJ[JN7+1H7/%"2V8PCC^[U8]2^#
M7P('I)'6<:3=47).TURIMFW9CDBG,Y$<-#)IUYJOO@+7<;.U\^Z]WQJHM;0"
MF2942)\V#VY:R(D=R6+8Y8Q'E%DK'O8J.3QQQ>\-0\XMH(:#F=1(E!]W1ZB<
M.;.NN+S8J2**I@1QQXY(\1^@VCY70N?5,>].M;4\I?.N"^\-]97K[OQI7&2Q
MMSRX4@'+6P4G3'RXRYM IM#]6G+HF.,$J[U8]E9\BY#=V]_2\4KHM539\/CT
MT:.*D,^?!C-FLAM8XA'N>4KL_'+$VHMN#7ES<\F]VO&N/\6DLI5,E%<0?5PR
M(EC*>B?-A8EI+%8[K]MCDZHJO8B8D215MG-JK[FG,Y]NU8YLHUG7\/OZJHO8
MS<ND'DD>RV%?X*4(O:[%96VT3E YDYG'*5C+/@$?BPH4QM3.(^.V;'APWV\<
M2PGHXQ%(YJZ?_68]YUO#DI6LEPHT2G2120G+83B\'97 GP.0&9W\%M=8$1';
M"Y:AJB^*XB&HO=]R"B;QKA7':3D$):!\65;VT/F?$+%L.MC!;KY!Z1'J9I^Z
M'K8J'Z.57NQ<3 \!Y;9-O_=K,XO1).XE, 2!R3UJ>L8\LLX0VT@PN,,[9#W,
M\C=2+FF.,\=IJ]E@2BI9G(Y-I.F2J^#\Z(<<,#CQ8DL,&;W5I$F//):!VA'>
M57/;CWE0$XURNJN/>)3UA:68ZALAUD"PD^[JO@O#86VUV]:2%:B<%RO<FAZ8
M2)4<(O\ BE0G&^#<3OH[Z9U/+/.'S>AE%)"$-$6<SBM;&E%6<W,61?*]4SQZ
MWR_C4ZS)$Y#[P($E\;CA>2#2WG4G%JNAYN/C@WAD6U;8"IY#5VU3;[E6ZFHK
MG(:IG<6CQ[UO%)3(G'(-8B=C*1IF000*[?L'Q)"1E;\FTCW#55;GCF9*%DZ#
M3=A[KQMI*^BB&B<A["^F'EBCR%!OQ?1V/W")'RR1WFQ>!GQ.11GFNN;G"*7P
M2/"J&!F<HFSHLH/-.Q9,G=Y$(CF#<96NUY)\5,>\GD!AD[@<WWM?-V@B\=:*
MXLW<B[N&&2:VWB2K:#+CNUQ@-"QJJK5S=DF.+1:1ED.P@<@O9+K'EGNR@T=?
M$<_A4P,(<NF9"A0YD(\Q$#W3D<1CR9)FJ(F*F:.//XW"I^#\/AEAW_'8$N5)
MMHD[EC[&$"RD &M<ZMG&0C7PT:U0D$J(C=.(5)7<'NZN^XQ[ON;TW+)SZ91,
MY!96<(,4$6OG,1?G0ZXMQ^H(YBD:U$S<J/=ECDO#747K$OE'+./OMK+L/FQP
MRVX52U#[".U2U5?-'53WRX_9RFZ3%(14R^35NGB4N_XR]+FI]W/-N.V\XE;N
M;UY4V/'ZNIE-FD UQR6D* XT0GB\3ET^U,/X]+X9<FY5?A]ULGC?(O2'$C4
M*2EXQ&.*?;JF?'S\6FUDLC@N5CR*7R(Y7KB#R"PJK5_$VS/>QS*?E#*252V2
MS+.(0# ]%;&Y%5"BR8S>B/)KR^-B@G2N(6_+*PG#>;52Q:ZB?=(RQM2<<=7B
MDIH<&#W#(Q40I%:UN2YJF 1N01>0N>Z-P:&<@>#QK^ELCP^$4]3/+)Y<:%(-
M6CC3Q/81PRM3R9K\9<6/$JCB4<0+OWA\YNIYYC34-<M-6ZV\;U6,2NF/TNM;
M$,J&/;5I.T=EI3-<)/YC[N;GDMORBG]WL:#NU:J"HL^/2S@OASK,K%3CX85J
MBV8R.TME#>W0KG=,<4LYI+0M0/FOO:E)5&IX\<%&&RD<@6%9/GL"V:05UO(X
M6\Y6KNII]F+WFR<;/Z;<GY)P?4)\TMT[CK*-85,8M(L!!BJ'<EJUE,D;ZN5D
MS/0C5SQ%@V7&[JVHJ.M]TIZY!54BSFDJ1\L]?O*(T-@R/D2^.'-(&HLE=VVW
MFF/>)$@\?GUJ<CY':V?'..OKT9.AU<RQK-M'TS,TBJ<X#RUCJB9-)YD1<\93
M:ZZ?-C>\.QGV%YQS@<*YK)E4?A!*VBLJKC#(4FL8CQHV-,1R%(.6CG:NK,<7
ML149%8_W8<BA$LK#CP*<P[@LCC(J_OXK8PF5=BX0BJP635$U'(W)$Q5Q \;O
MZDM'Q+W4\-FDMJ!SFMMZGF];+M3Q(4CY*YJZJ'$4Y"MSC/&OQO'*+(@U4\?+
M.+3_ 'HWA9 :_L./WUI)^:T>+&J@Q0CBQZCEO&6E$(7F<R4C]2JYBKCBU42B
M)+MH%9[NA^GF@;\^&Z+9<;]49L/&XH' BA)OITR8UV?3%Q-KN_C\?9[SO=?+
M90Q:2*L*?"K8O%F2K@,[8[L$2H4#D?M*@F["Y^W#H%E$Y%#E"K3-?&M."QZ&
M#$5MH]RBC<F;!!*NGD:5JHTA'YM35[,7%?"H[WO7<?\ >E >VQXR/C<2$VYN
M>]B1Z_DB,C&Y&7D0@H%$,I&A897(K,L>\VQHN"6=)52O=W74M?2V''O3)MER
MBO9=O:>!3N'N*6LA311&2$;\HO0:N:W/'%S55'%B-#PGF<7U(-8$<>NN#NXS
MZ.\IAAR#*8\97!^N32_3[<5U-7<"NZ,])[O"\4Y@IJ98GK=C-N.+,[2$8:?]
MXF#+7RYZRF;@VM?GJU/5,<GM>1U4V)+LN-0*G>. C&&9QB?9\<K6,(YJ(XDJ
MLK1R\O:R2COKL<<Y%90B6\D$?@#+KAE?QP-=,7CE%;>JSX-A#608O);J.<S2
M+N;>M *Q!YNP2SXO0NX[#L;WG%Q00^0<9"6'':_B'':UKK2GFHT=*G*+J"9P
M]QJ$;]D5BJY6XX$>+Q6QC @^Z;D5<7UBL:MI!MQKQ<,"%8G[=G\*,2.= Y(F
M;6NV_)@G'I?"[DW*N01_=;(XWR'TASXU &EI>,QCAGVZIGQXW%IU;*(X+E8\
MF[Y$<KUQ022UL_YN65Y[S^1'><!&K17$NQLJY!DU)\A Y#6)%DQ\\D<1'Y?&
MQ?7E-4V++"GMO>1?4RNCF9$N>[J^ 0/27$TZ2#Y#6,G!!\)A9I\3''*IU&2;
M;0:OW?"2 2 AY\1\6PXXEFS8>-Q0O#%"3>3IDQKL^F+.= 2?'X\SWL>[J:R@
MC4D7LID*OK.,#DW@IR [L,.L<!S7[:H%NRN?MP^!91.10Y0J^2CXUIP6/10(
MBI;/>HXW)VP02KIY6E:J-(5^;4U>S'*^,2ZGEBR;+N8Y*TO AU<<<21[P(DF
M0Z#RL4 <ZU(^M(IFM>5Z:<W?M?1+7FG&[;DE=1<XMXLUL.G)<'NHS.!4G'>.
M<O#5(Q[K!##@N&96(]0'D/\ 8CE2PC,X5R7C8.2\0X)6TH:^GF6=7QR1&'R$
M3X5C:PA.B1$J5L1*1572-,_@Q45 O=[R.!(XQ[N^1T'-]B$&IE<BG3/21MBT
M=H=CXW))1[&&:S&3Y4+E1&N\Q5;BDFFJ>1CA1^1\P(R^A>ZR(2[LP3Z#C816
M5YPE\$\&+)/+C$C)(V [S(Z/T-SS4P(W$+UME)]X? ^3UW)Y?&UJXD#C]5QS
MC++=Y;$@@"A&**%)BN@CZ[A59HRSR6U?#Y%Z::KX8$<BLX*#E$&86%;W9)4:
M3:G@RGT/;LDL5Q!.8Y&DU_6IAG'K"MG#X]?<5]YDL<F6$B?-[D?(;*( L(BN
M^P"DE@1["+GEF]Q,O#'%>77U+R"NNKSD/([*^97<0'RVPIQ XW!XS3@DTLN)
M+#LRAU6XUSF>7?S3QQ[Q:*+2<LC3>:U=6SCET_B\ZNK12/\ 9U75@SV,D$=D
M.B*"RC*UXUTH!_ER3$=O&>#6O%V5G%>&\;MP6/'=ADRY!SGB\T;4KT4?K\'C
M<6!+.:0U=EXC*B$\SLJ/0^[L GA<RL+.UXW[MX/(83;2[NJ*8E='X\0%K$I8
MCH\-58J.<17,=YO.N#Z8<^(V+(=#TV$)T)3[8Q.WXPW_ &2(]"9-<G3-%3V8
M/=NC#^8431RBNC^51K<F.]1T:B7/[6KIK%D^&G:VV?#^A^ZY'[&)]ZX^ZY'[
M&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[
M&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[
M&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[
M&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[
M&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX^ZY'[&)]ZX>0M35D(1[B$(^FI7O(1ZJY[WN
M=6JKGN<N:JOCA),"#"A2$1S4D1*NHC&1K^CFH4->QZ(Y/'KC[KD?L8GWKC[K
MD?L8GWKC[KD?L8GWKC[KD?L8GWKC[KD?L8GWKC[KD?L8GWKABNDF<HW:AJHX
M:JQRM<Q7,58OE=H>J?J+C[KD?L8GWKC[KD?L8GWKC[KD?L8GWKC[KD?L8GWK
MC[KD?L8GWKC[KD?L8GWKC[KD?L8GWKC[KD?L8GWKC[KD?L8GWKC[KD?L8GWK
MC[KD?L8GWKC[KD?L8GWKC[KD?L8GWKC[KD?L8GWKC[KD?L8GWKC[KD?L8GWK
MC[KD?L8GWKA6$D&(QR9.8\<-S7)\"M6*J*F/NN1^QB?>N/NN1^QB?>N/NN1^
MQB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^
MQB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^
MQB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^
MQB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^
MQB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^
MQB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^
MQB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^QB?>N/NN1^
MQB?>N/NN1^QB?>N/NN1^QB?>N+($CF-Q/+- T466>)4L+6$37F>,T,-@R/=J
M3[(CDZ8=7?/&X6:LSN4N>TJN\:#0C>R079]KLZDU9Z=>:^.6*V*#F-Q"D0FF
M;*GAB53SV:D5BL=)86&\(U#IR;MHWQZYXA3@\HLXD2,D7?JA1ZYT6=L/5Q5,
M0D5TEG=MZ.T.3+V98+9DY-92(!'&5E&2/7-A"0C<F-:9D9LQ4"O5,WY_#BS'
M(YA;SWS8ZBBG/%JF/JR+K^V8R!AL80B:DZ$1S>GA@E<O,;ATU\M)#;E8E5W@
M@HUB=FT20^U4*JW/-6ZLU\<5T0/,;B')AH;N;$42J=(L]UR*Q9+"0W!'L(F3
M=M&_3SQ F!Y3:0XT1D5LBN%&K71[!P"*\KSO)%<=CI;?*_0K41/#+!+1_)K(
MT!RD5M$^/7I!&CQ:&M0S(R3%03_,GG\?'%FV1R^WGK-C$#%>>+5,6K*_7IE1
MMF&Q"%'JZ(34WIX8/7NYC<$F%E,..X=$JDEQQ-1F<48DA]JHGZ5ZJU7>;QQ7
MPA<QN(DJ'O=S9"BU3I-ENNS9W R0W 'L)T;MM;T\<\5TD'*K2$"&**R3!#&K
M'ALG@(KRFD/+$<4;Y;5TNT*U$3PRPZT=R6R)7JKU2A='KT@MU VD1#-C)-R8
M3Y1//\;Z6+/N.76T_O8Q@Q=^+5L]+*75HE1MF&S<*#/HA-3>G5,2J]_,;@TP
M\@916[HE4DN(-FWJCB$V&D9PR:%S5S5=YL0((N8W$:7$<9TBT'%JG2;!".<Y
MC) WPUCL0"+DW0UO1.N*TP.5VL$4($84J,&-6/'9D 3461)<6(]XR2F^5VWI
M:B>")A;5>2V2U^:_P L>O[!,XVSEOI&[W)"_*?'^-]+%D\_+;:<V;'D!BC/%
MJV-K"&<JCDQE##8I"QDZ-0FIJ^U,3(!.8W!Y<DHB MGQ*I)4)@U8KPA$V&D9
M[#(U476U5Z],0H ^8W$>7&*5Y[9D2J65.:17JP1QOAK'8T*.1$T-1>G7%:0'
M+;:"R%'CAE"!%JWMLR!=F23)4T1[ADDIT<@]+4]B)CU7YRV25^:?P!V]?V'W
M-LY;_;=[DI?E/C_&^EBR,?E=K.'-!)%%CFC5C!UA#/U"D1G!B,>0D5O1NYJ:
MOM1<3X).8W$F7*>%T>U)%JFR:]!N:KV1QLAMCO0Z)DNMKO'IB+7LYC<!F .0
MIK=D2J67+&_<TQRB=#6,T8M:9*UJ+Y<5BQ^6VT!(4< 9301:M_JA!*W<DR=Z
M(_;*?+S(/2WKT3#;5O);(=>BLSH&QZ]8#M,?:5%,Z,LWSD^4^/\ &^EBQD'Y
M5:30S!2AQH9HU8P5:\Y$>(T9PHC"$?$;Y6[BN14\<\6$(O,;B5*EJ%8UF6+5
M-DUVVY%>D<8X;0/WTZ.UM=T\,1Z]O,;@<P,EYR7#8E4LN2)VYE%()8?:H)FM
M.J-1WEQ6)'Y=;P%A1QAE.!%JWK:$9HU29.]#>@RET]4'I;U\,,M&<EL@P&J-
M74+(]>L%^@6VY%,Z,LS(C_.OG\<3Y9N4VDR-+9*;'KBQJUL>O<<B/$2.\45I
MGNB-\K=:N14\<\6,,W,;B7)F;/;6)8E4V16[;LW]L,<-H";Z=';B.^E@5<G,
M;ADT<M9#[E(M5WA0JCT2&X2P^U02*Y%S1NKIXXK!Q^7V\!\&.T4HH(M4]]H1
M-&<B2AH;VC([2O0>EO7 K,?)K*/ 8HE?1CCUZPBH-FE[7&?&=,1#+U7)_P"I
MB;.-RBSEQ)*2D!5%C5K8L%3O1PE 0<5LAZQ&^5NMRYIXYXLHAN8W$V1-:%(M
M@:+5,/6*-7*]T9@H;0D4V?7<1WATPVN3F-PDULSN5N>UJN\>#2YO9*+L^UV<
MUSST:\T\<L5@0<PMX!((=J5(!%JGDM'_ "?R\EIH;V#?Y5^QHU/-@%D+DUE&
M@B4*DI!QZ]T(Z"3SM>8D9TM$/]=D_P#4Q+L"\GLY4.1W.S4%CUS8D/>=F+:*
M.*V2[M4Z-U.7/VYXLHQ^86\X\T8VQ9IHM4PU6YFO42,P4-@B*74F>XCO#ICT
M[YXW'>]YW/K/:57>;&C3V6UV?:[.?7/1KS]N6*R.#F%O!-"$]DJ8"+5/-:.=
MHR+)::&\0W,TKEMHU/-B-8BY-9Q80.WW:84>N=#E;*YDW"DBNE-[GZ[2Y,O9
MEB18EY-92H1E/MTI8]<V'&W?L:#*.,V6[M_K<W]?;BS ?F%O.+-"T<64>+5,
M+5O37F:,T,-@R/=J3[(CD\N%KOGC<+-69W*7/:57>(#0C>RVNS[79S3//1KS
M]N6*V*#F-Q"D0F%;*GABU3SV:O5FA\EA8;PC4.GIMHWQZXASQ<GLXL.-VV_4
MBCUSHLW8>KB[Q21726=TG1VER9>S+!K,G)K*3!(IE91DCU[804(W)C6F'&;+
M5 KU3-_ZN+,4CF%O/).!M13GBU3'U9//]L1D##8PA/,G0B.;TP2N7F-PZ:^6
MDAMRL6J[P8=+$[-HNS[7956YYZ=6:^.*Z('F-Q#DPD,DJQ#%JG2+/<5%8LEA
M8;@CV$3)-M&^/7$&:'E%G#BQ6Q4D5@H]:Z-/4!%>5QR$BN.Q9;?*[0Y,D\,L
M$LW\ELCP'J56T3X]>D$:/'H:UIF1DF*@G>9//X^.+-LCE]O/=.CO#%(>+5,=
M5D=KTR8VS#8TA&:DZ$U-Z>&#5SN8W!)I933LN5BU7> $B,18C!)#[51.TKU5
MNKS>.*Z&+F-Q$DP][N;(46J=(LMQV;.X&2&X ]A.C=MK>GCBOE!Y3:0H\,<5
MDF &-6N!8N 17E+(>6*XS'2V^5VA6HB>&6'VCN2V1:]RO5*%T>O2"S4#::B&
M;&29D-_G3S^/TL6?<<NMI_>QS!B[\6K9Z64FK1)C;,1FX4.?1":F].J8DU[^
M8W!9AY S"N'1*I)<4;-O5&$)L-(SADT+FKFJ[S8KX0N8W$65$<99-H.+5.DV
M*$<YS&R!DANCL0"+DW0UO1.N*TX.5VL$4(,8<J(&-6/%9O 364\EQ8CR#?*;
MY7;:M:B>")A;5>2V3J]5<J4"QZ_L$SC[*)OI&[W)I/E/C_&^EBR=(Y;;3VS8
M\@,5AXM6Q*PA551R8VS#8I"QT7RH34U?:F)D!_,;@\R081 VSXE4DJ$QBCUA
M")L-(SF%TKGJ:J^;IB#!'S&XCRXI#//:CB52RI[2.>K!G&^&L=C0HY$30U%Z
M=<5I <LMH+(0(PI00Q:M[+,@7:BR)*EB/<,DE.CD'I:GL1,>J_.6R]/SS] [
M>O[#[FV<M_MN]RW?E?C_ !OI8LBGY9:SAS02110&C5;&5A#/U"D1E#$8XA(J
M=&H34U?:BXG02<QN)$N40+H]J2+5)*@-&YBO& ;(:1WM,C<EUM=X],1(#.8W
M 9D<Q2FMV1*I9<QCU)I 83H:QFL%J3+2U%\O7%8Z/RVV@)"C@#*:"+5O2T*)
M44DJ3O0W[99&7F0>EJ>Q,):IR6R97HK56@2/7]@[*/LJBG6,LW)Q/E/C_&^E
MBRD'Y7:S0S0RAQ8AHU8P58\Y$>(\9PHC"$)$;Y6[BN:J>*+BPA%YC<2I4M0+
M&M"1*ILFN03D<](XQPVQW[Z)D[6UW3PRQ&KV\QN!3 R7F+<-B52RY0G;FF,0
M3H:QFC'K3)6M1WEQ6=OR^W@=E&$&4H(M4_U0H].N5)WH;T&4V75!Z6]>B89:
M-Y+9"@-4:K0MCUZP7HP.VYJF=&69D1_G7S^/TL6$HW*;29'ECE,C0#1JUH*Y
MQR(\18[Q1&F>Z(U-+-:N14\<\6,,W,;B7)F;';618E4V16[3LR=L,<-H";Z=
M';B.R3PRP"O=R^[22.6XY;<0*ADXX5:1&Q%:^O-#8)KG(N>WJ\OCB P?*K^$
ML(#0F)%2EUV+VZ<Y$WN*@[-YVGKM(-O7PPRR;R&Y#&8HU6F$E7Z81&,TN:_<
MK7S\BKU=D=.OAEB7,?R2[E!DMD(.ND)4]E"WWZF.B[-6*5G%3RLW"/Z?&U8G
MQ7\KY#+),02!G2$I>[KMM7*Y8>S3ACYF1<G;K">'3+#:_P"=G(&G;*[A;9$I
M/47CT.;VCLZ=87;YKGT"C\T^-ETQ $/E?((3H0=HQXJ4N[9.\OR\WN*<X]WR
M_M31MZ^&!6+.17,>.-1*M.%*KTTJ#3)S2;M82=D;Z[(R+\&6)4Y_([J2"1W&
MBK.E3V$3>=J9V^U6"F?:W@S65_3XV>)\8G+.0S"3&#:&9)2D[FN5BN5SX6Q3
M@!J+J\VZPGATRPE?\[.0[_==QZME2>HJ/1I[/_J?LNVS\WV'7G]=ETQ  /EG
M(83X8W#-*BI2;]BKM.19O<4YP[C-/3::-.OA@%@SD5U& %0:JD"57ITC:^.A
MMVL+-RD?7Z3-^EE@]@_D5U) 93Z:DZ57IT?=^(@=JL%-^U_K-1G?3SQ^'_+_
M -33QG+^CGZ%6NYYQ9'-545%N(>:*G147Y3 (D7F_&3R91A1XX!6T1Y3',]!
MB$-B$S<\A'(B)\/]DU]97E&?DE)Q"NL[6PI(T0LXEI*)*2KKH+(P!D>9SI,A
M2Y9+T JXC<;R<@:WGM.D%7IDKZR3;0YE8_K\,"0/^WCF%K627P["OH+&5#E#
MTJ0!Q <X96:T<W4U?A3'([OU3DGO"XE7<?XP=9-O5-HY8N5W%W&JC4];*-6P
M.]$V/+W5S8K?*B([KJ62RRX1-"#CL>D-SZ2&[K9+>)/Y 7*  36,3U]XX[F&
M.H%:T3'>W#XL[C,N#QMG+KOA*\J=91#1_7*@4J0QOIK!I-[27&B+\KX-?Y?-
MXXF6MIPRVK8Q>-%Y;Q;.?"E.Y%2BF1(;BE2.U?1C,2>$SV/W=$=ROS7+)1\J
M'QRL*KK>36.1.=<<2B:*-&63WK>2*NT[N/L8P*!LA3>56(F3EM^4J"5)H9'#
M/=Y9UE)(D@B KYW*+2VAFD3['9,V'%$HFH8RH]J(Q,F]<!Y5:) H8>B0244E
MY5V-7'%'D/!W++R&;L#0RZ-37KMKU\S6KTQ^'G#?YS4WW[BPO>*\MD5K:^ML
M;Z':\?+7S V;*^NFD9%4Y12XY(93-34H_-FWQQ[I)0;6ZYW*YC27_()]/.E5
M-8TSF\5IK 41L[LV#CPJXI2E:JH\CG+EUSQ0N;5*L*QJ..W%N>1<UL.94"Y+
M)[6(&%5G7NN0FBN17R.WRV@Y.^EC@$&NMN2U42YL;T5G\T:X5K>2!PZI),9L
M2"2-*WM$CJ_)OE'J7V8IX78S.<\MM^1<NK*FOD'K^.VJ5/&B[I2\H<0?:55M
M&A%%J#HS>I&)XJJXXQ=AH'FI;^-%-(/+O:FNLH9RW#J277P*4KB3[R;62QN4
MZ"1@VC3/5\%TD?A4N0.'S)_N_HS+=P MY#RIED6&L1C'A4M;"9$$IWR"HK$^
M(F>6>.>7W*G2(R4/,>8,+$.X,@M-5TXP'=6M)&1!26P&H]&N3/7XYXY"2#QB
M?Q>\-QFNY/QV0:TK9;C\8M+2+6.N$T"4<.QBK+'G%?F]NZCM73'NZK8UU=4E
MO=<NX?QVULGR:ZQNA#M!R1SV&FCAMKI<IA$ZD8)K'N;FB98)PF[Y!:7+Z?WD
M\*JXET(5=#F6-7RN@M+1E==L;$4!@12PG(]1(,K_ "KJ3PQ57!.&]HG(3V'S
M='9<KIJX-E!I!E6[G$FR1M% [>2QH8XB)N2WO33I3$ /%N(VO(JY:SC%K>SX
M\N''/2 Y8CGUPVUQ<R61HXF.?)T/:T+$SS7$<4OB3[GE5YRWF%;0U$:WK($<
MM7QHY'6!"SW#<"*.H;ICIK1SY)/,G1V(3J;B-I:0W<0+S.X.V;#CR*6OAS;:
MML8KH16J^?81K&J43!B=\KJSZ(W$R?Z9%KV1B14&Z%R"MY  S)<9)"-(^$@9
M$&;&STF"<+%:[XJN]DR4[B"ACKR:5Q.CDV')JFMAW%K72K =F\\J4-&T]?"B
MP=>\5%UD(@VHN6K%.O%>&VW)'2:4-]> BSX CTD(EO)I'"CL=K;=36S8)U1@
MW,1PAZ]7FPL+YMS?FRO*)/" \L6=$VB<KC!(]T!:G3W@X3Y 7!;)STJ3ZW'J
M">[JQ[=W%V\U&[YP5:9\9!-].LYST4.IAXTO+9#DKY#5U+MX-6P.$3K2*WD\
M7A\>Q'=5T5LJ^LZ=EO4QTC2!H00#C<N^5RZ0-Z^=5TXI9J\?=W,RMM+:ZKY%
M]5P2U$.GNY%!-' )+0:<AL73H95#'"C'E&S/IX895,XQ*?1KS&%PIW)6V<3:
M]4M:X-C5N'6J))9 G&7Y1<VH)%3JY5R3C-X&CM*_ACZ?WDV\=HY4*6;F$+C5
M>Q0E[-@T/62 28[G,&]V2L*CM2IGE*L?3HD!(\@0F+ OZWD,0[2QQR$5),'9
M-&D!W-!0G")S'>&I.N+#ALFC;5RHT&?8QB,OZJWD.CU]B*O(.V@URD=1S2[[
M2,"][U4:]<L2>-OIR^L YE4\7'&[QB;U=:U+[Q.2ZMC-D&+6QCN(S)<G"TZN
MN+:?7<4EUGJ7%^2WW ;:=.@G#=Q^/(G?RY4!J(2M+#B$[M@"*_?$S)%S5$QQ
M^BNJ= S"Q>)@Y'*?>U+9-?:<J )\#LZEJ,D7470819)8^38S2^"Y+C@=9#O.
M4TU=:QN5%L?FA6#M[<Y*X-4^%HA.AS'/$-QW:U1OE:N#\6K>=<CH(/%.(<;L
MG6#J^O%?W=SR44J9%D78I$32($&/'1A8K6,S?FBKGX<4GWW+^0\4A&X':3K,
M_$ZD-BV1?4_+9O'5FR $A261H,UL75J^3&CW-;FW/%=R+D]>2=R4%%WLZ"PD
M"N)+(BO[=QRF(&O@.+%T$.JJC1>;ITTXXU(J\J1PN6<KX]=1H%K!OH$QU;P:
MPNXI8EM%"V/-BH9XGHYJ)YV9=4Q0<P@?PER*33<2?)F2'1FJA+4]?'E3',,S
M9*4KY&A$R\KB:LLFKB_K[NEF2J61SGC7&F3?4H&UQ>7?T-6^/6LCM'O60FV1
M'[I$5K6HY')JSRP6DCU[88Y$2PL*.6EO7SS6$.KGM@2?4:V*O=4$IZD:40CY
M[@?-GTRQ.H$XK+D5M5R;C/&;7D#;.(,463RN-#+6%'7O%W,E&FEZ2HBHC&Y.
MS7/3@TDO%9X>.RF<L;QCD#K"(X?()O#XLZ581WP6,615"E-K#)'(37N:/BIA
M9$OW?V,6$"+Q6YFRO7:PO:\<Y?(##JK+9&/<+-=*-DL5.J,17.>WXN)M5 I+
M;EMI8\X]XE37QI5K65S8K.(CARRQQR%B,&*L;',NUKUF3+)=:JF./O94N6'9
M4]!<VY3W-;#EU >0RUA100JTZI*Y">,1JO.D?+;!D_VY8O(/I!"1*Z+RP]7(
MA6U?.L+<O#1$+9B+1A7OJ=DI@".B$/T.UBKY<2K'TV) ;'.(3%@<@K>0Q3M-
M&'(3[8@[)HLD&O04)PC<QWAJ3KB+<WDFZN70^,^\RZD0HZPT!-'1<]](@H5G
M;;S9$6,]K$(CD8,".5S7+C@,BDH8+07W.24%FL'DM)=Q),,%8Z;IA604\FMC
MW$(CPA,Q8JCR^4:JWDHE4]L.%56%M1NC6]=.FW08%H"GV)E:!>YX],ERI8G"
M'(U:@N5_LRQ[QHG(X1J9:CYGMB\?),B6(ZITZGDGE+'GQ!C9*'->UI,_8O3)
M,L<7J(]_R^FJYG'[N;*9PRH'<V1I<67!''<2*Z%-<D=K"NU.R1$Z?#B[X[5\
MZO..Q.#<:XJHI;85>EI>WM]5EL6V/(!R8BM2.$8D:2,UHT5ZN\,L4UI:<OY+
MQ4!_=K!ME9QBHCV,61R=.17=&\LIA8,ID6'8%@LT:GC9FY&H[ KZQEEI.7-@
M<6]4EQ1![B(>9;U4:Q>T"#,%#NC'?J8UJHCE5$3%\=KN0^\>AD\HXMQSA4^U
M@BXU9V5I>0YRSH:/EUT!I8T.;'$W<(,>G=^!,!AR^)38M*WD5?PJTY VT@R
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M86#I$?D'-N0M"[MME9/.(H(L\"Y!1^Q$;'11==6?QL\42UW(;R"VKK*BHLD
MRLW;V'132SJY#R2022*\J/,X9'QG#4H/(N+>1#Y'R&)76#+_ +*J@%A5Z4TK
MDKE)8S8=C%B#LS% 5RNB(8CVQE<N2+FN+N8EG*M[/D!8+[&;(B5E>U[*P!(\
M-K851$A1-Y&&<I2JU2&>NIRX".->W\4D>GY53@F0I (DT#>5<B;R21*#($%%
M8>)+;H9]8X6:/1<\1C"Y#9-N@\PB<R+;@KZ2$T\R+7EJ>T;40J\%3'B'@&<C
M] M;B.5ZJN+RF)<W1Z&SKIM96U'V@ -$"=9-M]V,<$-DJ?+A3QM6,24XJB&F
MCJF"6<#EMW9VUUR+B=CR2QL2PHSI=;QT,F.>%LP8 V/C38A$%LIIZHUVKH[5
M4\IJ./MN'UE#/J6*7D46I J6DH!Y"$C$JIAW$#V3-+D(C5UKTZ8DWU?367$[
M"RK!TUV^@YW5M9<UPE)LMD,F<:.@9D=A7-&=F3V-7+!QL]W<9U;(X-&X ZJ)
MS>$^,E1&E2YB2=Q>/=PMB0\QSE(J_&\WCBOX1R(]A$=&2L$X_?1+.PV:.VCS
MJY"S60HT8ZN%"&QR[2+I_ONN*))4@\?T#DM3R:/L;?RTJH<5P8YMQKOD";OF
MRR=]/#KOUBX95$Y''YC(XHUT7T8_*XHF##;O>L?OLM0FE<'<VW&:CE\,L0 \
MYFVLDHJCE52'C9)->^OHDY1.E)92:^5"$XKSRX6VK-92;+G.R^!MBI>9\GE7
MLT=/$'R _ICCQZJA<5U=3%K^Q],L:PBG<LH<@;TEN7-_7$&!'Y!=0MJLY)4V
M4B/&I,[.+RF5WUFT<8E8^'3_ &RB(SLQBT@^3\%5<7DB+-E2#7JU+SN.T&07
MU%'"HPN"T8VI\H&"CW9Y^=?@QR*+QOG?)CR[D,T@6S35T80+JRFQ9,B]?)C5
MRR23$V51RNU*X;E:F714XA)K:E;<G'+]G($3UJ-3M[J)#D1 "-W%=8*<!VSB
M*NC0YJL3KUQ57,7C9N,<@I62@0KJDYO7*=8<Y&=U EQYG'#1I<4BC1R(Y,V/
M3-/;CC$F/PI9)N-OY1(>2?SFODEOYW+PA%<3[LCN.(II!-E,M&EOL7IBZXE8
M1)-373#W(JV(MQ%NG5E9=#>Y\.%)%7P4;&AGD$VFD:]R>URX3W>.F2TKDX['
MXWWR;/>]M'BCB-/]CV-]6"S7RY9X[IM[=TS)U)&XUR.-6/B(+D5'$*XP8DM9
M$8SXQ44CV[P5:_:>K/!<<AL[B;90*%G.J[D51QV,6M?4VS*2IK!4TV0C1&FQ
MNSF">CA:V(5!,U-\K5PI&\AY(M?!!R$7%ZP<L$5G$2\H0J6DNGF1HXYJRF(9
MR1W%>_8:Y?'!)/SEM5OWW]/?I>-K>/"TR*.'-@0FOIQU:4\AZQK JD,4+RD,
MJ/5<TZU4V'964Q]1Q^VXX!)O;+NQ;;D;N2%/(<$(E?*')=H14R:K/%,\-Y&:
M]O3PP6K>21N,/D@=4AY*&O=7 M $*!\L.T%VIH=>RAO-EEY<4\&[FOLK:-!"
M.PFD(IGR)*)F1SC*P:F5%7+7I;JRSR3^L,*74V<^I-(Y1QZND3:R,.;8,@39
MFU,2'%*&0DB0HOB,TJKG9)CA/$*CFG*A?.^?RFQL.37U%#JN30ZOC<2"GI-?
M /! $*2Y1]2&<)7(W-4Z=,?-FRYA;!+0>\T/&Y_*JBHC2K>PX[/XQ*O(6Y6B
MA2QFL(RHC2J(7FTYY>.=O8V=E,NZQ+JP'Q._L8 *VPMZ(00H.5(B1V"9DR;N
ML:Y6-<Y&]4Q16C^4W?,0MXYRVWYY2RZ,<.#0)30)4NK?"NV5D8;B3),=HLFO
M*WS]?9BJ-%]WMK(L[:GF<L%3I=533!X7$'#<R_.=?DD/-)+T!A_9G*SKIS3$
MB5!XO9V/&ZV%Q"UN.0,FPHZ5M5S( R0)"UQ?MF3( \N11#5=*-<Y7)EU=')Q
MJT9QDMU;\9K>5,D1##LN14D>4>37AJ6KWK12'02BCFS5I2-RR3Q2\Y)#XPQ[
M:L-8>+'!ROCQV2&6A=M&6LIQ@)QR17M^4E-DLR&SXJO\,>[YT'56UMD+WCP;
MNJ'+AV<0]EQE:1D<T:TC,VYT1O=JX11:6O1_MZ8X9Q>CE,!7 Y-40N7R=0=1
M9%W"L)-91L0C'.^XX;I!U;EIW IGURQ&G>AI:QB#F'E&+>5=(&.&$P;W!CK8
M/W;.TDH_Y&*%BO)I7JF/3@<6L#TXKKB%-.OUGPA#B$YM75\ZF?Z>[.4=4=/1
MAD;T&B9ZESTXX#'KJR=4\2MK?G,(-@63 .'E(>/5<P.XL5B+,K$C6<57C1WV
M5O7/Q;@_'V\KYE0U3.+4TZ.#B?'@WJK/F6EC&,6;JKIKXP5$)OF56ITQ[S.5
MU/,Y-+&]V]E:U-11-@5YX-J_BM;'G6LB^<4*G.MPYZM9H4:!3JF.0&KN7<DI
M[$T;@Y>$\6KZ&+:5=C9\BXO66KJJ;+-7D:%QIDAR(CS-<K,W(BY8XY-;<'XQ
M(F\IXS77ME6@9-+!A36G]6[4#P3.XV=.;41CW.TIEGAH70[?WB>M<SLJ'A%C
M*#$XK/N:^+3CLEDRF38T0+(P3M(S><-BJB+TS;IQI?QBQ!QZ5,OJBDY*Z="=
M&MKSCD69)G0>R;]M0P&=7F& [LT*YGQ4Q(LKSBMK2")Q2+R^@8LR#/+R"OE3
M8=6P(6QU;V<M]G8!8QA.KAD0BZ?#$L5SQ,M1R:!>5=+,I;&_JP5D5+JME6M;
M92>3HQ]<&">+#(W-6YH9-"_KL<<LY?&']A=0(,Z85_)./C-$[V<R%VM3&'*D
M/Y-)!KWG]MDQ *CM7BC?>&^QD&G^B^\/DU57#0;-8:V!%K21H(6B&U2:'&=I
MSS<JNQ/@\VMN3MY$^FAW'S;Y%QZLI@Q(<J;)%WU0>$O=RXS'M0+TDL$1KOK?
M[#Z8$"L)9OK^24]]MBM(E4K7TLCO8Z/+,BRF$"8S$8Y&HCLES1<5$QG$9/'[
MSC\D\JDOJGF=.LN$Z6'MY@'AEU!8TJ',#DA!N3S:4^FBTQ%XG/GV%9RXW-9M
MK.YK3$FWMT> >N>LY6T[!ABLCFR&,2(C$:B?"J\H!)J345=;6Y+B#5+<0K>+
M!/8M?ZF.N=%B17Q8CC-:]!NS1%<NG+KA/=^*;*+ 2EL:3OB(+N]FQ9*80VEK
M4#N#[I<NF73''AUO([GC\^BXS\S26M<R"^19\<)'C DP90Y<<P1D>L5"#*-$
M<(BJJ>S+DL,DZTI>"O@>[VMC5L,M<4/):[B\%=4*<X@S6$58LN,)%(W:<5KW
MIUSS1UBM]>+3#N;7DU=QECX@8-5R2X!(!+MH<P4=M@BB640D<>O0 KM3?@Q>
M,E<GM)EG;IQ]@[<M90L($?&K1MO7.GQ 5XH=_,-*8G='F-(20U,EQ56Z75E8
MRJN=R^Q190H ^YD<S],=9*9(<>.)J"-6ZAH-K$37EX(F*[D4JJC!MXEW"N9<
MT06*:V[&.\ H4YS\\XJ_)N7+)<Q-Q$G%NK"H*&FN./R>SCULI)-5=M&DL8_4
MHDOL)68D^7#I+H56Y]<2F>K6#G2[K@UV1^W&3(_!8-9!A#:W1EMS65;5+\"N
M7+%3=!Y#<F@<?LN16/'^.E;!],JOG0&4VTCC(R,V:=BGE*\:D([;1-*>+E6V
MY35<56V[VCK:%I"<EKZ^.^/!/(G;[8I*\LD9M^8YBYO5%1N?MQ>R 4=W25/+
M"B-ROCM7SBC2NNRC&P)";IZ0DJN=."-&2=IWRS<<RB%X$\8.8>@.T@YE4#=0
MFXS6QZVH/3/])UC+&9%8[S9_!X*N.(!O9$J+8<?M^.<C-H)&D%/9T?G4,DPQ
M, 1D@JKN.&UO][ECBUR:0<)N*V$VQBB&C%')?-K)-8]A]2*Y&L')5R:?:F)\
MV'<6\N#'?R:YXYQ,RP6U59R+D4&:"7*%(V&2BC5\TFR,I-L#B*J8BQ>96MU,
ML9'!ZSB[(;RUS/FF(98=M(CU<F"#3(-&NHHWC,1Q51@FLS<U,6>]S.\D\BN;
M&#/M>02H=/)'9!K8):V#4V% :$ZDF5((IG*@GC7Y?Y3//$2NA\BN8,0?'HW'
MYK&QJB26<.'='Y!',T\F"\E:U;.2YQ!1=IA&:6>"=>3"%)E';RCD-MR&7J<@
M7QSVX(P# C$!H(P8VQDT.SUHJ^.)$U>:\FGVRQZ>I@V\Q82SH'&Z>S]4;1H0
M<=G=-GD56R3EU%(WX/;_ %XX#QJ)=3X]!85 #3J@1=,*45SN0(XAAY>9R]NS
M]BGZ6LJ7;R$K7\+L9"Q))@@JJUL&TJ$)*1-(TW"(9[B%*YRHW)$R:F.*2)0Y
M!'EY+5UCUCV%A$WJ^6DDAXJMARXXWH=PV]5Z_3Q;F<6NN^PX; Y-&C587C6L
MF2 6G_=26[NII3R8WIS6HY^DZJKM3?#$6R(6))/&A2A!D1R5';,;='X.A),V
M+#Y!+JF^C)9/>%3S YB<W=T>95M1OOJ:ED0Z:8.*G;@E3>1G.?DD <ZL+5V\
MJ/%EP?21JJ1WR CD;FM^A$RXAZ;*@G=/X]*MI%K*6L;%L#5<*J(.-NV-U6 &
M&S6:XCW!>>0@V9C8[JN)$))E75A6XE5J4Y1G+96H;6YY*.58U\PLW>&M<L+0
MFECAH]A,T:FAK>$55G>A( 48#B(*,Z+ZFVRX4.PCPI&Y-,ISP9 "/8_JYZ=5
M3-,\3)263(A@VW.YB)*MIE4P3>+K35=8E3VI&=YR$(6[\2,3Y KCE<_'+21C
MB%Z=R\=;#FSV*4%7#O)%%(DRI0U*+4&C??&72KT:UH=*JC4PD.NLH-C(EV=V
MIK9L61-2PB0;OWESUCU\1+%8P>Z2A&$2MU[6XN6M$8U(Z2K;C],.2%MHMW-#
M7R8L3^!26JT)HM9?3D9N/;F-Y"LENC,?\DCT1V)@WWM;+="OI#DKI,5>_O6V
MW.;.E](KU?-:>)Z+!",C$VW/;O#1[48G7BD6ZM*L\>_KJJ8X5=6QV/9(O8-C
M/#$D!)<K:Q6 ;$:@)(P2(Y$:3>VW:<N9QF\AK ,@2[:XB!M8R%W&U?'N)R(?
M%XB+8 <);9UD1^IJ*158JC:N;\481+'9 D0XIY5:T4:5:GESIBPP1"1R6$.>
M..8F0QGAAEJ,_P!F&@\EQ @P9E(&;8#[]D@D6OF:%=0EM?1UC5E_.9'8DH;&
M-,8C3[+UU"1R9K EUX(4:LG,6=!'+[ *SF19]91SJTLBQMJ\C'-LW2LG1AR#
MHK@_)Y9ZW18LNN &"#C9!U$F/N3^3+R"XE5<I*\W=">+T@($)\F(OF7Y3)N.
M7+/L(BV ^#UW(ZZ;707PE@EOJ*RD]LT:S#J;L),+,9-37+JZ^&)\\-E#NHMA
M.G C[D=KNW.&LXP];KO"V8XSH;$EF(X*N$%&Y*I&^9V!2+,L#<^>535'D$M1
M5=?-A Y3&B*ZRL*.99AK6F"FB3L&,UKD=ET\J=G$L:M 5,N<4,5TJ1?1^2(;
ME'I[*+BUW)..9+B5L,[&-*K"%221K%8C&:7>GP+"O+WLNGDQ):U417MKYT/F
M$TL2/ B7LTJ+(9QT+0+,4,EFZY2"^*F.;<A+90+Z5&X7QR\!!KQO'&@2R0N2
MV#J8@62I*[X2-:-SO*9S4;J34F..@F7E?=0:3UV2R=5QG1X%I)-2<?D#\H;
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M/7\;/#)'91-\92'&;MP[K#F8T1C,)HUM*4;$:YWBJ)E@,CM(W<1Q*".?8%O
M [XP0ETZQ"=E\5,DQNFA1"DW0R-PD<+W[\=%;'-J<Q7;H&N70[Q;GTP"0:,
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M<EC4&R0-7-56':Q,D<GF1,#D=I%WQ-<P1^W%O#8]^X]HR:=;&N)YER\5P]7
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M&]P[Q;FB+TQ^>CWI?]K1/O3'NM%_M(YQR.'R/DEC76%?>V;"PW@CT%A,9\D
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M>UXX.@8$,*3W 7:16<T;UZJGQ6KU\?ZBBU4"Y'0S8-[3WT6Q+7>J,'(IY/=
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M]W1^3/H4DCC)*X-I<<OHN.--:1"38@AVZR1*5P!2(SU49&-7XWAGC\,_=O\
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M#_N["Y)=&IVK*-#/45EVO,#FDSZAU=JC.].E16!U/;MM;M9-<5<I33AK6TR
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ML*C<V-2,!@^G70QJ>#4R^AP;_>KPC]]2?H<X_B^'_*]?BL_B^%^]A_0]^O\
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MRC&' C3$:-QLE=D\Q6HN77+'X!<"_G1+_P!%@O&K+B'#*^'+FU<@TN'R0QI
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M,BD)$J@E72N>1<AHNE=:"L&UM3')$@6L"2\?([.;\XO4;B-,C$?'E5?;T(X
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M&%QBOH?=Q/B5YK!X94SDEZ*01)UA*GKN##1J-JL=)RZ>Q,?@K[K_ .='(O\
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MIY0S8\ ,6JFQZ>CG)*: $.RMXH'EDFRES5=&>UVM(^T)SEXV(%G)<XLBNBS
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M,&-./SK=Q)MU'<^ZI23YTJ1%K8IA5\U+2RFJ1'R5SC9N\I-62<<LX[*D5Y7
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M2OE-L#<H,*)+A35EQK/0M\W1->HYL?23)2(_))L\#Z\T&44,=( 9,]XE9-N
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MF##.Y/:RX^]&.UI!J\!FK^E+OQP&S$\"[HF$S 56.*%=;5S$11MU-\%R3!9
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MF*CMZ/\ )NS^,SHO3&U%CAC#U*_; )@6:W?&=I&C6ZG?#_59XDD;31I02QY
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MZ+U3]!87<ICRAKP;SA#<$;RN5S1B$TD@@@#4I7HW-[FM3/JN(UGVO;=TQY&
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M\ G9+U;T^C[IK*QE A0(/O=XY)F2Y)&BCQHXJJ_<0QB.R:P;&IFJX_.#Q/\
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MN)Q+JLG5UR]@8NY 1B-$XZ,TE3>U(U49 ]5@US&VG%GQ%BQV2V+6CY+05E@
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M=)>S;GD'%L7;FZ\;B"9@\F.B>NV=V6NN+$L]I)$KB5K6Q*NP.Z1D/=D0=KN
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MXC08ON=][HHT, HP!_-5KM 0#:$;5<ZP5[U0;$ZJJJN,O]D'O=R_%,?M\?\
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M+Z3DQ_UQ[P?_ !%YC_K?'_7'O!_\1>8_ZWQ_UQ[P?_$7F/\ K?'_ %Q[P?\
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M*HI(&1(KY+0(UK4CYO7)&YKE[,U]U)./VO#B/T<\&V;R-PK+C3'LK*IQ1S$
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M7FXXU^-D']YSL<E_$EW[VJL2?Q?O/WHN'?Q)9_\ R.)GXQV'[TK<"_CB[_E
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M&DQ@E@#$]=W;VWYZ KO9G9UZ9."UD%[;&75UTB -@ SGS2++L"S90X\-Q2-
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M_P!DN."*O_\ B/'OY*B_0XG_ -$M?\]!Q_Y=?^E)^_:3'NI_&MO[]I<>^_\
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MJ)!%F>:Z(6S&]PQHKU9FJ)TQPZVJJ?D,2DX=6<H-/M+V@MN/"DS;^-"KXE?
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M@ @H":[XI-M%X=F)S(Z/@"3ERJI 3DP;O"$V+$.Z=)2<4O!4CM7)-9%=UME
M0-)#?VW&*EL?(PASZ$"+Q<$+P_!!Y)P*5L MAI0.:'* 2[,?B';XJ^$*^_AW
M4H)VITXPF" 7?&;OV2W)6/\ 9 "DT9KU@B>0316!C#I1_AR65199$8Z3 236
M/&VZ=3U+_<X5_-_0FB)D):=='H9N>+$XY ME9-M!4AH#K[Z#E;])Z6.<(?1
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M6-7,9SDZ3F0%>!T.U>T:H>U[F9Z<"Q5H]PV<N=-(7(-:1-192(V$?!<NK)U
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M# =8?$4/8?8DT.(;A$!>5UB@<HDJ%_$3\'GB2UL7F([F"@&EX(N:,#7&J0E
M22("]?FC)*,DE];%A)8)$=&%P:F7LV7TH0F;>WFU%+5%ULKRA8BR4X\+=8P.
MBY1T?!D74*4:&@/@*^EH;[VJ/3P26$.-$?/D!8R.="Q&=3*UD>-/&5Q94C[]
MF]!'>0FF,"62&)B"N[82B@S O8;B<7>>')0 $K&,I63J=BA"X&9<2CT#%J<+
M;.2SCIY/VI9" -XID;E@N1>@C<#KEQ7#(S%G9*L/NODP(  8!7.2N 26)?,#
M"CH/?Q]=DOPS"MK<(HO7W(<+HW9VO))J+?D(&R%^($O0QR/G)*W4Q^72L<D6
M6DE[&[E>_"5HXV,HWTY<56VM%G+J">3+,A0 J%+=OU,T]E5.**X]C\EQDR+:
M"U0J;>-!J;1.>.2\R'-OL<9_*:D,\>>(-=US]@1:!JT?EWO& ^A#DJ$U!VV]
MIY;<8(7#T%+X29.M $J>6#H>Y "]M1U,IJCZXHNT8&Y0N<=N]X@[]5JD-O9R
MP#6<ZN,NT&[^+71@R(='CQ2WYT'=PIS_ .H2)0(]WMQ 2A1M/1 N]^ID?!S,
M!6?]B"YE8\[7)HE<D;ZNP<C:49)=+1MKX3\N9HK%+5U9?G<(SP1N"O6"BS%8
M:Z(5/?Q7"5HZ2!VL/WW42VQP(H>S\QM=>X"2H2 5EUP:9.E4QY7>P#(U\-H.
M<).)PILIZL<XYW6G:2%N01HEZ"O7Q.F.' *5C-)[K6NXG3@4$K@CE(;%$"M9
MIAE+3JC\^L44G;&;1@KHS60:B67A#.XT4PC#X)8(&N%:[<246X.VINLQUHQ3
M]P\5;RS-)1!T:AKBN!-@%<43:2^N_P!X39Q.=X1(!JE2!W(FB7DN=2/0=-!9
M->SQP;F<U0Q"W:YS$(*7VT7.FR),+"2\,*,4C8 (]K[B"[&DXCGT7R>O[EJH
M<HW\,#MLH'=FK'+%R0"Q$$W48P2T4'&HBTPOO?PQS^)LA:!Y[=/0N5G,2*RL
M,-*PB_%Q=F?85UUY^K.<TP.77?6].><9B1TKHU1O"7B8\0P6DZ"C4<7%%+-]
M9W]CN\<9LNXV;OL_T845&8*LLS=.#/1!$^W'O3G Y!%$'>X>VMF]Y\[O+L[_
M '8N!4,V(2:-,;YSU05/OAVM7C'@$JM"RAJO?**K-#N?/K>W'& (A-(MIUUK
M3CC#@$L2XD!JAVP[P5(U=P=[<YR< BERMNC3KOG/F=Y=G?[L7"J 2I-P^ B^
M,]4$1[\>U>,:*FHM&RYIO#K-EW<F[[/]& J":X3J['9XXPX@@D)T$&O=.<)H
M1P#L<'>EGG.(TD#AVUUK;U9R[:93++DG/Y=*\C&0J &/1 0774!\'7DUCB:=
MG!-\^F&K-(FDTIUB<O'2AG8)'GBED7-,HS6(SU(J"A-$J8"C0^H&/"1:)<"E
M']OK;>0 E7 F 2KZ1/."281WV4AU+/B9?Z.%5.;\<Z9IT8Z!$M^S;BW2\E?4
MD4JTQ+R"Q-);)U%%3 A*&#=J&-<,6P-AH/AWU[T.#Z[(Y+$7GEE9%SQG#03$
MI#@F<%S-)XG>KVM]]=[=*M(\J!9+TDI-,4Q0G9*D.LG4![1B$3> KG N+6;H
M/EKC@,> TC&QTKS.Z5&TTG%6XJ[24+MB$<1),PD;,F-8$DQ4)K7[Y?,%C32Y
M_%1*X$DG(ZA *E<!I_$@Y*DN:Y6@9(26^U#BJ#D[+NYZ>*(@W> _-EQ+QY/U
ME?)*;:=9X)JGDP0#:PT)]D%+KGO^S_;!%VLHJ2JH$J H,8KGWM-K:T@F>_[/
M]L[V;AB4&J'&#2^Q^ /& 6>"8X>?*;/J1[2X#/$7Z(RF-K,7G%>ZJY*(M7@Q
M9Y7,\46>K=0Y[_L_VSW_ &?[9\E6W?)<9[_L_P!LO^3-H()KB"E!BJMK041(
MHFG/?]G^V1P4,J0E-M Q+]ZJ@@6\JZASW_9_MGO^S_;/?]G^V>_[/]L]_P!G
M^V>_[/\ ;/?]G^V>_P"S_;/?]G^V>_[/]L]_V?[9[_L_VSW_ &?[9[_L_P!L
M]_V?[9H]\WL;P[T_ )L""J,3OM#HW#!3-P -[-$KA\;YB_IJ0RR.5Q8A=B9V
M,7Y8-@(#4"%"R^-,W?8$H0(6\C"Q+2F%DYYY.:*CINR4)AQ4;;R8LRCFX!MD
MR]=_#""GEHC,0*Y/\10%:'Z4I;NS;D>RA!$8V:^G%A>_-&P9M25[YD\Y (U5
M*C[#RA>T]7)GX0>887I # (QP]^SE4>9[PH\L)AK)2BF31QCI5/$)3$HF I8
M=B17A1W%%IU?NJ,-@J'=;ID+ H D.*7A##USX8UI94%S1834"EH8;,BMV'G,
M:*+ =9<\4U+@$MA<$.SG('[+CFBO$Z %!6^:4<_".SMV!Q</D8.P\.6:142O
M.!;P<!5+R6/J-!&J6]F5E4$+>B$,K=M4HNR 4D[K&R]%$(O%'V</.V2#UTF8
M\(M!_*F-D9H\X&T+]ST14EB%GVLRH3&91\3ILW'7MD#+=I&%X#4EX)ECV[E'
M2;VS@/B.O>N +#.&U.T$&6,%?<B\N%C![,,=_*:D]U=]8,<5QBXF3,N4K;<C
MQ-3.P#(+6SY_2_'J]N;&YTH>^))U#YDB_I=;S*Q=3DQ5P6Z67)@L >9_^%O@
MK@ 5B64VDRO@JSC(%+=BGY9SKO![.7CHQL[T48N4Q8EA1:(IMAUE//@BJ,
MUE5\MT6G2%"\N'2F(S6XTR0$+./<LC<.O'N 7%.0F:IF*G0$,D6"B8'-(58<
M!S!W)-Q8$J[C'7ILALQM"K<6SNIWEEP85PS:JR$G.$RKKA7.TJN9O_R0'P91
MV-H;>=%Z*%S>.5R!Y#3O'EQ@@0$8">*SWCG(ICBO*TK8A@,$(78[WLC@[$%?
MRO;+;T <D?*>+IOV.FO@F;S15 X?BF!"N2;GB 0,4+C'R9,I*1$@X\UJ1$LH
M-'<;NC"P<? TZ?L#  ^(J06TR5#5,)&RW.XI&2@D9@BAJV)DN*SF$%A[A!E<
M?V:W@<)<N0$9A)WJPM&$ZEG"V$<FW!CEA-*69+4K-<1B=#?)9)K*/>'QH/Z[
MH/3]&X[,SCR;/AN#FJTUS.$_*6\,&SZU'_FGU7)'.?3@;440V:<>(L<$):U?
M +D*T#+[E_"3 ')"_@%.&0".\$RK/\W8U*-(L_ Q$YPA=R((.:H-'BIH\!;
M9B(@,D2W'XIXN2M(FL>63<F]7-)P-T>@2[[ N .F]NRNZX>"LJH"B@.*L*<@
MZSHQB;D['!8C,\D$(5H<) 5K4"!I(#JUC )C\\\':.07;@J3W<VYR_$5A2UZ
M*U-IU>4J&+S&.N]8$AA2Z"<]KH'"X*D6<A;PH"LBSE6I#!VMW7OW#@HG*D9
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MQ0FI:@66 ,Z8[;GUQVAZ.F#K34)4@K/I@B*=W<-3HA&IC3Q0?H).L8HE3\2
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M0%>[(EN^PW4P6_#3BS/<M)*#SB)R&!7'3N@@-H13=@ )V]UGBH6T9(FT"7@
M[T0I+_BH[$J4Y)3U*)3'#A.VL;@-H!^!J3NQ-N+N69[LCW9'NR"_5/H4^;/U
MB0%T[4O<:@F).P*J L[GB[Z9$51Q0^["!NS)04@N>[(!$)T\Y!M!G&!<!/#
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M.H/P% H 5& &U5T 8ZTC:"7O6I^ B9RP J&@&"_(C_7G8D\XM$;P<($"IW7
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MC>&^<Y>_739[]>7&%%>'A)  ,\9Y82GF-QQK9O?^.@4M$,W8OAGO%B7KKB4
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M1W&F;0W(G.Y!8*7, ,U :YCLG#6([S2UA4_5JU$#C#L=8N?@EDLE2S%NXKR
M*,MH8JRP8?J/#UID@,:M(BF DGUIPQ^5S_49_P!@&'ES<>S2 L-#W(83VU7'
M M)(NK*E6=!J:QGN_P!$GD):&7M5O1DGZ/+N'=]K[%_9HXTW(E<[;OURH?6,
MP9&:2YNC',AJBA/H%U3707=1%6%#E)=$31);X(UVNUSLP;\TD2GTNQ6-9-XN
MV7Z$8(+K&D_(=&8#056A!A8;:/RJQ3:UQM,3[E/JP/" X]C>EYO3:]X!PUEY
M2QW06VI61J^?OZBX+HT?+AJ?G3E.O"'*E&;OM*(/<R"VY9S;N7+XHL)U"&%]
MZ,([T2;;V8Z/ !+I.B6N#L&[U;BGJ]7HJKD(._P;:(0BHDQX8T8['32=QPL-
MF6SVI:T-1FOCX^[\'KJ[[&<:#P^!<5H36!1H-28Y8,;K))R^Q@9AAE_''MQV
M&\Y.,(Z[O&#;]A4+%&%7O<1.D6(3 F],O1^%0NQ. :]D0:#\Y8*F2B]\'[VA
M] 1F][9\8F_>EY8W7F3@L/+Y01J]J29"\%'W5<!*R36N*CU:M8WTF#?+ U*N
MEL!/][/X@5 \(SV*9_[?&_97)7*3*H7O)G4PP$H8EM8I 8!%Q+,I7Q=$6$L*
MX$]K(<;9+>VC<=@W"E^3E3>[DC#<FS$!#-4"KLM<UK8@]1BIE7;4#%<%W*$8
M8/F"MPP;]C8X:Q3D7R9$-#$!_1V:VF/W6O&$NV1G B,Q+4)N&66K9S\Q]1]2
M]C+$.YC,AK$'8M$=ZY.?0D)6(4H\KZMLV_1)R(!5*ORD;_0Q)'0\<9H$0HY2
M+B@2M.%K8'4\"<:TU$B3LBHF_P#&%V&X<@:V9YZ[ \%YSACJPRQS5/'T5EP2
MAD&ZN6RRDW=(PF=3UYJPVJ X<NAC+HNB3A[WLS2]PY:DDVR4*X'HWM'2 6S0
M[8S26UB)F@:@T0#G!@W0$<M)W0 &:=='\<?!28&&L^8>%B_OTJI$OX;JEI"J
M3L0,%R^]>Y/^O0^/C[OP<[980096%.G/!^+1HT:-&C1HT:-&BO7>*I]S*E,\
MJU^K\.C1HT00 T 0/0;_ *-1HT:-&C1HT:-&C1HT:-&C1HT:-&C1HT:-&C1H
MT:-&C1_ HT:-&C1HT25?Z.44>X_E*\V;-FS9LV;-FS9LV;-FS9H+0DV(*/D<
M^A?<[@/3!^!1HT:-&C19S2!T>P8O-N<_P ,H9/04E0QB;Q]2=##R[E\B$@2H
M2"6.G2Y#' +!W1Z,7K5D%=F4,?C!=MU N:8LMID2(1CUVA0:=!/.#O<Y*0-!
MQ6ZK5C\B,'DAV^S<8.-"N$"4L,]L^4)43"Q2J)']N+=IF"01&5PHRK18LO=$
MKN4GX%($PAZ4ED*)#;Q+<_G1KG3Y.'(Q.CB!P?[4 W08LID( =J3!RU06.!;
MPEDCP0"8=@.?\/V45(J.#EXQV'A0WA=LS]D1]KQT@OP*N" O$Z*I12IH!ZQK
M8ZM#7/SRE3?CVM)N\9G/:I8EWKS:X(N&D@"T"^<@Q3 8A29B)M-27L:V81.T
M$3D,M"*28&N,&0J-TXKL& DOBJ@*C4#2VM07759,+4?'G,B5NI89OH0,:\,6
MQ(#5#RP<XE:&\%Y(=XZ8 N,!:P8&X/ML&X<7$;++4)'<\#6\%7-=<:*T&Y'3
M.2[X7=,?Y-JWDS86G8GSDZ07!!'IW4#NB&;#B9LMY&\A84"@PZ6")>D;XC=$
MP?R+?FRW2F#1<0=EQ=TC6%1H8RW"K0+[)*O(<3Y,G/2HL</(S9TUM6IK5_:Z
MF\\8H?\ MU.#J\W<?LK!+N@8;QB)T25",VM %YRDS$S:VT4[ H.*.;\H+79X
MP*.6'-Z4!DRK (<- ]]4P*@*'S&://R0AT/UQJ[L #Q1)(\>ZK?IB6<72 Y1
M CQ<(I].LP.]SFI#U$'R=XQ10-E@E6(.(G*6D]3/GC'GP7=ZN0F_44Z=^QL)
M,.JDHA E\L&HKE;T-![<" X%*&/0$L\6"EW!NC"I19?(F^6,.".'V+O;M[F-
M@!8'<>+H>O0@^[&*3*[!*:Y=+O$3HLRFUK^6J=#/''ST-3;8"G-W5P>K1?0M
M2<F&Y8]SB<!Q2F9WPT+O9(U+%XQ .BF8]0T5OG/2#%)5LYW'01Q0B3=+:[7&
M!1RP9\RZ4GU:!#@P')[Z4S B-** _4)(SR%0PX-P@?DM"(5M4H%B6MNGE8D$
M$<L6$RD.K@\2<8&(,LY"Y(WR,(%86K;&FH!+)L<NS60S$]ZGY+AQ=\(>04@C
M=CA@!^*2L!K:+6ASF?\ :\WY-KQL=9VT1R!+;/;H C%QQ=W &]@)1K>(C,[F
M!R==7 '#+ELO+Y18&H7#_ISO(Q:8ZV.)H,YTMYH]BRS P#AK?,E5:#;GUM^#
M(NV1Z _&V+AHO:;8"AIN()W&G*H&4LIHJQ&U$W8]PGH\!EYG,V_H$\U%*&Z7
M3O+^-:/P539YV&%CP?(3,8>?I:\Y-PV*Z# 2BQN>O#2&IN7H98M!LJ%FRKFV
MZ@Y]WC^ 09V)Y64PR<<F;F0K]P2@86]TN@N5T !,,EO#2ZF#7A7H[RA2B_3^
MFRV$2'BI-_2H5XU!6H."0P\%;"O)'"70#*8S?TX1P+A2CO5$9((QFL$F<\&9
MBX;^ 4*\V77DSBA8#H)'%+2*]HS#&ADE0E>Q[ZW7Z.O=>0[@YQ=XE>PF4,;(
MP!N"D+!<O8:H8E?/QS;6B6!2YDV[(K",1]@C&2;;T --J5ZP)B=;!6YHZL4E
M#NM][B@ZD]/+U(_-;_TQ5$#?'%8N HC5,;>8:M4JG-()Q8Y7(S;,;]7NKLLI
M1,'I$F<\1'%Z'R!J*ZY@1V: X>Y.TTH, NCC#$1E1@"BG&QF%;I_X7?&%(_U
M/A70#[%2S5AZLBC6).%'!-2D,@?'!6)FP(BL[CN&[G7#'SU4#0!WI).:'_@D
MXK@B[\AU1M/RIK!HG5 \EQAZBNK'*[P!6)@+"%'SU?,2G@^Y?HL50#P:)Q]^
MY@AQR98*'RA1#LL@[(-",9DGS\7L]$^'N:K05<V:R?81\ZC\F,QN45EVMM (
MC:D*&.ZKS30-$M]+,>,@^+AE0L"-.>DJK(J>Q,+9!4 "3-N"[IZJF(W2(?<4
MJ((2:",Q"0@M-4Q_H'U&+A-%!#CRP :N%=4;6A@L3'?<9G$BU0BX$%J<+XY1
M;$@$Q:<JK,&4.B"=AVIJ(6A8\JW>:MDC2_HNGH>XKP9W>>0+U;:)N&">CSJ]
MB@K1SG@-CEM81F.]B K/>1;C**I6N6O,O%@AVNNU(&S#2;7SMHKQ(,WP,N3%
M1/0@[)=A_K8[M,1O)JIWLQM,!ON)0C0JP$ *R$!J<UU3)T6").#-S777,!)
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MA#H<; ;KK*:2D&EWA&D2'=X1P%D211)J"MOK#X>.<'.@\."!H&1N0@R_,;O
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MV=(%$5Z.],.9@*;;L/O;A& QFQM?S+W'L%A3\I[%9ACL-#+$41RXS\J.)57
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M8=F'[ 2/2$ -!B@;%AL*6(@U<5"58Z!'0D]U,5K:V%BJD,/87-::40TL1=<
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M-DF),@63ZHAQZ(^/^.1!R;=)STSAU^1PI3 >A._3:$;E_P 2W+1FU([2X16
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M('83]-0" H1$HCI$=(F    ! - ' >G2X5!4:E IFT._04$N  =]!KEP>$^
M#2#3X3IO6X@XI! 78#AH'QH./M=EKC6&L)4@-RZ.XJ^N:/U@%2E?HB5/Q-E.
M=<8%!KNY2=$Z0F3H:_8/X KTIW7SGF5[03KT;\E?8X!&.B"W#/V!_'1DX)#K
MYS;<!%$Z)]8[YU?G_$Z(=5A ^^P)P-5%:VYJO(/;/.<  PT!%0"*9"+DF\;H
M"[RZF@<7<MPO63J*F/;U.9SA/Y1>MI:FO!DHX2T\2!*D<X.&$0QK !(LM7G
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M7!*/0:YYN B,<HEF"WJ?[;?D( DRT_EP+"1VEI+YKGN'E\68Q'(#+I\HGOD
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MW- <[AOK(#H@N3FYL:LW0J#JB5OTQ**::G?H'L;=\\AY%P>975?%R!8MC8L
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M?$^O[/A.1-[:]I:P#NJL38Y-RY2J,7"MB8F,!L@W@P8$<2B(([$243%3F/\
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MB>HK:L,]W^S[+INM[@[=&@!R@[W^%5O+%E:,092;!Q8^7RPB_P#YW106E\
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M"S$06LPU+[P;QJUMM*EAXE\X-.'W)F< 0U -!T \!@LM4@2 >I4J5"GYG!%
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M*)=!O+TT\%,]\2)0Q[FH'5[*H\>!VGLDEZ9!$!E8!17MCA&I;_&)0("#\D'
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MF-PY;0?)V(*41Q.HM4UN$E[*&XC@["NQ98":EUA&$%J6@$XY>HV1+#&)86Z
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MS7PB*%DMCJ=:B.M'@H73JF3!8\$)-V:*V8?P%_- ZW\.L/Z&F,J#GO& P"F
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M[(-F21_F9^^!:32.C2''N%CP*)=_%Q(\;Z\/E1#0AVP,LXD YU*E;URPZ?\
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M 9 :'WY XDH33[%OW14$Q=':Z"X(8LW^H3LQ:+N\WH0-7(1%%0GHZJ_I1O\
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M%B=P[V'VGSYT=J/AYY"VU\29QH>;=^5<DU.Z=Z;N\-LX*:H[ U/BN$WX,_=
M"%N^(TX[\XZ1#GJ#^I'=Y:G$G(LM9W(T[7[*TU-% <C9Q-\RWQ3>LJ:!IX!G
MA75Y(1YMN0/(4-WQ6G'?G$6#('D.7S6U=^3'FEXIK9K.U=G=PR3]VA6' 4[I
MW]<B]LM&[":O<6M+F"@!4NWRE>[\) P+0NRNP=YMXN&DH'T*]FU.^@XM6L'U
M!;OQ)G&AYM[0O!-:-QW]3L-MY%H%AX'A\4T3?@SS KR0MWQ&G'?G>7, 0>0,
M\H[O+6O$V4 T#1S<\67Q76LH1CI.P13O!<\PVW>?0[Z%#PWH\D;YH#L/*;'?
MB1.-#S;I9:@FI#?S3:_4R, &O:Z?0N_3MG<TP D2'*%<G@Z,)"V:00)[^OCO
MO\HC:*>7Q/\ 9A F#+]E^^.<%V-^S_7G>; %#=CK17['W[7-_/*MU+/YU.<Y
MZ ,V_P ><1 V5^A1_AQ0)V++OF8".R7LMG\<Y1A'C>?TOW3^3$DG:?R^V-0I
M!EWO9^WX7=%_K;]C#6:VTZDOR<W7.LG$]/5.Q\^G.;$Z3]^/J^/1\8@=G9)K
MP?'OQSXQ8,"BO%\>^OY>!SGUQ;Z=W\GNZ-_ECH%NU?N!OWIHUK.!! <J!H<S
M3.UT%ABC%R0Q:IWW]08%-O8(Q&,WV:Y#V8[14GN/).=V>%FL"RM71W$6W<IJ
M&V1<*E:3OCLF[K?*VNUR%$K:^I8GN2([Q+:T33N(MNQJ-&%&9VBI/<>2<[L\
M+-8!EY)&(Q.^YZ!V+ W4M$,<8W='E;7;&KD('BM[D>=Z1N#F6-@:2;/27U5J
MNV-0%#3O-%]9#4X\U^%$8(1&Q/6(\QTFS %0ZO+>3N[ &Z:.YG# @.6@T.9I
MG:Z"PQ<@CL!KC6[O7"2&F);=H(Q&+;L>H>Q<[=4GN/).=V>%FL"RM5T[B<G<
MU"!6"XD@D:7T)5]VU7>/ *4=ZNV\N0X20DF))=#RW"#MV(1IHIK.!*@>0-#F
M:9VN@LU@F(Y$8C$[[GH/(Q1A%)P>"WB=[>]Q-I(FCKN:JV:Y@6#(9Y:/*!Z-
MP>.>(:_#IHC<7Z'QG_P&-$@;?:<?W\8KLH]8#EV<=O?(GX'ITUZ(?</7$=P-
MP@%9SLWGM.]UHUL78]@J?L>^5@^N!?:0X>3MQFEE"\O:+%[]S0L[&<DB3V5^
M\@?7+\X$]8_O?UQD^/./VA]3]FNQC[57NAC95X)-<^5\/C!ZE]MSOX>B^F/!
ML"2X [[/?/F#_>?(3_>?('^\^0G^\^0/]Y\A/]Y\P?[SY"?[SY _WA&D.\4U
M]GU+LUET$>R&--2-!ZQ7;G(3( -K86Z;I8ZW-1%<9<#GR\B=VN@A<G0O1 [.
MPZ3-N_=R:O<T78(\]UMO.N]P:EI.WAS[R;-&WNZ^0G^\^0G^\^0G^\^0G^\^
M0G^\^8/]Y\A/]Y\@?[Q877W/Q8TMG>P?8>=]':CP\3R%MKXDST'FW;EO3M.[
MYJF^&V25 ].P-3XKAY[,Y(/4(7?Q&G'?G'6(<] YZM[O+4XD&Z0XNY&G:_96
MFIHP:"[[3?,M\4WK65M T\"9X5U>2'K;\ \A0[^*TX[\Y' "0\AR^:VOU9W)
M^@V:?%:3NX:SS.:%0X"EVG?US@:A4-R(R]Q>P-RI0"+M\I7N_/;X1# M =E=
M@[S;Q>=8:R@?0KV1T[Z'%J5@]PMN_$F<:'FWL"\';1O\^IV&V['H%IX'A\4T
M>>S/."O)"[^(TX[\Y6P"#R!GE'=Y:^DV0-@'O<\67Q76M8&1EK.P13O*]X;;
MIMT*^A0\-Z/.GK07(/*6G?B3.-#S;I2-:=D W\TUOU,C !KVNGVN_3%K-L%B
M)J5"OL&<XD+9I! F;]=:[[X_#UDOS_D7WKG_ -SE> YX]/W_ -Y\>S;^Q4?2
MSI,Z]BXHSG=_GTVGV/V.WU_CALO@3[BW]NC[[IV[@>=<^O3=5_85GTRS<_K;
M]9,VYZGTN;.Y!S*EQTSIMS@SS_J_EFW.#?'(.;7GW_ QMJ?N]'UZ-JM)QV,\
M[_;IYWI_0V_7I2=X<.Y2\ZX]<KWH*^Q_;I2V_8[2?M^7G HVK] 3?O31K6<$
M" Y4#0YFD.UT%F+,7)#%JG=WKD$<,4W' 1B,C?8UR'L6=LJ3ER:<SGO/"S6)
M,K5Y;B<G<O8*R7"BM)WQV3EJO*VMMP+!*VOU(G?9(W$MK1Y;B<G8U*&%&9VZ
MI.7)IS.>\\+-8!FVDC$8G?<] [!P-IGHAAQC=T7E;>6-6$H'BM[B/.](W%VU
M; TDV;XE]5:6'&H 0T[S1?60U./-?A1&"$1L3Z(\@Z>3 52U>6\G=V "W@\9
M"0)#EH-#F:0[7068N01V%KC6[O7"2&F(;=H(Q&1OL>@]BYVZI.7)IS.>\\+-
M8%E:O+<3D[FI 5@Q)!(TOH2KWVVUSL"A'F7;>7(<)(3C$MK1Y;A#EV(1IHHS
M.!- <J#0YFF;ET%FL&Q<A&(Q.^YY!V!Q1A%IP::6\3O;WN0HD3E3N:JV:Y@6
M!WG<Z:/*!W2,'C3Q#7X8T3&OH14'H])/?1_H7%L];\;!6?4H$_?"E?@^X7W?
MSQ9"V&*OV(N!;8$]J.)I\ _9S7ZD/4>7S[X_N?QX&7]P>/Z5]L)5G[<ZPTM^
ME<3Y=\H*K?:?ZKE$;G/']S^&,2%?8;WY=L,6P>X3?Y=\5C8GG1<H*+?>_P"Z
MX BC]UG]+,1QO]8,.%^(X>/ZQ]^DY[466N Y?O\ M@&SN/V,*](CU'E^W[]"
M*'8G>M)_R^F#J^#[I^S^&?M_Y?A0V=Y [/#SOH[4>#A/(6V^DF>@^;'D+UW'
MR^:V]ER2H'IO0U/BO'V9][ %%^T:?7G'0(<YT'Y-[W=+7T@W:'UB%+W^RM-2
M"G #[3?:WQ3>M9:T#F]$SPWJ\D/6UX1Y"A^U2>EYN4@!J[V'+YCSY[YWH]1-
MFGQ73U:[8]8WH:!X&JU.YYQD&0E",B,O<KV!N5*(1=OE"]WYU\(@0J \5V/;
M;WYUAJ*!WT5W:CI;P[6H6!]0MOTDST'FV:@]1-<N]]ST%N[2B!9O0\/BK3QV
MSRH7DA?M$GUYRE #F] CRWN\M]I!3D ][GBR^-ZU@9"'T@#+V^Z+=WDT/WT4
M-M;T6NGK0VB/*6GZ2)Z#S;#2%:;B0W\T[^[(P :]AT^UWZ8LYMAM1-2H5[FF
M<XQ#9I!!QWZZUWWQ^&1U>P7T1OOGH8$I[7Z1QL?'7*Y7*Y7I7*Y7*Y7*Y7+E
M<KE<KE<KE<KERN5RN5_,3@B-3?81-\<TT:S@@2'*@:',TAVN@LQ1BYMHM4[N
MX<@C0Q*V. V(R-W1Y(^3G*:$Y<FG,Y[SPLUB#*U>6XG)W%\%9,%52#Q.R<N[
MRMK>< T%;7R;B=]DF\0VM'EN)R=B$@PMSTX3ER:<SGO/"S6!9MI-Q&5ON>AX
M,":L]%8<8W=%Y6UV<:H3@;*WN(\QT\F*M*V!I)LWQ+ZEI81* $=.\T+ZR&IQ
MYK\*(P4B-B?1'D'3R8"J6KRWD[NP'=PR4@D.6@T.9I#M=!9BP0CMM7&MW<.$
MD-,2W;0;B,C?8]!\G/3A.7)IS.>\\+-8!E:O+<3D[EU KIB @C2^357OMMWE
M< A'F6+]0.'48EM:/+<(<NQ-4:+<X4$!RH-#F:9N7068-BY#<1B=W9Y!X'%&
M$6G!IW7B=[>]S@&&;4O**K9HW L!WG<<:+R@=TC!XT\0U^'"X\OX3CVZ0U;R
M_:^>/[_R7>IB03Z"ZZ6&.]L]-XIGQH =D;[;+Z^'J><10B@;H1Y)V7>>"XO7
MW]O]8H+HE#=2^B<]K<%FU?/L%GV2><[B=5X]$=W]LH"-9_&_9N2!M>/#_%P-
MU(VU?>GV,Z-0.ZO$WCG^!]?C(88DWV[/K/9'SBKUQ<)/L2Z\Q]YXWH"V[7ZO
MV9SP.:Y7A>(UK[S#M 42 <A;]OW<99J$.\H#C<,([8I\VSGO_.>;Q]E\;_Q=
MG5?E"GM>C<U2MX/CXA^]^,Y7>9:5\S?H_?(F5<6LXW[#S[N=6Z5!O:D[C@MC
M0V:Q9K!4R%4WQ8/#3>!L*!6)-P7;33?US$$J53N-.5X8A!S5:+;ORNI.VLO!
MM'I-/=*/KZ3'H0"Z.$O+N\=WQB12RI5 ]4(+.=[\XE)IW7C[9Z,IY>F ">\:
M8?H$^KH3'JR'V?\ $N,2;2G[%]YT*O;%>&^/%/VGQV/+?8S?V49]<T([3S_M
MK_;-I$1\.C^G'IQBDT-AU-V3MO?OBP0X-\2'\!]C/4="?1M/K7[YK*R)]./M
MV\=L7*6%0["R_>'VQEVQM]V7[PP0(<.!![!OB0U] ^V"T.RV?S]YB-R'_$A6
M&?["1?;H_P!JQ>;\<V_2?&=VH4NMJZVM-7MBK16_ V#[GCL7"0M!%YK2QU9]
M-8(S13_C9Q:-33['W Y_\#-HD#QQX_\ LGI\8T&^$[F%>Q/MYP13F.+I)/>-
M\>N+]3O&PJ.KY&;WKCL$*B#ODOGYX_QLG5;'\HA]SH4@*ML\+S;]/C#V\1RX
M1LO-/JN<M'F.Z)OEKMO^\]+V;:&YS=M7??+:(ON_RK_C8> <-9]-'W??H"ZP
M+SKX]C]_CL+&1-[>+..)?/KDX?HO#=ZP9Z&SOAX_%1#N2CJ^3GOO!S:(6\V;
MOJ\^SO?^-J0,<']$U]WI%[Z5]+X@OUX^,0B5][_7KZ.5H)ZR$5OH<:WV[X:-
M(E$X3T^;=8\X/^-V+@XA/H/V:SUN!4G7? X\#]OC"\4;[T_LI[L$K<@PNT0>
M%;W?3:":4/+:UCK;J.M;R2P@3?8#NO\ C:52GC_1=SWSYN_O$NJ'F_''\K\;
MF' K>_3/<M\8"LU\D.P]B;FVOJS*01N&R\QR[N 6 5-I_;GS]-?XV$-5Y/W_
M *'MTGL03GE?R_H^,X=CR]@U]"?MD +BTV^P=<Z[>F6D!-2)XU_!,VHGA)/I
MJ?XV98N2SZ&CH^\M@YH_I\9$V_<%=3R[N<0K93-Z-CGCL^V^V%L-!>UJY-ZH
M4\:[9V,LW&E]-O\ ,MFO_?0 >%,:Y#PO^\JR5>7_ 'G''R]\C7N'/ISFQAQ8
MP6CU?]XJWL;7_?\ D'[9D@[3MZ9(1V8A P>.</CZ^X]O7QC75#6OMS@LL0_C
M$RWU/?\ R#4O&\XPWT&';QJ1C7:-9Q;KYYR8/71+OYN:M 5]7SZ>QDM3Y0<I
MUSEA_D!!7"YS)Q';?.++ [O; 'TW>]A]7VQZ$3PW7KB!/K7MB%0EW#7TS8HU
M=_M_D'[9@HX%-=S$:&O>,DCPN4G'O<.%!Z&+":-J.??*^UOYSB1.?2]O\@$'
MJ91*.\W@)6KO6+N#.>VO.%O1VY;//IFVY)HMSN_5N<](*#P[:_O_ "#]LRIY
M9_&>9SC,'<_;"O5-^1,:(4DP!H+=Y/;6M]O3CM_D JCDSVL46D3.7 :P*3NI
MB1'NKC8X2CE__FCW^4W_ (G6B-^AES4\S$R.0\>]XQ.:!D[WQC:)[>^\%'6P
MPPQ,WYR(O8>KX]'T<?!O*X84._SQ]>B@0[^W/O.\QKS&GSM]#"ZE[8FK3F=L
M;@@['DPTQ. R]/K_ #O%T'W6;N%*_@OX+G;X>^/X'?\ "/TG>.7W'B'H&*$B
MBU \OTT?7@RB!"HVS!\[F<>3=R@'V_0<*Q('K ,^N/;+5]N/WPXM<M0A". X
M)@%[7!JM*Y X"_\ 4<]5+R[SP\^^6>;=,0WPW^WWUT\Z+$T^Z\_OFE2"1WVV
M^F<O\>Z!0?7>6+N=J!W7QZ><\44/6$OU_C.,)E]'GYYRI6V=N.B2G$Y<^F)<
MOHCH"'UAQFSU!]W".QN'>>/P7\*=9D_!/P)^F7>XQ9S]'!HAU:7P2N,9&0\$
M#D9_7]W386E"'&/M) *LU].><F$IW[X*'Z]=OVZ],?[0%O[!#O\ +6+:IN_P
M,/A(*\AX.WSR]-Q,%N/43>1'3593GW\_)(PW)W*A]_.&3KX->.'U^^,S--/_
M (8^@=([KDQDJ5 EWMN!A56NR_7V-?7.[X7O[!#T_!?P;ERY<N7+ERY<N7+E
MRY<N7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+ERY<N
M7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+ERY?\ \=KYS8,>AK?N'>>E[O\ J7F^
MSTSAR0F/9"_<XV"]S9[0:>JQ(!CSM]/X>S$7W1'P]S_Z/I&7CN^GK_\ )KC.
M'A28]D/W+B\#PF_9#ISL<5 /U;?3Z./4:(^'N?\ T]HN28.^G._]0-<<X\"\
M)CV0_<LX<@)OV0FN=CZX_NF][Q]'_; 3W!']\_\ I[8LD0=].=O]0-'K7B7O
M8>T/W+G.'@"M^R$USHY_*+WO'T?1Z[Q=!R1^]6;P&H@[Z<\U_8./?%JJ.^'&
MR'[ES[8N@X*_:A-8?RF][Q]'T>N\Y? (W[JS?.AZ8<1>UI[U_8.,&VJ.^'&S
M^Y&WT@)4X5_:'_AG\HO>\?1]'KO(Y H;]U9OG0])AP+R&/=7]@P-M4=\.-_[
MD;XXGH-%?+V'_A[X&J?5_:^C@>!E#?NKVYT'IA\+R&/=7]B87[H[X>OF^S?&
M(NHU7R]A_P"'O0I*O.7T_E[L/(>QM[U[>@],Y>D!CW5OW&>GKO\ J>;[/3!4
MRT+Y=07_ $>]2M5YR]@'W+G#I!VMO>K;T'&+MC8,>AK?N,]/W?\ 4O-]GIBN
M8T+'H(7[N&/63O9>T'W+G#I [6WO5]@XP7,M@QZ&M^[E[9Z?N_ZGF^STQ<D:
M3'LA?N<>,'>R]H-/58D@!YV^C^SV8BC+8/AU3_Z>T9^.[_J>;[/3.'A28]D/
MW+B\#PFSVATYVO7%P!]6WTQ>HT1\/<_^GM%S*#OISN\WM&N.<>!>$Q[(?N6+
MT-B;]D.G.Q]<7^X/>\?1_P!L]1HCX>Y_]/;%DB#OISM_J!HUS7@7A,>R'[EE
M<@16_9":YT?7/YP>]X^CZ/7>"E#E'[U?_3%DF#OISMO[0X]Z\5.]A[0_<N?;
M.'P"M^R$UZ'/Y3>]X^CZ/7>+X.2-^ZLWZ,'43M:>]?V#CWQ:U1WPXV3]Y<^T
M'4."OVH?^&?RF][Q]'_;><N0$;]U9OG0],.)>0_45_8,&VJ.^'&S^Y&_:>@T
M5\O8?^'O0?N;WO'T?]L'@>0W[J]N=!Z8<"\ACW5_8,V=X=\.-_[D;XXQ[Q!7
M[4'\N,";?U88"(;V-/O5MZ!AA!R&?=6_9,/$GO\ K?\ R8^P.%?M0_RXP2;K
MSA@(@WL:?>K[ SG8 #/NK?LF>DGO^MD' +0OVH7[GC%"=^5'V_<6" 9\J?>K
M[!G_ -S_ /YBN. 7/0XP%XR//9Q+D<0Y'$1CSFR1N#;!F#;!F1E[9&7MFR1N
M;I&YLD;D;.^5XXS5HS-5C,B;>,C]\V2-S=(W.Q&X"\9&7MB6T<0VCB)SB)S^
MBS)\,;.^1ZQZ1ZQZ1_*$=\2=)&)E@#[?]8 G\M9^XS(0[9@-,$GR/!AS<N;Z
M?X9#Z;($>W]620[8_O/\N 8Q#?O_ +X#?O/\]&CRY4_)[X3\OQBO063A^K^6
M)RE.4\7RZS@^33H9L"'JOV$P:D(GK?!#N:)/'21!]4K<K^ @?=5LL?[E![0/
M[ M)5>:=ELOHD5]$UZ-IW<PX'=K5$X##?*':(\ [=C-)" :HB$$0VMULXQ$6
MCF\RWCY;#G6Y3^6:29KP3[H=.(.X>]1*-%G./U."F*6BB*DX"I3='+)]$Q!)
M)[(E<V;N\<N-%MJI>8.OBOG\)(8.-> :"_5>'L&"?"*>N$PKX5@B1/#=YZI2
M6O13.0?MCX+J/;:W26+PZ<&B\E[4XU]G.*74NVMR;M*=D-AO;D *@1[E]X_W
MG-UAY:;[[\]\4:2OV/NPI#7OO9OA,6=;UY\?0FMW>B=\"0-ASS8O$3=>7G'!
M;">]=KZ]WO[YLFFG.]T7QWOC D';V.W?B>._ ZN6'H/8ORU_O!\MQ[I=>^_;
M)S0$\^ ^G';_ %B@ER>Q-'_W@6>, K0V^KKCVCSS]6=\T]^P)['&^S],!H6_
M;A.GN2^-&\6/0=GK/V"?7.$,>'/<:_;MK1] $T)M^N]>L=\!VH;[N5]N_P"8
M7.WW+V_ZSY_VS]]F>EA/R'P8<L/V?#^)E\F\=,/W_P#EPQCY_KG\?^?@:&H^
M3^.I73]VZBE3QX\7R:=$"CT?4P42QT>32E6OO/#IL]T_4"?WDTYUIV\J)MW?
M$. SBL9V1X=FU0H^-3=,"D[A!![#1DP$,:$*\^&V;K2.\M!V6U44*^*8>K;B
M0$)NW>PX7]@0<1_(H@?MP]W!$2FQ$64IRH:^R5Q0+B)Q))?@ '.M-R9H]8"T
M[OD+MDU $)Z+5X5?0T';?=7\"S!Q#W']SR)WS1A('8KR>55?^8S.2/L_UE1/
M->Y:^N]O?GG#0'[")U)=\9J#<>J6! G/;P:]]0;D(]C>_G6GZ<ARM[3B<GE_
M;"(>*=U#=M)VU/K@!BV-N@U/V=^Y)W[)3ZNWV^^> -\:=F]4^AV['%MMG[@_
M??W,M^S9SIK?&GGO],2Y-T#;>>.VF3RL&6\V >VM!+WIXC;SC3?5W>3VEL5^
MIG G6EO?_9EKVNKN$-/KSVK"8!21\)-]SE=:<(6O/[?[KZ9W(J2R>QP-O:)F
MCKQ/$139WXB^5F#05T\^7+QIT\+Z97]T/"=M.?7.$\OE_P!;SUE@Y(4:?!&>
MCOC YA._G?'_ ,\/YA<[?<O;_K/G_;/WV9Z6$_(?!ARP_9\/XF7R;QTP_?\
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MD[/;T[N,&"E\"[?H8S6N \'8>@0/0Z/(DJG>,?O'[=#1B"1P[NKV:>%';'J
MFK\$>Y!^V.!=1XU5[<[>'DP![4V]J<:GCRP.J1$*:8/(QE&=Q)FHFT/!IH^?
M0P8<]V3U?3S[8]YI-+WT["]Q]=9;P &=AEUNW7M[81-A"^9&_4>^\(3Y/3DN
MN#GGT3OB^EX[\=G42[LTY&YJETWZQ.2OA]V\\U^YM1<=NWL&+ !\+)+^SU,
M-R;]1UJ>+W[\8"-#3LWW::F^_9PYV1^^_P!?=Q*W9<UYIMNN-=MO?",,]^^H
M)[R)7>:SS57]HHT32SUYQY6DWS"MX_OQ@Z1I^OZ?VW^V:^6I^M#31&E_:S!G
MMV&]>OC[>?RFDWI=NUXB><#5/K]57N]>]PV4([>'QLW]\6A0>5:\M_Q,UXZT
M'GUJU@A)H0_VL"H2XXT!W7QYSR\XCI ]5UYQ8RUH;L#L/&+G4KL;OV&=H[MY
M2>9/I@@.4][)YD^F>&@Z9(F]\^XRN#P1T>[EW=\D 4"/ESR[^<''#VK][^^<
M2D'EJ+N>7O<^IFCI^S]L4]<T=/V?M@IPZ+>YN_3M,5DI/+=\CSXF1;&)&=N.
M7;SD[%#J-3CEV\YW&CF@(&M\Z[W!,2SMX?9-ZQ8#E.[9/,GTP 81H;2G=><)
M$D:&T$[KSD2B6G&O=<BT(:>B>O\ ^W?_V@ ( 0,# 3\A_P#SF'SX&G:%/$1T
M$Q+SM Z#M+H_[!:: 6<0":'A>FN\$8VU8=LUW(KM ;Y"0#L <$!PP93!\PE(
M/A#;3DVQ!BB0VWFBP-0=DQ^ *(%2([*EV'V+7)Z"'T!=H]@LP;A>I$]DJD"5
M(N%I+]K,#Z@A:&>50_-^T2Z1["#'K)K@V"-)FE$JP%,8@@HBT%O\G#&X@P(
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MF_#LFM_EM$B08R:/QT"*+3C)+DITUS, 92L@1;,$<*M@0FH%QQE(4.H:'DE
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MTI0#SFR28Y#OP^."FF$::<T0G("2\&3"I =]8&G"9-JC,XFRM2T*($FKZQ2
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M9,G1-S)DR9#)DUB3)B3)T3)@7)N=2=0+T3 IB3HF3HF>C\$09-#+Z>]@/IZ
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ML"<Y1 L86L8,QZ*8IN4;')7T6!SH]#:\!M9FHLHI5PA=!*DHG.!DVI#6+-O
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M"]BA*>S6!X(T#[L"KT:TRUPB&;&=P D\&Q:-I4^&\7WPMKGM$ZGH&;+Y#Z#
M]#%')L+=G$TUS1OP32[\*K7#VF1!N'3;Z&@439K5P:*&EQ2 '@<TT[T&PKC>
ML8,OM?$<GHZ>T%FATT=+L@:K6; S<B#A\@ CDN9;DPIM/FU )@["+=H?<='D
MADMO<@<@6!EOFVQ">-N>N\<L@.E#4'B6+NX0*3,"1\#&AZQ;R=HJGI600B;V
MU>QH*4Z(B$U(J:-"C12I@%&IK2;,7=B!/>=B63[VCO>S652O C=DUL.,W6L,
MK)@J<&H(R_:KP1V110V"HHM^D3EQ-\Y_=[/ACD?\F>.@YR9,F3)O)TCASFN@
MR?;)DQR;PR=^B9/MDQ)T3SDZ)T3)]\29-7)DZ#.,F=\F3ADUB3)DZ)U$F3)T
M.&<9,/LR9.B9-SH\89ZY,><3MDR=$Q)G;\O<6.MRY<N7+>MRX.7+ERY<-9<N
M7+EQ;ERY<N7+ERXN+<NIER];EW<N7=RY<N7+ERY<6Y<N7+G:9<N7=Z7%\9>J
MWK<<N[@S+ERY<OZ$9ZY#'$,G1,DR3)K N3)K#C-9,,F3HF3''T_P\Z7'+NY<
MOWR]%RN#,N7.V7+UN+O67JO^#I^!/BGP=_BGQ:^*9W^.=9TF=L[_ !=OCG2?
M!.G?I.O?)UGQB&4Q3Q_DUU/SO;)UYWDR'0YZ!DQ_)=\>AZY,F3'#C)DR8_D#
MG.<>G;UR9K)T[9-Y,G^07](8=LOIU&7TP1>.N@R^F/%_)KZ8(O'709?3'B]#
MG+Z93QCS\4^%^(XN7TS2=6#)E].HR^F"/;\J=;UOQ\NG9[=#O[=.75X/RQRZ
MO!T_M\)R^&?#/P1P]>73L]NAWZ<OT*G?+X8MZ#,OAE/'6DWE\,74/R0S+X91
MVZTD<OABZAT-.7PR^&.W\*_&/9R^&4[=:/)E\,6]!F7PRGC_ ,)TZ$\=#H*Z
MZG0R4^$R9/CGP&^@KKJ=#)3H<]1T_D22O1I.K'0]#UZ-OT+ET[/;H=_;IRZO
M!^.W\;EU>#I_;H<]>7QZ_$'#UY=.SVZ=WMTY?H370OCH>O01UU-]#)#\2_$:
MZ"'KJ;Z&2'0YZCM_(DD>C0:ZM9]6/IT)WSZLT_\ "89/+$G0+D\LAUAWR>6)
MW_)!>B+K";Z$U3H9,3#I_5-9/P>73L]NAW]NG+J\'X"9/BF3)\+EU>#I_;H<
M]>7Z\Q[Y#S\!#S@!WZZ3(><>)^30\X0>>NDR'G&2=#G(><AYQY_\Z3)T"Y,F
M3I-9,F3]!F3H9,F3H%R:R9/U"Y>EF7+EZ7+ER_H-R].,OG+ERY<N7+^C3\$+
MD]<]WP)ZXDZ!=9/7/=^#,G6=9DR=9D^&?$;R>N3UZSOD]<G?K#SD/.)/Q[\5
MR];UO2]+TOP7\'N]NG+J]NCP^ .<>?CN7I>EZ7I?@N7+TOX'+H<X\]/[?"Y=
M.7XFNDR9/PITGQ3\<#K*'0\=.63 WCS^!W_,<LK(X\].<5G'4E>V?1G+_P '
MGXX7*RNM96(G3G*ROCGP3XY\/ITGX-974%RL4=:Z./R5RY<N7K>MZ7K?A<N/
MQ]WMTY=7MT>'P!SCS^!>MZ7K<OXK\ <X\]/[?"Y=.7X<Z3)\'?X)G?I.DZSI
M.LZ3K,GQ?TR. WJFC(X\'3ED<!N//X,R9/CGPS)\.O@*P&X\].?JRLDVZHW*
MSE^+?P;^H[^+>;_1;EZW\"Y?AOX3U<N/Y:]+TN7K<O2]+^@G69/@GQS)D_QJ
M_!?_ -]09$OX,OX/.1_2HG/Q1ZR_H'9T&\T_?#7OT[_7#?3M],.G^LF\_P!8
M]'G-=//1YR9_.?\ <[>F?VSM],F=L>AYSOG\YWS_ %G?.V/'UZ?SAG;TR8\Y
MZ=^K_71/OT?SDS_N?ZP]//36'.>F?ZZ.V:_?''C)OZYV^F'&=\_F9K'Q^>"?
MB3\L>GZ#9^E'X'?KKH]+^KW\=_$F:R9/P)UGPN3X)_AUZ7I?P+^)?\/GXK\/
M?K/R+\,^&?F9DSODZS)UG28=9^+]&>XSW&>XSW&>XSW&3U,GJ9[C/<9[C/<9
M[C/<9[C/<9[C/<9[C/<9[C/<9[C/<9[C/<9[C/<9[C/<9[C/HZ&\GJ9/4SW&
M>XSW&>XSW&>XSW&>XSW&>XR>IGN,GJ9[C/<9[C/<9[C/<9[C/<9[C/<9[C)Z
MF3U,G0.^3U,GJ9/4R>ID]3/<9[C/<9/4R>ID]3)ZF3U,GJ9/4R>ID]3)ZF3U
M,GJ9/4SW&3U,GJ9/4R>ID]3)ZF)/P>7Y(_&Y=.7YWNZ?V_._T_!Y?@^GX/;\
M;ETY?G>[I_;\[_3\'E^ ?A/XW+IR_.]W3^WYW^GX/+\#M^#V_'Y=.7YWNZ?V
M_._T_!Y?H'+IR_.]W3^WYW^GX-9<K*RLK*RLN7+ERY7*Y7-YO*Y7*Y7*Y7*Y
M7*Y65RN5RN5YZ%ROC*Y7*Y7*Y7*Y?#+X965RN5R^&5RN5RLKHKE97*Y65RN;
MZ"\&5RN5\97*Y7*Y7QE<KE97*ROC*^/@%965E965E9<N7%OY8_O&=L.+XS<,
M[N''US7/KGG#ASOCSGKAA_?3EGG#MG]L.)C_ %G^L>V/.-NLWJ9SK/7TSG[8
M<.'.'&=^C+C=YV,?[SW\9Q]L<[3H<8WOT'8PQ_O/-SMFMX?MCGGQCG\X<.':
MX^F=LU7/XQYQMSM,\><\8\_HU^"OP7I7*_!;ERY<O2Y7X*_!7*Y>E>E^*O6N
M5^&N5ROX%ZU_\#OZ7P+_ !G]2G[O'UPQ405A8>7QD?!)C'V\Y#W3"HKD;=>4
M?SEF@[)'[9N:,LC9[9ZDT$_QGJ;429W!O+-7Q>+E-J66:OBYHZ90C4\AW,1#
MKX*K],3'7P57V,*,:DF[[9H6KQ/W>/KGHCMJ3WXST1VU/OQ@IQQ,T^WG-/L"
M=^WGZ8.,GDJGN8*E3R53W,[)ZI&AY?!CL9!=%UYSO+>6:OB^<]2:*/YSW((C
M^<HEZA,8@5.Y.L9>WYT3P=.!FG(XHB1Q1 CCP"94TP(@5S1HX],[:^GO@I08
MY$8\YP:=\9/D==)W3KGT]\0Y'C(YZ;LN"T"N)E1GY3]ST(OEGC'R3Q^.^RSM
M^F?R7I^"H_*_=^M$M?@5&*O9UN;<#<T57OBI(_.Y;'MG4$N50"XZ6^8K3IWC
MU6M*>@5-HIO'CLEA,C5,<(IR&#$8$[K,N1*D)9Q5?*-R5(=;04/(M-+K&-],
M0-EHN#M%40#5MT7Q$7$$3P=Y0PAH3R"*1^0\QDTT A!E/-/A(QMSWC;ELXI[
M"P1VBG*TDE\].-Z_G> (L'(C1#[6Y.8HO,AU3TGN]8)0L-YA0C]KE8:B4X2_
MPL &:6Y?0("W[Z),*TI4% =@2([,G%4=[G9J($V,T@=X$A18=NGN2_;?Y Q;
M#T8()$Q6F".1O774#+;<A32)KD8+": @=V@9IDK8Y]S8415><4<.'0L ;^%V
MQ-#I031)A7>2I@N9L"> HF//A;4.;';P50JEQCJA(D.V5FS89[B3.< (,,D)
M^NP%>F,^"9$J"5:F*/VUU.WP-JD31PSI0:$4"5.0P.Y+=E\ZR+ZCM2N^Y2'&
MU%=\;XM1RX%#)@&M E VP-:MCC>QD-(KEFHEQ2\%2RR1*R,'T(P%G9OK&D[1
M.,NKG!2U\2V(1#TT"Q!Q$> @V2V&N\)I-JZ2H"P.\+! ]R&='M!1MY$*W6J&
MB%F2MVZV[3(=@OZW\G^YZ$7RSQCY)X_'?99V_3/Y+T_!4?E?N_6B6OQ*C$7^
M^F+_ #/S\:^:C_(S B%C71C1/*$-(CD';;E@!$!,75B,\EO[1O*4)=6AO&;:
M6!5:Y)JL*%/SE\SH5$=J)7/("AAH%X;HH-@J-NG2*%(0&F18 4!9E%O&(BK
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M3&84 1:H$PS1$?!]B.7L!T=,#HEW,"BDBERZ%&?/2%3D0-"+#1.E8H(D87F
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MH$)8F@Y1> X_6KJ?Y_,G_P"(_P#_V@ , P$  A$#$0  $
M
M
M                                                   0T>MRF+'H
M#2D                                       !Z6&S-[1=KC<P
M        *B                        RG]&1/$DJB*2             !
MUJ"1:!:#;;:*(0                                     7B7^LIL]M
ME_QV@                                     !8UA];H/P%P=ML
M                                  6LF]C>^UMFCM]@
M                          *!(:"07"8#8 8
M                      !_R9 (2*            !,"2++ 2)_@YQNP*
M               "                  /^YM1X'&1]%<D#)0
M                          2:P'SO:+F*29(TKB4HP      "  !
M     (           !%KZO9QHNN@LV_#I0M\       "22"90::2!::2;  &
M(>0                               +]'NZ^?/TZ&G['0 !=)7@
M.BL%06   !JEHS8C"0       !)9QPXFN))))):U^0         !#EL\^$K@
M +T)VXFS>    !/P  $DK,;^!-;57<(+F10JC      '/!_\X*: !US%8Z*"
M0    )T  !1AS(+/6'S1A3N"          !G(@ '%XP (D@Q 32P    !O0
M %7$B/LORLNT!RW@          /2I:X_$@  @?)%>&       .   ^WMWWW=
MNVZ_L6<           O1&(K-T@ )1Y,,3?Z     M@
M         )!0(;80*" *           .D  !X+S2
M M\NM'FYMP^\X          .0    85P                    #;:3);2"
M89:20         (D  !6M,0NSP                  +!0"731#9;3"20
M     !1P  (;N;TF^                  +/&!(E29C;.: P        &P
M !7D                      !)99(;;++03*;#(1"     ! 0  '(0
M                  )30"13#92()1*(9:0     #"  !]"
M          8;132P#2A9(          !(P  ".
M (!() !( ")#           "2  !&(                      !92 >*;X
M9Y"Q(":*9J     ?P  */                       +3;;+9::299322;9
M;0    $6  !R                       !8 !R2":"#:]0J)"+!2    D0
M  /70                      #;*_X)(0(+9 #9+3+20   $T  !5P
M                   #/OQ!2 &0
M          (   ()#991)!))))))(
M  (5O) ! 1IQ                                         )RU%( !
M * !    )                                   !2R+W  2(+" E2;8
MM@                                  %_<,( !  !(()
M                           !$Y(< !3*8:Z10(*>:0
M                   +VIE   ! )!) )((((
M          !.Y:$ !;;"*0#1:##+:0
M  *1;90   (!(
M                                             #1!
M                                     3CIET_
M                            )!*)#(
M                    );;1 999!1+08 ;P:*
M            )()! ) ) (!  )(()
M   *:;;H18#30                                          ((!)(
M)                 !)!       (0(! ,W*          (:1)Q9*:3!.2Y3
M3       !2(H/+301"+0"8;(!X30          ))) (((((!)(!!0
M+:2!38;8:332::30/*:                                "0*B9**3#
M(*" 0)!!@*0
M                                  .
M                     *   !3;;/[1+4+;>*3;;;;;;;;;;;;;;;;;;;'9
M>%I]JBRMJQ;;:    )R8)%WR/&043[K;;;;;;;;;;;;;;;;;;4<FU.WK#$1]
MRK;;0    HD!\WVH.^Q6LE;;;;;;;;;;;;;;;;;;;./DR%4UX<[AY;;:
M&DDDDDD\DETDDDDDDDDDDDDDDDDDDDDDETDDDDDDDDELDDDB   !#"!;*32;
M+:;;:232228+;;::29;202;3;33023(:21;;;#80  !8"3/+C"9*V<N3,::2
M!0:?&8(5Z),SF>&9:%;2799S<>X3W5<                #0  (
M                         :!#14"[R<" 4(<%#01+9(S1:)X)4)1:%<99
M!< 0'B6+;D63NX5N  (
M        !%H[0=2'*+92 1 *883))%-)):18)(*)A:%13!<#*:
M U; 2:;#+8";09  9011;(#!(")8!2)(# 0?#A)+8*                0S
M#":89!2+*1                                       *U# 0((8D;!
M10                            0    *!#":+;""13":+29(1*9:3(%*
M)#30 8309*0=81:18!2  7     ! (1!)!( !())(   ))! (0  !)()((()
M )() ( !"(  !0    !298     +0?2)J"        "1(1 >:         (1
M[Y1                  0 ((         ((1)()       !! *)(!
M !+#0)9   ) #!!YP#+!#0   0(+"#( 2)2900 !*)H (        # )3;;
M !!!00.,!*"819   *0! R:)!(*(2    ,( *                #B!F!LP
M    !   -P-@(_0 )( "0 +H)]!=P
M                            (   ((  +"+*!) !1"!+9  80)((! ((
M ( ! #"(8180       *1;9:"0 !!!10" !99;8;#0(*0! ":*1#283690!(
M( *         ! !(   +"#"!)  *+1#   98) )       ( +")(190
M                                                       (!
M  ** *  0       !(0!*+!                      #9!:390 !!!18*
M 07+::28(*0 !22                      (  !!(  ! +)!XP!(()(!)
M20#8!(
M                                      !0()*"
M X#19*;0                     !)1)81:*               #!0!* "
M  #1:8!;:02*(;;3:3230 L D0,J  1;;0;:2+2:3  "L0?P#    !3:++8<
M#!08)9 (01 *  0$ )9 !+89"+(#; +*0  3@ ("10   !*=3*#1!+"!**3"
M#0  !2 J 88  #;883(2      /, :Q)*    ! )((!)(!(  )9))
M      !                      0 !)(((!+))0 (!*: #: ;!:0 *0"3+
M321:3292(*D!=1!*    +(01::2#9:#!3+81"0! 0$ ))  +2()!  )""(!:
M1S@ ,"10   !!! 1)  110)!88) )0(* Q!*( !("22 :3 ::/82/T VP30
M   ";*23:33;0+2:213;3 #0*:(;  (33:303089++( +8+2)+     12(:8
M+#"#86*#!0)8P          091)!)+(#0              !  8;!)
M                                     !#300":222
M
M
M
M                                                       V+ *
M:   *( "  (  !!"    (   (+0 !2*(              ,B\VW)EY613CY@
MR\>0KTM\ +"/]%,W0U:6$GU=              <03;#++8")32;029#+ 391
M"883!3#0:2:11;:2+13:3:390    *#=*1;(9)1:+"2!03'(;6"" +#9"0:8
M+ &X;1 223+*+K**0   ! 9!1 #01!)0:!                     (  !
M   (        ";:;2":;2:;3;;   !
M   !;";9+;;*X2;     !!6 3" :"#92+#0 *0 +0#+*X *9((     ((()
M)()! !)))))!#)!( )( (!  )(300#  (I"& !) !28   !P   "    0
M  !90             .*             !    .   !0          +*
M         !Q0             (   !P  !*   "      !90
M .*             !    .               +*             !Q0
M        (   !P  (0   *      !90             ."             !
M    "6VV[;; (!>DNETO91UWWVLF^OWWGFUWC=]^WW]_WME__P!M\@
M   ##?1N*=F&@!YSS=* HBU<FF/3$\D?1$M$ON                 4&@VV
M@BR$T8RDVT6DBFFFRRTFPFF4T2V6F$
M                                  =$2PR4B"< D76P&2 0@022"
M  0@7CUI=LK+6_G]@        #G8D.:MG5][0]A T61MV8R40   29G!V J2
MZAZ\*M<          >@6KY$_KU>4SS29"B*(@@LO   !;]@#-DN2F0;Z!OK
M        !T"U?(G]>KRF>:3(              "L2#<(=4@@%XX      "[D
M2@6KY$_KU>4SS29""B"  =AF9&X8( 4\-F>I=3D![%@00    5XB4"U?(G]>
MKRF>:3("&V"@"H,9&"!ZP $4<N=(QR:0  ":    "]@;"&+Y^ZPVB/ F+%@
M
M                             &P
M                     VD
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MV\TVQAQBFB,=0\PN40*8ETZ-%HOP;((= W,./ *_>XR[W48%/)I4F;HQ2C%
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M2)QG!X#4P@MDDV1QC &D<(*1(Y05UO+).K[:K;MO_HQ-65,85 J'6:&M9XO
M;.E92"(YP@A+(T=";0A:O. @ LP#*2U53'<[SQ\E5Q+(Q55A^7APP#I0(Z_=
MX9J^7V(S>Y1JY9B/$Y&=T]BL3!&'R(AZ3[5R,R_0?3ML7?\ =B("5XBYQ$[A
M)CZ^N^0>[R!$5+X)R;'+?'8(L$=QAW1KKNBG<C<A_*MFXL&SUHY<D";8I=][
M%A_\S1*<.*/-K97WAE&( RU2_C-#$0G2U(ER^<=M2@^!8-H#H]3GEAT)[4QY
MBA>"J9SOESF>Q,>V[FAX$?JJ*+MPCD2%VT%7LGIKG*IS8]JIAF/R\7TEVNK0
M2]F%)2*=47D,4 XEOJ,RA<8F[@XH?^/0E0K[E0#?#(]F*QO2[?4. CN2VJD7
MY$O$8>4:&Q,M2!3!>- AC"JVI&G5-XVV/X1G[7Q% (^MJ1Z3FL'"ZV'85=_*
M3_6&Z,/3L45F4J%@#&4).ZVR;'MDP,4+EZ][I"T_2^_5J 2%FH1!R8&C3Y-L
M"UI!M=&%@[/,E!?(*VD'9)H+".#5;MRQ?0B-TXV\;L,N8+RC&[RL6"ZR.3N-
M _>24,4P.8'XKCNQW;B<^7,#='JW?4J[1CHL^6*4'-+2"=\F!NB!ZZ]C_ JO
M&(#C7\V:NI,Q3 Y@<P.8',#F!S Y@<P.8',#F!S Y@<P/NUQ8[NA/!M[\?@'
MG#JZY -I:.G0R"+\ORQ7J@/QQ&Q=]^7_ )V6>;/YGF'51]C*(YU@_B@@<T)S
M&Z>"-#NM(ZIK-A^17+(9:18UT*A??'W0N$D;'K1=YF('PN0:CI;]7Q(/TNKH
MA5T@%J@14PN=XOUC98GB"8:Y4MK6# ._7?Z=O#BE"D9R:H<6;B!];,)!Q.U<
MFE>JTSP2H1.'P8?$G:>N:?LG,*Y#T#G$O/%<@QE82(; B9[9:3)!3 $]>W20
M=C6\ 0[,D[)E0J& #"<KU#.(?EK%"M<EE-@SD$>32SVNN]M=? YKX12[]R X
MH,37$6?:J:=D<<[AQ@1[31P'@P.-'I('W6=*W!RO[(<3E&K/D&4WDE5<D&W?
M"_/7T4S?=%0D0&=3_%JC8I83,E4T 2@'J,'?REF!CUILQB1S^<'2C/?DRN02
M&HOC%Q$\^OT?$0I/A+,ZJ:K>WRP,:>JSFGY&0$3 *7Q_61O.=P:\N*3Z&_D'
M:D4O8P" ?6=:0P*XGI(Y_F@+(I'OO,80ALR%*_2B0U%X( +A494XDS3> MF]
M%>V6"'RLB)P9J^M*NE'V8/0*;<J&@&"&.XB;*Q#V^/G-2!8J ,P+W7U$H+X%
MR$PCG)>(P.RR *88#^<GL.=U  QTTM^K0<&&J[&PQ.NO8$)* HZ#_9I&\5G'
MUQ&@I'IT\8<M@0.'CT_8MI_F1Z]_R*$*YY9;8- 1,$A6][5;B;F=2@>'.!3E
MLUAJZX@[CS"-Y1 :,2M\;%HL9][HMN@4EHN5+"Z#,U4]W@<-$%$0R>S(+N@T
MFUW. 6L%D(NQ["Y.N+-WD'Y0UX%#]WQW /MU6<F 'DL\![:OH$_&UK/A7P51
M'<@>B[GR](QT@XDH=H(S';6B9IPR5N1HE!@@S ;>[PVYQ(3=:@FI1$NG5"7#
M"B">2PSZ:>PXB3?)(TEKT- U/#0L!*^TA)5C?)"*8)&HYV%"AL;SF6_!V* F
MC#N#8D+!)HS'50)%!7*L&_T9%Q=%-!D4&2%P=CTS:>%KP,HRIFQ:*+XYQ: N
M%^U)( SY[)B*?Y<W:0; VYY]\LJNNLB2.E]_:?+W8_G6F,F1HCK-Z\OF!J8G
MN#^HT'(%#*$=\^28Q%<'2\ I0EN"X3>5<7\WAEN9*DLA"MLKY1B/N>I<@ GK
MQ0>U'<%'_IQGFB-:U]OWT+C&2\A?M'P#"6<O(\B;12+1QR9M?N[<H@[E8<,6
MIKK0*58\Y-5V>> ;N!>;0W.I,RG#VW JY2.V'QHS463 '):M:H[4_J SA^@Q
M0W*&X3*3!" *DU4!'61*S4E_).4)477-^V(K;=FB:GQA<+D\B#+,R@HU'\:7
M\ZQHVAO'63)R$G@?[77N!RML#7.&B=A!\E]+1GBOMKW*,)OKGD(F) D <!-D
M20W;QR(Y58B^()='R!FFB3#PO &T#K%&I,*7(ZL?2D@!T,2"-(JZ&P6@P"A2
M?R0,C!N'L4$DT="F?-:!<BYSJ/=0*R@J7]&;?5 3]$4,!%)>NMP;:2LT/5;S
M(V\I+$A2/#J(X4Z";B+[- ?Z-WR@,EU'I0E#H11+<V9B*P \4'+Z$DDIV_>E
M-B-!  PE^!IS+AA;N%TO568U62( RQHAI5WOUUPC!$;))(Z9.7:DGAQYN$7A
MX;(<4^(J,EN/ DY> JCLT_Q$V961OHXE-3Q.RUV><797A>"$T)DP#*L!K",)
MMP38"^T\4U^!?6,A)BL4^ BTC/9!D6WF.$HYKG+KBG,?1NJ:D_;L-#W*H$&7
MGO6V7TW:,3_XH&H&P)T\&F;4O9*+K )?Y.^\MU?DY..W+OTVC2>I6C:XQE,]
M ZXTO=DD#XQ:H! 4:HR=FKDFHWDA 'C0&R6RPZ@0A9K7S/CG8 <A:0@ #C]/
MOTW=?,Z.JA*80- R4??$P#;"$]T$>\67V"/&L_,R""1,=C9%BR&IQP=$6AC?
M@F[<=PK"!I)ER2C7@=,K6XHX%;\PZ/I"BI4DF1J6Y[9"T'$-9(EEQASEM-AS
M*Y.2-#^Q0//LP)@PN$F.<\?->\NVV<<P$OK&;@UFE(Q_('86'10\N)93$;<7
M@8CE(ZEK039F7UV.]*,YDH1!NI[NF2;(:Q:2.!GI&AJR](GBKX@-".[H#H<%
M5,RW,XW^Q=$L@REMQF,).1C##7SD68,$>G3%1;IQ&V1/G!S(U8QKYR0"E#I!
MTV,83QVT@LOZS5.S8%^)6^1>BKFPL!OMYUCEWVM/.)%O[P(/ S\5HK_P+4B_
M9&%I.7[) %RLX!K'I\:U4!(=6UXP?C$&&-4"!6 JK,0JUQB,.*'";F/+WE\!
MZLS!51[)]Q:OR+$M_3Q [8^9:!:>(&S$RMES77Y5R/ASZ9M>K[(&O)E68H%9
M6(QD:*Z F(_-B.8QQ @"[$T=X(EV.09!@31:B]\R$+HK)1N!0#.IV0R883Q.
M%1Z?,_$6Q]VH1-"0*1A+IT1BBQ2BH:(?*!YLPA"]N!X'U\V>VH^IW08OE3Q%
MVI,UGZ$+XW)+@>R82K7*>M+;G6&F/]\B-V''[ M*EL1 T))N],<2#5$M9@6L
MZ4<D-0L(\*2>'Y!DD4C7D27ZB.#%+9Q=R[W4 DA,(8*TX4H9JQ2#YR_C)!M:
MF3ON262@WPS-]A",R9/XKLXI74!WO,8I]8A4>A^')E_/)L&R@6U[TF.=(B"\
MS0NX6 &8+< _ROKE2:YPX[5G<;0<??BWCNZH(\$OS:Q'H^-QP'>J#-,U2 ?B
M ;\L[)C>"_:R9:4)W<E\4K,S1[R''.!&0*O8:>*L$01KLOT_F/' HY*.$'&>
MD[MX:SJ1DICME.[CC 6DTG@]KGB<8]L!!K0:<B"3"MLRX,G3U9'I$]A3Y_EI
M[?")J9T<.((R2M)%RZ6XZLDL*!<%"#STQ>6\-'0?BO1: U$+G-<H_M&$)A38
M!88PVTS"CDPX"9L-(?6'J(2: &],QT$V)D0N(!8VAW, ]V6.:>8SBZVQV'>H
M/(R[B'T56XMU0I@%?/ U$ )S,YQ*G0>&\+"A2.U>-,9FQ" 28 '"H@WE=JBH
MX_+MR-N<= LHS;.]AL$+4YM<DI/(6/C7^<Y<-M$-A@&:<R&MG)^@#SB%<=QH
M! /],#P. @S1/740MP_3REGJU9!0;&3VK.<"( , RPCJL\O<EP0  ) SB0$%
M"),,(3D<K8M]$(G 9$/;5:1M;#>5<((4[$& TVFUVH0FPI+J"VW-/#C/!^:2
M-&& (?"86HT0E/<,V &@SWVIWZ7LRTC@#-8\YZ8A'G(%&>M+Z# ]I)Y@.,[9
MNTD@\S6_)HVSAVTR.A88"Q-YM[D@U;;2M 0@&<0TPS&RD"8)0QRH=M(UP^!J
M$(=7F%5)!$ &"$0:5$Y4BL(9%S&+["A1)\M36"INVRN.=G\W&DAH+*J"!5_+
MGYWPU*,#L,=QFEQ-*D)7LE-$/QR(J];Q,A0F XK?*B80 5VEG1FO[^4>D?>0
MP=N&\<!AN')C^GC=X_$?H';5$@((*ZB,JN9!#C0@+&&=]86%3BN'>6MX4F3@
M+*N/QVA ;RX(.(T&\E7S+H2[*[-;VZ+^9!9(&"E>M(,?VYYY)$5?_P!0W[=1
MX69\FTE ',LB93WQ)L5QD9\4),L=N7&W^ 2XRM^ KG?(?$X%"O%2FY0+C'K'
MI^RAD!!R][%C=I?8]MHY&>LSHFACU0\LW"X@IE 1;HFH9/LVU>.0X668O6,P
M J0-H&? 5Z944*'_ #/A7-@BE/7:,3RKH& M.5Q3LEJAX]?D5C"ZQ86':=8Y
M!&*O8)S<='+*P@T=B.,KI)1I=4.P-%DI3'HFIZCYM\ZC<)2TM7$0$$%RD/PM
M!M,1,C1/)^5&#D9<12L,".=].R$*"H=J?XKOXC\1TF;3B]HHXI$T?HJNWNO=
M4'IF&UH_GFIL77A$^*?,U*1\+!!E+2'%[BK$45%7"FVS\S@,'.6R'(-1'#(^
M%#3'Z<*GFU,9 BH>G*QH;)>!^IG X%X[> H',M [8J[$UO$H'%,2:-."6N*:
M$NX9B^X_)&H2C=(DQ [BM? -MF6&U5[9(0!CU3>0F\Z6@DH6) 4RK.(J403M
MTW&$)8I(C@8$IL'+_E%4S2_;P#"2'E 8DQ3B)IZ BK-%IJG1IHA*K;IP] >C
MW_)LDBG?C#E##;L6\,%$/1_"MBZ7XWQBD#D.\4) 7%?1LE^+!,!+ HS0YB9M
M0DTW],6!3!4L30Z#CEW610,T!M?J(33 /,58."'T)^;1P2&&CBYJ(P<$A0FR
MRM;+X0ESTY8<2:/G:COP;& T$ \(F^?H3(V/"P5[X7;R>4N,>HU>:V8;@70A
MP7%%;>H9 @V<.GD]PH(5ZE76A7$'D21VKC884A>&R["[OH ?P\= 2M4TR IM
MX,WB($F6,3KL.VA?B*[)?G7&GVD'$#L?IQY]Q0#&;JUJD1T<9##1\)\N1P2!
MAV _3B\L*)>31-PXP,Z"2'IY*Z TPU/1Z"J*2ER\G'=+OHNC3$X+0!S_ '9E
M=F C?!*63/G," I2.AF)3-Z-\(@?$46.C#['=>%=$2?\2:>[;WA5FG$C8U^5
M!]P97;+WGD/[A38M*3JF/7[[1@MP6"=R5))35@!/<5PU S-286>AVQS=DQGF
M2'$J=%=?8*L2R:^XZ13:5C^NY,>>%KXK?_7)]:4M3M)S.$UAH7%#H?=(N1DK
M-9"^.*T<S:Q[PYC1."448L=>85S84Y<P93!6D/1MY:;WYD)GW(C&3]-,,(;;
M)>2\:L5W88/VWQS3%<_M#,L_H& 33)F;;XY>KFL3$$4BQKN;&[G.T<V*.*)/
MEF!P:?+?H\OQ$BNZ@:E?;)*:P#<%015GF@^$D'86S?=8&6&Z$'_.85R")+$8
MF-_Q_%).'QL68WYA0?W7OH'#/#CUKQE(Z"^-*$*!SW*?EG,^"W?4BM1%L+N6
MW2[!B/(V]E*L[G:XA"3?.(I_3P;!/.>%B2NBF!5%JQ$D,*X9 @&9W!#\0)AO
M%"O0H765 KYPG&&AKN%<]7JX70A7B0K*&H"[/[JK[]\-&&XL;?2XD1<)S(?"
MG>#'%VVW-E-^CUL,7;4<B]G-/HL4\1$(X4P/#(1CG3KO!+J &/9QQ<K^XVG6
M1([#I@3>V>E#7L6,\F#O\!B,#F@&B8YGM_$18ZQ9UN1^B]R=G+PG4NHB7YL4
MCV;._4&VDSV&0+M^ITKNDH3<W<#"0'TA$D/+1!XDF0.YI%&+P>1M)15L/QA#
MM:'@JBWER524G8)R8>4FV&$R/LH0U KU4BGP@':^<5"4T>^10\*AOC"7[B!*
M#Y'WP7335:K& :#5@UF.J4Z+%/F]),"--F'.X'WA4<8RXHBS4"H*+A$22S5!
M )U-UZ'C6DC 9_@2>F$;,PBYM^'3.\IVQ8.Z@+ZCXXA2LA%[IM'"+FM0Z+J1
M##4?+(2'7%_?69P4$C2:N)JD$ @?I]9"8AF*SJ=Q8XGKYZ;C:OV=+@3>HLF4
M2L:YR;X;.*?(;,5,Y:RZ#O?Y$DQD_C#TV0EG$_$/ZUMHB*@0(#D5.XN^R9V6
M"Q-[2(=:]C ,@B,B(09G2;9 %L#:=\_M!:PES3[H&!2+#OIG9Z4 N.,P*9=L
M="$^\9B9Y"F#-,9>Q2V?^,4[FRG-=$2=PEC(J^H_.8<;$GJ28DK,@L#" E L
M5( WR%$\CBU[I:\312J' &OP/ZXM"[L-C,2M2]0?YY,JF5)22PH^&O?LC2=#
MHC$!!BXG-I^)+F)^_)&A#,)ZI9$) 4*V9447 R'*\TRH!  >9Q"4<JJ &:A*
M:O3FS:(<I,JF5 >D'0LP*04'$RJ95,JF53*IE4RJ95,JF53*IE4RKFKO7.YH
M36MO?C_ T3\B\/'[ 2!%,KCNVY+F.T$[NG$DK><I\L],9=8-[Y[)!?3V7J\@
M&<&L !&W!8U($G=*#" $Q!X5C"$P"@$J[Q\W!6"'HE:P1^'TD-G<V//<1L!P
MJ+>TL78@ZR)IL\V$Z<^;:CCA*M-4[V_K, &GWN'0B,!BY:I@K3H"7Q=%->MQ
MNVKA8F@SY2:GZ'>N;[I\9G.ZO]D<-7)\P:,F9@[&%D^O\2YI8[?8%;:"W-R2
M^Z5Y$P7:>"W/*6[Z#0KLL8.,@;IXI^1L +8!0# D&W:]F=SJ-2 XW:TCNCN'
M P+U3AL*80.$(Z6(LIX0/A];6GOJN7_H\[>K56@.CD\O2+X-'Y D?4P 5708
M\!"C22-@ND;/P'[ S.,(;55 "N(1RI;$)B !*4Q5<W<3Z7)(4$N;V Q43.'M
M+EQA]@9G&%=B(HC3_!FU)E"9E<J(+)D]'_=<O=UW 1#'U4Q<T7K(@%@X#(&$
M"J4:((XXA(!7T$S_ %>J\$M+!$ZP[@F!QOWZ-\6(7AVM<0S%D0$';19$T^'4
MEK6C ,X@ -^2&_VV#79M/:,S(WWPDB:7&"\H-0('O#-L_P S7W'#K,XT,-,M
ML&GH#@/:9P!L$/?+(^!V S1J\2N55&\>#2_"28-V$UGT6=+5=T]W,I6:9GEQ
MI+&E^#<^*+.9&AB>#<F&1U#9@TM5*K+4G<=U"0>P&:,^E1<#^YHH3;">K]RR
M7LK.O#\[\V&P>.&8;=OX8W*)J%G""6#2M9Y%K#,?9D^^R(3K$969ZW?>M@ @
M.$Q5.XTRWT&P"7_!C)24LY!RD*";$P5%I2S%WJW2C#%EKI)H)))CI"_D1<F1
M_B6 C3X*)HL6E*O'@W%\!?S+ALE4E96'^=+,."&:PAO)\7>*LND @ 1 1$B(
MZ1/AI=C2[%EEG,OQ4NQ10I4.6<PN ;$9IB,]YQT8(4@J%7 O*^.FH.@YKA:2
M]7"0 50$=!H<,#/#_AS!% &5T 45[!EO%FAM*@ KQ^+O!H![X4?:.* :,1KA
M-I[HB A1\I8B2RJ\88"Y< 8]#P58M SDAX11B2Z=BEQC.LU,+D>/OT^&!PT)
M#B) V^33L;H": %:Y]EAR:(A"6*QFU'.T(:0GO+YA>Q4^J>VKAB:"EK!/QU5
MQ(,BK"=0>)SE=,.28XA\LJSW-U(?#7^7,2F L/2XK_DQ>1@N6G+1Q4:0:_/D
M4DY%Q4]9"K:38YP/1J,H7S=,O&%S?J355MZ,6 -2_&Q-%FJUX)I=\S!_%Q@+
M[;@HU3)B IE>,+I%'L$] JS:1^>17((\5*LNY\(6HU=)0O-"C@:SF/K;A6Y@
M;+C@JI; >L30RZ)J)6G^".:'JXJ08@C1<<3#WV@-4SB,08BAJB'JB0%@HN U
MA$4)G8SP)8MHMP&* =?1 9:3=RY$1@@N^J4WV.RDQN&-)BI3&;*>*"GCOQ#)
M@D%@'D,!<:Y%[HWE-//'[8I:#2J#=M/DWUA;"R7O/%\8250Y 0W$Q'8/2&T&
M)H;-Z?)O(<PT(/@92]C6'H2MDY=N.[;TMV;,38I*%"5NU+'G5.+&<6:L[RS$
M!$$\)36S3Z] "P"M82L"OEA@Q5<[Y1(Y36,1!(@GAV=" $0T20FH36LHV/#'
MT8,?#'_!7+G,(8'KU%)AIL''++HBT3V5#8#*;ETZD6)C>2V%Q]VVB1K6:F#,
MH=Z$\H!2D&2^!H&,VQ,(A.%(4CTB!D))V?")$8% *F4+OC9!BFU"O+AEARH+
M!9__ ' Z6Y<5MZ4B&"6Z&;@*@O\ ^>^<H^HWX'Y>FP#IR<)TH@; ]ATONT$#
M7C+>K0Q6AJ]([TFN5[2K-SF;ZJI955\\.J1+W.09&1T78R=*7_N[N0I39 C:
M:AF9QAS 5?$,A#Z/$1?X+9ZI%X7 X?F3+:77)NA0 $<LC=@G,.2@*S> J(56
M%^2KI+B=P-?^"& XK**D1FZ,QS"CU85R ?X$D??HU19XJQ;#+@5$E+5P,AC&
M_P!)\9Z=+@YH0?U*PES]K7^!.6*B*Z!C0*$V8:?HA]2[QL ;R9XFA:*:]LK2
MXKIAY=N77+%K6&<G'=?N"(#=JUED';"G9!0;6A'QEX.8X\K(B R^8Y*X]Z1F
MB\OP#G%9@K6 !MQ!Y!V.][-C[CD<-@BG1HQ-CR8NW4@6\J+0*;BX]W4;22ZW
M<8(@X&S0>\-2PLI&O_G257E.1D>"@21,TE2]1\H<X<%$<05T$M1,RD*,2*3'
ML9[?WMV='VV1*"C>:FS-9W"G8^F :W-5YE"A.C](&9IIX=_'T?K0YHR<M7ZT
M]1"_X\<'=-,: 22VMG+Q^F)Y&-5%ML,?#_V%ZK=APJ?G*G:#7$<X$ G^'IED
M!2.Y#4.4)U^N;T,B&A:=,"9E6UP@ %4+(!U+$C>,](C+M$HC9%>3QD,^,F6(
M\((H7$DD]$3TQ;E80EA?$Q0OI9IZZ@(,F!I_C?$/XVTVAVF)LQ0-DM@4FJ0K
MH67&H1=-&,,3OYMW"0"  D%  0 \XF81L\5-\-9]M+D3X=F(L1P)D;CLC^80
MHK#>+-=Z.>=3*@!B\8 ZAAL."<L[2%:1H$M(D.X(IPW@=/$?Q!(Y $UGH.!$
M"NR!HA;W_CM? /-*!&UQ8K2LSM%NLNF(A,_9O]U?'JB9)HUR\SG['(630&I=
M!Q<,6+8]TSE2/J=!HD#-&Y8$9@UFFS^*ZAR7E3'F&GTIG5N#\)'Y(\[?V&SP
M; ;8Y ?- Z8]MKGQF'\4&XI'BJ&*S: L_P!GD @@\."U^JA92GWR (_F!<<5
M["!(P[( >.^[ #XQ(J-0NH\?MG<H*7H#TN0Y]VO !QZ"A(7*Q+:=?G3=*O(+
M*",J0-Y#Z=D@[^"S\]5MM=W:X^4/52*6 BD:*2J$[B+Q->2?HW.4WK@^;!;P
M.D0U:>3AL)#("NJ=%[/;J)@M!,TO)7)S1N=U87L*+KA0E[J]NW&F8EQ;$W""
M"')KC)US:+.<;V4DSR"J%F?V_C6M8F+BSB!B0<-FG;BVZ( I_6NH8%_@V',S
M!3!FBC#GY8\*8@N" A)H*>CP9[D:'_:^I0RWA@PI(#0!#1!&M0\8U:GKW-1-
M\+NVXG7T)"5!) @8!BQ(  D%0H&5[ =L5C5#:2IZY[,H. L"J)-Z[,J$*N*
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MKJ"\$('7BMV3"=1WLI2:@4 Z,*E#MB1A:8A*$SG2$M'#-GR]T)@M9F\AAN
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M&#V #P56<Y$WB<<UB<#JK$<I(@'M"H.P_F897"W=OL,Q1U[I*NI\-_/SHU1
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M, ^77I6>"3"0[8'.L&D_YRI@)-V*9?N;3!(N9/\ B'M><]F$0&-JV<7,(_\
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M?@.'#APX<.''.=R.G=H\$Q=5=5555>5>2_DP                     2@
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MLP,$/8AZ>R"'79J4L#%+D'UE%5$1>8X!,L,W8.4;"H)^*,96=%HV;9/ +?\
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M1N#B=3?T1.4V11.;6A!V*>=&-,QAR31R0*L84281<MZL&LGWOZ"H_D".Y&3
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M!K-!LZ -((_YNT\MZ\6:HX%7/5P?C+LR4HW)B,6(=.3&@,HB=4ONA*-JB40
MKC5G+KK$ *4?7,4REU^$VBJM.'^X$T2\QW $4.2@=<OQR:AA1)W<50-*H)3/
M=\3,.U%TU].ZU*PP=QDC_7ZXYG>'GHIUJ>H=QEPG0Z"XQ0C@&C<*U!N=3,TK
M&?))"TOGT#H:3/(7],EJ'*'2>GABNKJ,J:#DF(BGW49,NC9T4\Z9 ?V%@9I?
M@LS<#:%$KC5T(^HU772N9-1OG(>>U)HXP*!Q%7UPVX2%!Z9,%H<MP%R&#Y;
MXFV2&,VF<#3+_2% O8=/6F^>[XZI0/QTP&S7.;5K+*]MJ.%L4TA'>OVQB"EL
M[!28B!PW8Q=*"G934OBN*4E4HB[<"M%1)O@).\!H80@KT%)J.(I&K".<WH'*
ML-I_F2=#+B1'!Q :+QBAN!J,'S0SCKDH0M 6#F%0FOTR,$0A$GE0>)*.Y&KO
M=$\J,JC!1  JS-H/J-;!?2U-XZ<E/JC@->DAG'P%74*V0(E7:I1$Q/!%'2-
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M2]2;9:VO"+:TJ!8,%KA"/KZE_P 1?V?[*6?0]HL3#489F<<!NQ?KX(!7MX%
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M7NCEN+O_ ,0%54-*)2(Y*$K4@(!2A/NHLBKLL>8< & W*RU"@2010"J%,B"
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M(Q<8<"O)F8\ ..G>]%4$$I%M! S%QMI2.P;F2CC'<0&==*D!-$]L-3!=(C5
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M8\>#F:2!=\E0X"N+Q]<"5-Z^<I)5SLEL.F5H'*)PTYN&&:86!P#FEEI@=?\
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MAF;&/ 4>'-P%D0&ZNM>BR2Z8+<X:\CTL1(I"A0/)1\K;70J3J/0I;@X/JIC
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M*A[!,7SU@NC&4D^ZRC!^Q-."0ESJZ4=82=877VY&G]-<2%7*4/G,Q6D>]<"
ML+,5(]5T1/P9C'MF4E$$$/T4?T;U+'KMF)_U7W%<&5IX& TQ$ZVJ%A$%""QB
M)G-&3L+FM5G3K@+D/8S?**P2T4!/'+SBHUD *^\2A'?R/<.V1X[$M3(.OV#X
M"#2B/+/TP@V"TI]1^X!#Q5C:41%2,PZ Y8J-!@\=:DI#=X-$ @")P1@EWO\
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MMV[:Y>X-8JD6FFTHHZHZ,FKC<M,,(PMVB)733(QB**B*2;ZU($=U7@TR!!
M\$KR3& [&J#WP$I0=US5LC ^=#;3-IR._P 6>(CBH.3O-1HD-9+*"8#>RY&L
M<4P5Q3(5': #N6IM C;OT%J5$![X, :0Q\4>)[7'+ZEK.J:7S(25I>+4T,=.
M 4&U="D-13XAJF/$(1P-$<#J&M%!#0E&2@NX!Y@-901BKH$GO5<OJ6$;J%P
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M!"RN=":A0H& $1S5B;2KY75<\%KI0BQI*/0&@C11NPT$#B!'(P)Q11<-"2>
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MX($#;O;=$\KI]" 0T$+=NY-'EO%BH4AL'?I)UL\M;4V"(!""!994%EYQCR.
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MO^!SU[]#._YYZ[6/:.4PO>W@]"4A:6">XS.VYMTU\;89;< CJG+@W0(\'Q4
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M7.TP(P3L&E+O[7 A+H^PUJKSZ8(@&JV4#N-%*&MN:8D!LA/ 9L;Y\3=PP59
MP-:3FF[E 4! -:;!T_1\8$@.H<AR4E(HUSV9/\@^>>3#!TYTO&W ^<&K8;$W
M?4/.'I@AIP5QZZ[G.;!.#$!;:#:]E=M!*LP+&ZE [/G]O6E0P1 :%._/%X?;
M% "%CFIK=BM(]_\ (#/(">YO+\OV8Z&D.NSIQP@<:=DG\&;V^J;J\<=_&]7@
MQA"<-W4?Y#Y7+T[>*&B=G$Y-M^K?Y_UQ_P#O_?T_]9]?_P $;^(_R<_PN?\
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M@18@15[A92D[@#< 8' 'AVE5CQ-H<2M](FHA+5,<D+2CZT_O+Z+]UA&F]"R
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M4#TR>'=HA'>&<$A(!"BA*(C9.4Q5X%.J*@*"-!]"3?P@0,3 )HN$VE0Q,14
M5*I]0'NWD(;$%+0THB&M1SL7+C91RM O>'IV)*CML)C>!B.QJ';5(S2;*NOR
M?'W=$#Y)X<^=^/3S]V_CH!_N?5@/_D/1T//2UY^[_P ? C^YP_)IU\,?M_\
M/1H,2^5>?@0C@KY?X?T#USH&F%4*N@KM>,#JR-K53FC3V0D5!,@B27O:HO'*
M(5X%'<S<"B*DFA@J$'2A#@B5-#PBX*T70%)IK$T @A8]C$(TYKF'E:8--!#1
MHJ\"; 6F$I=&P\5+8!*")FU0:;RS^"VDE-D(Y%-5@K :#+)A$HV2HKA.-W6W
M<K0%@5H!4&6H&4#P;1C5H+ "S)%W IVA,"*H+#3O62CD5:#2!9W.T]>+5,A,
M/!6\#5-47DQHE%"78$02UFP61WFET[3@V_#X=R!MRZDY10 @&$2EC3A8Q? \
MQ8JH4"15P<:*40FA6EH&O4.X/LQS5D0M %4HJ:KO)O'5-&<C$%O\@=<<44%
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M'/.%E\L-'= FWA1&=S&E )(Z5&1:XY1=\Z)XK="@'2+'40=4[MFUSD; :#4
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MP6@8 4$CNK9O#(%,4@P8B^=ST,'@LQ0@!VJPWN7@/_V[_]H " $# P$_$/\
M\Y\*]L*T^$D[4&#+YZ'!6QMC1FIAJYNJC$4P,  SP:AYA59X*PK>,+0#CAI
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M[H#O88):T/Q"\^(.7(6#<7[F7[=IJ&L0S2(I>1Y&)\5T7;,'.S0$>H2 </@
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M@/*>DY*=Z=#[%(IL>P\O(-BQK\6ON:X%NVTP%JQV%/''30B!'R:LA*62J:<
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M^0XO? %W?GG(U/'0#77=\_OD_3^<@H\'^\@^C_>/.0@U>?O\F2\/FX!FM?\
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M$X;,I,PH Y@,>K#%4)4W",1R(=(6.L_@A104*^AO#$6H;A\$%?0QQ!%0%*5
ME$37#GG#&MBUBA$:DC<W1>15(I0E!->IFRRIM0Y*"4[^,^^.N*\'!N6S>#A6
MA:>51!FY;GTO0P70L!:"07M@9HU1(M2*A'8=GPX8:=4"WN%33P=GQA-%@4^A
M!;Z2X,.O%H2R.;T3ALG.?+,LZ:>MF1M[,OSIIZV8%R59$=-)(=,LQ%MI%H8Q
M'(ATE1UAA)HH6M@4-G)W/.'3D14&1A0:13N><[MMI2BA* E6&S&C((1 Y4&!
MW71B(8J%KBQ$TW+9EHNA%5J% 5!AZ.;M/*56H4!8.O1S3IQC*/#$&/9[X";0
M@B1X00T]GAZIAC?#-??K&7MD7CX(\]LCD7C.='2)S^)%X'(G/0%8<Y3HPNCM
MY]LC+VQ 1' QWN:\[UKOK/0=Y88>R1^V>G(41^SCP(/%$_G*L*$%FA;!?+&>
M8X00. %7[9Z^)8R^+Q<BL#<$8D4883G7.HWQ,")\"#&<S6Y'[8H @8G>^,FA
MIXG?MY^F-D4"Z=#H7P*@+SD<4%)\3W3V;UOOK 1(-%$HZIZ7OQGH.#H%X-.S
MR>33OC6-5>@7CG[9!<65$+XOGT_*?.?&/W?7$$OS/S\1:BT"+O['\>P0='(6
M?\'^&<727+1328PAZ/=;[F>KAJWCY]L6RJ[F-@)A;D>R[?(OWP:@<ZOW,.@.
MXK][&!*]W)D)7HHUT]42+T4OH+;C#+7>U:3E^A!]"W1_ &TYOB;E$!Q(9'%<
M/1@PYLA8_9'#'F674:M8C8VJ S.G,K?(UV&BWB7-Q@90;3<(/CLCYW:(>ND'
MD-",QR3?9X&$22*/#G1+$BI2XJNFC/K4W! 05 I@-?9,2#),T6"V!+51&NY/
M[.,D_@$% K;UP#(B5!!%8 %DHH@((WF$0 0CQ@I#96SP;J!E!6KW9R0$>(5!
M8=NB.(H0@:1TFX.DRXJ'P&'"E!E7%AA*9AI9! H-/"UN%&4@O"0:N!IN02JB
M;#"!:@P<-P*XB13&OII00I$$1BE(J: BY-H*I<M8.",&$)!.:FV/%BZY_.L9
M81#M.[<S"+#G=V%\&=K%2&0E6!'8J $.H#(3#[4U%N;O[A _%6$'P\R%X*E<
MD^3@;IQ5TI9G#=65O:2ZO@<L _-'8TL4$'G^V1!GZ#[%:!.IHX%ILK@)Z2])
M8Q+N+I:#=0(:Y1E.,";IOH3NH'!A_G DL+M!(+0'(SF ) +223#3@2+1".:A
M%[N85V_*?G/C'[OK@"7YGY^(M1>!%W]C^/((.CD+/^#_  SBZRY3?L_X0[KT
MQNQ-&DD2=1 7'6(D"X"<XK+5M>&J7HIEM'_%,'E,< !1?\XGEZZ(K:8C:<OE
M9I"&&0)Y"0C@CLESZF PD\]9W21X0=QF:)*\,8V&1-RL+@S(&:M&52GOW'@9
M+[* C18E]MM?<UD05K6;OM-J22S90P=(+.5"N.I!I!)BIL.TLAVV'Q^!7"<4
M0D%HFC7GAB\(:4Y'Y-";^IHO@*I0M@=QJ //$#&JH<2!*A2)>3UW'RUL2(-=
M90O2L'9""$6D091-83$/P21AA39BL4QYD&U<9R1;W@VHD89/Q(1,I8)/D^21
MI$ ?@1Z22 1@I&O&F#<.FQYF6$E/"!(ASF1L(MC:+?F*TES$%=$P1M5Q:DT=
M-8"""<BH$D'Q".LJLL:, @QBZ0'@)O=_$QD7\T5M2*5S+FTBY6J):/H./($P
MN+[E3PF_+@;@(LD0@B#<G=C5@$A$+HNZ";-M8[J:]J4U6!*"*0K.6X;7+=%R
MN4U6M!SQJ"1\KP3C,X%N["\#40C,O)P90($D;-4&*I"1U'BL(1IIQ$<]N3#
M(6M0, _E/S'QC]WUP!+\S\_$6HO B[^Q_'D$'1R%G_!_AG%UERF_9_T<=UZ8
MW8FC24&*D:08(2HH6C A>MG<#Q13!0V(4?!5 '3<U^;:D7FP"@Y<Y[ ,!.X*
M-X95<TO7.S'Z62%2 0TM)@4_A5J5YH0:65NSS=A%M ?:.\R>H'!($@09"7.P
MZ3G9%PZ4<!#(C 2S4+%Y(/,&X& 8"-* '@&XC)L4(Y8TQ'C52%<WAT#OX6Y
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MO7,+&_\ ;,B68396D&=R!I8)R<@BJR.!LPI0SG3M8\LT/?1X@=$>OLBO696
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g573774new02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g573774new02.jpg
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M P,# P,# P,#_\( $0@$)0,T P$1  (1 0,1 ?_$ 3   0 " @,! 0$
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M<9$P\(&AL<'Q(%!@T4!PX8# D/_:  P# 0 "$0,1   !_?P
M
M
M                      'P^@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      %)+C2P
MDSQCS)GPZ2.DF,6>8R9'SF9T[CVD0.9(3"'E/4=9S,H><P)(C$&7/*94\!\.
ML])FCM(H>@[CH.LZS$F6.9S/*>LRAX3P'E) >D[3"'O(X=9FCM/*>L\AS,2=
M)DR0$?/.<CWF4.HQYZ#RF/,R9DP)AC*@])XB0D9/*3(U&7<A/0  #5M8$M2+
M?[-!K*2KEAD637),A+L;<Z=-6(E3+M\FKBV\D;BH5V&LK>7N*K.-;^LZI->H
MRZ>DIY;H2@5D9>J90UD6Q"=)C2GE],;#65U$OJI5[R1%.$MBR$INV2E^)2:X
MZ)0F:J,RT\;'V4C+M-9K%+XJVI2NS.FIS5Z27_<Z9-76E9KR+ADHBVQR)FRB
M5A&?K759?%PV4'+A"TJL--?E^1>B4?;(X_4&X_*";_82X 'E
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M^R9#/FXKX=^GX?3WX\HAWH_?NSP?"
M                      :3-=(
M         !W&[+(      KPX@
M       '(L,      'XL-YV-D;.X]1>"7:G$H%?SCFML;(,6@GB(^L-BTZV@
M9_*-O-FTJ8L^'494E":M+:A)"4)N4GY"3>Q=D]3;-
M               -)UD)7:TU'DK<U,"8I;@32Z6E5MZR&D%6WTX$M-U$J4HQ
M:>EV4N=0YJ2'RK.D@-6;$H*BK?Q-!UGQ-DW)23@
M      'YBM?ITR    *-7@ 5B6:?0  4:MS)[    "(DN  .!UG>
M                    <R\D&D:_D=-_II<_HRR   !JTO5
M                              ';6TJ :=KN(@    J0^F7,.9 ]![CP
MF.)B0HR9 U[3+%H)6QFCM, 9\CA[3,'494K1<B7$E1'C6PDC)A%R">DQ2_4[
MS%K($LP]0                             !^23=<1@3;NS6Y;)DO>S1I
MK8E+I34UJ<2699KZOMEV*N=6VIK&Z5SHW+5"[VW-.RZQKMO9J)-5P;^W,P35
M>:E!LW<TK+K"UR-@;G<9-$5DQK#-;*W.]J;!H
M      !!SJ*T7#DZ)2F (HOE(D24DA.$UM7+1L;90:W6F;(28I8:90])&RV$
MBZUX;3IJ\M[)UE8+*BNS*F:)LE,K8Q69LDF?
M      /RVFIW5&KL,D4CW5K,OZ3,ZR+@R!Q.:V(2FEV-379:$6Q$CD6&40MY
M66NF2-8UVA36IJ629>H?$SKV1KVM^6>,G9K0N3DS9'U_7"XTH6NUJ"7XGZ2W
M.H[5SI-TT/FOA(C],+GW@                        U86"E7+?B2(P1J7
M-;[W'Y]S=EV>B*]MD:2@S!FDUZEO:S$RWO9J_+#JLLMM-=E_2-G15J9')*JE
MSU21*TEFM06)804EQ.+*>7=1G59J&GBB1UO\S4ZU 38II<V8HWY9SX
M
M
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M$ZHM6JA+@*_.,;=V5P0B6J:S9:"5DMB)4[5T,],M45*R.&W*;5(
M          /,>D        \YZ         "+GN,T#"&;   !&B2@
M
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M(8L6K]#V?S0FK3-TKG3Y=I$T$FMP+*1B>U0:W*F6BKS)EIE2D*6VK("MF24
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M%%\9AS+GC.P\Y-4F)6"]!X#L)BE:KZS('4<B6'P@A9B1A8Z>(RA9"8=;R0
M             ?E$U Y<O4Q2AUW:9H!8C+LW<T%-;#7-EFBTU-*M=-<9;)LH
M^7<6YDYI7-;$6:M+<DFP-FK#6XS.D$UB:V"2CEB1N/)D;-1VMM$M%-"9K/F[
MMS^2,W=EFUR80UZ6>I@I<A9$UO-+;2C5KB75==M[FWC4==CDQ44W;,S=N9H]
M=65W-L_-V:V.LL](\4W+LW9^D3(
M
M                         JLKY?(6@E7+GS'F3+'2MUQ9\,,3HAQ-B$EC
M)#UY%@I7:^8S1+DKY<N=@++2IEX&6("3$\1+DMX
M           'YB36M-MCQN1<ZA-84MY,"7ZFKDU8ME9K(Y*C6)%YGL-L+FKE
MUWEV^N=0&J\+_DZ:J:665[XC=;1IKO+L?9DDU=FHY47B_$_5BY
M                      $5)4                 14E0
M
M          !K^ML)32V6E:KG3K!Z$L(JQ9NE7KZ2TDZBK%MA*N7%DR,.24DB
M54N<,89U(<OF+R2/GG.1UD(6[4B9'5ZCQF>3&+E3VI].!'%S)ZTXE:+?:5<O
M0=9L0@                      'Y?M2M->Y<,L1-Z&=;FNBH6;:)@HU@7<
MJRAR12U'61+SDUW79Q,>4%;@#9U*=EQIF2GS9ZR-DOB_[/S;FOTXN:C-"9K]
M%+G3>:NVSH*T6C(NXCM68F:-;Y;3JZ4JU:MBQJO9G6YJX$A$?K!<YH
M                  'P^GP^@PQF0    ?#Z  ?#Z
M
M          4DO22Y*<6R$R)"EQ)L*E;'([ROUSYFDB2V2E>+ZR0I"E]Q.DCQ
M/"GEP):25TN:/,6*D"7'GH-ATY@                                '
MYF-1\UUEVJ376U$=-@++"--9K%GZ$W,O31B:V+LTQE_2NY_.R:EQ 2ZR)&XM
MSI'-;BV:A2R@KPEADZK67]1KC\NIK(5EH_;.XY
M           ' '( XGT'T  XG( X'TY ^GP^@'P^GP^GP^GP^GP^@
M
M
M
M'Y_-9 WQ9                                                  _
MENG6(K_1[>7YW36P-DS33UJW9/M90M=-:);5,!7Z<L@
M                          ?AO-\C]CKBN5C9<"5XL;)$FIDUO;<T>MDI
M7*[5)] !VGJ      .)R                                  /SJFJH
MMF! HVFN8-+K[;');GL])N$S8::(S4EK%EMI#E^$K2MUN5->U]T2:LX0\[R>
MIN0@ &,,F                     8X_!V;OZSC&:JP2KCW1C*Y1-JW&2]$
M      'YR-2@R)5);"?3@O6<SK/8G,ZU\1VF&,V?4[5\QS3BHZCN.H[3F>A
M /&>@ ])W@                XF#@"R:V<2H"8G>0$LXY$7)<8HPAWD]!BS
M1%J5ESI>"   #25K=ID                                    #1IK=
M=G\]U%R%;DP/>0F)A6OA)R_S9Y!%#7Q=KDTJ:W59   &DK6[3(
M                          &C36[3-#%B%3K\)<F;*77-F>2%K:Z6X"-'
MYLS=X)E:W&9   &DK6[3(                                    &C3
M6\3.JBV>E8+F4G)X",+Z$S9T&8+>      !I*UNTR
M                 !HTUNTS^>2YT\!)BLU]A+4M VG0       #01K<]G+@
M                                  XF( -/VMZ6?,=AXC('F.1Q("6<
M        :O+U'0                                   >@ MA+-
M
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MTJN9*                                           #7%=CD
M
M
M
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M#+.>BBW;@+/2[;>E=3K9KD+#G(+?A(Z5;C@W4V-V Q^LO[@B?C_:[P)N:^U
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M"Y#OD=I:%;0DAK/G=MEYA:1"E[-I(8[\91L4Y919+*)%9GCX,0/2RQ6V2-3
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MC:NK'HOGC?&^>%\NO#KMGC:K98]%\L;XWSQO?KPZ\<\;7MEC;"^6-\/JZ_\
ME1__V@ ( 0,  04"_P"3=\?!O_57^/\ O_3?O5_C7^-S_P!?-:A<DW;?7)/6
M:%R35OTJT^M+FJ3Y(]RU+MRNN276:5R36HTJT^I-DJ3W1;EJ7;62Y)=9J7)-
M:G2K3ZM%U:>Z+<L3;;9KTF2S6N28*M*Q-JT^K3^BW+$VW7L7I,U>M<DP5Z5B
M;5AZM/Z+<L3;=6Q>DS58+TF*O2L3:L;*T_HMRQ-MT;5Z38JQ7I,5FE:EU5BK
M3V1;E:?:FW+TFQ19<DLLTKDNK+!6GQ1[E:?8EW+TFW?9<D]9I7)-6S6K3X(]
MJM/L2;UR3;N]<D]9H7)-6W4K3X)-BM/FCWKDFW9ZY)ZS0O2:M^I6GUI<U:?)
M'N7)=N=UR2ZS2O2:E&E6GUILE:?)%N6I=M\EZ2ZS4O2:U.E6FU)[JT]T6Y:F
MVVS7I,E>I>DP5:5B;5I]6G]%N6)MN.:])DKUKTF"O2L3:M7JT_HMRQ-MU;%R
M3-7@O28J]*Q-JQLK3^BW*TVW3M7)-BK!>DQ6:5J;55E:>R+<K3[4^Y<DV*<5
MR2RS2M2ZKXJD^*+<K3[$NY<DVJ++DEEFA<EU9X*D^*/:K3[$F]<DV[O7)/6:
M%R75MUJD^"38J3YI/NP[CYKXKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XK
MBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XK
MBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKBN*XKCYV_;\./@<
M?CQ7'RY^]<US?^AY^#_U^M_M\;_OX'_?RA^WPN:YKFN:YKFN:YKFN:YKFN:Y
MKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:Y
MKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:YKFN:Y
MKFN:Y^>?VO\ #_>OV_-^WX_O^]6^4>?R<US\7G\.?R\_DY^8>/D_G]#Y_/\
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MVV1K2F8O#MZC'E?+0]__ &66_-<NYVOA_KRWUQ$QFEAC<Q+B#*LGS72N 7X
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M2"0^J'&9(\Z,ME:3G[Y>:#>KM,[30NG/Y29;VY9 2"/]V'/@C-.S30LF:BR
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MBN"[&RKDCDY)]0!D-8@I(^^R.D1^WTM7UY35-BRPI[;U(OJ97#S,$N?-U>
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M<;@R7$,$K:6&OIS+.KQP@:/(8GA6-J%$X01*E;&)9%5>,:;_ #:J*B+T]R,
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M$[=\YO?J)W]TCV/[2Q-^9$U[S^\%QY;?_N3:J]U_F.SMO[L]X_3^L_O'T_\
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M#_ ,G_@VOC#_  #)_P"#:^,/\ R?^#:^,/\  ,G_ (-KXP_P#)_X-KXP_P
MR?\ @VOC#_ ,G_@VOC#_  #)_P"#:^,/\ R?^#:^,/\  ,G_ (-KXP_P#)_X
M-KXP_P  R?\ @VOC#_ ,G_@VOC#_  #)_P"#:^,/\ R?^#:^,/\  ,G_ (-K
MXP_P#)_X-KXP_P  R?\ @VOC#_ ,G_@VOC#_  #)_P"#:^,/\ R?^#:^,/\
M ,G_ (-KXP_P#)_X-KXP_P  R?\ @VOC#_ ,G_@VOC#_  #)_P"#:^,/\ R?
M^#:^,/\  ,G_ (-KXP_P#)_X-KXP_P  R?\ @VOC#_ ,G_@VOC#_  #)_P"#
M:^,/\ R?^#:^,/\  ,G_ (-KXP_P#)_X-KXP_P  R?\ @VOC#_ ,G_@VOC#_
M  #)_P"#:^,/\ R?^#:^,/\  ,G_ (-KXP_P#)_X-KXP_P  R?\ @VOC#_ ,
MG_@VOC#_  #)_P"#:^,/\ R?^#:^,/\  ,G_ (-KXP_P#)_X-KXP_P  R?\
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MQ2(*Y7N!3R]B6)#((]\Y*RP3P0->UZ2/:]';HNRIJ,1:R'OM_P#>";GJM]X
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M]JU\>8C_ )AJ_P!JU\>8C_F&K_:M?'F(_P"8:O\ :M?'F(_YAJ_VK7QYB/\
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M J#[._\ 6Z^ J#[._P#6Z^ J#[._];KX"H/L[_UNO@*@^SO_ %NO@*@^SO\
MUNO@*@^SO_6Z^ J#[._];KX"H/L[_P!;KX"H/L[_ -;KX"H/L[_UNO@*@^SO
M_6Z^ J#[._\ 6Z^ J#[._P#6Z^ J#[._];KX"H/L[_UNO@*@^SO_ %NO@*@^
MSO\ UNO@*@^SO_6Z^ J#[._];KX"H/L[_P!;KX"H/L[_ -;KX"H/L[_UNO@*
M@^SO_6Z^ J#[._\ 6Z^ J#[._P#6Z^ J#[._];KX"H/L[_UNO@*@^SO_ %NO
M@*@^SO\ UNO@*@^SO_6Z^ J#[._];KX"H/L[_P!;KX"H/L[_ -;KX"H/L[_U
MNO@*@^SO_6Z^ J#[._\ 6Z^ J#[._P#6Z^ J#[._];KX"H/L[_UNO@*@^SO_
M %NO@*@^SO\ UNO@*@^SO_6Z^ J#[._];KX"H/L[_P!;KX"H/L[_ -;KX"H/
ML[_UNO@*@^SO_6Z^ J#[._\ 6Z^ J#[._P#6Z^ J#[._];KX"H/L[_UNO@*@
M^SO_ %NO@*@^SO\ UNO@*@^SO_6Z^ J#[._];KX"H/L[_P!;KX"H/L[_ -;K
MX"H/L[_UNO@*@^SO_6Z^ J#[._\ 6Z^ J#[._P#6Z^ J#[._];KX"H/L[_UN
MO@*@^SO_ %NO@*@^SO\ UNO@*@^SO_6Z^ J#[._];KX"H/L[_P!;KX"H/L[_
M -;KX"H/L[_UNO@*@^SO_6Z^ J#[._\ 6Z^ J#[._P#6Z9(S!*%KXWMD8Y!W
M[M>QR.:Y/K/:CD_\#&?4I+U@S,>!C#6F6M69Q?;6T7N)8>?B2#?WC[.R_P"A
M^'I_HEK+W+L<IK!L<<S@K.Y ");%-OVI5A(GC>D<G%=E]BZ%;=9;CM6XX2.P
M"0ZX!&4P&7=(C!>[.WOC2\5XO;NUWR:7)VY#2KCK6JY;Q+(1:M-I.PJ*;W>Q
MR2?P;;[\_#[=6-U6912'5=0SN6IHU@/+#71\5?W#E:]5%9P:J[OV141=5DQ6
M15$,=T'/85#W'0;60 HJ&DF!;/7S HX:]Q[V[M:SJNJNWDOJIM9=D#"5!RFP
M>6LRC.7E1P9>7$F:?@O%K=U7;26.17%=2@K*V!I-B5$+$^=Z.<V&-97)W95:
MQ5XMW79%U)DPN0TTV/0MD=-=,L15K8$B=PE[Q?<[,+HWKLJ.5%1>FCB:+)J6
MU@K(UFL7A6 \WD84:]_>*:U_*"'C&Y>3D1J[+IEV+8"$5$@JG1V4,\<@3PVL
M61Q+2&JL:PHQJKRWVVT!>V.3T@5/:HBUE@18#QCV"*WEN$]7_P!I\/5>&^R:
MJ38\@J)!+Y\D5,3&>/)!9RPLDDEC"E8]63OB9$[DB=6\5WT.$'G6+DEESQ#"
MC0W ;YIR)Y&Q0PQ1MEY/DED<B(GRJNFU\><XNXUY"",%2Y"[SBED[2#HSN[]
MU9?"C?;OJ2G(S3%A[6(I09:Z>]K83(S4D[2B/@D(;(TCN^'@J;\NFB;"Q+'!
M #B?.687*R 8:"--WRSS2*V..-B>U57;4@M-F&-6A,0\I<@P%U7ED-&'3E.1
MV89WR=F%O5SMMFZ'R%<BI?<1<K8!;CWD)[M)G?,\=L,!G=[$LKIXW,XHN_)%
M30SLDR"GHFF+*@CK:P%KT)6#MK,D"DR1]Q8DE;RV]G)-0OK\NQTYA%D)3P.#
MMPB6RVI[97A5S%AF?R,*9 ]6,^DY&K\VK*"PO*P.:G!ALK6(@N&)]?7D2=J
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MXA5Y#@1-_6AXP+:DQ4\N.W-3%7L<AZPEO0T>>/FJ+]-.JNY=-,]-PI0"+_M
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M#R3FJP(_A',HT6R20;*C4:K.E:0?%:17S['$3@#TP^<HF&J'QBKA,83F,YT
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M:_DD;D3*Y<DQZULO_5W,ONQ+'7D$+164F=Y@;.?*YC?]@^\ Y@IXS).U'./
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M0HAK=UZ-WW79-1D]DH/N231I ? HA.\,\L'6!_B1LO:Y,_UF*BZ'L[2MB+L
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M, /GM*FLO")9QJVS%A.;(//<LACD2/Q2QNX*NV^FT(T#VVS\/JX8PIT[$CS
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MN2;@6;2;UPMH4X.LXXEE#I["5@B'N<$*E3YDJ!!5Y=QC59^'59,5+?Q^]X+
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M=OAJ1G-9/:%I4!&>4 C>_;N2<6K\GL70>3&'JZGL?=[:R8(4RPGLI+;A[NA
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M<J.9&[;GK+Z7WE<Y58.ICTC+.CB(M2W33)(R'M@#0MD[35XM1K-^*:SC#Z\
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M(+!JF*6\L&3U[0:4L06-[9W=Q7P/A147ER<VFR*CKRRSL2Q0N_KG0"SSL=8
M9;C3_*<HF.WFGKWS^#Z3F;]-,]/ZJD4DNUSS'KBS]\PG"T)0&-X;CMU9QV9T
M(LRM'L;YK8O"BJ][7-]N^V  Y+2V?#TZSO+AIUHJRUN1O<MWCQ!51-7R1AI.
M8%'/9N@:O%%:D>R[:I,H,%SC&:J^]3/4/)H)Z"J(=E%14V6/UM< 1*"T0YP,
MMN2([FQ\:_5R*OX=5D@Y^1VD>YK$/RT9XE^0L9Y37*=!(*$YO!R<8_JV[Q(U
M>OM_T+\9L/?OO9C^#81L<N3(R/J1R'O%G'#DB*CAC)9W',548J[+KWFA<WE/
MO3]S>?DR>7O[WE[I\MP[?+M>=7;N?0VZ[ZEKP6Y"7-$0>*LD&,W<@CIZSOH7
M&PQ _*O<QPSFIXNKNFL5CKCGFOS(,NPI&P#3O5P8$:/,(,\'^SXX'+VU[O'Z
MWP?2Z:M0+,N08FFQI^6FHHT[FI1QD2B/(A>UBMGD:1%Q[;=W[JG3KJD=[QG<
MF05E;<5RQ@&/Y VUH+2@R3[1?V9TMB8V/B_9R;+\RZMKP8E[ZVDGN1K&91R&
M.AEH))HK-&Q.C265(7CNVXHO/Y-]5UO7R+*!:@BV(4KF/B600V!A [UCD1LD
M:OBD1=G(BIHNEN";.,NO&&,L'BTEM8" BEM<^&<LH(2>*"-6,5=U^;4]0^:X
M.+&@KR9EJ*"WMQVP6HD9P$GF0!)X>)(TB.;UU%:W$T@X,IH '?2"65(IK,B,
M459T8U5AA6>5K5>[HW?KJY%MK%19*"M L[1?+$RLAAM2)!:V!CH8G]\\V:->
MW S>1R==MM'VS9;G:I+&#M:Y:"W]]5TAD,I TI=5Y53(Q)H87.2;CV^GMWT'
M8LEOG#V)3A*_CC-XLQTC!?.O<' @7=)A:/XE>Q%;JK(*=?1^]X#RA(/NS>.,
M06L)04P@@-H2DCPQRK])S414ZZ"N:@N(ZLL(&DB%P[\)87?+LY&O8YJILYKD
M1S7(J*B+I[:Z>U:/$&=8261M':@5+ ZYKWF3NLRA8PN$38W?U_DU8.%/-B2O
MIS,@3S]395ZV-(!&Z4JRJ/-CQ>\AXV,W^KW?^#3*JI+.983A+9"#V=19U2G
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M_P#)HNG-/L!Y0+*.I--6EM7U ITRPI'%/:QB/"B1ZSL\2OX^+?V:EH3[.=A
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M[-/RIYTJ4,-I)4$'^1-X#%Q6;JB526=CNPC1V#>"RJG;^7?;5OCP<[Y[*BA
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M&![)Y'R6</@9NY.?X%T7;23W4 81E;7RJ3C5^/-(7;*2@,(P\U>R8ITJB/\
MS:.X]-_:FDMBI[X<#S$PRS38KD4?;D'8-)(LK7UJ.BCV+9LYVS7+T3V+HJPF
M//&'#J67A/FJ2W&GCK'W3<?80HTP;)UY6;T;QX\N/B^CUU80EVT,"5>/B90:
M0]LOE(Z0Z6> 4QA*,6*;OR#.1K&*YZ]-DZIHL.D+*\\%#"7,#8UQU48H)"[#
MGPP'P0/G#E7V/;NB;IOMNG_B'U[IGX_D=H;F]1C5;C<==CML>&>4N'K6JY;"
M 1X [!"RFJ]SY&\>*_*FLF'R"NR[LA9'Z8M^].*QG>],?-JO3D>OER2O8. ;
M+;A0F(\8A(D79)/];;6$9QD=?=V6/4&3^H5;[XCQ(L.[,KKNOKHJ;+K7'0 _
M/=PJ8::"2?LK*YO%SMU=U]/+3%:RQ]-YR%]5" K!U)#(YO=AJT!M;L(FN;"!
M)DKHU5S9F]]4ZM<[HNO3Z8MWJ%B10(7J"-E5G349UQ<?>DJWKICGO[-(9 X"
MYD^MA>R+AVMD1V[7+KT0,"??VXX^4SO)LK>L*$M%CBH+H5QMP,\,5P+I9D]K
MXXVKNFWM31>:&4UR904?JMD4EBP*J..GB%O,'IJT&^'#@@DF-#"+B<U\D37\
M=^G75A8K47H&,9MZJ8[$$DU8< :P.IP6^JRLG>)-%'."/-921NCDE:SDK4WU
MZCLRD><&_GR509BY(9HHCIP,=JZCWN+(]C$(@,>+WN;-VJKNFO3GTNBQC(0\
MLQO,:*6W?-16$%74#X_<RGG9"R[D';6SPG0(JQ+'(KI72[?*FXUH?>WL(<IF
M4L9AYP(HH02RY+8K&4Q9!([/E*UG=3D]6KW>G3;7I45$,1(**!Z@(43'!*\<
M9Q%;4M@0B=K5B@6=S51G)4Y*G33+;WAE/E_]_;9_NKY)GNORGWW[GOGM^0]X
M]KM?6=WN=GCU]FI CKWU& )ESC*>&,MQBP^Z4\9UP?Y6>:T6B=&R"=)4F5_F
MD:B_,FB1ZB\,Q< KTL9765K'106T)PY&1GL(J(YS> XA:PR]SDQW=:G7;7J8
M#B1=[!14N+^G=033P!0NES3'0:(D&V"#M)P"7LM1Z]DFWEFNWDDXJW=6ZSQ\
MV,9,94YMC>*D86T+&[>S<>"%BK*6/&#>P,0M<>)(SBZ(CAT>JN]J;^GR?=6>
MT?Z.XQ0666->*:LUXIMC7G_=.L<QGE[:6@$'4AS4[D;96<?;T=@N11!'OKK&
MA)O;#Z@J*NGM<?9&W%B[2)T;61V(<-U+VDEVD3@B;>%=8!FIE=9V&/5@634]
MA/5UIEO/2%6\(3A+%X($)!:CSM%?"][&+QW_  HBBSK675'69AZE9K>TTLX!
M@156D&$I!3Y"=!VVRUWGKVN9*B2\5?LG^LFO4?([RE.AR9,IRNT=5QUY2REV
MR@5L4?DADB[A Q=DSPN8BLX^Q=DUD-5:X\V.#-/2:_ <^B>?<R&933"FVD9M
MRB 1^3L[*&VFA:SQ)(]J-:JJFJ_&K"M*)PR/T_O)Z:<H:=X\(>5$41%EC9<S
MF=IK@[*(GC&YW<6*3V:R%TD%@PV;*+6K9/:=_P VZBQR=U1CH\;B&M<H U?#
M]5MX5YJJ=-9WZ428SD!687N7W"UDL5%8RU-M!=7T5D'DCKQ@SJV$<,=461TD
MB/C=%M\B[.G= 3*,ST?C <?V)?+2&MRB1[H/,<>TI+F>/AOSX]=M>B=@2?E)
M<2F7??QTT%C <<Y4-^UCTC8!$<+W'*C4\P]=U?LGM35I0OM_4DNWD]-LI!3$
M++%+,?'Q2_<YLB0B&+0#J^9B,VA3S#U>YW%-U5$UC/WN)N[YD_IZ,W#+.6OB
M#!Q]5'"?>X]91 A0M98\(6=F6=^[HF\>LGLR@BMK;!1<IR7&L%M"6!%+"['K
MK'\:+-,[S8EC<('+2/8^3?ML<[951=8IBM=C4;Q\:P>_=-]X5/I(!+O*K6S&
M!F#>X&7S-E4 !-E8Q=D9WNJIOKT4O[&JM1B68=F8UZI=>7!Y.VCBI@IVF=V%
MGE5,*$D="C]NXSJW=->O$C0#7Q6'IY1# 2((0L1Y#*3)8WCAR)'Q*G8^1J*R
M/DY%<GSIJ_HH;3U-N;?_ '? C_=F\Q*U$JJ\@26G2<:H(6@$4F816K%$WNR.
M?$BKXMM]7;,N+NLBL9L3KX\6RD@&(6M^[R%)-84<\=>%" +<#6FS_$]9)HO$
MB-^6$[RI/D4]*RQ%-[$OD_-KE8LJ"^9X=CS*Q)RX;\N/7;;7HS>'&9<2*)DE
MF6;B\]9N+CT$(F22J1&-%7LLH7RHS9O>>J.=-LGM;K#\WN<:8*+FQ]^+?D!+
M8E7.V83K=U#L@K7 L2I'IR XH>3G*D37;.X^S14)@I(DRY9F4J1%02CRK%-D
MEC)#*D<S6/6*:-R.:[V.:NZ:R,&&CMG5>0.]0,H/1*PY7.ML2.SN*CC1J#^)
M]DER*Z%/;-P:K.6K?,ZC&D)AP5,-%I)CO>(=XW[FCQV]TVBJO(.]Z#VQ5C-"
MJHY$D2/9O)4VUD>2Q5]E!7S8[5Y!4-+@*@KQKO*X^SD)(T<T;8HK4D6JA0A/
MSC>;N2=4UD E;?&XQ4G^FU766IT5$/916@I%O<Q%5<!9O"$,E()=U=&JR-1W
MLUZIP8W-?QXQ4B>GE988Z(#"XC,L8 Q84"S@K;2< B;WD('$Y/[/NCEY-5.6
MR:]4ZB;&,E/3.PQCL,4'&[<^&XKK'%1JD"CFFB%E\A/3OCX2QDJQ8VJOM^7)
ML7/R"PQRI3#?2RER2.&E%-3(U!QMT!@H-R9T&4"6%T;GP=S?GXM9:PN[]1*&
M%^?P3@U%)C%B?CMP"P2I'CE./;1')VB.RL,BI.W:-N_X=8Y:7$E^;A2>KU\1
M88O!6,A=3GLR(V3'\D=)& ^T.I/.[/G17<.*M<BJW5EZ9Y%59"TNYO,X&)B(
MQF\CK7"6%O;F,E]\OK_=D?,5W*-_<^GMMUVU6D'1'LN[@FP/NIK5LS;*<F,R
M:O%4CS+&SHV*M"A:Q'?U>ORZQOTQ-PRXL,JKLFN(CRR:4J.JJ8GV%N='G ]Z
M0!)6SKV2FK#VY$F>YRM14Z<L"]*F8UD(N7T&8TS[262BL8JJJ'I+^6S,R1EX
M\=M;,.8,U5C<R17R.EV^5-[H%E):^ZK<3,\T+C]VF\_?>/6N;T=5 C.QUF,@
MM1I6-^E(UK7-14ZZRUUA>>H]"A&8UI8]90XO8'T5R.VKIXUD--CHCFHV:2-8
M9.,S-F-_Z=>G%BAN4TX8@>9QE7>*4I-V>$\H>G8/"Z""MM&L88YJM\4?L1=M
MO;KTU(L'YUC0(7^]"**^HL:LB,B*$.N "*ZPN*Y:RUE"+OG.>Z1'QINC=V[-
MU5&TV4YI4"1^EH4#LF+I(Q+.WF'RVT9*'9Q6]5'% 2NW<XI''(K.+OHKU]:L
M5LL:R&TMLXLK4[%Y*^@L;,*\'OZ0:M"$]X"C3BC>YR6+W4F<SMIU;OKU!C'*
MN_)UE'Z85V3T5># Y^:U86' @Y%#46DX14OG1&1R-3R_)'=6JBNVUEQOOGU)
MQBI-FPDBF%QO%+4\&UKAL4JHFL/D]PV+XI!D:D#V\V.;XD7JFLA&!%)-)EEH
M%C&$'F)(D1F24\K^$$+'RN[<3%<[IT:BKK(R +7(\?&B]+0V>=IAH5@M2&VU
MTY:F6<P(J"1W%R.6./:7Q:QF6QL/4?$H_P#=)A8/F,4Q:RLI9S1R;-Q%?8(V
MBL_+2BM>CN"]MZ<NNL)JQ(+ V*URJC2620(A"H!2Z&ZC:?90=ED@/:EG8LO<
M:SMO79=EUEN06E#>I=97@K2BXVU%BI32 /4+'*L85(O++*I;:RD\PV+;GVEY
M[<>NFL!R'U4R!X.=818DFW6'V@MK2A0E'=\^B&^[H:FR#HWN.1(YN+FLW3KU
MS\*LL\XRPM%A1LF3X^=77#ED)K'H*$&ZHK9"AHVQ*_=D;ME<[KK(TAJK T8G
MTOQ,%5&"*GCFD3U1KYR1&OAC<CIV![O<U/$V/Q>SKKU"QQU58W N*TF&08ZO
MEYI/O)BM'F<V2#UD<RL[1AXM60H_:;NYSQT;MUU>Y'Y?(+'"A<6YK)-Z;EU%
MM4G2VE;"-C@QLHB6]ZK%DFGD:WZMO5=E1O+_ ..^S;<6C UIJP.WL]QRYD%"
ML#)0 %<X<>5'D&F0N9% W>>14Z-U+D#KY[:V"VAHI^5/>H?!;$1.F@#FJ/=G
MO:-\T3%5JK#Q=MT74%U)<F,KRK.:G'>[&\H2>:Q'%C-F@C!6F\\Y&#2H[GV^
MW\F^Z*FB<I -E?1AQ'3$F3UUF$^**M8^0QZA'!CGJD3&+[(_%_5WU:F!9'SA
MI:OWU8=ZHO1)HZKN,B\_",760$FC]R5J;PMDZN3Y]6?NJ_8Y:8!UK9-/ M*9
MXU8S?F>K+@$!SQ(]O$]O)K?E]J:LYJR]>0E152WAD:T]X.2M1#OW;$,0FMA*
MLQ6;=7#,E_\ G323D7K5@6CK\E=..!:&00T=J7$%7V!,H84\8L9!$S4VD5KT
M;NY41J*NC<=%-0BWK@ [,T>*$A\8P=@YZ!/D,2+R*2$]M7-C[G<5GBX\>NI<
M99>HZWB*,!6+W?:^5>?7Q.F, @L_(^ZR3X&-7>&.9TG+PHG+IJ.CI+DHJSD2
M54'DH,C!;&D(TA;_ #!!]2,*-_9HE<G<>WE\F^H,I6_<^A)/*K(SQZB\*:A@
M37/)CF@&K921V1L9R[DC&QJW94545- GNO2_+64QL *IC64NF)?7QAS%K&*V
ME4GM11GQ+W.'!W+HJ[+M0U 5N]UEDP!5I2"3UEN'(8$'(9$1+_; (&C.8\"7
MP2JQ[D9NB*FVA[;[POD +M#Z4:4>DR E\UE60PD&CL&'JI252& ACN?#MN1>
MBKJA%!MG*3D[+1]' 56VU?*>E*[A8\66 (RPN@7V-DX+(B;LY(F@YC;Z>.*P
M\R@DL=!DA,<SQ+(NHGB1XU1,ULS;$"6-&+LYW'=$5JHJP9D=8RCXZ2@JPFNK
M;597^>F; *GNY@3K-KY97(FRPHJ?+I^1NNYHJIEG'3)(12WXQ4]I+$R9@8=8
M15Q69TKHG\OJ87IMO\RZ@RAU_P J8BV]Q,FBJ[F<IMPD<LJUT]7#7R6@Q21P
MJ[C)"WIM\Z;S6&-V3;$88EX9.XY@1 Q3&M>Z$@.P'%,@=P>BIR8FZ>S45%49
M DUH0\J(:">LN:]A<H2O0F(0JQKQ0RI8NV[PQO<O3579$9 OE+@4PX%T%3>%
MRN!KRGA&&D#"ULQ((<)4;F=R=D;%5.BKJN6XOXHO>M>VW!\J'96G<J7\>%I)
M[K#,\M7OY])I.$:_(O1=6S([6.7W)1B9)9/BA*EABI#QR2A#XIXX'0EQSCB/
M<B0N>_9/9U3>NC.R%L7O.NK+8=Z5MO-!#77/%:PJQ(@KY(*AAB/16^:="NW5
M=M)C!UZV&X4D()\7D;.0. RR8D@(I=M$$^I#()8Y%:R69J[*GSZ)L3;ML0PF
M0%XM(C0;.<I]^ _MEUPH$ 4AQLD#O:Z&-\>W7EMJEM(;^!P.073<<JYG#'1J
M^\=S5*TJ*05DU:3X/82V).J?ZR;VP]<3YB:CLG5%HSLSQ>5L&##EN'Y311MF
MV'+C=RCY,Z[;[[Z3&@LABFM7ED 0M\G91@DG"_GPP[>4-E082S_4CG<JK[-]
M)CM5;$E6SB30TB]Q9#$-YFN[WG(_>,]5%6IVO+OZ]W953IONFCQKJTE&GJV5
MLA\<-3<GJ/';H:X"1WN^O*1S)DKY=U;OV^/CVW;O!:)?E*$48X :5N-Y0YY)
M3!6F.; .E*I$S$&<CN;6JS\.L<&'N)._ELI\./Q$5-T$\Z6L?VS&JAE=!Y3M
MOZ)WNWW/ZN^K&Q]_\Q:J^^[!:Q5EQ-,M[L]R5P@L5>\JQE5L3EW'9(SBU5WV
M35-[IMXRO?[;1:I/+F0.(?2K$EH,]A(\+A#1$F15@F1DJLW<C5:BJG_,+UP;
M:5US8P)9>FSYEH9EAN:NJ@J 9Q[NM^I(=(ZGLFD3\$8O+B[Y-]3%>^[:UHJ_
MU3P(BL]1X\1D!R,T:"ML_>)4PB5_F[J7&W(QD4LL+W/5>.VVS4P&Q'S;.+ >
MJS:Y0[+9L-.AO*A)L:<D4<%.N/1J0,JR(WGY:1/K7=>G3*%#N;S*7?=[+!?>
M5S3$5%J9/[O-<V'W=)7U\GU:2MC8K8O'M\JZ-RB\OBK^R;Z2B4%#204$58ZE
M -BJC)1)6CR3%V9T7EVQ<GM:OA7P[KTSVEN2[?)\E/\ 34&/"K9M>-7!F8Z-
M9@V=[CBBUHD4++WS8O%$=(Y\\2ILB?+B.4TU-=LI?3_$\M*RGS&/V=>L26-6
M*"!B<,18</O ]"X_S47<9TW1?;ME&'9?C:!KG=(/D0>S"YA6XX;%,(_$)29V
M\12<=\SX8=^>TKE^33C"VG.N+6VLVV!5IW//S#T9D^/TT3UF:V3RX]36Q=M/
M9XE5/;H$.@AR2(DKU(*FO_3V^H)+BCK!IR"G&YS09%+6QC5,;HW=^+M2J]72
MJW=6?2_]X&2L!.DL[TS"J*A[0T_UYEQC0=1WQY.'!6@J0Y[G_19PZZ]7,'LL
M=;506WIP1?T(=21-< *2%C[L;MF1F-#'Y65E*+ 0L/'GNY53=->B1L]MD6,0
M!X5<#E75%1$W1P4\U3CC(Q) XZVS[?FGL5J\HMTV]J:I,WQJ6^R0O&<!!+!M
MSJ4P"PLII,PL\=/9,#Y$62$CL6CGK'VFJL;.>W'KK&0Y2\@QT6A]3,U@FOJ:
MD*M30X_N30A(7 '& ?WX; Q'1\^T]NSG+\FZ8+88[<7MY;8_C&87%%D=Q4%4
MY).1TV049@8=D',#7,CB+AYB(BQM1\2\NNRZ]-GRUAHQ<GJU5V10+A"4G#CG
M]0+,N198GQ-FCAA;+])S43CUU&* I#"I,HQ%(IQ1_-3"K]X0/[6V'A(U_E?I
M^)./3KTUZ:9-DMI;YI4XW=Y,MY:I2Q/+K67U/&'5'/JJ(5>8M:1"_>1L:N;W
M?GV34^2X\RVHJW*/6O"YL=L9:27OP,J,3MJ\_*/=%D.U$#*-<FRSL:U^WBZZ
MS@7(_/S9JW*'NR2S*@9 )<Q^6CBI+.GC'%%%CK9JV)$1C>3F/1W)>J)KTOPH
M"MNOO%CGJ;-D=O+-16HH513!WV0V!$\EL4'$ [SH9;(VMCD=S5_%>O36%$$2
M9AAUXS#LB%!OZ^B*O:NY5^57$_W+O<?]W$\UE5S9HUF5D3FR]=]DT=>9OBY_
M_K?Z8X:/5U=9CIA07O&K!-'M,-8*"&3%5/+F)8Y()6LB8U=E]FVLS?98[;4S
M<X](J&MQNHK:4VQ@'MX*^X"?B[7U(;Q1B@9#XV;.2*-&)OTZ:&&@CRF@RZ+
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M"Q6INUBLK[DPG>3V)LQ4^?61Y% R.L@'O<Z:7;PY!:S65T.M[:UPM=-4K!$
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MX*^M"MRRR>Q8R#QPPUQ['JWN=]%WCX=WP:K!Y@2R0;"ILK+S@C&S.[PI=*$
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MD7O1E,5"1$^MR<J.8S'_ #)]>]SPQA!!AXIF,BF8D"*Q6;[:DM!S[*5B16T
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MRXJQ2>^B;Y:Z58W+,_@)Y?V1[+XOEUZ?EF7=!B:90_,$L,JL* VSJXBZ2[)
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M+]+9W#?V:1K)X7N7V-;*QSE^7HB+O[/]%F?_ /3I?_NCI_\ D76#?^Q^-?\
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MXI:Y!T# $N8\W2*\;TH-0"<-I&H-B O-F:W+$!K?\-U3B+OBJ21<KR5!<,*
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M*![>;,%4B8-!VC5:>6'U( $R*1N4"KJ;R% 8%Q9J@;PS/0,C/G (O#_;C 0
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M<8\KZ(A\-397_%H0/)%<*9HN=937V(D'_D"'<@B>DQ:P1#38M807;8J4KY@
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M=1C[GC<R(%J1O/9NL":0A6?3&4$"%;"J"L89:]G72.NG :1;V@5A<L/=>:B
M R6RHS-CY(\1'4*MJML)=4'8/TKZ<H5'R:W(U66Y9N4DXECRGZD[$%@=*D'P
M:JBM@TN<)[#E:&<RHG&WJ(>*)UYE9E.5R)=9_I9&4H+;!JM"F!HU6E"@E7Y,
MZB_507 "&L1MG#NY62",XP7D64')-MZ,O 6D$H84L8!2%0*QO8'#"]4)J+%
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MA*2$(>P8(<DO)*,/1&44JW:-:V_L@B<&EE)&<HF],"M18%HH*M491[K4 _\
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M$[3#K<!P!=F&06C2*QPGU;X0J9J8;1&3(,)AZ,-#^6CQY+G>K57H62#J@:Q
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M;FH?5A2X(P^4QG,_X-W1)06"??!1VL,3Y>>5-/4Y8<U3Y!PE;#1"J!"(YI)
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M7?3P>B-Y(XV) X9T+BE*.*KDI"^ :SMZ"#P&>3I1>U\<-BG)WW,(E=/<W51
M+")#PL;J4%51GL[DV0X(C*\,\GC:*<)R(6D_G9_DTP)5F!QMJ(8=+Z(LWZ"?
MW5T_C$,9TFP9T@DF#OT6@N=,8V(&3@;"&"G3H+F<Q,<_:B'ZE@+GY3=O BOJ
M"F';P<%"+9_O;T&5?C(B)5;1YPU=\ZKKB%!!F\&)A(NE6+[LL14F,L!0Y&,?
M4%"5C^ +/#HA+Z*!?F]@#5H\4M?R3N9/$HYU<GQ(7 "JP0SZ1KL)2GMD+,B<
MYOE26T/8DPDMHH%(+_%3.E,&#4)K6/!=-=)0<&#30FP-R*,R!*LT[B'"H@G-
MZ?N/#;:=%[VO,C9QL)I&Y<!DV9V8,SAMF>4AV#*$Q88(=M"EV0R8+3)>$TGP
M/2.QW]F"\\!'DX8"'4H'*)(?,Z>TYJ)WU'#&(WILL1;_ !P9T]3@P@_H"="(
MU[%\!;=V*EF@H]O/!K;NV 8\WC0U)(_-K7K-E*UIV.1R(![Z_&+=C=13)WRM
M1R=:;R@Q&5R%D KYX0*84C@ H';R2JB"G^"\2 0E)J(EF1N+F<X!0+(:#]F1
MZ]>O7KUZ]>O7KUZ]>O7KUZ]>O7KUZ]>O7KUZ]>O7KU_L.O7KUZ]>O7KUZ]>O
M7KUZ]>O7KUZ]>O7KUZ]>O7K7,8R!:% #+^@%"A8-'R\!FI6'<12JU$?J(01&
M& :CX4"@JM<] E+CC89&=;=#LMZP,H,(3A,QE*%Y8"DD@$0!-!:;;;CDJE&V
M)?(E#7<6N2ZQ[]\@[O+"IFIH%3?!#T@3,<M?1UGK/*\?X2"?W7*Y&R*^<6$7
M'"+I'8_LR=&C1HT:-&C1HT:-&C1HT:-&C1HT:-&C1HT:-&C1HT:-^PQHT:-&
MC1HT:-&C1HT:-&C1HT:-&C1HT:-&C1HT:O(29'4Q^0Q^0Q^0PZ(30LQK)\S_
M '3R#;.571#3D? IV(/I0S_FH:RO+5ROLJ,6J0,&,(%2ME3MC*J L'1:#F43
MLX0$);@L5@@FI=OO@,^"WA,)[2 >''")'>H#7ZFX4.DAJ8!O4L><N*DN1.6<
MC,TT^CF03/T1SIEA5J[&=1&-<%=]#,1%:K/"JZU-,8JFH +<#1[XHJJY H1O
M'WH?(,"E(B\!O"J\JI!&'<?BGA5MU0L-*5AK.],\$==2]>)M29K_ $N(/L<3
MIH@_Z .)Q<H2O&8N73(6J<M=DOE2FAR&S#$C+G8&73!R\+C(W*O G8?+MR$Y
MYUS&F_W$T$3"H:M8E4TZOT"(L9QAL%O2S^,*#'1DA1K)(GB7V+"R4@-^D1#"
M*F[,<LP8@U-%%!!4-@S12X=T562-0AH"@_%%:]-B\H4>A!*[LC8S64#EI_D8
MR?<,D@:M-KYBL2$58Y0E'.F6T%P<QP*]C6-4R$1K%A+'W6O)0A4RRN0TH)[8
M.*W0A;(LK9RP.]!.P %(%"[%T?J&RC2HNZ5:7JHSTN9DL-$5CA.]LZBCP4<Q
M/EQ^V3H8L&&VX40KZZT%C5(%3?Q0"XD&L9U;JW1$M1 ?OX\)K5=P%-16B9-C
MRKD694#-?;6]-*3"F[$W)>?:<1<+6UAIFJYELWHFE1!.^B,(C-EMBA)T>=DB
MU!1% !A9(Y\E[%O;1#6,%:S2\0* @M,4%V2SM&YA<VJ.*'5OF" CT:1@)U/M
M;(2QDY()Q0"Y'W!,]8AHHW&FY$*5PE,V:/*2':*&DQ4/Q\#5IM:E<7I]RUP!
M=U;!3)*ZSL,!6B$=B8$VFB"JZ/196A0QBKY"!9Q)K,IU:DG]2/$):NY[(H1L
MBA5!27'T#B][K9T=LZEV>\% JW5"_+VF;Y!^GL[U2/RE9V]G>RV/2;IS&-[#
M68?AE)CRUPOHW+:M R>"R*PNYP *]5"SJF)8%I2&5>L %5*LA<#&*Q9V.C !
MJPS6!K1D:92PA;-S1TR[G$+I6E(0';'\TIXF10C**_ (E,#=44.CC79-.Y-A
M1E?B[@8.J6Y"'*CMXVCVMJ<"AYQ,"'==(YJ22[ZLT/;W(9N!3)ZH[@Q^0&!R
MA4RW%KY!F.4*H#2[KM6BS 74NK5=2RX4/-I&95H)9G(K_P"*S8%C7V$:$_%F
MZ"HA?/7"S!075NZ(#T+T<0OHD&RKA7MH2%-#\ %FTJ?2KP:_AU*'-BC,LQ=\
M$+(WKH*SM1869@NV"%N.A/=!$T!3OFR=]F=*(1ECJUJGUXBX!:TE/(X(#0-2
M@/*PNYNYR[;MAD+R)FP3[54A:5<J8V*']J=]H"(FA1"P""<8X>H5BQR%[7/
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MHEYN<0KP6$Q+*HF*S+\+S<N62\W,3*7Z2S?/LRDY(I]D8EY?^-7BO_4?_]H
M# ,!  (1 Q$  !
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     0P@6RDTFRVFVVDDTDDF"VVVFDF6TD$FTVTTT$DR
M&DD6VVPV$   6 DSRXPF2MG+DR&FD@4&GQF"%>B3,YGAF6A6TEV6<W'N$]U7
M                 D  "                                 4?N2.&
M3=BM6_MX/OG3K(,!?2+&=*AE+N<YYHE?5I6.*R-R7?$C_@
M
M                      "       &VVVTVVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVVVVVVVVVVVD      "Z  0,"F<&2 "6R4(4
M             6CD63NTFF&8M#UJPVD                            $
M    "22R220"2222222022222222222222222222222222222 %P    '_\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P"0!0    #:323"8 #;;2:0(12*9:#
M                      &Y>:1%:B$&C_-R6J]B"<8
M             +99;!0+6;:80#89;9+!;#
M    !P @8 X))(WH;:/>$I(&T(,[(?\ P                        "&&
M'%3 R%W#T&R2H5AYXV@L4$R
M
M                                " "222B$ " 6"&4FB $T"0&B D0V
M@6R26F@02B"4000"20D     2WO3P7@".4S$B  0J@TVN&TR"R2&"0. 0$V<
M &2"2BPT, R@    "22P$@ 0&0" 22 $" 2R "422& 0D0 T4 $" 2 ""2R
M"2     @@2R60V:06E H4 @D"ER"T68,""PTS "62281$&RT!DB",R    2@
M6B$  2"   " "6VP   $622@ 4B2 " 0 0" """B$"D       &1@R"N [X&
M0CS0 $VF'IB4$)40V!&VE^@0#&4J)D@0ZU&ER    6202PP2F2"00@D2&D 4
M" $202220"022& 6            0    0  6"UBN"62P&DHTP&VBB@V7B@N
M%6&6%44                    0                  2 0
M
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M
M                                                           $
M2R24"6$2@6$&0 R2@4                                #70"6ZA[I&
M:RNL8#0Z/@                                0
M
M                         0"R060B$@P@ R"R&TD2@ @4D TF
M                "WO]"C.'0+90#):UE@^\T=2GR#P@L
M          00"     0  0
M                                                    4TP"D@&$
M B6T$P"P0                                 "G\_F)2J,M?8Z-?!3W
M0                                 00 " "0 0"00 00000
M
M
M
M                                                   !J:&<2_$
M                                           /D2R'VVP2
M                                  !@*^H27FF0DUB64
M             !WV5G@       4 FR"&@"2B6" 26VVDD@
M  '_ )E L!@! %@    @                                      I!
M,<(@%(    $                                      %HA,%A *0
M  @                                      AE)%-H      $
M                                EE( @        @A)))))))))))))
M)))))))))))))))))))))@)D$@@A        %I))))))))))))))))))))))
M))))))))))))-)-
M
M           NP    # LLEE8XN 0,%?\0\_/@MHLG).((8K'#$F(    $$
M  %?     $"$-%FLD,&2Y)H(@-LBD(-@M-DI%-@1@,!H    F@    OY
M
M
M
M
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M*S]&";?FM@!65F=?9@QE ;2O(!!A:8B$Y.VH&U^/"FT*CG>C4//,HF\D;,=
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MFEHG"-.T&&1O/?\ MEG6J50H2X+@/-<#.*.-PFIMH-H$Y5]D_1NA!G''5_\
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M;)0+[AL\HSIR,&>A=)#.\9)(-[5HM)A,M"<K)]*D$U0S/Z=CYU-0KC87=94
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M0;D,,,/8BLEW)Z(U<AW\,[VS_P#E1V:.Q%;E"1S 626V@6I:_%F+PJW-$J&
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M=P[1QRX%%JL$ ).[X'6U! ;5I@\U&6A&B)8!L(BLWN5\%  5#J9Z90BZUN$
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M#4:O.*BQ"$4EC0%MC.+P7' F8M, (M0%Q9$&FJ@K#+8FTU9UE&(7SMRD W4
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M\(01P88W#G.5@8'7=8/[2$@ FUIY>W39T>M5W!]2#N4%J3ENXA:+4J$<(@P
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MB0Z/S6(MO,-D)DWGIW<XZ$0<'5SG,L%8,P,PZ:XD907J9!Q08GDEOHF=3F1
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M,*!FK=XJNQ=@(R*R]\A84^T.1=,Q)N\)W83$7?.N^K(0S5]1)1D6-[FU#A-
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MQW?Q5D(->XXTD^K LU0[7H>>#*BB,R.'KN-O?J-8I%O,43RA9:,4B9TG4OB
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M&@EFW:"J+%T+Y3V$3TS>]P)IG35N,'9B\K)QJKYJ (<XN$R;/#.[7@V&\;
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M@<'E+!;U7#W@56V_ZEF2X4EF>WGF*9IPI++N\+OW[Q04=!-4NFR(;%<\]^D
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MS?I-#UOX8K_L:4ZNO^[P74S5,U<Q$:YB42W$L,&]935\3!?$2+=3-AF<7]3
MO!,U5Q%%]H-J"6FYFKF9JYB*IB1:8F2JR0;4I@VH(6:@C1TF2JR2DE1?$0+=
M03J9JYFSM.+M%&_X&/#O +XNV+@5>#77OYQ*XRF)J!,)@O/GUEA*K4CNDU]>
MOQBOLK_LW9K6_M"G+6?K%$#S7WF2,.93*H%E[87^T$"-4IZ4S%SW8G4Z/TA5
M@H7WYA04UC[I7%<(X7"J_J;726>Y$I2TOY@6%.E]LRCNLGS(+RJJWR393=$'
MLL^[4 )6JCM<L/SC-471GX3CYOVFZ:?S,+5%H?)BVV5KUSJ-"^[C^!WBOV2\
M5_JH8L,2JB1:8E)GK$MD5M,&&((UVECX2J@"P@+J#%UB4%\0%UQ*:OB7:-0%
M:-S-599EJLQ#<&T2B[-2FZYB3298ELW$MDMGM*LU.U*:OB6OJEL=X+2*-P;1
M*IKF6OJB#59F2JRS-59EJOB(;)DPS!.24U?$48>)07Q!:11OK$3<[41,O,Q7
M6)BNL1(MU^X41MS$4$U7]PWP<9B10Z_$Y%H:?'O#S50+RJJW]HX(;KZ)9;RS
MF^=0YQD @*:ZP1=M_)[L2D=S[S,NN#,87R?E"@OI7VJ(VKJ@BGC,*Q6L^M31
MQ68& W?]S!=Y,?2+2],>D]#'V@*C! E"8+SY]8/B"+:>4S\*A6@98?(_N%70
MD>*]8AH[7]9K\X@=EY/O'-T7D^D%9X"841V)\8"-+P_" F%RC\/S+4'>?I%-
M&E'UA@:!N66!S3\B(/,?B+;T51ZQ ZC'PLB9X//Y3<4.2#1:@666O0W[^>(9
M&+RQ2$U7W9\E]JB#6Z0XNL=8E-/^_3(""%AB4U?$MX9;<IWQ!-$&T:FL3)59
M8)HB)N8L,3!=8@M"78K4I&N8DTD$+#$T8WJ7%UB4%UB N"6Z:E)$BTQ.W!.I
MFJLRAJLLS568B88ALG-4&+#'\%!#H^7>4@Z/>Y8XY+[1]_QE OBGUB;&<%2M
ME6T2R@*;/O$*./>Y8@//X@C7)?M TN[GW?:)D^'VU#8XN5=T7K$I*Z;E4F*<
MX^&X%AZ.M5$4'I?S95EJ\?=E)[C4%H=$OEL^[7I "!JI1@+D'.[E@*TM^_S@
M4%*,\]ITQK.^OOJ!FJS;$-.JB.W&3R92IP%]960+W_[A[<1RF/Y,+4U&A V4
MPV#O*NMD^\HY+K/RC3)JAE+>B_+;"B\U3ZRFW6/F0.ERW\I2F_?,67@NI@S>
MKE<G)_&ERD8XPK$%&S<H*XNY:*NYHSK4S7+>_:%3.\_/Z04GSI;Y3UOXT7HQ
M3<0MA[U$K//Y3WNL!8RU  #JQ%5QC'E*7=?\Q!NO'SFI]_?RE"-1#J2RP[$I
M*_.4H2CXO]2BFO?4!4<_]E;@%ITE->^Y1JSWS*4]??WS,!T@'.8AM@!W_<T,
MG5^C4KWE'RQ](%Z\?.$YJG$HK6:^\2//NU*@^_-2M\TU]8#%W!37MTL.7E/=
M$]T,;</2>Z&>Z&5^)E?@9[H9[H9[H9[H9[H97XF>Z&4&]O)GNAGNAGNAGNAG
MNAGNAGNAGNAGNAGNAGNAGNAGNAGNAGNAGNAGNAGNAGNAGNAGNAGNB5U?*5U?
M*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?
M*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?*5U?
M*5U?*5U?*5U?*>Z)[HGNB!1&Q\+%]IOP%->-//C4J_T)-/R3W1,1['=_#/E/
MOX6=_!>VOQ-(I1(I4^3_ )$.I=LV@T>)N;?/P^D?3V.[^&?*??PM*\0+E9\%
MI6+FD1/$W+1*/.>X91PZ'L=W\,^4^_@Y1;CT13!J7F_!;+Q4N+?M]W\,^4^_
M@AZ2B'5"K^'VE%4^^I0?C]Y1S$H_PCG*93*93*93*93*93*93*93*93*93*9
M3*93*93*93*93*93*93*93*93*93*93*93*93*93*93*93*93*93*93*93*9
M3*93*93*93*93*93*93*93*9\I]_T7^E;_PN[.ZSNL[K.ZSNL[K.ZSNL[K.Z
MSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[
MK.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZS
MNL[K.ZSNL[K.ZSNL[K.ZSNL[K.ZSNL[K%;?[ITRCI*.DW>?LA:OHR@Z2(%[+
M/CJ9;WW0,R-G?_D"X\T#A=4K\(X66,%#2VP-@<C\H U.4])KTN4S\WPU*5?.
M7S\*&-_:55RRHB,IJK/6)0/4E/([^L %.R5M 6JQ N,U**,!C?%KOUEJB[)Z
MS?I<HO"Z0 ^=0&U+GB QL;.__("C2WW_ .0#1E:")VE$%)[^4ZZ8X"]7\KE"
MBUORCF>1@;2E3B-6UJ$"OCY^  OE &AJY3'*SYP1QJH3=VT2MFPJV4BET.IA
M99[]HHLF;A):+GB"UYOR(%%7NHBPI"]^Y"X(P!L6P.<*8KXQK@U,*CFN8.O,
M0/1<\<0+IQ'':X $^,$NA*F2EW7VOVFSS_KV>GQW^;[((!S2>O@E/*9K7%Y'
M*Q/T1"B]*8C!=7S"@-V/$I;JOYQ4%ZRM!S3*75:5WAH;JJ^=QZ+BJ_)@E<%R
MYIO"HAH-!+R.:.DPV.KOC^XTJN.E2[Z5=NE0M7R1:[7?I&Q%VE:3L1Q<A6X.
M"VY==ML$+.LM ;Q"ASJ!)NB_G!02V8*M*]JOM4%#*R=7-KZQ55O<0W:C4CN6
MKH@HJV)=4=8A>5LIDX3[5&%FB2MAG"O6*,B!KP#[2].;B&[OM 7;U7UA0"ZL
M8M[+W'8-\P52T;B>7R\ 4X%?*%#.[(67D;XA2KK+.AJXT(AF);&[:[3)2\/M
@4:X]DAHJ"4ZL8)35>R2K-SR9Y,6VW?\ &1"X/_J/_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
